(3518,2,'2015-06-21 13:18:17','2015-06-21 13:18:17','<strong>Heading towards Environmental and Public Health Concerns</strong> <p>Dear readers and respected members first of all I would heartly like to thanks you all for yours loving appreciations and supports for smoothly publication of each issue of Microbioz India Magazines, A monthly official publication of Microbioz Journals.</p> <p>I hope cover story of June 2015 Issue of Microbioz India no doubt will highly attracts huge number of readerships from all around the world ,The cover story of this issue is interconnection between climate change and public heath which entitled: &ldquo;Coping with Climate Change and Reducing Infectious Disease Risks: Heading towards Environmental and Public Health Concerns&rdquo;The cover story of Magazine is covered by Microbioz India team member Rodel Estadillo Alo, Biology Department, College of Natural Science and Mathematics, Mindanao State University, General Santos City, Philippines.</p> <p>Dealing with such significant issue unties us into reality that people are undeniably contributors leading environmental anomalies. Evident paradigm on this is recently the threat brought by the climate alterations caused by human activities, and thus its effects are greatly extended to mankind premises; terrestrial, aquatic and wildlife habitats.</p> <h3>An Interview with Pf.Neil Woodford</h3> <p>As we introduce our readers each month with Scientists/Academicians this month Microbioz India team performs an Interview with one of eminent Scientist and famous Microbiologist from England, named <strong>Pf.Neil Woodford,Head, Antimicrobial Resistance and Healthcare Associated Infections Reference Unit (AMRHAI), Public Health England.</strong></p> <strong>Research News Information(Inside)</strong> <p>Microbioz India June 2015 issue of magazine also has huge collection of different research news information collected from worldwide sources. Along with research news magazine also has collection of few business news updates from all around the world. For better support to young students here is also a collection of recent scholarships updates for pursuing higher education from different reputed university of the world.</p>','Coping with Climate Change and Reducing Infectious Disease Risks','','publish','closed','closed','','coping-with-climate-change-and-reducing-infectious-disease-risks','','','2019-11-23 07:16:11','2019-11-23 07:16:11','',0,'https://microbiozindia.com/magazines/coping-with-climate-change-and-reducing-infectious-disease-risks/',51,'magazines','',0),(3519,2,'2015-07-21 13:18:17','2015-07-21 13:18:17','<p>Dear readers/friends I hope you all are doing well, I would like to say thanks to all of your for giving me great support  loving appreciations which helped me to putting out our great effort in each issue of Microbioz India and I hope will do the same in coming future too.</p> <h3>Special Report</h3> <p>Apart from cover story this month we got great chance to introduce you all with Professor Piero Cappuccinelli: the man for cooperation with developing countries, Pf.Cappuccinelli is one of eminent scientist, you can find a detailed report of his speech at On June 8th, 2015 an International Symposium entitled &ldquo;From Basic Research to International Cooperation&rdquo; was held at Sassari University, Italy, all credits and giving me a great chance to publish this short coverage with July 2015 edition of Microbioz India magazines goes to: Prof. Salvatore Rubino, Department of Biomedical Sciences, University of Sassari, Sassari, Italy.</p> <h3>An Interview with Dr.K.P.Ranjan</h3> <p>Dear friends as we did in our earlier issues that introducing our readers with Scentists/Academicians for his experience with our readers each month, This moth we perform a short interview with Dr.K.P.Ranjan,Department of Microbiology,Gajra Raja Medical College Gwalior,M.P,India,.Dr.Ranjan has deep interest in Medical Microbiologist and have scientific research publications in premier  Journals.Dr.Ranjan shares his person experiences with us, Our team prays god for his best academic future a head.</p>','Top 10 ideas of making healthy and disease free life','','publish','closed','closed','','top-10-ideas-of-making-healthy-and-disease-free-life','','','2019-11-23 07:16:27','2019-11-23 07:16:27','',0,'https://microbiozindia.com/magazines/top-10-ideas-of-making-healthy-and-disease-free-life/',52,'magazines','',0),(3520,2,'2015-08-21 13:18:17','2015-08-21 13:18:17','<p>Dear friends/Readers/Supporters we are happy to launching this special issue of Microbioz India Magazines on August 2015 edition.This issue of Magazine is dedicated to our former president Dr.A.P.J.Abdul Kalam died on July 27th 2015 at Indian Institute Management-Shillong (IIM-SHILLONG) while delivering a lecture.</p> <p>The cover Story of Magazine is &ldquo;Journey&rdquo;&hellip;&hellip;From Book Seller Boy to president of India!!! As title indicate  we tried to provide a short report focusing his life from start of his career ,the time when he collect money for his in his early age by sailing  news papers in his early age. His life is no doubt is an inspiration to all of us because he doesn&rsquo;t have luxurious life to live and enough financial parental support for better living. His father\'s name was Jainulabdeen, a boat owner, and his mother Ashiamma, a housewife. No doubt Kalam was born in Muslim but love to Hindu religion and more as he read &ldquo;Bhagwati Gita&rdquo; is one of holy Hinduism epic. Kalam was the youngest of four brothers and one sister in his family. Dr. Kalam elected as a 11th President of India and he is one first India&rsquo;s bachelor president most favourate and proved as a youth icon.</p> <h3>Errors in Clinical Laboratory.........The Dark Side of the Moon</h3> <p>Apart from cover story magazine has a featured article on &ldquo;Errors in Clinical Laboratory: The Dark Side of Moon&rdquo; submitted by Dr.Moslim Dhaher Musa.</p> <h3>An Interview with Dr.Duro Damisa,Federal University of Technology,MInna,Nigeria</h3> <p>As we perform in each month like introducing our readers with scientists, academic staff. This month we introduce our readers with Dr.Duro Damisa, Associate Professor, Federal University of Technology, and Minna Nigeria.</p> <h3>Open Scholarship Positions</h3> <p>Collect number of Research news information and admission and scholarship updates collected from different sources around the globe for pursuing higher education in number reputed Universities and laboratory. And finally how we can forget to announce the list of students solve Microbioz India Cross word of July edition.</p>','Journey News Paper Seller Boy to President of India','','publish','closed','closed','','journey-news-paper-seller-boy-to-president-of-india','','','2019-11-23 07:16:45','2019-11-23 07:16:45','',0,'https://microbiozindia.com/magazines/journey-news-paper-seller-boy-to-president-of-india/',53,'magazines','',0),(3521,2,'2015-09-21 13:18:17','2015-09-21 13:18:17','<p>Dear friends, I hope each and everyone of you is doing great out there. I would like to thank you all for the great support that enabled  us to keep launching our magazine every month. As we know, our earth is our only home yet we forgot to save it. Day by day, we keep hearing frightening news like the melting of glaciers, rise in the sea level, shrinking of lakes and other issues that actually putting our planet in a big danger. Therefore, as an early step in saving our planet earth, Microbioz India is planned to spread awareness among the readers via our magazine\'s special edition of September 2015 issue. In conjunction with the international ozone day, we are planning to launch our September issue with the cover story of &ldquo;Ozone or NO zone? Is all in your hands&rdquo;!! This interesting cover story was written by Sivashankari Ramamoorthi, one of our influential team member and also the author of Microbioz India. She had presented her full efforts in this write up mainly to urge our society to preserve our precious ozone layer. Enjoy reading them and start doing something to preserve our one and only protective ozone layer !</p>','Ozone Or No Zone Is Now All In Your Hands','','publish','closed','closed','','ozone-or-no-zone-is-now-all-in-your-hands','','','2019-11-23 07:16:59','2019-11-23 07:16:59','',0,'https://microbiozindia.com/magazines/ozone-or-no-zone-is-now-all-in-your-hands/',54,'magazines','',0),(3522,2,'2015-10-21 13:18:17','2015-10-21 13:18:17','<p><span style=\"font-size: large;\">D</span>ear friends, I hope each and every one of you is doing great out there. I would like to thank you all for the great support that enabled us to keep launching our magazine every month. The theme of this month&rsquo;s cover issue is &ldquo;Geo engineers of planet earth &ndash; Microbes&rdquo;, which mainly focuses on the vital roles of microbes in reshaping our planet earth to be an ideal home for living organisms.This interesting cover story was written by Sivashankari Ramamoorthi, one of our influential team member and also the author of Microbioz India. She had presented her full efforts in this write up. Enjoy reading it and best wishes from my side.</p> <p>Apart from the interesting cover story and featured articles, this magazine also serves as a big news storage for recent research news in the field of Microbiology and Medical sciences. In order to make this magazine even more interesting especially for young researchers and academicians, we also provide information on the admissions and scholarship updates to pursue higher studies from reputed Universities and Institutions.</p>','Geoengineers Of The Earth Microbes','','publish','closed','closed','','geoengineers-of-the-earth-microbes','','','2019-11-23 07:17:16','2019-11-23 07:17:16','',0,'https://microbiozindia.com/magazines/geoengineers-of-the-earth-microbes/',55,'magazines','',0),(3523,2,'2015-11-21 13:18:27','2015-11-21 13:18:27','<p><span style=\"font-size: large;\">D</span>ear friends Microbioz India going to launch November 2015 issue of magazine featured with &ldquo;Top 10 most influential Microbiologist of 21st Century&rdquo; as a cover story.</p> <p>Friends,I was stuck while deciding names of scientists because Microbiology is one of vast area of applied Biological sciences and no doubt there are huge support of scientist for making this area more valuable among our society. After discussion with number of bloggers and research scholars we decided to launch this cover story. Dear friends the credit of this opinion and cover story goes to Dr.Tim Sandle, Ph.D, Scientist in Bio-product Laboratory, U.K.We would like to say thanks to Mr.Sharad Kamble, Ph.D student at University of Bradford, England for making this title.</p> <p>Apart from cover story magazine has featured article which include cope up with common microbial infections in winter season in winter season. Dear friends we all are very exciting to announce a group celebration of &ldquo;World Diabetes Day&rdquo; on 14th of November 2015 and find an exclusive article over diabetic management inside this issue of magazine.</p>','Top 10 most influential Microbiologist of 21st Century','','publish','closed','closed','','top-10-most-influential-microbiologist-of-21st-century','','','2019-11-23 07:17:28','2019-11-23 07:17:28','',0,'https://microbiozindia.com/magazines/top-10-most-influential-microbiologist-of-21st-century/',56,'magazines','',0),(3524,2,'2015-12-21 13:18:27','2015-12-21 13:18:27','<p>Dear friends,readers,supporters I hope you all are doing great, first of all I would like to say thanks for successful completion of this year of Microbioz India and by the end of this year Microbioz team going to complete its three successful year.We are going to launch our annual edition with Cover story entitled by: Boost your brain power with microbes .The cover story explains how does healthier microbes helps in boosting our brain strength.</p> <p>Apart from cover story magazine also has rich research news information collected from worldwide sources the research may help our audience for stay updated with current research news information happening across the globe. Apart from research news information magazine focus in few aspects of biotech and Pharma business news updates. Find annual updates on scientists speak in favour of Microbioz India.</p> <p>Dear friends Microbioz India magazine from since last one year dedicated to build huge academic audiences and as we know our team members ,authors always tried to win heart of each audience for expel out quality cover story and maintain magazine contents in each edition and we ensure you all for doing same in near future. Collect lot of open scholarship position for pursuing higher education in the field of Microbiology, Biotechnology and Medical Sciences from reputed Universities of across the globe.</p>','Boost Your Brain Power With Food Microbes','','publish','closed','closed','','boost-your-brain-power-with-food-microbes','','','2019-11-23 07:17:45','2019-11-23 07:17:45','',0,'https://microbiozindia.com/magazines/boost-your-brain-power-with-food-microbes/',57,'magazines','',0),(3525,2,'2016-01-21 13:18:27','2016-01-21 13:18:27','<p>Dear friends first of all I would like to wish you all a great Happy New Year. May god fulfil your wishes and gear your life with lot of happiness and success. I would also like a positive strength and more as support of our team members, supporters who all inspired me for continuous launching of Microbioz India. Dear friend on this special edition we are going to introduce January 2016 edition of Microbioz India cover story entitled: &ldquo;Harnessing Microbial Strength/Potential to cure Malnutrition worldwide.&rdquo;An Invisible solution to the highly visible problem!&rdquo; authored by: Deshdeep Hira, student of Biochemical Engineering, Harcourt Butlar Technological University, Kanpur, India.</p> <p>Apart from cover story, magazine has a very special article written by Dr.Venkatesh Devanur, CEO &amp; MD, Agrilife, and the article, no doubt ,will motivate you guys for looking career options in the Agribiotech industry. This featured issue of magazine is devoted for motivating and sharing thoughts for performing organic farming because we all know, organic farming is the only way to make our globe clean and green. Dear friends, Microbioz India magazine from last one year is dedicated to build huge academic audiences and our team members and authors have always tried to win the hearts of &nbsp;our audience by expelling out quality cover stories and maintaining magazine contents in each edition and we ensure you all for doing the same in near future.</p>','Harnessing Microbial Strength Potential to cure Malnutrition worldwide An Invisible solution to the highly visible problem','','publish','closed','closed','','harnessing-microbial-strength-potential-to-cure-malnutrition-worldwide-an-invisible-solution-to-the-highly-visible-problem','','','2019-11-23 07:11:20','2019-11-23 07:11:20','',0,'https://microbiozindia.com/magazines/harnessing-microbial-strength-potential-to-cure-malnutrition-worldwide-an-invisible-solution-to-the-highly-visible-problem/',34,'magazines','',0),(3526,2,'2016-02-21 13:18:27','2016-02-21 13:18:27','<p>Dear friends  welcome you all in February 2016 edition of Microbioz India magazine, featured with most interesting cover story and valuable articles and globally picked  research news information. Dear friends cover story of this month entitled &ldquo;New estimate of microbial numbers in our bodies&rdquo; authored by one of famous Microbiologist, writer Dr.Tim Sandle, Ph.D, from Bioproduct Laboratory, U.K. Cover story make you clear number mysterious concept over Human Microbiota and some of featured Micro-organism.</p> <p>Dear friends start of year 2016 continuous with one of most contagious viral infection, outbreak named &ldquo;ZIKA&rdquo; virus transmitted through bite of infected Aedes mosquito  number of Health Society and organization launch several notification of prevention and control of this outbreak.</p> <p>Dear friends Microbioz India magazine from since last one year dedicated to build huge academic audiences and as we know our team members ,authors always tried to win heart of each audience for expel out quality cover story and maintain magazine contents in each edition and we ensure you all for doing same in near future. Collect lot of open scholarship position for pursuing higher education in the field of Microbiology, Biotechnology and Medical Sciences from reputed Universities of across the globe.</p>','New Estimate Of Microbial Numbers In Our Bodies','','publish','closed','closed','','new-estimate-of-microbial-numbers-in-our-bodies','','','2019-11-23 07:11:45','2019-11-23 07:11:45','',0,'https://microbiozindia.com/magazines/new-estimate-of-microbial-numbers-in-our-bodies/',35,'magazines','',0),(3527,2,'2016-03-21 13:18:27','2016-03-21 13:18:27','<p>Dear friends first of all I would like to say you all deeply thanks for being here either as a our readers or supporter or our audience and how we can forget your great support for continuous launching of Microbioz India magazine. Dear friends Microbioz India going to launch anniversary edition of magazine featured with most interesting cover story for our audience entitled : &ldquo;Top 10 most dangerous bacterial toxins: The Bacterial threat to keep us away from the globe&rdquo; written and covered by Microbioz India editorial office. I hope the list of bacterial toxin in this cover story will boost the knowledge and awareness about serious deadly bacterial infections.</p> <p>Dear friends Microbioz India magazine from since last one year dedicated to build huge academic audiences and as we know our team members ,authors always tried to win heart of each audience for expel out quality cover story and maintain magazine contents in each edition and we ensure you all for doing same in near future. Collect lot of open scholarship position for pursuing higher education in the field of Microbiology, Biotechnology and Medical Sciences from reputed Universities of across the globe.</p> <p>In last phase of this magazine how we can forget to announce the names of winners of our February 2016 edition of crossword, Dear friends we request you to all for earlier submission of your answers and other feedback about magazine editions.</p>','Top 10 Most Dangerous Bacterial Toxins: The Bacterial Threat To Keep Us Away From The Globe','','publish','closed','closed','','top-10-most-dangerous-bacterial-toxins-the-bacterial-threat-to-keep-us-away-from-the-globe','','','2019-11-23 07:12:02','2019-11-23 07:12:02','',0,'https://microbiozindia.com/magazines/top-10-most-dangerous-bacterial-toxins-the-bacterial-threat-to-keep-us-away-from-the-globe/',36,'magazines','',0),(3528,2,'2016-04-21 13:18:27','2016-04-21 13:18:27','<p>Dear friends first of all I would like to say you all deeply thanks for being here either as a our readers or supporter or our audience and how we can forget your great support for continuous launching of Microbioz India magazine. Dear friends Microbioz India going to launch anniversary edition of magazine featured with most interesting cover story for our audience entitled: &ldquo;10 interesting facts of Zika&rdquo; written and covered by Microbioz India editorial office. The cover story of this month will boost awareness and more as suggest few interesting on Zika virus updates and disease transmission. Dear friends apart from cover story magazine have an interesting featured article named 5 Bacterial mysteries uncovered: 2016 one of interesting uncovered over few bacterial mystery.</p> <p>Dear friends Microbioz India magazine from since last one year dedicated to build huge academic audiences and as we know our team members ,authors always tried to win heart of each audience for expel out quality cover story and maintain magazine contents in each edition and we ensure you all for doing same in near future. Collect lot of open scholarship position for pursuing higher education in the field of Microbiology, Biotechnology and Medical Sciences from reputed Universities of across the globe.</p>','10 Interesting Facts Of Zika','','publish','closed','closed','','10-interesting-facts-of-zika','','','2019-11-23 07:12:13','2019-11-23 07:12:13','',0,'https://microbiozindia.com/magazines/10-interesting-facts-of-zika/',37,'magazines','',0),(3529,2,'2016-05-21 13:18:27','2016-05-21 13:18:27','<p>Dear readers would like to say thanks for your great appreciation for Microbioz India magazines which forces we all day to day to increase quality of articles as well as cover story publish in magazine. As per magazine edition Microbioz this issue has one of interesting topic featured with &ldquo;Oral Bacteria Vs Deadly infection&rdquo; which says you certain basics and mysterious facts of microbial flora residing in your oral cavity and responsible for number deadly infection in our oral place as well as other body parts. As we all knows microbioz magazine each month introduce our self with few interesting news and information on Research and Development collected from worldwide sources, inside this issue find what happen this month in research and development and news story from inside world class laboratory.</p> <p>Dear readers to make this magazine more interesting we introduce one of most important section entitled: Scholarship updates which helps our young readers to grab amazing open scholarship position for pursuing higher education in the field of Microbiology, Biotechnology and Medical Sciences from reputed Universities of across the globe.</p>','Oral Bacteria Vs Deadly Infections','','publish','closed','closed','','oral-bacteria-vs-deadly-infections','','','2019-11-23 07:12:26','2019-11-23 07:12:26','',0,'https://microbiozindia.com/magazines/oral-bacteria-vs-deadly-infections/',38,'magazines','',0),(3530,2,'2016-06-21 13:18:27','2016-06-21 13:18:27','<p>Dear friends I hope you all are doing great there, we would like to say thanks to all of you for continuous support to Microbioz India magazines and make it India&rsquo;s most popular magazine of Laboratory, Microbiology and Health Sciences with love and hand support of +90,000 readers across the country.Dear friends here we are presenting one of most interesting issue of Microbioz India authored by Dr. Saif Hameed, Amity Institute of Biotechnology, Amity University Haryana, Gurgaon (Manesar)-entitled &ldquo;Hospital Acquired Infections: A concern for neonates&rdquo;</p> <p>As title indicates cover story indicates few neonatal infections associated with Hospital Borne. A neonate is also called a &lsquo;newborn&rsquo;. This period includes first 4 weeks of a newborn child\'s life. During this time changes are very quick and many critical events can happen. During this period the birth defects (congenital defects) are discovered and genetic abnormalities may appear. This is the most prominent period prone to severe infections from the surrounding environment. .Nosocomial infections or hospital acquired infections could be a major cause for infecting infants. Apart from cover story magazine has one of most interesting featured article discussing ten beneficial health effect of daily yoga practice.</p>','Hospital Acquired Infections: A Concern to Neonates','','publish','closed','closed','','hospital-acquired-infections-a-concern-to-neonates','','','2019-11-23 07:12:41','2019-11-23 07:12:41','',0,'https://microbiozindia.com/magazines/hospital-acquired-infections-a-concern-to-neonates/',39,'magazines','',0),(3531,2,'2016-07-21 13:18:27','2016-07-21 13:18:27','<p>Dear Friends, I hope you are doing great out there, Thanks lot for your kind response and appreciation on the Microbioz June 2016 issue of the magazine based on Hospital Acquired Infections. Dear friend&rsquo;s magazine latest issue is one of health special issue featuring &ldquo;Top 10 natural Probiotics&rdquo; products boosting your health and maintaining your body defense mechanism. Apart from the cover story magazine has one of most interesting featured article discussing ten beneficial health effect of daily yoga practice. As we all knows microbioz magazine each month introduce our self with few interesting news and information on Research and Development collected from worldwide sources, in this issue find what happen this month in research and development and news story from an inside world class laboratory.</p> <p>Dear readers, to make this magazine more interesting we introduce one of most important section entitled: Scholarship updates which help our young readers to grab an amazing open scholarship position for pursuing higher education in the field of Microbiology, Biotechnology and Medical Sciences from reputed Universities of across the globe. In last phase of this magazine how we can forget to announce the names of winners of our June, 2016 edition of crossword.</p>','Top 10 Natural Probiotics Boosting Body Defense','','publish','closed','closed','','top-10-natural-probiotics-boosting-body-defense','','','2019-11-23 07:12:53','2019-11-23 07:12:53','',0,'https://microbiozindia.com/magazines/top-10-natural-probiotics-boosting-body-defense/',40,'magazines','',0),(3532,2,'2016-08-21 13:18:27','2016-08-21 13:18:27','<p>Dear reader&rsquo;s greetings and welcomes you   all in our new issue of the magazine featured with one of most   interesting cover story and research news information collected from   worldwide sources. Dear friends, it was very appreciated feedback and   response and more as day to day increase in subscriber list of Microbioz   magazine enable us to expel out our whole effort in making Microbioz   magazine one of most informative magazine in the country. The cover   story of this month entitled: &ldquo;Understanding Food Hygiene: and how it   can help prevent diseases&rdquo; written by Ms. Gurdeesh Kaur Sethi. The cover   story tries to cover few important tricks and step you should use in   your daily life.</p> <p>Dear readers, to make this magazine more   interesting we introduce one of the most important section entitled:   Scholarship updates which enable young readers to grab an amazing open   scholarship position for pursuing higher education in the field of   Microbiology, Biotechnology and Medical Sciences from reputed   Universities of across the globe. In last phase of this magazine how we   can forget to announce the names of winners of our July, 2016 edition of   crossword.</p>','Understanding Food Hygiene: and how it can help prevent diseases','','publish','closed','closed','','understanding-food-hygiene-and-how-it-can-help-prevent-diseases','','','2019-11-23 07:13:12','2019-11-23 07:13:12','',0,'https://microbiozindia.com/magazines/understanding-food-hygiene-and-how-it-can-help-prevent-diseases/',41,'magazines','',0),(3533,2,'2016-09-21 13:18:27','2016-09-21 13:18:27','<p>Dear friends, readers and supporters, I   am feeling both happy and excited to present before you the September   issue of one of your favorite magazine. The journey of the Microbioz   India has been extremely wonderful so far and I am really thankful to   you for extending your love and support to Microbioz India with every   coming month.</p> <p>Friends, before starting my career in   the magazine, acting as an Editor, I was a bit confused about why should   audience place Microbioz India under their readership category when   there are already a number of media companies/newsstands providing a lot   of information and updates on Laboratory/Microbiology and Health   Sciences.</p> <p>The cover story of this month&rsquo;s magazine is featured with <strong>&ldquo;LAB SAFETY: LIFE IS PRECIOUS</strong>&rdquo;   authored by one of most stunning author Ms. Bhawana Jain,   M.Tech-Biotechnology, Amity University, Noida. The cover story will be   useful for the people working as Laboratory Technicians, Researchers who   work in laboratories every day and for those preparing for the job in   any Laboratory.</p>','Lab Safety:Life is precious','','publish','closed','closed','','lab-safetylife-is-precious','','','2019-11-23 07:13:31','2019-11-23 07:13:31','',0,'https://microbiozindia.com/magazines/lab-safetylife-is-precious/',42,'magazines','',0),(3534,2,'2016-10-21 13:18:27','2016-10-21 13:18:27','<p class=\"MsoNormal\">The October issue&rsquo;s cover story titled<strong> &ldquo; The Era of Medical Testing: A Blessing for People&rdquo;</strong>, authored by Bhawana Jain, M.Tech, Biotech, Amity University, Noida, clearly highlights the importance of various diagnostic and screening tests that have revolutionized the Healthcare Industry. Also, the emphasis is laid on the benefits of early diagnosis and the vital role it plays in preventing people from various diseases and prolonging their lives.<br /> As we close this edition, we want to congratulate the winners of Sep&rsquo;16 issue&rsquo;s CROSSWORD GAME and request you for earlier submission of the answers. We appreciate the immense support received from our valuable readers. Also, we would like to make you know that, we are always open to any suggestions and feedbacks and the same can be penned down at editor@microbiozindia.com.</p> <p class=\"MsoNormal\"><o_p>&nbsp;</o_p></p>','The Era of Medical Testing: A Blessing for People','','publish','closed','closed','','the-era-of-medical-testing-a-blessing-for-people','','','2019-11-23 07:13:42','2019-11-23 07:13:42','',0,'https://microbiozindia.com/magazines/the-era-of-medical-testing-a-blessing-for-people/',43,'magazines','',0),(3535,2,'2016-11-21 13:18:27','2016-11-21 13:18:27','<p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"font-family: Tahoma;\"><span lang=\"EN-IN\"><span style=\"font-family: Tahoma;\">The cover story titled, <strong>&ldquo;Digital Clinical Laboratories: A Fate to Behold&rdquo; </strong>talks about the role technological innovation and revolution has played in making breakthrough advances in medical sciences and its contribution to the improved quality in healthcare services.<br /> The article also emphasizes how digital laboratories can benefit areas like overall wellbeing, women&rsquo;s health, chronic diseases, etc.by developing new tests and technologies which can help ease the tension in medicals.Microbioz India also got an opportunity to have an interview with Dr. Mustapha Abubakar Jamda, Associate Professor and Head of Department of Community Medicine, College of Health Science, University of Abuja, Nigeria.&nbsp;<br /> </span></span></span></p> <p class=\"MsoNormal\" style=\"text-align: justify;\"><span style=\"font-family: Tahoma;\"><span lang=\"EN-IN\">The main message he gives through this interview is to work hard and spread happiness and never allow hatred to harbour in your heart for your colleagues and competitors. We wholeheartedly thank him for giving his precious time for the interview.</span></span></p>','Digital Clinical Laboratories: A Fate to Behold','','publish','closed','closed','','digital-clinical-laboratories-a-fate-to-behold','','','2019-11-23 07:14:00','2019-11-23 07:14:00','',0,'https://microbiozindia.com/magazines/digital-clinical-laboratories-a-fate-to-behold/',44,'magazines','',0),(3536,2,'2016-12-21 13:18:27','2016-12-21 13:18:27','<p>Dear friends and readers, with extreme pleasure I present before you the last issue of this amazing year. It was a great year for MICROBIOZ INDIA full of challenges and achievements and we wholeheartedly thank our readers for their love and support all throughout the year and we wish for the same for the upcoming year in the journey of MICROBIOZ INDIA.</p> <p>As we have always been doing, the December issue is out to bring for you the 50 topmost research news of the year based on their popularity by the team of Microbioz India.</p> <p>These news and stories have been picked from various sources like science daily, microbes post, biology news, etc and reframed in short for you by our editorial staff with an intent to highlight all the major discoveries and researches in a small windows.</p>','50 Top most stories of the year 2016','','publish','closed','closed','','50-top-most-stories-of-the-year-2016','','','2019-11-23 07:14:12','2019-11-23 07:14:12','',0,'https://microbiozindia.com/magazines/50-top-most-stories-of-the-year-2016/',45,'magazines','',0),(3537,2,'2017-01-21 13:18:27','2017-01-21 13:18:27','<p>Our Mother Earth is currently facing lots of Environmental concerns like waste disposal, water pollution, air pollution, etc. which is affecting everyone on the planet. Over the past decade, the exploitation of our planet and degradation of our environment has gone up at an alarming rate. Thus, there is an extreme need to check the above problems before we get overburdened with them.</p> <p>This month&rsquo;s cover story addresses the above concerns with respect to the applications of Environment Biotech Laboratory in meeting the demand for cleaner water, air and soil.</p> <p>The cover story titled &lsquo;From Environmental Biotech Laboratory to Bioremediation&rsquo; is written by Mr.Siddhesh U. Sapre, who is currently pursuing his Masters&rsquo; Degree in Virology at the National Institute of Virology, Pune, India.</p>','From Environmental Biotech Laboratory to Bioremediation','','publish','closed','closed','','from-environmental-biotech-laboratory-to-bioremediation','','','2019-11-23 06:47:57','2019-11-23 06:47:57','',0,'https://microbiozindia.com/magazines/from-environmental-biotech-laboratory-to-bioremediation/',22,'magazines','',0),(3538,2,'2017-02-21 13:18:27','2017-02-21 13:18:27','<p>Dear friends and readers, a heartfelt thanks to you all for showering your love and blessing for Microbioz India and making this journey amazingly beautiful so far.</p> <p>It is my great pleasure that I am again ready to present before you yet another issue of Microbioz India. It is a &ldquo;Health Special Issue&rdquo; so as to bring forth the importance of Prebiotics &amp; Probiotics in our lives.</p> <p>The cover story which is titled &lsquo;Prebiotics and Probiotics- the avengers of Colon-Neuro-Microbiome&rsquo; is authored by Mr. Sudershan Mishra who is currently pursuing his Masters&rsquo; degree at GBPUA&amp;T Pantnagar, Uttarakhand. The article focusses on how food supplements when taken under suitable recommendations at consistent doses can actually act as putative medicines in maintaining gut homeostasis.</p>','Prebiotics and Probiotics the avengers of Colon Neuro Microbiome','','publish','closed','closed','','prebiotics-and-probiotics-the-avengers-of-colon-neuro-microbiome','','','2019-11-23 06:48:17','2019-11-23 06:48:17','',0,'https://microbiozindia.com/magazines/prebiotics-and-probiotics-the-avengers-of-colon-neuro-microbiome/',23,'magazines','',0),(3539,2,'2017-03-21 13:18:27','2017-03-21 13:18:27','<p>Dear friends and readers, with a great sense of excitement, I inform you that your favourite magazine Microbioz India has completed three years of beautiful journey which became possible all because of your extreme love, support and encouragement all through these years.</p> <p>So, with gratitude in heart for all the support and your presence, I hereby present yet another issue of Microbioz India.</p> <p>It is a &ldquo;Pharma Special Issue&rdquo; which is supported by the cover story titled &lsquo;Risk assessment and pharmaceutical processing hazards&rsquo; authored by Dr. Tim Sandle.</p> <p>The article focusses on some of the main hazards to pharmaceutical manufacturing and provides a basis for assessing risks. Because, even though the pharmaceutical medicines are considered to be efficacious and safe for consumption as they are licenced and directed by practitioner, still there is always a chance of expected manufacturing problems.</p>','Risk assessment and pharmaceutical processing hazards','','publish','closed','closed','','risk-assessment-and-pharmaceutical-processing-hazards','','','2019-11-23 06:48:34','2019-11-23 06:48:34','',0,'https://microbiozindia.com/magazines/risk-assessment-and-pharmaceutical-processing-hazards/',24,'magazines','',0),(3540,2,'2017-04-21 13:18:27','2017-04-21 13:18:27','<p>Dear friends and readers, I cannot thank you enough for the love and support you have been showering on me since the very beginning.</p> <p>Your encouragement and love are the two things which have always led me to pour in more of efforts to make the magazine more interesting and entertaining for you without compromising with the content.</p> <p>Here, I am happy to release another issue of Microbioz India. It is a &ldquo;Cleanroom Special Issue&rdquo; and in this issue we have added a new section called Product Launch.</p> <p>The magazine includes the Product Launch by the two leading companies namely Sai Scientific and Tiny Mart.</p>','Cleanroom Laboratory and Contamination Control','','publish','closed','closed','','cleanroom-laboratory-and-contamination-control','','','2019-11-23 06:48:47','2019-11-23 06:48:47','',0,'https://microbiozindia.com/magazines/cleanroom-laboratory-and-contamination-control/',25,'magazines','',0),(3541,2,'2017-05-21 13:18:27','2017-05-21 13:18:27','<p>There is no doubt that technology advancement has changed the overall scenario of how one looks at the world. People from all walks of life are continuously putting their efforts to modernize and revolutionize technology.</p> <p>One such area which has seen tremendous growth is the world of automation and digitalization as it has saved the precious time of doctors as well as patients by giving faster results than never before.</p> <p>In this month&rsquo;s issue, the cover story titled &ldquo;DIGITAL LABORATORY AND ITS ROLE IN IMMEDIATE TREATMENT AND DIAGNOSIS&rdquo; authored by Ms.Rebecca Scolastica Bello talks about the role that digital instruments play in enhancing care pathways.</p>','DIGITAL LABORATORY AND ITS ROLE IN IMMEDIATE TREATMENT AND DIAGNOSIS','','publish','closed','closed','','digital-laboratory-and-its-role-in-immediate-treatment-and-diagnosis','','','2019-11-23 06:49:01','2019-11-23 06:49:01','',0,'https://microbiozindia.com/magazines/digital-laboratory-and-its-role-in-immediate-treatment-and-diagnosis/',26,'magazines','',0),(3542,2,'2017-06-21 13:18:27','2017-06-21 13:18:27','<p>Technology has always been a driving force for improvements in healthcare. With new innovations and techniques, people can now monitor their health more often at the comfort of their own homes without wasting their precious time and money in commuting to and fro the clinics.</p> <p>These new techniques with increased accessibility to early diagnosis and treatment are not only safer and time-saving but more reliable as well. Microbioz India&rsquo;s current issue&rsquo;s cover story &lsquo;Laboratory on the fingertips: Revolution in Healthcare&rsquo;, authored by Bhawana Jain, M.Tech- Biotech &amp; Editor- Microbioz India highlights the importance of these techniques in day-to-day lives of people who are vulnerable to diseases or have a history of a particular disease in their ancestors.</p> <p>The cover story also focuses how people can utilize these diagnostic techniques to keep a check on the various health parameters of the body. To read more, please turn to the cover story.</p>','Laboratory on the fingertips:Revolution in Healthcare','','publish','closed','closed','','laboratory-on-the-fingertipsrevolution-in-healthcare','','','2019-11-23 06:49:16','2019-11-23 06:49:16','',0,'https://microbiozindia.com/magazines/laboratory-on-the-fingertipsrevolution-in-healthcare/',27,'magazines','',0),(3543,2,'2017-07-21 13:18:44','2017-07-21 13:18:44','<p>It is the month of July and this reminds us of one of the India&rsquo;s largest medical equipment exhibition for Medical professionals named &lsquo;Medicall&rsquo; going to be held in Chennai this month. So, with immense pleasure here I am releasing our Event Special Issue for 2017 &ndash; A Medicall Special Issue which do not only mark the presence of Microbioz India in Medicall but also many other National and International events that have been lined up for this year.</p> <p>the list of the events with the brief can be found in the magazine.</p> <p>&lsquo;Medicall- Hospital Needs Expo&rsquo; is organized by Medexpert Business Consultants Pvt. Ltd. Promoted by Dr. Manivannan, the Joint Managing Director of Kauvery Hospital, a 1000 bedded Hospital in South India.</p>','Laboratory Information Management System','','publish','closed','closed','','laboratory-information-management-system','','','2019-11-23 06:49:31','2019-11-23 06:49:31','',0,'https://microbiozindia.com/magazines/laboratory-information-management-system/',28,'magazines','',0),(3544,2,'2017-08-21 13:18:44','2017-08-21 13:18:44','August has started and this marks the presence of Microbioz India in another Mega Event of Pharma named Pharmalytica going to be held in Hitex Exhibition Centre, Hyderabad. So, with a deep sense of pleasure, I release a Pharmalytica Special Edition for our readers &amp; friends. <p>Pharmalytica is organized by UBM India who also organize CPhI / P-MEC India, the leading global pharma trade show and conference. This is the 4th edition of Pharmalytica which will go on for 2 days. Pharmalytica will start on 11th August 2017 and will end on 12th August 2017.</p> <p>The August issue of Microbioz India contains a write-up of Pharmalytica. Go through it to know more about Pharmalytica. The cover story for this editorial is titled &lsquo;THE ROLE OF PHARMACEUTICAL IN THE TRADITIONAL DRUGS THERAPY&rsquo; and is authored by one of the stunning author and editor of Microbioz India Rebecca Bello.</p>','PharmaLytica 2017:The role of pharmaceutical in the traditional drugs therapy','','publish','closed','closed','','pharmalytica-2017the-role-of-pharmaceutical-in-the-traditional-drugs-therapy','','','2019-11-23 06:49:44','2019-11-23 06:49:44','',0,'https://microbiozindia.com/magazines/pharmalytica-2017the-role-of-pharmaceutical-in-the-traditional-drugs-therapy/',29,'magazines','',0),(3545,2,'2017-09-21 13:18:44','2017-09-21 13:18:44','<p>A courageous decision, continuous effort and strive for excellence are the perfect ingredients that have ever been used by any company to become successful. Microbioz India is a newly emerged successful name in the list of Laboratory, Healthcare Diagnostics &amp; Pharma Magazine category which through its constant efforts day in and day out has now grown into a multinational brand and is in the top list of magazines in this sector across the world.</p> <p>After successfully exhibiting at Medicall, Chennai; Pharmalytica Hyderabad and Thailand Lab Expo, Bangkok with Event Special Editions, Microbioz India is all set to blaze the trail and sail its ship crossing all frontiers in the International Exhibitions. Pittcon (USA), Achema (Germany), Nepal Lab Expo (Kathmandu) are some of the names in the list.</p>','Anacon India and India Lab Expo : Microbioz India Special Edition','','publish','closed','closed','','anacon-india-and-india-lab-expo-microbioz-india-special-edition','','','2019-11-23 06:50:04','2019-11-23 06:50:04','',0,'https://microbiozindia.com/magazines/anacon-india-and-india-lab-expo-microbioz-india-special-edition/',30,'magazines','',0),(3546,2,'2017-10-21 13:18:44','2017-10-21 13:18:44','<p>Dear friends and readers, I would like to thank you for your extreme love, support and encouragement throughout all these years. It is with your support only that Microbioz India, in just a short span of time has become a successful name in the list of Laboratory, Healthcare Diagnostics &amp; Pharma Magazine.</p> <p>Recently, in last few months, Microbioz India team exhibited at the leading events of Medical, Pharma &amp; Laboratory like Medicall, Chennai; Pharmalytica Hyderabad, Thailand Lab Expo, Bangkok and analytica Anacon India &amp; India Lab expo with Event Special Editions. It is so wonderful to be a part of such exhibitions as we are able to connect &amp; interact with more people, build more trust, develop business relations &amp; penetrate the Laboratory Industry, Medical Diagnostics Market as a whole.</p> <p>Moreover, with your hearty blessings Microbioz India has now media partnered with the world&rsquo;s largest Laboratory &amp; Medical events around the globe. Pittcon, USA; Achema (Germany), Med-Lab Singapore are to name a few.</p>','Laboratory Balances latest launches : October 2017 Issue','','publish','closed','closed','','laboratory-balances-latest-launches-october-2017-issue','','','2019-11-23 06:50:20','2019-11-23 06:50:20','',0,'https://microbiozindia.com/magazines/laboratory-balances-latest-launches-october-2017-issue/',31,'magazines','',0),(3547,2,'2017-11-21 13:18:44','2017-11-21 13:18:44','<p>Dear friends and readers, I am extremely thankful to you for the love, support and encouragement you have been showering on Microbioz India throughout all these years.</p> <p>It is because of your love and blessings only that in such a short span of time Microbioz India has become a leading brand in the list of Laboratory, Healthcare Diagnostics &amp; Pharma publications.</p> <p>I am also pleased to inform you that Microbioz India has now media partnered with more world&rsquo;s largest events &amp; exhibitions like CISILE (China) 2018; Cambodia &amp; Myanmar Lab Expo 2018 apart from Pittcon (USA) 2018; Achema (Germany) 2018. It feels so good to be a part of such exhibitions as we are able to connect &amp; interact with more people, build more trust, develop business relations &amp; penetrate the Laboratory Industry, Medical Diagnostics Market as a whole.</p>','CPHI Special Edition November 2017','','publish','closed','closed','','cphi-special-edition-november-2017','','','2019-11-23 06:50:52','2019-11-23 06:50:52','',0,'https://microbiozindia.com/magazines/cphi-special-edition-november-2017/',32,'magazines','',0),(3548,2,'2017-12-21 13:18:44','2017-12-21 13:18:44','<p>The year is going to end soon with a just few days left to complete unfinished tasks and add on more victories.</p> <p>It was a great year for MICROBIOZ INDIA full of challenges and achievements and we wholeheartedly thank our readers for their love and support all throughout the year and we look forward to the same support from you for the upcoming year too in the journey of MICROBIOZ INDIA.</p> <p>With extreme pleasure, I hereby present yet another exclusive event special edition for my esteemed readers. This time with a focus on Nepal Lab Expo.</p> <p>The edition starts with a Pre-Show Report on the Nepal Lab Expo, an Exhibition &amp; Conference on Laboratory, Analytical, Medical &amp; Biotechnology Instruments from 14th to 16th December 2017 at Bhrikuti Mandap Exhibition Hall, Kathmandu.</p>','Nepal lab special edition December 2017','','publish','closed','closed','','nepal-lab-special-edition-december-2017','','','2019-11-23 06:51:05','2019-11-23 06:51:05','',0,'https://microbiozindia.com/magazines/nepal-lab-special-edition-december-2017/',33,'magazines','',0),(3549,2,'2018-01-21 13:18:44','2018-01-21 13:18:44','<p>We all understand the importance of cleanliness at our homes and the workplaces. The same is required in practically every industry where small particles interfere with the manufacturing process.</p> <p>So, in this issue, we have brought a cover story titled &ldquo;Tips to keep your Laboratory Clean &rdquo; which focuses on the importance of Cleaning equipments, lab glasswares, etc for eliminating the risk of contaminants that might affect the manufacturing process.</p> <p>The article also emphasizes on certain key measures that must be employed to ensure the safety during the manufacturing process and to have sustained repeatability of a quality product.</p>','Tips to keep your Laboratory Clean','','publish','closed','closed','','tips-to-keep-your-laboratory-clean','','','2019-11-23 06:44:46','2019-11-23 06:44:46','',0,'https://microbiozindia.com/magazines/tips-to-keep-your-laboratory-clean/',10,'magazines','',0),(3550,2,'2018-02-21 13:18:44','2018-02-21 13:18:44','<p>Dear friends &amp; industry colleagues, we would like to thank you once again for giving me an opportunity to present for all of you our new issue.</p> <p>Hope you liked our New Year Edition which had a focus on keeping our laboratories clean. In this issue, we have brought for you some management skills which are really important to become a leader in laboratory.</p> <p>The cover story is titled &ldquo;Become good Laboratory Leader&rdquo; which talks about the four main categories of management to become a good manger in your laboratory. It also emphasizes on why managing your timelines and budget while you are working on multiple projects is of utmost importance to keep current with research in the fields.</p> <p>The current edition also brings for you some of the interesting news from the laboratory market so as to update you with what is going on this industry. Added to this, we have our regular segment covering featured articles. This time we have one of the featured article titled &ldquo;Sifter Sieves&rdquo; by Ami Polymer Pvt Ltd. There are many more. Please check out.</p>','Become Good Laboratory Leader','','publish','closed','closed','','become-good-laboratory-leader','','','2019-11-23 06:44:59','2019-11-23 06:44:59','',0,'https://microbiozindia.com/magazines/become-good-laboratory-leader/',11,'magazines','',0),(3551,2,'2018-03-21 13:18:44','2018-03-21 13:18:44','<p>Dear friends and readers, I am pleased to inform you that your favourite magazine Microbioz India completes one more year of this beautiful journey which has only become possible because of your extreme love, support and encouragement all through these years. So, with gratitude in heart for all the support and your presence, I hereby present yet another issue of Microbioz India. It is a &ldquo;Pharma Special Issue&rdquo; which is supported by the cover story titled &lsquo;Quality Control &amp; Safety Tips. The article discusses how pharma quality control testing laboratory plays a vital role in ensuring the safety and efficacy of pharmaceutical products which are typically drugs and other chemical preparations particularly used in the diagnosis, cure, treatment &amp; prevention of diseases.</p>','Pharma Laboratory Quality Control and Safety Tips','','publish','closed','closed','','pharma-laboratory-quality-control-and-safety-tips','','','2019-11-23 06:45:10','2019-11-23 06:45:10','',0,'https://microbiozindia.com/magazines/pharma-laboratory-quality-control-and-safety-tips/',12,'magazines','',0),(3552,2,'2018-04-21 13:18:44','2018-04-21 13:18:44','<p>Dear friends and readers, I am pleased to bring for you another issue of your favorite magazine Microbioz India. It is a &ldquo;Laboratory Events Special Edition&rdquo; for the two Mega Events of Laboratory &amp; Analytical Equipments namely &lsquo;India Lab Expo&rsquo; &amp; &lsquo;Asia Labex&rsquo; going to be held in Mumbai &amp; Chennai respectively this month.<br /> The issue is supported by a cover story titled &lsquo;Analytical Industry&rsquo;s contribution for Affordable Healthcare&rsquo; by Srushti Sanghavi-Shah, Manager Technical Sales and Support Nanghavi Chromatographic Solutions Pvt. Ltd. The article talks about the role of longer lasting and more-cost efficient equipments and consumables used in the manufacturing process of medicines so as to reduce the cost of healthcare and ensure that it is affordable to all.</p>','Analytical Industry contribution for Affordable Healthcare','','publish','closed','closed','','analytical-industry-contribution-for-affordable-healthcare','','','2019-11-23 06:45:31','2019-11-23 06:45:31','',0,'https://microbiozindia.com/magazines/analytical-industry-contribution-for-affordable-healthcare/',13,'magazines','',0),(3553,2,'2018-05-21 13:18:44','2018-05-21 13:18:44','<p>Dear friends and readers, I am extremely grateful to you all for your love, support and guidance throughout all these years and making your instrumental contribution in the journey of your favourite magazine Microbioz India. With immense pleasure, here I release before you another special edition for the upcoming largest event ACHEMA going to be organized in Frankfurt, Germany.</p> <p>The special edition brings for you a cover story titled &lsquo;Evaluating powder characterisation techniques for the optimisation of a dry granulation process&rsquo; authored by Tim Freeman, Managing Director, Freeman Technology and Hartmut Vom Bey, Vice President, Gerteis Maschinen + Process engineering AG. The article presents a collaborative study between Gerteis AG, a market leader in the design and supply of premium roller compaction equipment, and Freeman Technology, specialists in powder characterisation, to identify powder properties that characterise dry granulates to support the optimisation of roller compaction processes. For more information, please turn to the cover story.</p>','Evaluating powder characterisation techniques for the optimisation of a dry granulation process','','publish','closed','closed','','evaluating-powder-characterisation-techniques-for-the-optimisation-of-a-dry-granulation-process','','','2019-11-23 06:45:42','2019-11-23 06:45:42','',0,'https://microbiozindia.com/magazines/evaluating-powder-characterisation-techniques-for-the-optimisation-of-a-dry-granulation-process/',14,'magazines','',0),(3554,2,'2018-06-21 13:18:44','2018-06-21 13:18:44','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the new edition of your favourite magazine Microbioz India. It is a &ldquo;Laboratory Edition&rdquo; supported by the cover story titled &lsquo;Increased evaporation efficiency: Hybrid ceramic bearing extends lifetime and reduces maintenance cost of fans for mechanical vapour recompression&rsquo; by TLT-Turbo GmbH, one of the world\'s leading manufacturers of technology-driven industrial fans and ventilation systems.</p> <p>Process industry, chemical and pharmaceutical applications require high amounts of process steam resulting in high energy usage. Thus mechanical vapour recompression is frequently used to minimize energy usage.</p> <p>A fan compresses the vapour boosting to a higher pressure and adds heat to it until the requested temperature has been reached.</p>','Pharma Laboratory Special Edition','','publish','closed','closed','','pharma-laboratory-special-edition','','','2019-11-23 06:45:59','2019-11-23 06:45:59','',0,'https://microbiozindia.com/magazines/pharma-laboratory-special-edition/',15,'magazines','',0),(3555,2,'2018-07-21 13:18:44','2018-07-21 13:18:44','<p>Welcome to the July 2018 edition of Microbioz India magazine, edition is designed especially for laboratory and analytical professionals. This is for readers who want to know the basic steps and rules need to follow while working in the laboratory.</p> <p>It is a &ldquo;Laboratory Edition&rdquo; supported by the cover story titled &lsquo;Are you working safe? Rethinking Laboratory Safety, by Microbioz India editorial team, The best way to prevent lab accidents is to be prepared and knowledgeable about what you are working with, be it equipment, chemicals or biological materials.</p> <p>Having a range of knowledge for each type or chemical/biological class of hazard you will work with, in advance, is what I call a &ldquo;working understanding&rdquo; of your environment in the lab.</p>','Laboratory Safety edition : July 2018','','publish','closed','closed','','laboratory-safety-edition-july-2018','','','2019-11-23 06:46:11','2019-11-23 06:46:11','',0,'https://microbiozindia.com/magazines/laboratory-safety-edition-july-2018/',16,'magazines','',0),(3556,2,'2018-08-21 13:18:44','2018-08-21 13:18:44','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the new edition of your favourite magazine Microbioz India. It is a &ldquo;Laboratory Edition&rdquo; supported by the cover story titled &lsquo;Process Analytical Technology for High Shear Wet Granulation&rsquo; by Tim Freeman, Managing Director, Freeman Technology Ltd</p> <p>High shear wet granulation (HSWG) transforms fine powder blends into free-flowing granules with improved compression properties during the tabletting process. Granulation also enhances the uniformity of a blend, increases density and reduces dust levels, an important health and safety benefit. The pharmaceutical industry is one of several which rely heavily on HSWG processes, most especially in the manufacture of oral solid dosage forms.</p> <p>A Quality-by-Design (QbD) approach in drug development and manufacture relies on data collection at relevant points in the process to control the critical quality attributes (CQAs) of the product.<br /> <br /> Read full cover story<a href=\"http://www.microbiozindia.com/business-news/process-analytical-technology-for-high-shear-wet-granulation.htm#sthash.xqtjRE80.KCHOMb5E.dpbs\"> ..Click here&nbsp;</a></p>','Process analytical technology for high shear wet Granulation','','publish','closed','closed','','process-analytical-technology-for-high-shear-wet-granulation','','','2019-11-23 06:46:22','2019-11-23 06:46:22','',0,'https://microbiozindia.com/magazines/process-analytical-technology-for-high-shear-wet-granulation/',17,'magazines','',0),(3557,2,'2018-09-21 13:18:44','2018-09-21 13:18:44','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the new edition of your favourite magazine Microbioz India. It is a &ldquo;Laboratory Edition&rdquo; supported by the cover story titled FEP tubing &amp; its rising demand by Shrikant Dethe (B.Tech. Chemical Engineer &ndash; IIT Bombay) Ami Polymer Pvt. Ltd. The accidental discovery of PTFE in 1938 by Dr. Roy J.</p> <p>Plunkett has turned out to have the lowest coefficient of friction of any known solid material. But as PTFE lacks the melt-processability, a need of other fluoropolymers was generated. FEP shares the same basic monomer and is commercially obtained by free-radical polymerization in an aqueous media via addition of tetrafluoroethylene (TFE, CF2=CF2) and hexafluoropropylene (HFP, CF3-CF=CF2).</p>','FEP tubing and its rising demand','','publish','closed','closed','','fep-tubing-and-its-rising-demand','','','2019-11-23 06:46:33','2019-11-23 06:46:33','',0,'https://microbiozindia.com/magazines/fep-tubing-and-its-rising-demand/',18,'magazines','',0),(3558,2,'2018-10-21 13:18:44','2018-10-21 13:18:44','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the new edition of your favorite magazine Microbioz India. It is a &ldquo;Laboratory Edition&rdquo; supported by an Interview of Mr. Yogesh Mudra, Managing Director UBM India, and other guest articles.</p> <p>While interaction with him we discussed on several topics;</p> <p>For instance, within the realm of the IPW, the CEO Roundtable stands out as one of the most distinguished and successful events.  For the last 2 years, the exclusive, closed-door CEO Roundtable has been eminently successful as a strategic gathering of CEOs of the nation&rsquo;s leading Pharma companies who deep dive into thought-provoking discussions on subjects.</p>','Laboratory Special Edition','','publish','closed','closed','','laboratory-special-edition','','','2019-11-23 06:46:42','2019-11-23 06:46:42','',0,'https://microbiozindia.com/magazines/laboratory-special-edition/',19,'magazines','',0),(3559,2,'2018-11-21 13:18:44','2018-11-21 13:18:44','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the new edition of your favourite magazine Microbioz India. It is a &ldquo;Laboratory Edition&rdquo; supported by the cover story titled       Digital Marketing- Bringing Revolution in the Pharmaceutical Sector by covered by our editorial team.</p> <p>The Pharmaceutical companies operate in a regulated environment which poses constraints in the nature of promotional and marketing activities they can pursue. It has been observed that mostly the pharmaceutical promotional initiatives consist of below &ndash; the-Line (BTL) activities with an objective to engage their customer segment with the healthcare professionals with a positive brand experience.</p> <p>The current edition has also brought for you a featured article on &ldquo;10 year - Zero Replacement Gaskets! Guarantee Long Life Gasket/ Sealing Solutions! &rdquo;   from Unispares&trade; by Arihant Jain CEO-Director, (IIT-Madras) National Rubber Industries, includes with advancements in Seal Engineering and access to best technology platforms from across the globe; Unispares&trade; now have developed break through sealing solutions for complex Industrial applications.</p>','Digital Marketing Bringing Revolution in the Pharmaceutical Sector','','publish','closed','closed','','digital-marketing-bringing-revolution-in-the-pharmaceutical-sector','','','2019-11-23 06:46:53','2019-11-23 06:46:53','',0,'https://microbiozindia.com/magazines/digital-marketing-bringing-revolution-in-the-pharmaceutical-sector/',20,'magazines','',0),(3560,2,'2018-12-21 13:18:44','2018-12-21 13:18:44','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the annual edition of your favourite magazine Microbioz India. It is a &ldquo;CPHI and P-mec India special edition&rdquo; supported by the cover story titled &lsquo;Analysis of Food Ingredients by an Analytical Technique &ndash; HPLC by Srushti Sanghavi- Shah Nanghavi Chromatography Solutions.</p> <p>The story features the food we consume today is more versatile and processed than ever before. Therefore, the quality of food is a major topic of concern for human health. To ensure the nutritional quality and safety of food many countries have implemented regulations that specify tolerable levels for individual chemical additives and contaminants in food product and list those ingredients with respect to their content.</p>','Analysis of Food Ingredients by an Analytical Technique HPLC','','publish','closed','closed','','analysis-of-food-ingredients-by-an-analytical-technique-hplc','','','2019-11-23 06:47:04','2019-11-23 06:47:04','',0,'https://microbiozindia.com/magazines/analysis-of-food-ingredients-by-an-analytical-technique-hplc/',21,'magazines','',0),(3561,2,'2019-01-21 13:18:44','2019-01-21 13:18:44','<p>Dear Reader, first of all, A Very Happy New Year to all of you!!</p> <p>Success only comes when we keep on improving our faults &amp; implementing tips &amp; suggestions for our betterment. In the year 2018, we received great support &amp; strength from our readers, Subscribers &amp; everybody who is a member of Microbioz India.</p> <p>January, the very first month of the year we have come up with the cover story &ldquo;Dehumidification in Pharma Industry&rdquo; this topic is focusing on what&rsquo;s the role of dehumidification in the pharmaceutical industry &amp; what&rsquo;s the importance of controlling the humidity in R&amp;D &amp; Pharmaceutical sectors.</p> <p>Following to this our featured article is focusing on the rubber industry, &ldquo;Metal Detectable silicone rubber&rdquo; as this product is high in demand and usually covers multiple industries so it\'s basically &ndash;&ldquo;A unique solution to multiple industries&rdquo;.</p>','Dehumidification in Pharma Industry: Importance of humidity Control in Pharma Industry','','publish','closed','closed','','dehumidification-in-pharma-industry-importance-of-humidity-control-in-pharma-industry','','','2019-11-23 06:02:29','2019-11-23 06:02:29','',0,'https://microbiozindia.com/magazines/dehumidification-in-pharma-industry-importance-of-humidity-control-in-pharma-industry/',0,'magazines','',0),(3562,2,'2019-02-21 13:18:44','2019-02-21 13:18:44','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the February 2019 edition of Microbioz India magazine. It is a &ldquo;Microbiology special edition&rdquo; supported by the cover story titled &lsquo;Advances in antimicrobial research&rsquo; by Dr. Tim Sandle an eminent Pharmaceutical microbiologist and editorial board member of Microbioz India.</p> <p>The cover story features the introduction of penicillin in the 1940s antimicrobial medicines have become an essential tool for combatting microbial infections in humans and animals.</p> <p>Added to this, the current edition has a special featured article Imaweld&reg; - Heat Sealable Thermoplastic Elastomer Tube by Amipolymer Pvt Ltd by Amipolymer Pvt Ltd the article includes, Imaweld&reg; is thermoplastic elastomer opaque tubing designed for fluid transfer in pharmaceutical and biotech applications.</p>','Advances in antimicrobial research','','publish','closed','closed','','advances-in-antimicrobial-research','','','2019-11-23 06:02:44','2019-11-23 06:02:44','',0,'https://microbiozindia.com/magazines/advances-in-antimicrobial-research/',1,'magazines','',0),(3563,2,'2019-03-21 13:18:50','2019-03-21 13:18:50','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring for you the March 2019 edition of Microbioz India magazine, supported by the cover story titled Unlock cleaning procedure of Pharma manufacturing equipments: Better pharma quality control by editorial team of Microbioz India magazine.</p> <p>The cover story features A Quality Management System necessitates forethought into the myriad number of variables that must be managed in a Corrective Action, Preventative Action (CAPA) approach. A well thought out cleaning, disinfection and decontamination program for the pharmaceutical manufacturing environment is one of the fundamental components of a successful operation.</p> <p>Added to this, the current edition has a special featured article Metal detector silicone rubber by Amipolymer Pvt Ltd the article includes, Silicone elastomer based on polydialkyl siloxane is one of most curtail material use in most critical application like medical industry, food industry, pharmaceuticals, biotechnology, microbiological research and as well as in prosthetic application owing to its biocompatibility.</p> <p>We have the latest market research news and insightful product launches inside, collected from worldwide sources to keep you updated with what is going on in the industry.</p>','Unlock cleaning procedure of Pharma manufacturing equipments','','publish','closed','closed','','unlock-cleaning-procedure-of-pharma-manufacturing-equipments','','','2019-11-23 06:02:57','2019-11-23 06:02:57','',0,'https://microbiozindia.com/magazines/unlock-cleaning-procedure-of-pharma-manufacturing-equipments/',2,'magazines','',0),(3564,2,'2019-04-21 13:18:50','2019-04-21 13:18:50','<p>Dear friends and readers, I hope you would haveenjoyed reading our previous issue. Once again, I am delighted to bring for you the April 2019 edition of Microbioz India magazine, supported by the cover story titled &ldquo;Development of biologics: The market requires short development times and high productivity-Using a high-speed workflow to generate a production cell line&rdquo;By UGA Biopharma GmbH.</p> <p>The cover story featured Biologics this month which includes their new therapy option for numerous diseases: They are already used to treat cancer and autoimmune diseases such as rheumatoid arthritis as useful alternatives to standard therapies.</p> <p>Added to this, the current edition has a special featured article titled &ldquo;Increasing demand of Fluorosilicone &ldquo;By Anuj Singh-Polymer Technologist Amipolymer Pvt Ltd, the article includes Fluorosilicone rubber called as modified version of silicone rubber which has been fluorinated to finish up the polymer chains so that its chemical resistance is improved. Fluorosilicone is also known as FVMQ(fluorovinylmethylsiloxane).</p>','Development of biologics: The market requires short development times and high productivity','','publish','closed','closed','','development-of-biologics-the-market-requires-short-development-times-and-high-productivity','','','2019-11-23 06:03:08','2019-11-23 06:03:08','',0,'https://microbiozindia.com/magazines/development-of-biologics-the-market-requires-short-development-times-and-high-productivity/',3,'magazines','',0),(3565,2,'2019-05-21 13:18:50','2019-05-21 13:18:50','&nbsp; <p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the May 2019 edition of Microbioz India magazine, supported by the cover story entitled &ldquo;Pharma Laboratory and Waste Management&rdquo;authored by Microbioz editorial team.</p> <p>The cover story features Pharmaceutical laboratory wastes and their management and includes some discussion on sustainability- as more and more pharmaceutical companies launch new projects, an even greater amount of pharmaceuticals are secreted into the environment. However, companies are still working towards that aim. According to the statistics reported by WHO, 15 percent of the waste generated by health-care activities is considered to be hazardous: infectious, toxic, or radioactive.</p> <p>Added to this, the current edition has a special featured article entitled &ldquo;Element speciation using HPLC coupling &ndash; PlasmaQuant MS and PQ LC&rdquo;. LC-ICP-MS and IC-ICP-MS by Analytik Jena are versatile, robust and highly sensitive methods for the determination of element species in various fields, e.g. the characterization of environmental, food and agricultural samples or consumer goods. The coupling of the PlasmaQuant MS instruments and the systems of the PQ LC series offers outstanding precision and accuracy in element speciation, with well-defined and clearly separated peaks.</p>','Pharma Laboratory and Waste Management','','publish','closed','closed','','pharma-laboratory-and-waste-management','','','2019-11-23 06:03:17','2019-11-23 06:03:17','',0,'https://microbiozindia.com/magazines/pharma-laboratory-and-waste-management/',4,'magazines','',0),(3566,2,'2019-06-21 13:18:50','2019-06-21 13:18:50','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the June 2019 edition of Microbioz India magazine, supported by the cover story entitled &ldquo;Electrophoresis Equipment and Supplies Market expected to expand at a CAGR of 4.5% by 2027 &rdquo;  a market research on Electrophoresis equipment.</p> <p>According to a recent market report published by FMI titled &lsquo;Electrophoresis Equipment and Supplies Market: Global Industry Analysis 2013&ndash;2017 and Opportunity Assessment 2018&ndash;2027,&rsquo; the global Electrophoresis Equipment and Supplies market was valued at US$ 1,854.8 Mn in 2017, and is expected to register a CAGR of 4.5% from 2018 to 2027.</p> <p>Added to this, the current edition has a special featured guest article entitled &ldquo;3D MicroPrint use the FT4 Powder Rheometer to push AM to its limits&rdquo; by Freeman Technology a Micromeritics company.  3D MicroPrint GmbH (Chemnitz, Germany), a company pioneering the use of Additive Manufacturing (AM) to produce complex, micro-scale metal parts, is using the FT4 Powder Rheometer&reg; from Freeman Technology (Tewkesbury, UK) to identify ultra-fine powders that will process efficiently. The company works with powders less than five microns in size to deliver components with cutting edge accuracy and resolution.</p>','PharmaLytica Special June 2019 edition','','publish','closed','closed','','pharmalytica-special-june-2019-edition','','','2019-11-23 06:03:29','2019-11-23 06:03:29','',0,'https://microbiozindia.com/magazines/pharmalytica-special-june-2019-edition/',5,'magazines','',0),(3567,2,'2019-07-21 13:18:50','2019-07-21 13:18:50','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the July 2019 edition of Microbioz India magazine, supported by the cover story entitled &ldquo;Biologics vs Biosimilars : Research and Development in Pharma&rdquo; a review study on comperative study of Biosimilars and Biologics.A biosimilar is exactly what its name implies &mdash; it is a biologic that is &ldquo;similar&rdquo; to another biologic medicine (known as a reference product) which is already licensed by the U.S. Food and Drug Administration (FDA).</p> <p>Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. In approving biosimilars, the FDA may require that manufacturers conduct a clinical study (or studies) sufficient to establish safety, purity or potency in one or more uses for which the reference product is licensed and the biosimilar seeks licensure.</p> <p>Added to this, the current edition has a special featured guest article entitled &ldquo;Take a look at Blood with analysis machines &rdquo; by maxon precision motor India Pvt Ltd. Includes product description with Blood analysis.Our blood is a fascinating fluid it transports oxygen and nutrients, fends off foreign objects and closes wounds. At least in normal cases some people, however, suffer from coagulation disorders. These cases are unpleasant for the patient and can have severe consequences &ndash; or even lead to death. This is why early detection of a blood disorder and the hunt for a cure are so important. This requires a lot of testing. We have the latest market research news and insightful product launches inside, collected from worldwide sources to keep you updated with what is going on in the industry.</p>','Biologics vs Biosimilars:Research and Development in Pharma','','publish','closed','closed','','biologics-vs-biosimilarsresearch-and-development-in-pharma','','','2019-11-23 06:03:37','2019-11-23 06:03:37','',0,'https://microbiozindia.com/magazines/biologics-vs-biosimilarsresearch-and-development-in-pharma/',6,'magazines','',0),(3568,2,'2019-08-21 13:18:50','2019-08-21 13:18:50','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the August 2019 edition of Microbioz India magazine, supported by the cover story entitled ââ‚¬Å“Gene & Stem Cell Therapy: Adding future in Bio-Pharmaceutical Industryââ‚¬Â a review study.</p> <p>Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patientââ‚¬â„¢s cells instead of using drugs or surgery.Researchers are testing several approaches to gene therapy, including: Replacing a mutated gene that causes disease with a healthy copy of the gene. Inactivating, or ââ‚¬Å“knocking out,ââ‚¬Â a mutated gene that is functioning improperly. Introducing a new gene into the body to help fight a disease.</p> <p>Added to this, the current edition has a special featured guest article entitled ââ‚¬Å“Innovative Precision-Weighing Solutions Offer Top Speed and Accuracy in Tough Environmentsââ‚¬Â by Mettler Toledo, focused on product launch of new range of flexible XPR precision balances. These balances are designed to speed up weighing processes and simplify sample preparationââ‚¬â€even under challenging conditions. Lab operators around the world know that a small mistake in weight value can become magnified in subsequent analysis steps. This makes getting weighing right the first time key to analytical success. Efficient weighing also saves time and let users focus on the analysis.</p>','Gene and Stem Cell Therapy Adding future in BioPharmaceutical Industry','','publish','closed','closed','','gene-and-stem-cell-therapy-adding-future-in-biopharmaceutical-industry','','','2019-11-23 06:04:07','2019-11-23 06:04:07','',0,'https://microbiozindia.com/magazines/gene-and-stem-cell-therapy-adding-future-in-biopharmaceutical-industry/',7,'magazines','',0),(3569,2,'2019-09-21 13:18:50','2019-09-21 13:18:50','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the September 2019 a special edition of Microbioz India magazine for distribution in Analytica Ancon India and Thailand Lab in the month of September 2019, supported by the cover story entitled &ldquo;How Powder Testing Solutions Can Improve Product Quality and Manufacturing Efficiency&rdquo; an Interview interaction with Tim Freeman, Managing Director-Freeman Technology (a Micromeritics company).</p> <p>The interaction includes discussion on multiple topics related with Powder testing and Characterization.</p> <p>It is estimated that up to 80% of manufactured products are handled in powder form at some point, extending powder processing capability is a major goal for industry as it works to improve manufacturing efficiency.</p>','How Powder Testing Solutions Can Improve Product Quality and Manufacturing Efficiency','','publish','closed','closed','','how-powder-testing-solutions-can-improve-product-quality-and-manufacturing-efficiency','','','2019-11-23 06:04:50','2019-11-23 06:04:50','',0,'https://microbiozindia.com/magazines/how-powder-testing-solutions-can-improve-product-quality-and-manufacturing-efficiency/',8,'magazines','',0),(3570,2,'2019-10-21 13:18:50','2019-10-21 13:18:50','<p>Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the October 2019 edition of Microbioz India magazine supported by the cover story entitled &ldquo;Quantifying Adeno-Associated Virus Aggregation&rdquo; an informative product specification article submitted by Postnova Analytics GmbH.</p> <p>Adeno-associated viruses are gaining widespread popularity as vehicles for gene therapy due to their versatility and safety. However, one of the biggest concerns for manufacturing a uniform AAV suspension is the presence of viral aggregates, which can create problems with transduction efficiency, bio distribution, and immunogenicity. Due to their large size, often over 100 nm in diameter, AAV aggregates are challenging to separate and characterize by traditional column-based chromatography techniques.</p> <p>Along with cover story the issue also having a featured article titled &ldquo;New way to test for drug resistant infections&rdquo; based on a method to test whether an infection is resistant to common antibiotics. Scientists from the University of York modified an antibiotic from the beta-lactam family so that it can be attached to a sensor, enabling them to detect the presence of bacteria resistant to treatment.</p>','Quantifying Adeno Associated Virus Aggregation','','publish','closed','closed','','quantifying-adeno-associated-virus-aggregation','','','2019-11-23 06:04:40','2019-11-23 06:04:40','',0,'https://microbiozindia.com/magazines/quantifying-adeno-associated-virus-aggregation/',9,'magazines','',0),(3571,2,'2019-11-21 14:24:49','2019-11-21 14:24:49','','Archives','','publish','closed','closed','','archives','','','2019-11-21 14:24:49','2019-11-21 14:24:49','',0,'https://microbiozindia.com/?page_id=3571',0,'page','',0),(3573,2,'2019-11-22 13:03:37','2019-11-22 13:03:37','','Subscriptions','','publish','closed','closed','','subscriptions','','','2019-11-22 13:03:37','2019-11-22 13:03:37','',0,'https://microbiozindia.com/?page_id=3573',0,'page','',0),(3644,2,'2019-11-25 05:41:16','2019-11-25 05:41:16','','right-banner','','inherit','open','closed','','right-banner','','','2019-11-25 05:41:16','2019-11-25 05:41:16','',26,'https://microbiozindia.com/wp-content/uploads/2019/11/right-banner.png',0,'attachment','image/png',0),(3645,2,'2019-11-25 05:50:12','2019-11-25 05:50:12','','Lab world','','publish','closed','closed','','nanghvi','','','2020-04-20 12:58:24','2020-04-20 12:58:24','',0,'https://microbiozindia.com/?post_type=ads&#038;p=3645',0,'ads','',0),(3646,2,'2019-11-25 05:49:57','2019-11-25 05:49:57','','right-banner1','','inherit','open','closed','','right-banner1','','','2019-11-25 05:49:57','2019-11-25 05:49:57','',3645,'https://microbiozindia.com/wp-content/uploads/2019/11/right-banner1.png',0,'attachment','image/png',0),(3647,2,'2019-11-25 05:52:00','2019-11-25 05:52:00','','Advertisement','','publish','closed','closed','','advertisement','','','2019-12-27 16:41:58','2019-12-27 16:41:58','',0,'https://microbiozindia.com/?post_type=ads&#038;p=3647',0,'ads','',0),(3648,2,'2019-11-25 05:51:42','2019-11-25 05:51:42','','right-banner2','','inherit','open','closed','','right-banner2','','','2019-11-25 05:51:42','2019-11-25 05:51:42','',3647,'https://microbiozindia.com/wp-content/uploads/2019/11/right-banner2.png',0,'attachment','image/png',0),(3649,2,'2019-11-25 05:55:13','2019-11-25 05:55:13','','Thermo Fisher','','publish','closed','closed','','thermo-scientific','','','2020-07-22 11:32:59','2020-07-22 11:32:59','',0,'https://microbiozindia.com/?post_type=ads&#038;p=3649',0,'ads','',0),(3650,2,'2019-11-25 05:54:55','2019-11-25 05:54:55','','top-header','','inherit','open','closed','','top-header','','','2019-11-25 05:54:55','2019-11-25 05:54:55','',3649,'https://microbiozindia.com/wp-content/uploads/2019/11/top-header.jpg',0,'attachment','image/jpeg',0),(3651,2,'2019-11-25 05:58:12','2019-11-25 05:58:12','','Hi Media','','publish','closed','closed','','himedia','','','2020-07-18 13:42:49','2020-07-18 13:42:49','',0,'https://microbiozindia.com/?post_type=ads&#038;p=3651',0,'ads','',0),(3652,2,'2019-11-25 05:57:52','2019-11-25 05:57:52','','home-page1','','inherit','open','closed','','home-page1','','','2019-11-25 05:57:52','2019-11-25 05:57:52','',3651,'https://microbiozindia.com/wp-content/uploads/2019/11/home-page1.jpg',0,'attachment','image/jpeg',0),(3653,2,'2019-11-25 06:02:23','2019-11-25 06:02:23','','MT','','publish','closed','closed','','galssco','','','2020-05-04 16:04:08','2020-05-04 16:04:08','',0,'https://microbiozindia.com/?post_type=ads&#038;p=3653',0,'ads','',0),(3654,2,'2019-11-25 06:02:10','2019-11-25 06:02:10','','home-page2','','inherit','open','closed','','home-page2','','','2019-11-25 06:02:10','2019-11-25 06:02:10','',3653,'https://microbiozindia.com/wp-content/uploads/2019/11/home-page2.gif',0,'attachment','image/gif',0),(3656,2,'2019-11-25 06:35:41','2019-11-25 06:35:41','','home-page3','','inherit','open','closed','','home-page3','','','2019-11-25 06:35:41','2019-11-25 06:35:41','',0,'https://microbiozindia.com/wp-content/uploads/2019/11/home-page3.jpg',0,'attachment','image/jpeg',0),(3657,2,'2019-11-25 06:08:55','2019-11-25 06:08:55','Porvair Sciences has developed a new range of filters for pipette tips for a leading separation science supplier who was looking to bring control of supply and manufacture of these components in house.\r\n\r\nInitially Porvair Sciences undertook testing to fully characterise (air flow, pore size, material make-up) the outsourced pipette tip filters the customer sought to replace. Then working closely with an injection moulding company who were reverse engineering the pipette tip itself, Porvair Sciences developed a high-performance pipette tip filter based upon their proprietary Vyon® porous plastic.\r\n<img class=\"alignnone wp-image-3658 \" src=\"https://microbiozindia.com/wp-content/uploads/2019/11/PORVAIR22.jpg\" alt=\"\" width=\"453\" height=\"255\" />\r\n\r\nFollowing a lengthy competitive evaluation of filtered pipette tips from a number of different suppliers the customer elected to go with Porvair Sciences. This decision has enabled the customer to both improve upon their existing product as well as bringing control of supply and manufacture in house.\r\n\r\nBenefitting from Porvair Sciences proprietary Vyon® porous plastics, the pipette tip filters are fully compliant with FDA, USP Class VI and European Pharmacopoeia statutory regulations as well as being free from heavy metals. The unique combination of these ultra-clean materials, with excellent porosity properties, has produced a highly reproducible filtered pipette tip with an excellent edge finish that always provides an optimum fit into the pipette tip enabling labs to routinely achieve superior liquid handling and dispensing.\r\n\r\nFor further information please visit https://www.vyonporousplastics.com/pipette-tip-filters/. To discuss OEM development of high performance porous plastic components for filtering or separation applications please contact Porvair Sciences Ltd on +44-1978-661144 or enquiries@porvairsciences.com.','Porvair Secures Major Contract for Pipette Tip Filters','','publish','open','open','','porvair-secures-major-contract-for-pipette-tip-filters','','','2019-11-29 18:28:29','2019-11-29 18:28:29','',0,'https://microbiozindia.com/?p=3657',0,'post','',0),(3658,2,'2019-11-29 06:10:33','2019-11-29 06:10:33','','PORVAIR22','','inherit','open','closed','','porvair22','','','2019-11-29 06:10:33','2019-11-29 06:10:33','',3657,'https://microbiozindia.com/wp-content/uploads/2019/11/PORVAIR22.jpg',0,'attachment','image/jpeg',0),(3659,2,'2019-11-29 06:11:54','2019-11-29 06:11:54','','Porvair-Secures-Major-Contract-for-Pipette-Tip-Filters26_18','','inherit','open','closed','','porvair-secures-major-contract-for-pipette-tip-filters26_18','','','2019-11-29 06:11:54','2019-11-29 06:11:54','',3657,'https://microbiozindia.com/wp-content/uploads/2019/11/Porvair-Secures-Major-Contract-for-Pipette-Tip-Filters26_18.png',0,'attachment','image/png',0),(3661,2,'2019-11-21 06:16:01','2019-11-21 06:16:01','Bristol-Myers Squibb Company (NYSE: BMY) announced that it has completed its acquisition of Celgene Corporation (NASDAQ: CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders.\r\n\r\nUpon completion of the acquisition, pursuant to the terms of the merger agreement, Celgene became a wholly owned subsidiary of Bristol-Myers Squibb Company. Under the terms of the merger, Celgene shareholders received for each share, 1.00 share of Bristol-Myers Squibb common stock, $50.00 in cash without interest and one tradeable Contingent Value Right (CVR), which will entitle the holder to receive a payment of $9.00 in cash if certain future regulatory milestones are achieved. Celgene common stock ceased trading as of the close of trading today. On November 21, 2019, newly issued Bristol-Myers Squibb shares and CVRs will commence trading on the New York Stock Exchange, with the CVRs trading under the symbol “BMYRT.”\r\n\r\n“This is an exciting day for Bristol-Myers Squibb as we bring together the leading science, innovative medicines and incredible talent of Bristol-Myers Squibb and Celgene to create a leading biopharma company,” said Giovanni Caforio, M.D., Chairman and Chief Executive Officer of Bristol-Myers Squibb. “With our leading franchises in oncology, hematology, immunology and cardiovascular disease, and one of the most diverse and promising pipelines in the industry, I know we will deliver on our vision of transforming patients’ lives through science. I am excited about the opportunities for our current employees and the new colleagues that we welcome to the Company as we work together to deliver innovative medicines to patients.”\r\n\r\nSince announcing the transaction on January 3, 2019, there have been a number of tangible advancements toward delivering on the key value drivers for the merger, including: further progress relating to the patent estate for REVLIMID®, the U.S. Food and Drug Administration (FDA) approval of INREBIC® (fedratinib) for the treatment of certain forms of myelofibrosis, the U.S. FDA approval of REBLOZYL® (luspatercept-aamt) for the treatment of anemia in certain adult patients with beta thalassemia, and regulatory filings of luspatercept and ozanimod in the U.S. and Europe. The Company has also made substantial progress toward the planning of a successful integration. For an overview of the combined company and the milestones achieved while the transaction was pending, visit www.bestofbiopharma.com.\r\n\r\nStory source and credit: May be edited or resized for style and length, for more information please visit: https://www.bms.com/','Bristol-Myers Squibb Completes Acquisition of Celgene','','publish','open','open','','bristol-myers-squibb-completes-acquisition-of-celgene','','','2019-11-29 07:10:55','2019-11-29 07:10:55','',0,'https://microbiozindia.com/?p=3661',0,'post','',0),(3663,2,'2019-11-29 06:17:51','2019-11-29 06:17:51','','Bristol-Myers-Squibb-Completes-Acquisition-of-Celgene09_01','','inherit','open','closed','','bristol-myers-squibb-completes-acquisition-of-celgene09_01','','','2019-11-29 06:17:51','2019-11-29 06:17:51','',3661,'https://microbiozindia.com/wp-content/uploads/2019/11/Bristol-Myers-Squibb-Completes-Acquisition-of-Celgene09_01.jpg',0,'attachment','image/jpeg',0),(3664,2,'2019-11-29 06:42:56','2019-11-29 06:42:56','a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:9:\"post_type\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:4:\"post\";}}}s:8:\"position\";s:15:\"acf_after_title\";s:5:\"style\";s:8:\"seamless\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}','Posts Field','posts-field','publish','closed','closed','','group_5de0bdac9dba8','','','2019-12-05 05:57:23','2019-12-05 05:57:23','',0,'https://microbiozindia.com/?post_type=acf-field-group&#038;p=3664',0,'acf-field-group','',0),(3665,2,'2019-11-29 06:42:56','2019-11-29 06:42:56','a:15:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:11:\"show_column\";i:1;s:20:\"show_column_sortable\";i:0;s:18:\"show_column_weight\";i:1000;s:15:\"allow_quickedit\";i:1;s:14:\"allow_bulkedit\";i:1;}','Source','post_source','publish','closed','closed','','field_5de0bdb86fa66','','','2019-11-29 10:21:04','2019-11-29 10:21:04','',3664,'https://microbiozindia.com/?post_type=acf-field&#038;p=3665',0,'acf-field','',0),(3670,2,'2019-11-29 07:06:41','2019-11-29 07:06:41','a:15:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:15:\"Kumar Jeetendra\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:11:\"show_column\";i:1;s:20:\"show_column_sortable\";i:0;s:18:\"show_column_weight\";i:1000;s:15:\"allow_quickedit\";i:1;s:14:\"allow_bulkedit\";i:1;}','Author Name','author_name','publish','closed','closed','','field_5de0c36473433','','','2019-11-29 10:21:04','2019-11-29 10:21:04','',3664,'https://microbiozindia.com/?post_type=acf-field&#038;p=3670',1,'acf-field','',0),(3870,2,'2019-11-30 06:17:11','2019-11-30 06:17:11','{{unknown}}','','','publish','closed','closed','','e59b0957a0a4291ac34ffa953207648a','','','2019-11-30 06:17:11','2019-11-30 06:17:11','',0,'https://microbiozindia.com/uncategorized/e59b0957a0a4291ac34ffa953207648a/',0,'oembed_cache','',0),(4020,2,'2019-12-02 10:55:21','0000-00-00 00:00:00','','Enter Title here !!!','','draft','open','open','','','','','2019-12-02 10:55:21','2019-12-02 10:55:21','',0,'https://microbiozindia.com/?p=4020',0,'post','',0),(4021,2,'2019-12-02 11:01:23','0000-00-00 00:00:00','Magazien Description Here ','Magazine Title Here (Cover Story)','','draft','closed','closed','','','','','2019-12-02 11:01:23','2019-12-02 11:01:23','',0,'https://microbiozindia.com/?post_type=magazines&#038;p=4021',0,'magazines','',0),(4022,2,'2019-12-04 05:32:24','0000-00-00 00:00:00','','Microbioz','','draft','closed','closed','','','','','2019-12-04 05:32:24','2019-12-04 05:32:24','',0,'https://microbiozindia.com/?post_type=magazines&#038;p=4022',0,'magazines','',0),(4027,2,'2019-12-04 10:41:11','2019-12-04 10:41:11','','popup','','inherit','open','closed','','popup','','','2019-12-04 10:41:11','2019-12-04 10:41:11','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/popup.jpg',0,'attachment','image/jpeg',0),(4028,2,'2019-12-04 10:51:53','2019-12-04 10:51:53','','#Dexamethasone proves first life-saving Corona drug I Microbioz India I #coronavaccine #covid2019','','publish','closed','closed','','zika-virus','','','2020-06-21 16:12:42','2020-06-21 16:12:42','',0,'https://microbiozindia.com/?post_type=videos&#038;p=4028',0,'videos','',0),(4029,2,'2019-12-04 17:57:46','2019-12-04 17:57:46','Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.\r\n\r\n<strong>Types of pharmaceutical reference standard (RS)</strong>\r\n\r\nIn the pharmaceutical area, there are four major types of reference standards:\r\n\r\n1;-Primary RS\r\n\r\n2:-Pharmacopoeial RS (for monograph use)\r\n\r\n3:-Secondary RS\r\n\r\n4:-Impurity RS\r\n\r\nApart from the pharmacopoeial standards, all of the above come with certificates of analysis (CoAs), or – in the case of a secondary RS – with a comparison statement. The information provided on the CoA should be suitable with regard to the specific use planned for the corresponding RS.\r\n\r\nThere is a fifth type – research materials – which is often used at the very beginning of analytical research and development, but not normally for method development, validation, transfer or quality control.\r\n\r\n<strong>Primary reference standards</strong>\r\n\r\nIn the pharmaceutical context, a primary reference standard is a standard for which the properties (usually identity, very often also purity/assay values) have been characterized by certain analytical techniques, without, however, being compared to any other standard of the same kind.\r\n\r\nThe definition for a primary standard in the GMP guideline Q7 of the ICH states:\r\n\r\n<em>Reference Standard, Primary</em>\r\n\r\n<em>A substance that has been shown by an extensive set of analytical tests to be authentic material that should be of high purity. This standard can be: (1) obtained from an officially recognized source, or (2) prepared by independent synthesis, or (3) obtained from existing production material of high purity, or (4) prepared by further purification of existing production material. </em>\r\n\r\n<strong>When to use a primary standard?</strong>\r\n\r\nIn pharmaceutical QC, the use of reference standards to calibrate the analytical procedure is mandatory when measurements are performed with relative methods such as HPLC in combination with a UV or MS detector. These measurements need to be traceable to a primary standard. This requirement is realized either by using the primary standard directly for the calibration purposes, or by using a secondary standard which is compared to the primary one.\r\n\r\n<strong>ICH guideline Q7 states:</strong>\r\n\r\n<em>11.17 Primary reference standards should be obtained as appropriate for the manufacture of APIs. The source of each primary reference standard should be documented. Records should be maintained of each primary reference standard’s storage and use in accordance with the supplier’s recommendations. Primary reference standards obtained from an officially recognized source are normally used without testing if stored under conditions consistent with the supplier’s recommendations.</em>\r\n\r\nOfficially recognized sources, however, are not specified in Q7, but the FDA does mention sources in their ‘Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics’ but, interestingly, does not refer to these institutions as an official or definitive list:\r\n\r\n<em>Reference standards can often be obtained from the USP and may also be available through the European Pharmacopoeia, Japanese Pharmacopoeia, World Health Organization, or National Institute of Standards and Technology. </em>\r\n\r\nInstead, the FDA states that <em>“reference materials from other sources should be characterized by procedures including routine and beyond routine release testing” and that producers “should consider orthogonal methods for reference material characterization”. </em>\r\n\r\nFor primary RSs, both the ICH guideline and FDA guidance allow other sources than the “officially recognized sources”. Independent manufacturers can provide such primary standards, ideally characterized by processes like those outlined in the general text 5.12. of the European Pharmacopoeia (Ph.Eur).\r\n\r\n<strong>Correct use of primary reference standards: what to keep in mind?</strong>\r\n\r\nIn essence, a primary RS needs to be fit for its intended purpose. A pharmacopoeial RS has been shown to be fit for its compendial purpose, but has not been demonstrated to be fit for any other purpose; this needs to be proven by the user. Consequently challenges of compendial standard use for non-compendial purposes have been reported in regulatory inspections. Other primary standards with fully documented CoAs can be used for most applications, providing they have been characterized appropriately. If a primary RS is used to establish a secondary standard then the secondary RS can only be used for the same purpose as the primary one.\r\n\r\n<strong>Pharmacopoeial reference standards</strong>\r\n\r\nReference standards from the pharmacopoeias – also often referred to as compendial RSs – are, in principle, primary standards that have a special status for use in connection with the monograph methods for which they have been designed.\r\n\r\nThis position is specified in the USP (United States Pharmacopeia) general chapter &lt;11&gt;:\r\n\r\n<em>When approved as suitable for use as comparison standards … in the United States Pharmacopeia (USP) or National Formulary (NF), USP RS also assume official status and legal recognition in the United States. Assessment of the suitability for use in other applications rests with the user.</em>\r\n\r\nIt is also described in the European Pharmacopoeia (Ph.Eur.) in general text 5.12.6:\r\n\r\n<em>European Pharmacopoeia reference standards are shown to be suitable for their intended purpose; they are not necessarily suitable for other purposes. Any value assigned to a reference standard is valid for the intended use and not necessarily for other uses.</em>\r\n\r\nSo, strictly speaking, the special status of a pharmacopoeial RS can only be assumed when the standards are used as required by the monographs. For anything other than these monograph purposes, compendial RSs stand on the same level as RSs from other sources. This means that you need to prove suitability of a compendial RS for the desired non-compendial purpose in the same way you would need to for any other RSs. This is clearly mentioned in the Ph.Eur. chapter 5.12., and can be seen as a blueprint for other compendial RS use as well:\r\n\r\n<em>If a European Pharmacopoeia reference standard is to be used for any purpose other than that for which it has been established, its suitability for the new use has to be fully demonstrated and when applicable, to be described in the marketing authorization application.</em>\r\n\r\nThe use of a compendial RS for non-monograph applications is also made difficult by the fact that certificates of analysis, which might otherwise provide a rich data set of characterization testing results, are normally not provided by the compendial institutions.\r\n\r\n<strong>Impurity reference standard (IRS)</strong>\r\n\r\nAlthough the term ‘primary impurity standard’ does not really exist, any impurity standard that is not compared to another material of the same chemical structure and which is fit for its designated purpose can be considered such a primary material.\r\n\r\nIRSs are designed to detect, identify, quantify and qualify impurities in a drug substance in accordance with the ICH guidelines (Q3A to Q3D and Q7). ICH Guidelines 3A to 3D regulate the approach to impurities in the pharmaceutical industry. ICH does not prioritize at any point any given range of standards over another, whether officially recognized or not, for use within the pharmaceutical industry.  According to these guidelines, impurities can be primarily classified into either drug substance or drug product impurities, referring in the first case to any component in the drug substance which is not the chemical entity itself. A drug product impurity, meanwhile, is any chemical entity present that is not the drug substance or an excipient used to manufacture the drug product. Based on the cause triggering their appearance, impurities can be classified as starting materials, by-products, intermediates, degradation products or reagents/ligands and catalysts. Finally, by their chemical nature, impurities can be classified as organic, inorganic or solvents.\r\n\r\nPharmacopoeial IRSs, like all compendial materials, are designed for the specific monograph purposes. For other purposes, an IRS from other sources suitable for the intended purpose should be preferred, for two major reasons:\r\n\r\n1:- The use of a pharmacopoeial IRS outside the monograph can be challenged by regulatory authorities. Customers have reported to us that authorities have insisted on a CoA for a pharmacopoeial IRS used for non-compendial purposes. A CoA is not provided by pharmacopoeial sources, rendering the material unsuitable for use without separate detailed internal characterization.\r\n\r\n2:-Furthermore, supply of pharmacopoeial IRSs can be insecure. For example, there have been occasions where a change in a monograph has resulted in a neat impurity standard being replaced by a system suitability or peak identification mixture, usually consisting of a mix of the API and traces of one or more impurities. Such a replacement is not a problem if the user works according to the monograph methods. However, if the pharmacopoeial material is used for non-compendial purposes, the laboratory might face a challenge replacing the neat IRS if it is not available anymore. If the pharmaceutical company has stated the use of that specific material in their dossier, they may even need to report the change to the authorities. Cessation of supply is also a risk with any catalogue reference standard provided by a third party, but switching between suppliers is significantly easier when the materials are “primary” and accompanied by CoAs.\r\n\r\nIn addition, the current regulation situation – especially for the finished dosage forms dealt with in ICH guideline Q3B – often requires additional impurity testing, on top of the requirements of the pharmacopoeial monographs. Then it can often be the case that there are no suitable impurity standards available from compendial sources, and the support of experienced commercial IRS manufacturers thus becomes necessary.\r\n\r\n<strong>Secondary standards</strong>\r\n\r\nThese compounds are second-line materials. They consist in each instance of a material that is compared against the primary material, and used in its place.\r\n\r\nIt does not matter whether the secondary standard is compared against a pharmacopoeial primary standard, or against a primary standard obtained in-house or from a third source. A secondary standard can only be used for the same purposes as the primary standard. Thus if a primary standard was designed solely for a qualitative purpose (i.e. identification via IR, system suitability test or peak identification), then to use the corresponding secondary standard for quantitative purposes is not valid. For example, a large number of Ph.Eur. reference standards for APIs have been set up for IR comparisons only, and should not be used as a basis for quantitative secondary standards.\r\n\r\nIn addition, the EDQM (European Directorate for the Quality of Medicines) does not recommend measuring secondary standards against even their quantitative materials. This is because:\r\n\r\n1:-While pharmacopoeial primary RSs have a determined measurement uncertainty (MU) in line with the requirements of the relevant pharmacopoeial monograph, the value of this uncertainty is not currently specified.\r\n\r\n2:-The comparison of a candidate material for a secondary RS to the pharmacopoeial RS will result – by the principle of uncertainty propagation – in a larger but non quantifiable MU for the secondary standard, by virtue of the fact that the MU for the pharmacopoeial material is not published\r\n\r\n3:-This unknown but enlarged MU for the secondary RS might no longer be appropriate for the acceptance interval specified in the relevant monograph.\r\n\r\nFor the same reason, the use of a pharmacopoeial RS with a non-compendial method can be difficult to justify on the basis that the uncertainty of its value assignment is unknown.\r\n\r\n<strong>Research materials</strong>\r\n\r\nOften used at the very beginning of analytical research and development, these should not be employed when the methods are fully developed. During validation and implementation in the QC or stability testing lab, they are usually replaced with better-characterized materials, especially when any quantitative purpose is connected with their usages.\r\n\r\nResearch materials come with only basic characterization data that makes them useful for initial development and identification work. They cannot be considered reference standards and can be distinguished from reference standards by their relatively simple CoA.\r\n\r\nCopyright © LGC Limited 2019 All rights reserved.\r\n\r\nFor further details on Mikromol reference standards,\r\n\r\n<strong><u>Please contact: </u></strong>\r\n\r\nJane Firth at LGC UK on <a href=\"mailto:jane.firth@lgcgroup.com\">jane.firth@lgcgroup.com</a> or\r\n\r\nSuryakanth.G at LGC India – <a href=\"mailto:Suryakanth.gudgunti@lgcgroup.com\">Suryakanth.gudgunti@lgcgroup.com</a>','Pharmaceutical quality control: the reference standards labyrinth','','publish','open','open','','pharmaceutical-quality-control-the-reference-standards-labyrinth','','','2019-12-05 11:36:17','2019-12-05 11:36:17','',0,'https://microbiozindia.com/?p=4029',0,'post','',0),(4030,2,'2019-12-04 17:53:37','2019-12-04 17:53:37','','hhh','','inherit','open','closed','','hhh','','','2019-12-04 17:53:37','2019-12-04 17:53:37','',4029,'https://microbiozindia.com/wp-content/uploads/2019/12/hhh.png',0,'attachment','image/png',0),(4031,2,'2019-12-04 17:57:46','2019-12-04 17:57:46','Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.\r\n\r\n<strong>Types of pharmaceutical reference standard (RS)</strong>\r\n\r\nIn the pharmaceutical area, there are four major types of reference standards:\r\n<ul>\r\n 	<li>Primary RS</li>\r\n 	<li>Pharmacopoeial RS (for monograph use)</li>\r\n 	<li>Secondary RS</li>\r\n 	<li>Impurity RS</li>\r\n</ul>\r\nApart from the pharmacopoeial standards, all of the above come with certificates of analysis (CoAs), or – in the case of a secondary RS – with a comparison statement. The information provided on the CoA should be suitable with regard to the specific use planned for the corresponding RS.\r\n\r\nThere is a fifth type – research materials – which is often used at the very beginning of analytical research and development, but not normally for method development, validation, transfer or quality control.\r\n\r\n<strong>Primary reference standards</strong>\r\n\r\nIn the pharmaceutical context, a primary reference standard is a standard for which the properties (usually identity, very often also purity/assay values) have been characterized by certain analytical techniques, without, however, being compared to any other standard of the same kind.\r\n\r\nThe definition for a primary standard in the GMP guideline Q7 of the ICH states:\r\n\r\n<em>Reference Standard, Primary</em>\r\n\r\n<em>A substance that has been shown by an extensive set of analytical tests to be authentic material that should be of high purity. This standard can be: (1) obtained from an officially recognized source, or (2) prepared by independent synthesis, or (3) obtained from existing production material of high purity, or (4) prepared by further purification of existing production material. </em>\r\n\r\n<strong>When to use a primary standard?</strong>\r\n\r\nIn pharmaceutical QC, the use of reference standards to calibrate the analytical procedure is mandatory when measurements are performed with relative methods such as HPLC in combination with a UV or MS detector. These measurements need to be traceable to a primary standard. This requirement is realized either by using the primary standard directly for the calibration purposes, or by using a secondary standard which is compared to the primary one.\r\n\r\n<strong>ICH guideline Q7 states:</strong>\r\n\r\n<em>11.17 Primary reference standards should be obtained as appropriate for the manufacture of APIs. The source of each primary reference standard should be documented. Records should be maintained of each primary reference standard’s storage and use in accordance with the supplier’s recommendations. Primary reference standards obtained from an officially recognized source are normally used without testing if stored under conditions consistent with the supplier’s recommendations.</em>\r\n\r\nOfficially recognized sources, however, are not specified in Q7, but the FDA does mention sources in their ‘Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics’ but, interestingly, does not refer to these institutions as an official or definitive list:\r\n\r\n<em>Reference standards can often be obtained from the USP and may also be available through the European Pharmacopoeia, Japanese Pharmacopoeia, World Health Organization, or National Institute of Standards and Technology. </em>\r\n\r\nInstead, the FDA states that <em>“reference materials from other sources should be characterized by procedures including routine and beyond routine release testing” and that producers “should consider orthogonal methods for reference material characterization”. </em>\r\n\r\nFor primary RSs, both the ICH guideline and FDA guidance allow other sources than the “officially recognized sources”. Independent manufacturers can provide such primary standards, ideally characterized by processes like those outlined in the general text 5.12. of the European Pharmacopoeia (Ph.Eur).\r\n\r\n<strong>Correct use of primary reference standards: what to keep in mind?</strong>\r\n\r\nIn essence, a primary RS needs to be fit for its intended purpose. A pharmacopoeial RS has been shown to be fit for its compendial purpose, but has not been demonstrated to be fit for any other purpose; this needs to be proven by the user. Consequently challenges of compendial standard use for non-compendial purposes have been reported in regulatory inspections. Other primary standards with fully documented CoAs can be used for most applications, providing they have been characterized appropriately. If a primary RS is used to establish a secondary standard then the secondary RS can only be used for the same purpose as the primary one.\r\n\r\n<strong>Pharmacopoeial reference standards</strong>\r\n\r\nReference standards from the pharmacopoeias – also often referred to as compendial RSs – are, in principle, primary standards that have a special status for use in connection with the monograph methods for which they have been designed.\r\n\r\nThis position is specified in the USP (United States Pharmacopeia) general chapter &lt;11&gt;:\r\n\r\n<em>When approved as suitable for use as comparison standards … in the United States Pharmacopeia (USP) or National Formulary (NF), USP RS also assume official status and legal recognition in the United States. Assessment of the suitability for use in other applications rests with the user.</em>\r\n\r\nIt is also described in the European Pharmacopoeia (Ph.Eur.) in general text 5.12.6:\r\n\r\n<em>European Pharmacopoeia reference standards are shown to be suitable for their intended purpose; they are not necessarily suitable for other purposes. Any value assigned to a reference standard is valid for the intended use and not necessarily for other uses.</em>\r\n\r\nSo, strictly speaking, the special status of a pharmacopoeial RS can only be assumed when the standards are used as required by the monographs. For anything other than these monograph purposes, compendial RSs stand on the same level as RSs from other sources. This means that you need to prove suitability of a compendial RS for the desired non-compendial purpose in the same way you would need to for any other RSs. This is clearly mentioned in the Ph.Eur. chapter 5.12., and can be seen as a blueprint for other compendial RS use as well:\r\n\r\n<em>If a European Pharmacopoeia reference standard is to be used for any purpose other than that for which it has been established, its suitability for the new use has to be fully demonstrated and when applicable, to be described in the marketing authorization application.</em>\r\n\r\nThe use of a compendial RS for non-monograph applications is also made difficult by the fact that certificates of analysis, which might otherwise provide a rich data set of characterization testing results, are normally not provided by the compendial institutions.\r\n\r\n<strong>Impurity reference standard (IRS)</strong>\r\n\r\nAlthough the term ‘primary impurity standard’ does not really exist, any impurity standard that is not compared to another material of the same chemical structure and which is fit for its designated purpose can be considered such a primary material.\r\n\r\nIRSs are designed to detect, identify, quantify and qualify impurities in a drug substance in accordance with the ICH guidelines (Q3A to Q3D and Q7). ICH Guidelines 3A to 3D regulate the approach to impurities in the pharmaceutical industry. ICH does not prioritize at any point any given range of standards over another, whether officially recognized or not, for use within the pharmaceutical industry.  According to these guidelines, impurities can be primarily classified into either drug substance or drug product impurities, referring in the first case to any component in the drug substance which is not the chemical entity itself. A drug product impurity, meanwhile, is any chemical entity present that is not the drug substance or an excipient used to manufacture the drug product. Based on the cause triggering their appearance, impurities can be classified as starting materials, by-products, intermediates, degradation products or reagents/ligands and catalysts. Finally, by their chemical nature, impurities can be classified as organic, inorganic or solvents.\r\n\r\nPharmacopoeial IRSs, like all compendial materials, are designed for the specific monograph purposes. For other purposes, an IRS from other sources suitable for the intended purpose should be preferred, for two major reasons:\r\n<ul>\r\n 	<li>The use of a pharmacopoeial IRS outside the monograph can be challenged by regulatory authorities. Customers have reported to us that authorities have insisted on a CoA for a pharmacopoeial IRS used for non-compendial purposes. A CoA is not provided by pharmacopoeial sources, rendering the material unsuitable for use without separate detailed internal characterization.</li>\r\n 	<li>Furthermore, supply of pharmacopoeial IRSs can be insecure. For example, there have been occasions where a change in a monograph has resulted in a neat impurity standard being replaced by a system suitability or peak identification mixture, usually consisting of a mix of the API and traces of one or more impurities. Such a replacement is not a problem if the user works according to the monograph methods. However, if the pharmacopoeial material is used for non-compendial purposes, the laboratory might face a challenge replacing the neat IRS if it is not available anymore. If the pharmaceutical company has stated the use of that specific material in their dossier, they may even need to report the change to the authorities. Cessation of supply is also a risk with any catalogue reference standard provided by a third party, but switching between suppliers is significantly easier when the materials are “primary” and accompanied by CoAs.</li>\r\n</ul>\r\nIn addition, the current regulation situation – especially for the finished dosage forms dealt with in ICH guideline Q3B – often requires additional impurity testing, on top of the requirements of the pharmacopoeial monographs. Then it can often be the case that there are no suitable impurity standards available from compendial sources, and the support of experienced commercial IRS manufacturers thus becomes necessary.\r\n\r\n<strong>Secondary standards</strong>\r\n\r\nThese compounds are second-line materials. They consist in each instance of a material that is compared against the primary material, and used in its place.\r\n\r\nIt does not matter whether the secondary standard is compared against a pharmacopoeial primary standard, or against a primary standard obtained in-house or from a third source. A secondary standard can only be used for the same purposes as the primary standard. Thus if a primary standard was designed solely for a qualitative purpose (i.e. identification via IR, system suitability test or peak identification), then to use the corresponding secondary standard for quantitative purposes is not valid. For example, a large number of Ph.Eur. reference standards for APIs have been set up for IR comparisons only, and should not be used as a basis for quantitative secondary standards.\r\n\r\nIn addition, the EDQM (European Directorate for the Quality of Medicines) does not recommend measuring secondary standards against even their quantitative materials. This is because:\r\n<ul>\r\n 	<li>While pharmacopoeial primary RSs have a determined measurement uncertainty (MU) in line with the requirements of the relevant pharmacopoeial monograph, the value of this uncertainty is not currently specified.</li>\r\n 	<li>The comparison of a candidate material for a secondary RS to the pharmacopoeial RS will result – by the principle of uncertainty propagation – in a larger but non quantifiable MU for the secondary standard, by virtue of the fact that the MU for the pharmacopoeial material is not published</li>\r\n 	<li>This unknown but enlarged MU for the secondary RS might no longer be appropriate for the acceptance interval specified in the relevant monograph.</li>\r\n</ul>\r\nFor the same reason, the use of a pharmacopoeial RS with a non-compendial method can be difficult to justify on the basis that the uncertainty of its value assignment is unknown.\r\n\r\n<strong>Research materials</strong>\r\n\r\nOften used at the very beginning of analytical research and development, these should not be employed when the methods are fully developed. During validation and implementation in the QC or stability testing lab, they are usually replaced with better-characterized materials, especially when any quantitative purpose is connected with their usages.\r\n\r\nResearch materials come with only basic characterization data that makes them useful for initial development and identification work. They cannot be considered reference standards and can be distinguished from reference standards by their relatively simple CoA.\r\n\r\nCopyright © LGC Limited 2019 All rights reserved.\r\n\r\nFor further details on Mikromol reference standards,\r\n\r\n<strong><u>Please contact: </u></strong>\r\n\r\nJane Firth at LGC UK on <a href=\"mailto:jane.firth@lgcgroup.com\">jane.firth@lgcgroup.com</a> or\r\n\r\nSuryakanth.G at LGC India – <a href=\"mailto:Suryakanth.gudgunti@lgcgroup.com\">Suryakanth.gudgunti@lgcgroup.com</a>','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4029-revision-v1','','','2019-12-04 17:57:46','2019-12-04 17:57:46','',4029,'https://microbiozindia.com/uncategorized/4029-revision-v1/',0,'revision','',0),(4032,2,'2019-12-04 18:08:02','2019-12-04 18:08:02','Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.\n\n<strong>Types of pharmaceutical reference standard (RS)</strong>\n\nIn the pharmaceutical area, there are four major types of reference standards:\n<ul>\n 	<li>Primary RS</li>\n 	<li>Pharmacopoeial RS (for monograph use)</li>\n 	<li>Secondary RS</li>\n 	<li>Impurity RS</li>\n</ul>\nApart from the pharmacopoeial standards, all of the above come with certificates of analysis (CoAs), or – in the case of a secondary RS – with a comparison statement. The information provided on the CoA should be suitable with regard to the specific use planned for the corresponding RS.\n\nThere is a fifth type – research materials – which is often used at the very beginning of analytical research and development, but not normally for method development, validation, transfer or quality control.\n\n<strong>Primary reference standards</strong>\n\nIn the pharmaceutical context, a primary reference standard is a standard for which the properties (usually identity, very often also purity/assay values) have been characterized by certain analytical techniques, without, however, being compared to any other standard of the same kind.\n\nThe definition for a primary standard in the GMP guideline Q7 of the ICH states:\n\n<em>Reference Standard, Primary</em>\n\n<em>A substance that has been shown by an extensive set of analytical tests to be authentic material that should be of high purity. This standard can be: (1) obtained from an officially recognized source, or (2) prepared by independent synthesis, or (3) obtained from existing production material of high purity, or (4) prepared by further purification of existing production material. </em>\n\n<strong>When to use a primary standard?</strong>\n\nIn pharmaceutical QC, the use of reference standards to calibrate the analytical procedure is mandatory when measurements are performed with relative methods such as HPLC in combination with a UV or MS detector. These measurements need to be traceable to a primary standard. This requirement is realized either by using the primary standard directly for the calibration purposes, or by using a secondary standard which is compared to the primary one.\n\n<strong>ICH guideline Q7 states:</strong>\n\n<em>11.17 Primary reference standards should be obtained as appropriate for the manufacture of APIs. The source of each primary reference standard should be documented. Records should be maintained of each primary reference standard’s storage and use in accordance with the supplier’s recommendations. Primary reference standards obtained from an officially recognized source are normally used without testing if stored under conditions consistent with the supplier’s recommendations.</em>\n\nOfficially recognized sources, however, are not specified in Q7, but the FDA does mention sources in their ‘Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics’ but, interestingly, does not refer to these institutions as an official or definitive list:\n\n<em>Reference standards can often be obtained from the USP and may also be available through the European Pharmacopoeia, Japanese Pharmacopoeia, World Health Organization, or National Institute of Standards and Technology. </em>\n\nInstead, the FDA states that <em>“reference materials from other sources should be characterized by procedures including routine and beyond routine release testing” and that producers “should consider orthogonal methods for reference material characterization”. </em>\n\nFor primary RSs, both the ICH guideline and FDA guidance allow other sources than the “officially recognized sources”. Independent manufacturers can provide such primary standards, ideally characterized by processes like those outlined in the general text 5.12. of the European Pharmacopoeia (Ph.Eur).\n\n<strong>Correct use of primary reference standards: what to keep in mind?</strong>\n\nIn essence, a primary RS needs to be fit for its intended purpose. A pharmacopoeial RS has been shown to be fit for its compendial purpose, but has not been demonstrated to be fit for any other purpose; this needs to be proven by the user. Consequently challenges of compendial standard use for non-compendial purposes have been reported in regulatory inspections. Other primary standards with fully documented CoAs can be used for most applications, providing they have been characterized appropriately. If a primary RS is used to establish a secondary standard then the secondary RS can only be used for the same purpose as the primary one.\n\n<strong>Pharmacopoeial reference standards</strong>\n\nReference standards from the pharmacopoeias – also often referred to as compendial RSs – are, in principle, primary standards that have a special status for use in connection with the monograph methods for which they have been designed.\n\nThis position is specified in the USP (United States Pharmacopeia) general chapter &lt;11&gt;:\n\n<em>When approved as suitable for use as comparison standards … in the United States Pharmacopeia (USP) or National Formulary (NF), USP RS also assume official status and legal recognition in the United States. Assessment of the suitability for use in other applications rests with the user.</em>\n\nIt is also described in the European Pharmacopoeia (Ph.Eur.) in general text 5.12.6:\n\n<em>European Pharmacopoeia reference standards are shown to be suitable for their intended purpose; they are not necessarily suitable for other purposes. Any value assigned to a reference standard is valid for the intended use and not necessarily for other uses.</em>\n\nSo, strictly speaking, the special status of a pharmacopoeial RS can only be assumed when the standards are used as required by the monographs. For anything other than these monograph purposes, compendial RSs stand on the same level as RSs from other sources. This means that you need to prove suitability of a compendial RS for the desired non-compendial purpose in the same way you would need to for any other RSs. This is clearly mentioned in the Ph.Eur. chapter 5.12., and can be seen as a blueprint for other compendial RS use as well:\n\n<em>If a European Pharmacopoeia reference standard is to be used for any purpose other than that for which it has been established, its suitability for the new use has to be fully demonstrated and when applicable, to be described in the marketing authorization application.</em>\n\nThe use of a compendial RS for non-monograph applications is also made difficult by the fact that certificates of analysis, which might otherwise provide a rich data set of characterization testing results, are normally not provided by the compendial institutions.\n\n<strong>Impurity reference standard (IRS)</strong>\n\nAlthough the term ‘primary impurity standard’ does not really exist, any impurity standard that is not compared to another material of the same chemical structure and which is fit for its designated purpose can be considered such a primary material.\n\nIRSs are designed to detect, identify, quantify and qualify impurities in a drug substance in accordance with the ICH guidelines (Q3A to Q3D and Q7). ICH Guidelines 3A to 3D regulate the approach to impurities in the pharmaceutical industry. ICH does not prioritize at any point any given range of standards over another, whether officially recognized or not, for use within the pharmaceutical industry.  According to these guidelines, impurities can be primarily classified into either drug substance or drug product impurities, referring in the first case to any component in the drug substance which is not the chemical entity itself. A drug product impurity, meanwhile, is any chemical entity present that is not the drug substance or an excipient used to manufacture the drug product. Based on the cause triggering their appearance, impurities can be classified as starting materials, by-products, intermediates, degradation products or reagents/ligands and catalysts. Finally, by their chemical nature, impurities can be classified as organic, inorganic or solvents.\n\nPharmacopoeial IRSs, like all compendial materials, are designed for the specific monograph purposes. For other purposes, an IRS from other sources suitable for the intended purpose should be preferred, for two major reasons:\n<ol>\n 	<li>The use of a pharmacopoeial IRS outside the monograph can be challenged by regulatory authorities. Customers have reported to us that authorities have insisted on a CoA for a pharmacopoeial IRS used for non-compendial purposes. A CoA is not provided by pharmacopoeial sources, rendering the material unsuitable for use without separate detailed internal characterization.</li>\n 	<li>Furthermore, supply of pharmacopoeial IRSs can be insecure. For example, there have been occasions where a change in a monograph has resulted in a neat impurity standard being replaced by a system suitability or peak identification mixture, usually consisting of a mix of the API and traces of one or more impurities. Such a replacement is not a problem if the user works according to the monograph methods. However, if the pharmacopoeial material is used for non-compendial purposes, the laboratory might face a challenge replacing the neat IRS if it is not available anymore. If the pharmaceutical company has stated the use of that specific material in their dossier, they may even need to report the change to the authorities. Cessation of supply is also a risk with any catalogue reference standard provided by a third party, but switching between suppliers is significantly easier when the materials are “primary” and accompanied by CoAs.</li>\n</ol>\nIn addition, the current regulation situation – especially for the finished dosage forms dealt with in ICH guideline Q3B – often requires additional impurity testing, on top of the requirements of the pharmacopoeial monographs. Then it can often be the case that there are no suitable impurity standards available from compendial sources, and the support of experienced commercial IRS manufacturers thus becomes necessary.\n\n<strong>Secondary standards</strong>\n\nThese compounds are second-line materials. They consist in each instance of a material that is compared against the primary material, and used in its place.\n\nIt does not matter whether the secondary standard is compared against a pharmacopoeial primary standard, or against a primary standard obtained in-house or from a third source. A secondary standard can only be used for the same purposes as the primary standard. Thus if a primary standard was designed solely for a qualitative purpose (i.e. identification via IR, system suitability test or peak identification), then to use the corresponding secondary standard for quantitative purposes is not valid. For example, a large number of Ph.Eur. reference standards for APIs have been set up for IR comparisons only, and should not be used as a basis for quantitative secondary standards.\n\nIn addition, the EDQM (European Directorate for the Quality of Medicines) does not recommend measuring secondary standards against even their quantitative materials. This is because:\n<ul>\n 	<li>While pharmacopoeial primary RSs have a determined measurement uncertainty (MU) in line with the requirements of the relevant pharmacopoeial monograph, the value of this uncertainty is not currently specified.</li>\n 	<li>The comparison of a candidate material for a secondary RS to the pharmacopoeial RS will result – by the principle of uncertainty propagation – in a larger but non quantifiable MU for the secondary standard, by virtue of the fact that the MU for the pharmacopoeial material is not published</li>\n 	<li>This unknown but enlarged MU for the secondary RS might no longer be appropriate for the acceptance interval specified in the relevant monograph.</li>\n</ul>\nFor the same reason, the use of a pharmacopoeial RS with a non-compendial method can be difficult to justify on the basis that the uncertainty of its value assignment is unknown.\n\n<strong>Research materials</strong>\n\nOften used at the very beginning of analytical research and development, these should not be employed when the methods are fully developed. During validation and implementation in the QC or stability testing lab, they are usually replaced with better-characterized materials, especially when any quantitative purpose is connected with their usages.\n\nResearch materials come with only basic characterization data that makes them useful for initial development and identification work. They cannot be considered reference standards and can be distinguished from reference standards by their relatively simple CoA.\n\nCopyright © LGC Limited 2019 All rights reserved.\n\nFor further details on Mikromol reference standards,\n\n<strong><u>Please contact: </u></strong>\n\nJane Firth at LGC UK on <a href=\"mailto:jane.firth@lgcgroup.com\">jane.firth@lgcgroup.com</a> or\n\nSuryakanth.G at LGC India – <a href=\"mailto:Suryakanth.gudgunti@lgcgroup.com\">Suryakanth.gudgunti@lgcgroup.com</a>','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4029-autosave-v1','','','2019-12-04 18:08:02','2019-12-04 18:08:02','',4029,'https://microbiozindia.com/uncategorized/4029-autosave-v1/',0,'revision','',0),(4033,2,'2019-12-04 18:06:49','2019-12-04 18:06:49','Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.\r\n\r\n<strong>Types of pharmaceutical reference standard (RS)</strong>\r\n\r\nIn the pharmaceutical area, there are four major types of reference standards:\r\n<ol>\r\n 	<li>Primary RS</li>\r\n 	<li>Pharmacopoeial RS (for monograph use)</li>\r\n 	<li>Secondary RS</li>\r\n 	<li>Impurity RS</li>\r\n</ol>\r\nApart from the pharmacopoeial standards, all of the above come with certificates of analysis (CoAs), or – in the case of a secondary RS – with a comparison statement. The information provided on the CoA should be suitable with regard to the specific use planned for the corresponding RS.\r\n\r\nThere is a fifth type – research materials – which is often used at the very beginning of analytical research and development, but not normally for method development, validation, transfer or quality control.\r\n\r\n<strong>Primary reference standards</strong>\r\n\r\nIn the pharmaceutical context, a primary reference standard is a standard for which the properties (usually identity, very often also purity/assay values) have been characterized by certain analytical techniques, without, however, being compared to any other standard of the same kind.\r\n\r\nThe definition for a primary standard in the GMP guideline Q7 of the ICH states:\r\n\r\n<em>Reference Standard, Primary</em>\r\n\r\n<em>A substance that has been shown by an extensive set of analytical tests to be authentic material that should be of high purity. This standard can be: (1) obtained from an officially recognized source, or (2) prepared by independent synthesis, or (3) obtained from existing production material of high purity, or (4) prepared by further purification of existing production material. </em>\r\n\r\n<strong>When to use a primary standard?</strong>\r\n\r\nIn pharmaceutical QC, the use of reference standards to calibrate the analytical procedure is mandatory when measurements are performed with relative methods such as HPLC in combination with a UV or MS detector. These measurements need to be traceable to a primary standard. This requirement is realized either by using the primary standard directly for the calibration purposes, or by using a secondary standard which is compared to the primary one.\r\n\r\n<strong>ICH guideline Q7 states:</strong>\r\n\r\n<em>11.17 Primary reference standards should be obtained as appropriate for the manufacture of APIs. The source of each primary reference standard should be documented. Records should be maintained of each primary reference standard’s storage and use in accordance with the supplier’s recommendations. Primary reference standards obtained from an officially recognized source are normally used without testing if stored under conditions consistent with the supplier’s recommendations.</em>\r\n\r\nOfficially recognized sources, however, are not specified in Q7, but the FDA does mention sources in their ‘Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics’ but, interestingly, does not refer to these institutions as an official or definitive list:\r\n\r\n<em>Reference standards can often be obtained from the USP and may also be available through the European Pharmacopoeia, Japanese Pharmacopoeia, World Health Organization, or National Institute of Standards and Technology. </em>\r\n\r\nInstead, the FDA states that <em>“reference materials from other sources should be characterized by procedures including routine and beyond routine release testing” and that producers “should consider orthogonal methods for reference material characterization”. </em>\r\n\r\nFor primary RSs, both the ICH guideline and FDA guidance allow other sources than the “officially recognized sources”. Independent manufacturers can provide such primary standards, ideally characterized by processes like those outlined in the general text 5.12. of the European Pharmacopoeia (Ph.Eur).\r\n\r\n<strong>Correct use of primary reference standards: what to keep in mind?</strong>\r\n\r\nIn essence, a primary RS needs to be fit for its intended purpose. A pharmacopoeial RS has been shown to be fit for its compendial purpose, but has not been demonstrated to be fit for any other purpose; this needs to be proven by the user. Consequently challenges of compendial standard use for non-compendial purposes have been reported in regulatory inspections. Other primary standards with fully documented CoAs can be used for most applications, providing they have been characterized appropriately. If a primary RS is used to establish a secondary standard then the secondary RS can only be used for the same purpose as the primary one.\r\n\r\n<strong>Pharmacopoeial reference standards</strong>\r\n\r\nReference standards from the pharmacopoeias – also often referred to as compendial RSs – are, in principle, primary standards that have a special status for use in connection with the monograph methods for which they have been designed.\r\n\r\nThis position is specified in the USP (United States Pharmacopeia) general chapter &lt;11&gt;:\r\n\r\n<em>When approved as suitable for use as comparison standards … in the United States Pharmacopeia (USP) or National Formulary (NF), USP RS also assume official status and legal recognition in the United States. Assessment of the suitability for use in other applications rests with the user.</em>\r\n\r\nIt is also described in the European Pharmacopoeia (Ph.Eur.) in general text 5.12.6:\r\n\r\n<em>European Pharmacopoeia reference standards are shown to be suitable for their intended purpose; they are not necessarily suitable for other purposes. Any value assigned to a reference standard is valid for the intended use and not necessarily for other uses.</em>\r\n\r\nSo, strictly speaking, the special status of a pharmacopoeial RS can only be assumed when the standards are used as required by the monographs. For anything other than these monograph purposes, compendial RSs stand on the same level as RSs from other sources. This means that you need to prove suitability of a compendial RS for the desired non-compendial purpose in the same way you would need to for any other RSs. This is clearly mentioned in the Ph.Eur. chapter 5.12., and can be seen as a blueprint for other compendial RS use as well:\r\n\r\n<em>If a European Pharmacopoeia reference standard is to be used for any purpose other than that for which it has been established, its suitability for the new use has to be fully demonstrated and when applicable, to be described in the marketing authorization application.</em>\r\n\r\nThe use of a compendial RS for non-monograph applications is also made difficult by the fact that certificates of analysis, which might otherwise provide a rich data set of characterization testing results, are normally not provided by the compendial institutions.\r\n\r\n<strong>Impurity reference standard (IRS)</strong>\r\n\r\nAlthough the term ‘primary impurity standard’ does not really exist, any impurity standard that is not compared to another material of the same chemical structure and which is fit for its designated purpose can be considered such a primary material.\r\n\r\nIRSs are designed to detect, identify, quantify and qualify impurities in a drug substance in accordance with the ICH guidelines (Q3A to Q3D and Q7). ICH Guidelines 3A to 3D regulate the approach to impurities in the pharmaceutical industry. ICH does not prioritize at any point any given range of standards over another, whether officially recognized or not, for use within the pharmaceutical industry.  According to these guidelines, impurities can be primarily classified into either drug substance or drug product impurities, referring in the first case to any component in the drug substance which is not the chemical entity itself. A drug product impurity, meanwhile, is any chemical entity present that is not the drug substance or an excipient used to manufacture the drug product. Based on the cause triggering their appearance, impurities can be classified as starting materials, by-products, intermediates, degradation products or reagents/ligands and catalysts. Finally, by their chemical nature, impurities can be classified as organic, inorganic or solvents.\r\n\r\nPharmacopoeial IRSs, like all compendial materials, are designed for the specific monograph purposes. For other purposes, an IRS from other sources suitable for the intended purpose should be preferred, for two major reasons:\r\n<ol>\r\n 	<li>The use of a pharmacopoeial IRS outside the monograph can be challenged by regulatory authorities. Customers have reported to us that authorities have insisted on a CoA for a pharmacopoeial IRS used for non-compendial purposes. A CoA is not provided by pharmacopoeial sources, rendering the material unsuitable for use without separate detailed internal characterization.</li>\r\n 	<li>Furthermore, supply of pharmacopoeial IRSs can be insecure. For example, there have been occasions where a change in a monograph has resulted in a neat impurity standard being replaced by a system suitability or peak identification mixture, usually consisting of a mix of the API and traces of one or more impurities. Such a replacement is not a problem if the user works according to the monograph methods. However, if the pharmacopoeial material is used for non-compendial purposes, the laboratory might face a challenge replacing the neat IRS if it is not available anymore. If the pharmaceutical company has stated the use of that specific material in their dossier, they may even need to report the change to the authorities. Cessation of supply is also a risk with any catalogue reference standard provided by a third party, but switching between suppliers is significantly easier when the materials are “primary” and accompanied by CoAs.</li>\r\n</ol>\r\nIn addition, the current regulation situation – especially for the finished dosage forms dealt with in ICH guideline Q3B – often requires additional impurity testing, on top of the requirements of the pharmacopoeial monographs. Then it can often be the case that there are no suitable impurity standards available from compendial sources, and the support of experienced commercial IRS manufacturers thus becomes necessary.\r\n\r\n<strong>Secondary standards</strong>\r\n\r\nThese compounds are second-line materials. They consist in each instance of a material that is compared against the primary material, and used in its place.\r\n\r\nIt does not matter whether the secondary standard is compared against a pharmacopoeial primary standard, or against a primary standard obtained in-house or from a third source. A secondary standard can only be used for the same purposes as the primary standard. Thus if a primary standard was designed solely for a qualitative purpose (i.e. identification via IR, system suitability test or peak identification), then to use the corresponding secondary standard for quantitative purposes is not valid. For example, a large number of Ph.Eur. reference standards for APIs have been set up for IR comparisons only, and should not be used as a basis for quantitative secondary standards.\r\n\r\nIn addition, the EDQM (European Directorate for the Quality of Medicines) does not recommend measuring secondary standards against even their quantitative materials. This is because:\r\n<ul>\r\n 	<li>While pharmacopoeial primary RSs have a determined measurement uncertainty (MU) in line with the requirements of the relevant pharmacopoeial monograph, the value of this uncertainty is not currently specified.</li>\r\n 	<li>The comparison of a candidate material for a secondary RS to the pharmacopoeial RS will result – by the principle of uncertainty propagation – in a larger but non quantifiable MU for the secondary standard, by virtue of the fact that the MU for the pharmacopoeial material is not published</li>\r\n 	<li>This unknown but enlarged MU for the secondary RS might no longer be appropriate for the acceptance interval specified in the relevant monograph.</li>\r\n</ul>\r\nFor the same reason, the use of a pharmacopoeial RS with a non-compendial method can be difficult to justify on the basis that the uncertainty of its value assignment is unknown.\r\n\r\n<strong>Research materials</strong>\r\n\r\nOften used at the very beginning of analytical research and development, these should not be employed when the methods are fully developed. During validation and implementation in the QC or stability testing lab, they are usually replaced with better-characterized materials, especially when any quantitative purpose is connected with their usages.\r\n\r\nResearch materials come with only basic characterization data that makes them useful for initial development and identification work. They cannot be considered reference standards and can be distinguished from reference standards by their relatively simple CoA.\r\n\r\nCopyright © LGC Limited 2019 All rights reserved.\r\n\r\nFor further details on Mikromol reference standards,\r\n\r\n<strong><u>Please contact: </u></strong>\r\n\r\nJane Firth at LGC UK on <a href=\"mailto:jane.firth@lgcgroup.com\">jane.firth@lgcgroup.com</a> or\r\n\r\nSuryakanth.G at LGC India – <a href=\"mailto:Suryakanth.gudgunti@lgcgroup.com\">Suryakanth.gudgunti@lgcgroup.com</a>','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4029-revision-v1','','','2019-12-04 18:06:49','2019-12-04 18:06:49','',4029,'https://microbiozindia.com/uncategorized/4029-revision-v1/',0,'revision','',0),(4034,2,'2019-12-04 18:09:22','2019-12-04 18:09:22','Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.\r\n\r\n<strong>Types of pharmaceutical reference standard (RS)</strong>\r\n\r\nIn the pharmaceutical area, there are four major types of reference standards:\r\n\r\n1;-Primary RS\r\n\r\n2:-Pharmacopoeial RS (for monograph use)\r\n\r\n3:-Secondary RS\r\n\r\n4:-Impurity RS\r\n\r\nApart from the pharmacopoeial standards, all of the above come with certificates of analysis (CoAs), or – in the case of a secondary RS – with a comparison statement. The information provided on the CoA should be suitable with regard to the specific use planned for the corresponding RS.\r\n\r\nThere is a fifth type – research materials – which is often used at the very beginning of analytical research and development, but not normally for method development, validation, transfer or quality control.\r\n\r\n<strong>Primary reference standards</strong>\r\n\r\nIn the pharmaceutical context, a primary reference standard is a standard for which the properties (usually identity, very often also purity/assay values) have been characterized by certain analytical techniques, without, however, being compared to any other standard of the same kind.\r\n\r\nThe definition for a primary standard in the GMP guideline Q7 of the ICH states:\r\n\r\n<em>Reference Standard, Primary</em>\r\n\r\n<em>A substance that has been shown by an extensive set of analytical tests to be authentic material that should be of high purity. This standard can be: (1) obtained from an officially recognized source, or (2) prepared by independent synthesis, or (3) obtained from existing production material of high purity, or (4) prepared by further purification of existing production material. </em>\r\n\r\n<strong>When to use a primary standard?</strong>\r\n\r\nIn pharmaceutical QC, the use of reference standards to calibrate the analytical procedure is mandatory when measurements are performed with relative methods such as HPLC in combination with a UV or MS detector. These measurements need to be traceable to a primary standard. This requirement is realized either by using the primary standard directly for the calibration purposes, or by using a secondary standard which is compared to the primary one.\r\n\r\n<strong>ICH guideline Q7 states:</strong>\r\n\r\n<em>11.17 Primary reference standards should be obtained as appropriate for the manufacture of APIs. The source of each primary reference standard should be documented. Records should be maintained of each primary reference standard’s storage and use in accordance with the supplier’s recommendations. Primary reference standards obtained from an officially recognized source are normally used without testing if stored under conditions consistent with the supplier’s recommendations.</em>\r\n\r\nOfficially recognized sources, however, are not specified in Q7, but the FDA does mention sources in their ‘Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics’ but, interestingly, does not refer to these institutions as an official or definitive list:\r\n\r\n<em>Reference standards can often be obtained from the USP and may also be available through the European Pharmacopoeia, Japanese Pharmacopoeia, World Health Organization, or National Institute of Standards and Technology. </em>\r\n\r\nInstead, the FDA states that <em>“reference materials from other sources should be characterized by procedures including routine and beyond routine release testing” and that producers “should consider orthogonal methods for reference material characterization”. </em>\r\n\r\nFor primary RSs, both the ICH guideline and FDA guidance allow other sources than the “officially recognized sources”. Independent manufacturers can provide such primary standards, ideally characterized by processes like those outlined in the general text 5.12. of the European Pharmacopoeia (Ph.Eur).\r\n\r\n<strong>Correct use of primary reference standards: what to keep in mind?</strong>\r\n\r\nIn essence, a primary RS needs to be fit for its intended purpose. A pharmacopoeial RS has been shown to be fit for its compendial purpose, but has not been demonstrated to be fit for any other purpose; this needs to be proven by the user. Consequently challenges of compendial standard use for non-compendial purposes have been reported in regulatory inspections. Other primary standards with fully documented CoAs can be used for most applications, providing they have been characterized appropriately. If a primary RS is used to establish a secondary standard then the secondary RS can only be used for the same purpose as the primary one.\r\n\r\n<strong>Pharmacopoeial reference standards</strong>\r\n\r\nReference standards from the pharmacopoeias – also often referred to as compendial RSs – are, in principle, primary standards that have a special status for use in connection with the monograph methods for which they have been designed.\r\n\r\nThis position is specified in the USP (United States Pharmacopeia) general chapter &lt;11&gt;:\r\n\r\n<em>When approved as suitable for use as comparison standards … in the United States Pharmacopeia (USP) or National Formulary (NF), USP RS also assume official status and legal recognition in the United States. Assessment of the suitability for use in other applications rests with the user.</em>\r\n\r\nIt is also described in the European Pharmacopoeia (Ph.Eur.) in general text 5.12.6:\r\n\r\n<em>European Pharmacopoeia reference standards are shown to be suitable for their intended purpose; they are not necessarily suitable for other purposes. Any value assigned to a reference standard is valid for the intended use and not necessarily for other uses.</em>\r\n\r\nSo, strictly speaking, the special status of a pharmacopoeial RS can only be assumed when the standards are used as required by the monographs. For anything other than these monograph purposes, compendial RSs stand on the same level as RSs from other sources. This means that you need to prove suitability of a compendial RS for the desired non-compendial purpose in the same way you would need to for any other RSs. This is clearly mentioned in the Ph.Eur. chapter 5.12., and can be seen as a blueprint for other compendial RS use as well:\r\n\r\n<em>If a European Pharmacopoeia reference standard is to be used for any purpose other than that for which it has been established, its suitability for the new use has to be fully demonstrated and when applicable, to be described in the marketing authorization application.</em>\r\n\r\nThe use of a compendial RS for non-monograph applications is also made difficult by the fact that certificates of analysis, which might otherwise provide a rich data set of characterization testing results, are normally not provided by the compendial institutions.\r\n\r\n<strong>Impurity reference standard (IRS)</strong>\r\n\r\nAlthough the term ‘primary impurity standard’ does not really exist, any impurity standard that is not compared to another material of the same chemical structure and which is fit for its designated purpose can be considered such a primary material.\r\n\r\nIRSs are designed to detect, identify, quantify and qualify impurities in a drug substance in accordance with the ICH guidelines (Q3A to Q3D and Q7). ICH Guidelines 3A to 3D regulate the approach to impurities in the pharmaceutical industry. ICH does not prioritize at any point any given range of standards over another, whether officially recognized or not, for use within the pharmaceutical industry.  According to these guidelines, impurities can be primarily classified into either drug substance or drug product impurities, referring in the first case to any component in the drug substance which is not the chemical entity itself. A drug product impurity, meanwhile, is any chemical entity present that is not the drug substance or an excipient used to manufacture the drug product. Based on the cause triggering their appearance, impurities can be classified as starting materials, by-products, intermediates, degradation products or reagents/ligands and catalysts. Finally, by their chemical nature, impurities can be classified as organic, inorganic or solvents.\r\n\r\nPharmacopoeial IRSs, like all compendial materials, are designed for the specific monograph purposes. For other purposes, an IRS from other sources suitable for the intended purpose should be preferred, for two major reasons:\r\n\r\n1:- The use of a pharmacopoeial IRS outside the monograph can be challenged by regulatory authorities. Customers have reported to us that authorities have insisted on a CoA for a pharmacopoeial IRS used for non-compendial purposes. A CoA is not provided by pharmacopoeial sources, rendering the material unsuitable for use without separate detailed internal characterization.\r\n\r\n2:-Furthermore, supply of pharmacopoeial IRSs can be insecure. For example, there have been occasions where a change in a monograph has resulted in a neat impurity standard being replaced by a system suitability or peak identification mixture, usually consisting of a mix of the API and traces of one or more impurities. Such a replacement is not a problem if the user works according to the monograph methods. However, if the pharmacopoeial material is used for non-compendial purposes, the laboratory might face a challenge replacing the neat IRS if it is not available anymore. If the pharmaceutical company has stated the use of that specific material in their dossier, they may even need to report the change to the authorities. Cessation of supply is also a risk with any catalogue reference standard provided by a third party, but switching between suppliers is significantly easier when the materials are “primary” and accompanied by CoAs.\r\n\r\nIn addition, the current regulation situation – especially for the finished dosage forms dealt with in ICH guideline Q3B – often requires additional impurity testing, on top of the requirements of the pharmacopoeial monographs. Then it can often be the case that there are no suitable impurity standards available from compendial sources, and the support of experienced commercial IRS manufacturers thus becomes necessary.\r\n\r\n<strong>Secondary standards</strong>\r\n\r\nThese compounds are second-line materials. They consist in each instance of a material that is compared against the primary material, and used in its place.\r\n\r\nIt does not matter whether the secondary standard is compared against a pharmacopoeial primary standard, or against a primary standard obtained in-house or from a third source. A secondary standard can only be used for the same purposes as the primary standard. Thus if a primary standard was designed solely for a qualitative purpose (i.e. identification via IR, system suitability test or peak identification), then to use the corresponding secondary standard for quantitative purposes is not valid. For example, a large number of Ph.Eur. reference standards for APIs have been set up for IR comparisons only, and should not be used as a basis for quantitative secondary standards.\r\n\r\nIn addition, the EDQM (European Directorate for the Quality of Medicines) does not recommend measuring secondary standards against even their quantitative materials. This is because:\r\n<ul>\r\n 	<li>While pharmacopoeial primary RSs have a determined measurement uncertainty (MU) in line with the requirements of the relevant pharmacopoeial monograph, the value of this uncertainty is not currently specified.</li>\r\n 	<li>The comparison of a candidate material for a secondary RS to the pharmacopoeial RS will result – by the principle of uncertainty propagation – in a larger but non quantifiable MU for the secondary standard, by virtue of the fact that the MU for the pharmacopoeial material is not published</li>\r\n 	<li>This unknown but enlarged MU for the secondary RS might no longer be appropriate for the acceptance interval specified in the relevant monograph.</li>\r\n</ul>\r\nFor the same reason, the use of a pharmacopoeial RS with a non-compendial method can be difficult to justify on the basis that the uncertainty of its value assignment is unknown.\r\n\r\n<strong>Research materials</strong>\r\n\r\nOften used at the very beginning of analytical research and development, these should not be employed when the methods are fully developed. During validation and implementation in the QC or stability testing lab, they are usually replaced with better-characterized materials, especially when any quantitative purpose is connected with their usages.\r\n\r\nResearch materials come with only basic characterization data that makes them useful for initial development and identification work. They cannot be considered reference standards and can be distinguished from reference standards by their relatively simple CoA.\r\n\r\nCopyright © LGC Limited 2019 All rights reserved.\r\n\r\nFor further details on Mikromol reference standards,\r\n\r\n<strong><u>Please contact: </u></strong>\r\n\r\nJane Firth at LGC UK on <a href=\"mailto:jane.firth@lgcgroup.com\">jane.firth@lgcgroup.com</a> or\r\n\r\nSuryakanth.G at LGC India – <a href=\"mailto:Suryakanth.gudgunti@lgcgroup.com\">Suryakanth.gudgunti@lgcgroup.com</a>','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4029-revision-v1','','','2019-12-04 18:09:22','2019-12-04 18:09:22','',4029,'https://microbiozindia.com/uncategorized/4029-revision-v1/',0,'revision','',0),(4035,2,'2019-12-04 18:11:19','2019-12-04 18:11:19','Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.\r\n\r\n<strong>Types of pharmaceutical reference standard (RS)</strong>\r\n\r\nIn the pharmaceutical area, there are four major types of reference standards:\r\n\r\n1;-Primary RS\r\n\r\n2:-Pharmacopoeial RS (for monograph use)\r\n\r\n3:-Secondary RS\r\n\r\n4:-Impurity RS\r\n\r\nApart from the pharmacopoeial standards, all of the above come with certificates of analysis (CoAs), or – in the case of a secondary RS – with a comparison statement. The information provided on the CoA should be suitable with regard to the specific use planned for the corresponding RS.\r\n\r\nThere is a fifth type – research materials – which is often used at the very beginning of analytical research and development, but not normally for method development, validation, transfer or quality control.\r\n\r\n<strong>Primary reference standards</strong>\r\n\r\nIn the pharmaceutical context, a primary reference standard is a standard for which the properties (usually identity, very often also purity/assay values) have been characterized by certain analytical techniques, without, however, being compared to any other standard of the same kind.\r\n\r\nThe definition for a primary standard in the GMP guideline Q7 of the ICH states:\r\n\r\n<em>Reference Standard, Primary</em>\r\n\r\n<em>A substance that has been shown by an extensive set of analytical tests to be authentic material that should be of high purity. This standard can be: (1) obtained from an officially recognized source, or (2) prepared by independent synthesis, or (3) obtained from existing production material of high purity, or (4) prepared by further purification of existing production material. </em>\r\n\r\n<strong>When to use a primary standard?</strong>\r\n\r\nIn pharmaceutical QC, the use of reference standards to calibrate the analytical procedure is mandatory when measurements are performed with relative methods such as HPLC in combination with a UV or MS detector. These measurements need to be traceable to a primary standard. This requirement is realized either by using the primary standard directly for the calibration purposes, or by using a secondary standard which is compared to the primary one.\r\n\r\n<strong>ICH guideline Q7 states:</strong>\r\n\r\n<em>11.17 Primary reference standards should be obtained as appropriate for the manufacture of APIs. The source of each primary reference standard should be documented. Records should be maintained of each primary reference standard’s storage and use in accordance with the supplier’s recommendations. Primary reference standards obtained from an officially recognized source are normally used without testing if stored under conditions consistent with the supplier’s recommendations.</em>\r\n\r\nOfficially recognized sources, however, are not specified in Q7, but the FDA does mention sources in their ‘Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics’ but, interestingly, does not refer to these institutions as an official or definitive list:\r\n\r\n<em>Reference standards can often be obtained from the USP and may also be available through the European Pharmacopoeia, Japanese Pharmacopoeia, World Health Organization, or National Institute of Standards and Technology. </em>\r\n\r\nInstead, the FDA states that <em>“reference materials from other sources should be characterized by procedures including routine and beyond routine release testing” and that producers “should consider orthogonal methods for reference material characterization”. </em>\r\n\r\nFor primary RSs, both the ICH guideline and FDA guidance allow other sources than the “officially recognized sources”. Independent manufacturers can provide such primary standards, ideally characterized by processes like those outlined in the general text 5.12. of the European Pharmacopoeia (Ph.Eur).\r\n\r\n<strong>Correct use of primary reference standards: what to keep in mind?</strong>\r\n\r\nIn essence, a primary RS needs to be fit for its intended purpose. A pharmacopoeial RS has been shown to be fit for its compendial purpose, but has not been demonstrated to be fit for any other purpose; this needs to be proven by the user. Consequently challenges of compendial standard use for non-compendial purposes have been reported in regulatory inspections. Other primary standards with fully documented CoAs can be used for most applications, providing they have been characterized appropriately. If a primary RS is used to establish a secondary standard then the secondary RS can only be used for the same purpose as the primary one.\r\n\r\n<strong>Pharmacopoeial reference standards</strong>\r\n\r\nReference standards from the pharmacopoeias – also often referred to as compendial RSs – are, in principle, primary standards that have a special status for use in connection with the monograph methods for which they have been designed.\r\n\r\nThis position is specified in the USP (United States Pharmacopeia) general chapter &lt;11&gt;:\r\n\r\n<em>When approved as suitable for use as comparison standards … in the United States Pharmacopeia (USP) or National Formulary (NF), USP RS also assume official status and legal recognition in the United States. Assessment of the suitability for use in other applications rests with the user.</em>\r\n\r\nIt is also described in the European Pharmacopoeia (Ph.Eur.) in general text 5.12.6:\r\n\r\n<em>European Pharmacopoeia reference standards are shown to be suitable for their intended purpose; they are not necessarily suitable for other purposes. Any value assigned to a reference standard is valid for the intended use and not necessarily for other uses.</em>\r\n\r\nSo, strictly speaking, the special status of a pharmacopoeial RS can only be assumed when the standards are used as required by the monographs. For anything other than these monograph purposes, compendial RSs stand on the same level as RSs from other sources. This means that you need to prove suitability of a compendial RS for the desired non-compendial purpose in the same way you would need to for any other RSs. This is clearly mentioned in the Ph.Eur. chapter 5.12., and can be seen as a blueprint for other compendial RS use as well:\r\n\r\n<em>If a European Pharmacopoeia reference standard is to be used for any purpose other than that for which it has been established, its suitability for the new use has to be fully demonstrated and when applicable, to be described in the marketing authorization application.</em>\r\n\r\nThe use of a compendial RS for non-monograph applications is also made difficult by the fact that certificates of analysis, which might otherwise provide a rich data set of characterization testing results, are normally not provided by the compendial institutions.\r\n\r\n<strong>Impurity reference standard (IRS)</strong>\r\n\r\nAlthough the term ‘primary impurity standard’ does not really exist, any impurity standard that is not compared to another material of the same chemical structure and which is fit for its designated purpose can be considered such a primary material.\r\n\r\nIRSs are designed to detect, identify, quantify and qualify impurities in a drug substance in accordance with the ICH guidelines (Q3A to Q3D and Q7). ICH Guidelines 3A to 3D regulate the approach to impurities in the pharmaceutical industry. ICH does not prioritize at any point any given range of standards over another, whether officially recognized or not, for use within the pharmaceutical industry.  According to these guidelines, impurities can be primarily classified into either drug substance or drug product impurities, referring in the first case to any component in the drug substance which is not the chemical entity itself. A drug product impurity, meanwhile, is any chemical entity present that is not the drug substance or an excipient used to manufacture the drug product. Based on the cause triggering their appearance, impurities can be classified as starting materials, by-products, intermediates, degradation products or reagents/ligands and catalysts. Finally, by their chemical nature, impurities can be classified as organic, inorganic or solvents.\r\n\r\nPharmacopoeial IRSs, like all compendial materials, are designed for the specific monograph purposes. For other purposes, an IRS from other sources suitable for the intended purpose should be preferred, for two major reasons:\r\n\r\n1:- The use of a pharmacopoeial IRS outside the monograph can be challenged by regulatory authorities. Customers have reported to us that authorities have insisted on a CoA for a pharmacopoeial IRS used for non-compendial purposes. A CoA is not provided by pharmacopoeial sources, rendering the material unsuitable for use without separate detailed internal characterization.\r\n\r\n2:-Furthermore, supply of pharmacopoeial IRSs can be insecure. For example, there have been occasions where a change in a monograph has resulted in a neat impurity standard being replaced by a system suitability or peak identification mixture, usually consisting of a mix of the API and traces of one or more impurities. Such a replacement is not a problem if the user works according to the monograph methods. However, if the pharmacopoeial material is used for non-compendial purposes, the laboratory might face a challenge replacing the neat IRS if it is not available anymore. If the pharmaceutical company has stated the use of that specific material in their dossier, they may even need to report the change to the authorities. Cessation of supply is also a risk with any catalogue reference standard provided by a third party, but switching between suppliers is significantly easier when the materials are “primary” and accompanied by CoAs.\r\n\r\nIn addition, the current regulation situation – especially for the finished dosage forms dealt with in ICH guideline Q3B – often requires additional impurity testing, on top of the requirements of the pharmacopoeial monographs. Then it can often be the case that there are no suitable impurity standards available from compendial sources, and the support of experienced commercial IRS manufacturers thus becomes necessary.\r\n\r\n<strong>Secondary standards</strong>\r\n\r\nThese compounds are second-line materials. They consist in each instance of a material that is compared against the primary material, and used in its place.\r\n\r\nIt does not matter whether the secondary standard is compared against a pharmacopoeial primary standard, or against a primary standard obtained in-house or from a third source. A secondary standard can only be used for the same purposes as the primary standard. Thus if a primary standard was designed solely for a qualitative purpose (i.e. identification via IR, system suitability test or peak identification), then to use the corresponding secondary standard for quantitative purposes is not valid. For example, a large number of Ph.Eur. reference standards for APIs have been set up for IR comparisons only, and should not be used as a basis for quantitative secondary standards.\r\n\r\nIn addition, the EDQM (European Directorate for the Quality of Medicines) does not recommend measuring secondary standards against even their quantitative materials. This is because:\r\n\r\n1:-While pharmacopoeial primary RSs have a determined measurement uncertainty (MU) in line with the requirements of the relevant pharmacopoeial monograph, the value of this uncertainty is not currently specified.\r\n\r\n2:-The comparison of a candidate material for a secondary RS to the pharmacopoeial RS will result – by the principle of uncertainty propagation – in a larger but non quantifiable MU for the secondary standard, by virtue of the fact that the MU for the pharmacopoeial material is not published\r\n\r\n3:-This unknown but enlarged MU for the secondary RS might no longer be appropriate for the acceptance interval specified in the relevant monograph.\r\n\r\nFor the same reason, the use of a pharmacopoeial RS with a non-compendial method can be difficult to justify on the basis that the uncertainty of its value assignment is unknown.\r\n\r\n<strong>Research materials</strong>\r\n\r\nOften used at the very beginning of analytical research and development, these should not be employed when the methods are fully developed. During validation and implementation in the QC or stability testing lab, they are usually replaced with better-characterized materials, especially when any quantitative purpose is connected with their usages.\r\n\r\nResearch materials come with only basic characterization data that makes them useful for initial development and identification work. They cannot be considered reference standards and can be distinguished from reference standards by their relatively simple CoA.\r\n\r\nCopyright © LGC Limited 2019 All rights reserved.\r\n\r\nFor further details on Mikromol reference standards,\r\n\r\n<strong><u>Please contact: </u></strong>\r\n\r\nJane Firth at LGC UK on <a href=\"mailto:jane.firth@lgcgroup.com\">jane.firth@lgcgroup.com</a> or\r\n\r\nSuryakanth.G at LGC India – <a href=\"mailto:Suryakanth.gudgunti@lgcgroup.com\">Suryakanth.gudgunti@lgcgroup.com</a>','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4029-revision-v1','','','2019-12-04 18:11:19','2019-12-04 18:11:19','',4029,'https://microbiozindia.com/uncategorized/4029-revision-v1/',0,'revision','',0),(4036,2,'2019-12-05 05:27:10','2019-12-05 05:27:10','a:15:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:18:\"hello how are you.\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:11:\"show_column\";i:0;s:20:\"show_column_sortable\";i:0;s:18:\"show_column_weight\";i:1000;s:15:\"allow_quickedit\";i:0;s:14:\"allow_bulkedit\";i:0;}','About Author','about_author','publish','closed','closed','','field_5de894e05c7d0','','','2019-12-05 05:57:23','2019-12-05 05:57:23','',3664,'https://microbiozindia.com/?post_type=acf-field&#038;p=4036',2,'acf-field','',0),(4037,2,'2019-12-05 05:59:29','2019-12-05 05:59:29','Postnova Analytics has posted a new on-demand webinar introducing how advanced analytical techniques are impacting the field of nanogeochemistry.\r\n\r\nThe webinar discusses the advanced analytical approaches that are used to apply Asymmetric Flow Field-Flow Fractionation with online UV-Visible and ICP-MS detectors to nano-geochemical systems in the SWAMP (Soils, Water, Air, Manures, and Plants) laboratory, at the University of Alberta, Canada (https://swamp.ualberta.ca/).\r\n\r\nThe application of AF4-UV-ICPMS to nano-geochemical systems in water, soils and aquatic ecotoxicology is discussed. Nano-geochemical systems are composed of the interacting nanoscale particles (ca. 1&amp;ndash;100 nm), which form the basis of geochemical systems. These particles and particle systems govern the transport and distribution of natural and anthropogenic metals, pollutants, and nutrients in aquatic environments, and play important roles controlling mineral formation, transformations/stability, and geochemical reactions. Yet, our understanding of relationships between the properties and functioning of the nano-geochemical environment is limited by the lack of appropriate analytical techniques for its non-destructive separation and analysis.\r\n\r\nInterest in the production and measurement of engineered nanomaterials has led to advances in analytical methods such as field-flow fractionation and ICP-MS, which are capable of separating and characterizing nanoparticle systems at the mesoscale (groups of particles with similar properties), and at the nanoscale (individual particles). These technologies are thus now available for application to nano-geochemical systems; however, additional analytical methods must first be developed and standardized to allow the collection, storage and measurement of these particles and particle systems under conditions that are comparable across studies, and either minimize disruption to their natural condition or permit accurate extrapolation to their behaviour and properties under in-situ conditions.\r\n\r\nTo download the on-demand webinar please visit https://info.postnova.com/separation-and-analysis-of-nano-geochemical-systems/ or contact Postnova Analytics on +1-801-521-2004 / +44-1885-475007 / info@postnova.com for further information.\r\n\r\n<strong>For more information</strong>\r\n\r\nPostnova Analytics GmbH\r\n\r\nMax-Planck-Stra&amp;szlig;e 14\r\n\r\n86899 Landsberg am Lech\r\n\r\nGermany\r\n\r\nTel: +49-8191-985-6880\r\n\r\nEmail: info@postnova.com\r\n\r\nWeb www.postnova.com','Separation and Analysis of Nano Geochemical Systems','','inherit','closed','closed','','2762-revision-v1','','','2019-12-05 05:59:29','2019-12-05 05:59:29','',2762,'https://microbiozindia.com/uncategorized/2762-revision-v1/',0,'revision','',0),(4038,2,'2019-12-05 06:01:21','2019-12-05 06:01:21','Postnova Analytics has posted a new on-demand webinar introducing how advanced analytical techniques are impacting the field of nanogeochemistry.\r\n\r\nThe webinar discusses the advanced analytical approaches that are used to apply Asymmetric Flow Field-Flow Fractionation with online UV-Visible and ICP-MS detectors to nano-geochemical systems in the SWAMP (Soils, Water, Air, Manures, and Plants) laboratory, at the University of Alberta, Canada (https://swamp.ualberta.ca/).\r\n\r\nThe application of AF4-UV-ICPMS to nano-geochemical systems in water, soils and aquatic ecotoxicology is discussed. Nano-geochemical systems are composed of the interacting nanoscale particles (ca. 1&amp;ndash;100 nm), which form the basis of geochemical systems. These particles and particle systems govern the transport and distribution of natural and anthropogenic metals, pollutants, and nutrients in aquatic environments, and play important roles controlling mineral formation, transformations/stability, and geochemical reactions. Yet, our understanding of relationships between the properties and functioning of the nano-geochemical environment is limited by the lack of appropriate analytical techniques for its non-destructive separation and analysis.\r\n\r\nInterest in the production and measurement of engineered nanomaterials has led to advances in analytical methods such as field-flow fractionation and ICP-MS, which are capable of separating and characterizing nanoparticle systems at the mesoscale (groups of particles with similar properties), and at the nanoscale (individual particles). These technologies are thus now available for application to nano-geochemical systems; however, additional analytical methods must first be developed and standardized to allow the collection, storage and measurement of these particles and particle systems under conditions that are comparable across studies, and either minimize disruption to their natural condition or permit accurate extrapolation to their behaviour and properties under in-situ conditions.\r\n\r\nTo download the on-demand webinar please visit https://info.postnova.com/separation-and-analysis-of-nano-geochemical-systems/ or contact Postnova Analytics on +1-801-521-2004 / +44-1885-475007 / info@postnova.com for further information.\r\n\r\n<strong>For more information</strong>\r\n\r\nPostnova Analytics GmbH\r\n\r\nMax-Planck-Stra&amp;szlig;e 14\r\n\r\n86899 Landsberg am Lech\r\n\r\nGermany\r\n\r\nTel: +49-8191-985-6880\r\n\r\nEmail: info@postnova.com\r\n\r\nWeb www.postnova.com','Separation and Analysis of Nano Geochemical Systems','','inherit','closed','closed','','2762-revision-v1','','','2019-12-05 06:01:21','2019-12-05 06:01:21','',2762,'https://microbiozindia.com/uncategorized/2762-revision-v1/',0,'revision','',0),(4039,2,'2019-12-05 11:21:59','2019-12-05 11:21:59','New Delhi, 05 December 2019: Mankind Pharma, a Rs 5,600 crore pharmaceutical company, has launched a Dydrogesterone-containing drug, for treatment of pregnancy-related complications. Mankind Pharma becomes the first Indian and second global company to develop the drug and make it available at an affordable price.\r\n\r\nProgesterone is a natural hormone involved in the menstrual cycle, implantation, and in successful maintenance of pregnancy. Any deficiency of progesterone during different stages of the reproductive process can cause infertility, menstrual disorders and miscarriage. Dydrogesterone has a similar molecular structure to natural progesterone but it has enhanced bioavailability and fewer side-effects.\r\n\r\nIt took nine years for a team of 400 scientists at Mankind Research Centre to develop this drug, which is the only retroprogesterone available commercially. The manufacturing process of Dydrogesterone is very complex as it involves the conversion of natural progesterone.\r\n\r\n<strong>Mr. R.C. Juneja, Chairman and Founder, Mankind Group</strong> said, “<em>The launch of this drug is an important milestone for Mankind Pharma. We are the first Indian pharmaceutical company to develop this drug &amp; second company in the world. We have been successful in developing the drug as an ideal alternative.  It was only possible after the endless efforts of our scientists that we could achieve the unachievable. Our focus is to earn the trust of our customers by marketing it at an affordable price while ensuring high quality.”</em>\r\n\r\nMankind has a strong presence in pharmaceutical, veterinary, OTC &amp; FMCG segments with more than 50 brands ranked at No. 1 position in their respective segments. Besides having a strong presence in the domestic market, Mankind is present across North America, Asia, Africa and CIS countries.\r\n\r\n<strong><u>About Mankind Pharma</u></strong>\r\n\r\nMankind Pharma, the 4th leading Pharmaceutical Company of India, incepted in 1995, today with an employee base of more than 14000, racing towards a turnover of $1 Billion. Mankind is a fully integrated pharmaceutical company, with a comprehensive network of over 40 C&amp;F agents &amp; 5000 stockists. With a pan India presence and offerings spanning across Antibiotics, Antifungals, Anthelminthics, Gastrointestinal, NSAIDs, Anti Diabetics, Gynecology, Cardiology, Dermatology, Erectile Dysfunction and several other categories. The strong portfolio of products ranging from Pharma to popular OTC &amp; FMCG brands - Manforce Condoms, Unwanted72, Prega News, Adiction, Gas-O-Fast, and Kaloree-1 provides the edge to Mankind pharma in the competitive market. Mankind is further expanding the horizon of Serving Life in International Markets.','Mankind Pharma becomes first Indian company to develop dydrogesterone for infertility & pregnancy related complications','','publish','open','open','','mankind-pharma-becomes-first-indian-company-to-develop-dydrogesterone-for-infertility-pregnancy-related-complications','','','2019-12-05 11:28:58','2019-12-05 11:28:58','',0,'https://microbiozindia.com/?p=4039',0,'post','',0),(4040,2,'2019-12-05 11:20:33','2019-12-05 11:20:33','','MANKIND','','inherit','open','closed','','mankind','','','2019-12-05 11:20:33','2019-12-05 11:20:33','',4039,'https://microbiozindia.com/wp-content/uploads/2019/12/MANKIND.png',0,'attachment','image/png',0),(4041,2,'2019-12-05 11:21:59','2019-12-05 11:21:59','<strong>New Delhi, 05 December 2019: </strong>Mankind Pharma, a Rs 5,600 crore pharmaceutical company, has launched a Dydrogesterone-containing drug, for treatment of pregnancy-related complications. Mankind Pharma becomes the first Indian and second global company to develop the drug and make it available at an affordable price.\r\n\r\nProgesterone is a natural hormone involved in the menstrual cycle, implantation, and in successful maintenance of pregnancy. Any deficiency of progesterone during different stages of the reproductive process can cause infertility, menstrual disorders and miscarriage. Dydrogesterone has a similar molecular structure to natural progesterone but it has enhanced bioavailability and fewer side-effects.\r\n\r\nIt took nine years for a team of 400 scientists at Mankind Research Centre to develop this drug, which is the only retroprogesterone available commercially. The manufacturing process of Dydrogesterone is very complex as it involves the conversion of natural progesterone.\r\n\r\n<strong>Mr. R.C. Juneja, Chairman and Founder, Mankind Group</strong> said, “<em>The launch of this drug is an important milestone for Mankind Pharma. We are the first Indian pharmaceutical company to develop this drug &amp; second company in the world. We have been successful in developing the drug as an ideal alternative.  It was only possible after the endless efforts of our scientists that we could achieve the unachievable. Our focus is to earn the trust of our customers by marketing it at an affordable price while ensuring high quality.”</em>\r\n\r\nMankind has a strong presence in pharmaceutical, veterinary, OTC &amp; FMCG segments with more than 50 brands ranked at No. 1 position in their respective segments. Besides having a strong presence in the domestic market, Mankind is present across North America, Asia, Africa and CIS countries.\r\n\r\n<strong><u>About Mankind Pharma</u></strong>\r\n\r\nMankind Pharma, the 4th leading Pharmaceutical Company of India, incepted in 1995, today with an employee base of more than 14000, racing towards a turnover of $1 Billion. Mankind is a fully integrated pharmaceutical company, with a comprehensive network of over 40 C&amp;F agents &amp; 5000 stockists. With a pan India presence and offerings spanning across Antibiotics, Antifungals, Anthelminthics, Gastrointestinal, NSAIDs, Anti Diabetics, Gynecology, Cardiology, Dermatology, Erectile Dysfunction and several other categories. The strong portfolio of products ranging from Pharma to popular OTC &amp; FMCG brands - Manforce Condoms, Unwanted72, Prega News, Adiction, Gas-O-Fast, and Kaloree-1 provides the edge to Mankind pharma in the competitive market. Mankind is further expanding the horizon of Serving Life in International Markets.','Mankind Pharma becomes first Indian company to develop dydrogesterone for infertility & pregnancy related complications','','inherit','closed','closed','','4039-revision-v1','','','2019-12-05 11:21:59','2019-12-05 11:21:59','',4039,'https://microbiozindia.com/uncategorized/4039-revision-v1/',0,'revision','',0),(4042,2,'2019-12-05 11:28:58','2019-12-05 11:28:58','New Delhi, 05 December 2019: Mankind Pharma, a Rs 5,600 crore pharmaceutical company, has launched a Dydrogesterone-containing drug, for treatment of pregnancy-related complications. Mankind Pharma becomes the first Indian and second global company to develop the drug and make it available at an affordable price.\r\n\r\nProgesterone is a natural hormone involved in the menstrual cycle, implantation, and in successful maintenance of pregnancy. Any deficiency of progesterone during different stages of the reproductive process can cause infertility, menstrual disorders and miscarriage. Dydrogesterone has a similar molecular structure to natural progesterone but it has enhanced bioavailability and fewer side-effects.\r\n\r\nIt took nine years for a team of 400 scientists at Mankind Research Centre to develop this drug, which is the only retroprogesterone available commercially. The manufacturing process of Dydrogesterone is very complex as it involves the conversion of natural progesterone.\r\n\r\n<strong>Mr. R.C. Juneja, Chairman and Founder, Mankind Group</strong> said, “<em>The launch of this drug is an important milestone for Mankind Pharma. We are the first Indian pharmaceutical company to develop this drug &amp; second company in the world. We have been successful in developing the drug as an ideal alternative.  It was only possible after the endless efforts of our scientists that we could achieve the unachievable. Our focus is to earn the trust of our customers by marketing it at an affordable price while ensuring high quality.”</em>\r\n\r\nMankind has a strong presence in pharmaceutical, veterinary, OTC &amp; FMCG segments with more than 50 brands ranked at No. 1 position in their respective segments. Besides having a strong presence in the domestic market, Mankind is present across North America, Asia, Africa and CIS countries.\r\n\r\n<strong><u>About Mankind Pharma</u></strong>\r\n\r\nMankind Pharma, the 4th leading Pharmaceutical Company of India, incepted in 1995, today with an employee base of more than 14000, racing towards a turnover of $1 Billion. Mankind is a fully integrated pharmaceutical company, with a comprehensive network of over 40 C&amp;F agents &amp; 5000 stockists. With a pan India presence and offerings spanning across Antibiotics, Antifungals, Anthelminthics, Gastrointestinal, NSAIDs, Anti Diabetics, Gynecology, Cardiology, Dermatology, Erectile Dysfunction and several other categories. The strong portfolio of products ranging from Pharma to popular OTC &amp; FMCG brands - Manforce Condoms, Unwanted72, Prega News, Adiction, Gas-O-Fast, and Kaloree-1 provides the edge to Mankind pharma in the competitive market. Mankind is further expanding the horizon of Serving Life in International Markets.','Mankind Pharma becomes first Indian company to develop dydrogesterone for infertility & pregnancy related complications','','inherit','closed','closed','','4039-revision-v1','','','2019-12-05 11:28:58','2019-12-05 11:28:58','',4039,'https://microbiozindia.com/uncategorized/4039-revision-v1/',0,'revision','',0),(4043,2,'2019-12-05 11:36:17','2019-12-05 11:36:17','Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.\r\n\r\n<strong>Types of pharmaceutical reference standard (RS)</strong>\r\n\r\nIn the pharmaceutical area, there are four major types of reference standards:\r\n\r\n1;-Primary RS\r\n\r\n2:-Pharmacopoeial RS (for monograph use)\r\n\r\n3:-Secondary RS\r\n\r\n4:-Impurity RS\r\n\r\nApart from the pharmacopoeial standards, all of the above come with certificates of analysis (CoAs), or – in the case of a secondary RS – with a comparison statement. The information provided on the CoA should be suitable with regard to the specific use planned for the corresponding RS.\r\n\r\nThere is a fifth type – research materials – which is often used at the very beginning of analytical research and development, but not normally for method development, validation, transfer or quality control.\r\n\r\n<strong>Primary reference standards</strong>\r\n\r\nIn the pharmaceutical context, a primary reference standard is a standard for which the properties (usually identity, very often also purity/assay values) have been characterized by certain analytical techniques, without, however, being compared to any other standard of the same kind.\r\n\r\nThe definition for a primary standard in the GMP guideline Q7 of the ICH states:\r\n\r\n<em>Reference Standard, Primary</em>\r\n\r\n<em>A substance that has been shown by an extensive set of analytical tests to be authentic material that should be of high purity. This standard can be: (1) obtained from an officially recognized source, or (2) prepared by independent synthesis, or (3) obtained from existing production material of high purity, or (4) prepared by further purification of existing production material. </em>\r\n\r\n<strong>When to use a primary standard?</strong>\r\n\r\nIn pharmaceutical QC, the use of reference standards to calibrate the analytical procedure is mandatory when measurements are performed with relative methods such as HPLC in combination with a UV or MS detector. These measurements need to be traceable to a primary standard. This requirement is realized either by using the primary standard directly for the calibration purposes, or by using a secondary standard which is compared to the primary one.\r\n\r\n<strong>ICH guideline Q7 states:</strong>\r\n\r\n<em>11.17 Primary reference standards should be obtained as appropriate for the manufacture of APIs. The source of each primary reference standard should be documented. Records should be maintained of each primary reference standard’s storage and use in accordance with the supplier’s recommendations. Primary reference standards obtained from an officially recognized source are normally used without testing if stored under conditions consistent with the supplier’s recommendations.</em>\r\n\r\nOfficially recognized sources, however, are not specified in Q7, but the FDA does mention sources in their ‘Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics’ but, interestingly, does not refer to these institutions as an official or definitive list:\r\n\r\n<em>Reference standards can often be obtained from the USP and may also be available through the European Pharmacopoeia, Japanese Pharmacopoeia, World Health Organization, or National Institute of Standards and Technology. </em>\r\n\r\nInstead, the FDA states that <em>“reference materials from other sources should be characterized by procedures including routine and beyond routine release testing” and that producers “should consider orthogonal methods for reference material characterization”. </em>\r\n\r\nFor primary RSs, both the ICH guideline and FDA guidance allow other sources than the “officially recognized sources”. Independent manufacturers can provide such primary standards, ideally characterized by processes like those outlined in the general text 5.12. of the European Pharmacopoeia (Ph.Eur).\r\n\r\n<strong>Correct use of primary reference standards: what to keep in mind?</strong>\r\n\r\nIn essence, a primary RS needs to be fit for its intended purpose. A pharmacopoeial RS has been shown to be fit for its compendial purpose, but has not been demonstrated to be fit for any other purpose; this needs to be proven by the user. Consequently challenges of compendial standard use for non-compendial purposes have been reported in regulatory inspections. Other primary standards with fully documented CoAs can be used for most applications, providing they have been characterized appropriately. If a primary RS is used to establish a secondary standard then the secondary RS can only be used for the same purpose as the primary one.\r\n\r\n<strong>Pharmacopoeial reference standards</strong>\r\n\r\nReference standards from the pharmacopoeias – also often referred to as compendial RSs – are, in principle, primary standards that have a special status for use in connection with the monograph methods for which they have been designed.\r\n\r\nThis position is specified in the USP (United States Pharmacopeia) general chapter &lt;11&gt;:\r\n\r\n<em>When approved as suitable for use as comparison standards … in the United States Pharmacopeia (USP) or National Formulary (NF), USP RS also assume official status and legal recognition in the United States. Assessment of the suitability for use in other applications rests with the user.</em>\r\n\r\nIt is also described in the European Pharmacopoeia (Ph.Eur.) in general text 5.12.6:\r\n\r\n<em>European Pharmacopoeia reference standards are shown to be suitable for their intended purpose; they are not necessarily suitable for other purposes. Any value assigned to a reference standard is valid for the intended use and not necessarily for other uses.</em>\r\n\r\nSo, strictly speaking, the special status of a pharmacopoeial RS can only be assumed when the standards are used as required by the monographs. For anything other than these monograph purposes, compendial RSs stand on the same level as RSs from other sources. This means that you need to prove suitability of a compendial RS for the desired non-compendial purpose in the same way you would need to for any other RSs. This is clearly mentioned in the Ph.Eur. chapter 5.12., and can be seen as a blueprint for other compendial RS use as well:\r\n\r\n<em>If a European Pharmacopoeia reference standard is to be used for any purpose other than that for which it has been established, its suitability for the new use has to be fully demonstrated and when applicable, to be described in the marketing authorization application.</em>\r\n\r\nThe use of a compendial RS for non-monograph applications is also made difficult by the fact that certificates of analysis, which might otherwise provide a rich data set of characterization testing results, are normally not provided by the compendial institutions.\r\n\r\n<strong>Impurity reference standard (IRS)</strong>\r\n\r\nAlthough the term ‘primary impurity standard’ does not really exist, any impurity standard that is not compared to another material of the same chemical structure and which is fit for its designated purpose can be considered such a primary material.\r\n\r\nIRSs are designed to detect, identify, quantify and qualify impurities in a drug substance in accordance with the ICH guidelines (Q3A to Q3D and Q7). ICH Guidelines 3A to 3D regulate the approach to impurities in the pharmaceutical industry. ICH does not prioritize at any point any given range of standards over another, whether officially recognized or not, for use within the pharmaceutical industry.  According to these guidelines, impurities can be primarily classified into either drug substance or drug product impurities, referring in the first case to any component in the drug substance which is not the chemical entity itself. A drug product impurity, meanwhile, is any chemical entity present that is not the drug substance or an excipient used to manufacture the drug product. Based on the cause triggering their appearance, impurities can be classified as starting materials, by-products, intermediates, degradation products or reagents/ligands and catalysts. Finally, by their chemical nature, impurities can be classified as organic, inorganic or solvents.\r\n\r\nPharmacopoeial IRSs, like all compendial materials, are designed for the specific monograph purposes. For other purposes, an IRS from other sources suitable for the intended purpose should be preferred, for two major reasons:\r\n\r\n1:- The use of a pharmacopoeial IRS outside the monograph can be challenged by regulatory authorities. Customers have reported to us that authorities have insisted on a CoA for a pharmacopoeial IRS used for non-compendial purposes. A CoA is not provided by pharmacopoeial sources, rendering the material unsuitable for use without separate detailed internal characterization.\r\n\r\n2:-Furthermore, supply of pharmacopoeial IRSs can be insecure. For example, there have been occasions where a change in a monograph has resulted in a neat impurity standard being replaced by a system suitability or peak identification mixture, usually consisting of a mix of the API and traces of one or more impurities. Such a replacement is not a problem if the user works according to the monograph methods. However, if the pharmacopoeial material is used for non-compendial purposes, the laboratory might face a challenge replacing the neat IRS if it is not available anymore. If the pharmaceutical company has stated the use of that specific material in their dossier, they may even need to report the change to the authorities. Cessation of supply is also a risk with any catalogue reference standard provided by a third party, but switching between suppliers is significantly easier when the materials are “primary” and accompanied by CoAs.\r\n\r\nIn addition, the current regulation situation – especially for the finished dosage forms dealt with in ICH guideline Q3B – often requires additional impurity testing, on top of the requirements of the pharmacopoeial monographs. Then it can often be the case that there are no suitable impurity standards available from compendial sources, and the support of experienced commercial IRS manufacturers thus becomes necessary.\r\n\r\n<strong>Secondary standards</strong>\r\n\r\nThese compounds are second-line materials. They consist in each instance of a material that is compared against the primary material, and used in its place.\r\n\r\nIt does not matter whether the secondary standard is compared against a pharmacopoeial primary standard, or against a primary standard obtained in-house or from a third source. A secondary standard can only be used for the same purposes as the primary standard. Thus if a primary standard was designed solely for a qualitative purpose (i.e. identification via IR, system suitability test or peak identification), then to use the corresponding secondary standard for quantitative purposes is not valid. For example, a large number of Ph.Eur. reference standards for APIs have been set up for IR comparisons only, and should not be used as a basis for quantitative secondary standards.\r\n\r\nIn addition, the EDQM (European Directorate for the Quality of Medicines) does not recommend measuring secondary standards against even their quantitative materials. This is because:\r\n\r\n1:-While pharmacopoeial primary RSs have a determined measurement uncertainty (MU) in line with the requirements of the relevant pharmacopoeial monograph, the value of this uncertainty is not currently specified.\r\n\r\n2:-The comparison of a candidate material for a secondary RS to the pharmacopoeial RS will result – by the principle of uncertainty propagation – in a larger but non quantifiable MU for the secondary standard, by virtue of the fact that the MU for the pharmacopoeial material is not published\r\n\r\n3:-This unknown but enlarged MU for the secondary RS might no longer be appropriate for the acceptance interval specified in the relevant monograph.\r\n\r\nFor the same reason, the use of a pharmacopoeial RS with a non-compendial method can be difficult to justify on the basis that the uncertainty of its value assignment is unknown.\r\n\r\n<strong>Research materials</strong>\r\n\r\nOften used at the very beginning of analytical research and development, these should not be employed when the methods are fully developed. During validation and implementation in the QC or stability testing lab, they are usually replaced with better-characterized materials, especially when any quantitative purpose is connected with their usages.\r\n\r\nResearch materials come with only basic characterization data that makes them useful for initial development and identification work. They cannot be considered reference standards and can be distinguished from reference standards by their relatively simple CoA.\r\n\r\nCopyright © LGC Limited 2019 All rights reserved.\r\n\r\nFor further details on Mikromol reference standards,\r\n\r\n<strong><u>Please contact: </u></strong>\r\n\r\nJane Firth at LGC UK on <a href=\"mailto:jane.firth@lgcgroup.com\">jane.firth@lgcgroup.com</a> or\r\n\r\nSuryakanth.G at LGC India – <a href=\"mailto:Suryakanth.gudgunti@lgcgroup.com\">Suryakanth.gudgunti@lgcgroup.com</a>','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4029-revision-v1','','','2019-12-05 11:36:17','2019-12-05 11:36:17','',4029,'https://microbiozindia.com/uncategorized/4029-revision-v1/',0,'revision','',0),(4044,2,'2019-11-05 17:43:42','2019-11-05 17:43:42','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the November 2019 a special edition of Microbioz India magazine for distribution in CPHI and P-mec India in the month of November 2019, supported by the cover story entitled “Pharmaceutical quality control: the reference standards labyrinth” authored by Martina Christiane Kotthaus,Ph.D, worked as Site Director at LGC GmbH in Luckenwalde, Germany. LGC, a global leader in the extended life sciences sector,with a comprehensive range of reference materials, proficiency testing schemes and research and measurement services, launched their latest white paper “Pharmaceutical quality control: the reference standards labyrinth”, by Dr.Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.','Pharmaceutical quality control: the reference standards labyrinth','','publish','closed','closed','','microbioz-india-november-2019-edition','','','2019-12-05 17:48:50','2019-12-05 17:48:50','',0,'https://microbiozindia.com/?post_type=magazines&#038;p=4044',0,'magazines','',0),(4045,2,'2019-12-05 17:22:39','2019-12-05 17:22:39','','magcvr','','inherit','open','closed','','magcvr','','','2019-12-05 17:22:39','2019-12-05 17:22:39','',4044,'https://microbiozindia.com/wp-content/uploads/2019/12/magcvr.png',0,'attachment','image/png',0),(4046,2,'2019-12-05 17:26:30','2019-12-05 17:26:30','','WEB01 (1)','','inherit','open','closed','','web01-1','','','2019-12-05 17:26:30','2019-12-05 17:26:30','',4044,'https://microbiozindia.com/wp-content/uploads/2019/12/WEB01-1.png',0,'attachment','image/png',0),(4047,2,'2019-12-05 17:26:42','2019-12-05 17:26:42','','WEB04','','inherit','open','closed','','web04','','','2019-12-05 17:26:42','2019-12-05 17:26:42','',4044,'https://microbiozindia.com/wp-content/uploads/2019/12/WEB04.png',0,'attachment','image/png',0),(4048,2,'2019-12-05 17:26:52','2019-12-05 17:26:52','','WEB01 (3)','','inherit','open','closed','','web01-3','','','2019-12-05 17:26:52','2019-12-05 17:26:52','',4044,'https://microbiozindia.com/wp-content/uploads/2019/12/WEB01-3.png',0,'attachment','image/png',0),(4049,2,'2019-12-05 17:27:01','2019-12-05 17:27:01','','WEB01 (2)','','inherit','open','closed','','web01-2','','','2019-12-05 17:27:01','2019-12-05 17:27:01','',4044,'https://microbiozindia.com/wp-content/uploads/2019/12/WEB01-2.png',0,'attachment','image/png',0),(4050,2,'2019-12-05 17:41:53','2019-12-05 17:41:53','','WEB01 (2)','','inherit','open','closed','','web01-2-2','','','2019-12-05 17:41:53','2019-12-05 17:41:53','',4044,'https://microbiozindia.com/wp-content/uploads/2019/12/WEB01-2-1.png',0,'attachment','image/png',0),(4051,2,'2019-12-05 17:43:42','2019-12-05 17:43:42','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the November 2019 a special edition of Microbioz India magazine for distribution in CPHI and P-mec India in the month of November 2019, supported by the cover story entitled “Pharmaceutical quality control: the reference standards labyrinth” authored by Martina Christiane Kotthaus,Ph.D, worked as Site Director at LGC GmbH in Luckenwalde, Germany. LGC, a global leader in the extended life sciences sector,with a comprehensive range of reference materials, proficiency testing schemes and research and measurement services, launched their latest white paper “Pharmaceutical quality control: the reference standards labyrinth”, by Dr.Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.','Microbioz India: November 2019 edition','','inherit','closed','closed','','4044-revision-v1','','','2019-12-05 17:43:42','2019-12-05 17:43:42','',4044,'https://microbiozindia.com/uncategorized/4044-revision-v1/',0,'revision','',0),(4052,2,'2019-12-05 17:46:42','2019-12-05 17:46:42','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the November 2019 a special edition of Microbioz India magazine for distribution in CPHI and P-mec India in the month of November 2019, supported by the cover story entitled “Pharmaceutical quality control: the reference standards labyrinth” authored by Martina Christiane Kotthaus,Ph.D, worked as Site Director at LGC GmbH in Luckenwalde, Germany. LGC, a global leader in the extended life sciences sector,with a comprehensive range of reference materials, proficiency testing schemes and research and measurement services, launched their latest white paper “Pharmaceutical quality control: the reference standards labyrinth”, by Dr.Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4044-revision-v1','','','2019-12-05 17:46:42','2019-12-05 17:46:42','',4044,'https://microbiozindia.com/uncategorized/4044-revision-v1/',0,'revision','',0),(4053,2,'2019-12-05 17:48:50','2019-12-05 17:48:50','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the November 2019 a special edition of Microbioz India magazine for distribution in CPHI and P-mec India in the month of November 2019, supported by the cover story entitled “Pharmaceutical quality control: the reference standards labyrinth” authored by Martina Christiane Kotthaus,Ph.D, worked as Site Director at LGC GmbH in Luckenwalde, Germany. LGC, a global leader in the extended life sciences sector,with a comprehensive range of reference materials, proficiency testing schemes and research and measurement services, launched their latest white paper “Pharmaceutical quality control: the reference standards labyrinth”, by Dr.Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry.','Pharmaceutical quality control: the reference standards labyrinth','','inherit','closed','closed','','4044-revision-v1','','','2019-12-05 17:48:50','2019-12-05 17:48:50','',4044,'https://microbiozindia.com/uncategorized/4044-revision-v1/',0,'revision','',0),(4055,2,'2019-12-05 17:56:57','2019-12-05 17:56:57','','microbioz india ad_micro_352x286[h]px_1_high res_RGB','','inherit','open','closed','','microbioz-india-ad_micro_352x286hpx_1_high-res_rgb','','','2019-12-05 17:56:57','2019-12-05 17:56:57','',26,'https://microbiozindia.com/wp-content/uploads/2019/11/microbioz-india-ad_micro_352x286hpx_1_high-res_RGB.jpg',0,'attachment','image/jpeg',0),(4056,2,'2020-02-27 14:23:50','2020-02-27 14:23:50','','','','inherit','closed','closed','','3645-autosave-v1','','','2020-02-27 14:23:50','2020-02-27 14:23:50','',3645,'https://microbiozindia.com/uncategorized/3645-autosave-v1/',0,'revision','',0),(4057,2,'2019-12-05 18:01:03','2019-12-05 18:01:03','','microbioz india ad_micro_352x286[h]px_1_high res_RGB','','inherit','open','closed','','microbioz-india-ad_micro_352x286hpx_1_high-res_rgb-2','','','2019-12-05 18:01:03','2019-12-05 18:01:03','',3645,'https://microbiozindia.com/wp-content/uploads/2019/11/microbioz-india-ad_micro_352x286hpx_1_high-res_RGB-1.jpg',0,'attachment','image/jpeg',0),(4058,2,'2019-12-05 18:38:42','2019-12-05 18:38:42','','subscription@microbiozindia.com','','inherit','open','closed','','subscriptionmicrobiozindia-com','','','2019-12-05 18:38:42','2019-12-05 18:38:42','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/subscription@microbiozindia.com_.png',0,'attachment','image/png',0),(4061,2,'2019-12-05 19:06:51','2019-12-05 19:06:51','','subscription@microbiozindia.com','','inherit','open','closed','','subscriptionmicrobiozindia-com-2','','','2019-12-05 19:06:51','2019-12-05 19:06:51','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/subscription@microbiozindia.com_-1.png',0,'attachment','image/png',0),(4062,2,'2019-12-05 19:15:35','2019-12-05 19:15:35','','SUBSCRIBE NOW','','inherit','open','closed','','subscribe-now','','','2019-12-05 19:15:35','2019-12-05 19:15:35','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/SUBSCRIBE-NOW.png',0,'attachment','image/png',0),(4063,2,'2019-12-06 11:43:46','2019-12-06 11:43:46','a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:9:\"post_type\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:5:\"popup\";}}}s:8:\"position\";s:15:\"acf_after_title\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}','Popup link','popup-link','publish','closed','closed','','group_5dea3df7265e6','','','2020-06-15 12:54:57','2020-06-15 12:54:57','',0,'https://microbiozindia.com/?post_type=acf-field-group&#038;p=4063',0,'acf-field-group','',0),(4064,2,'2019-12-06 11:43:47','2019-12-06 11:43:47','a:7:{s:4:\"type\";s:3:\"url\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:33:\"Eg : http://www.bytesinfotech.com\";}','Popup Link','popup_link','publish','closed','closed','','field_5dea3e35b36f7','','','2019-12-06 11:43:47','2019-12-06 11:43:47','',4063,'https://microbiozindia.com/?post_type=acf-field&p=4064',0,'acf-field','',0),(4066,2,'2019-12-07 07:37:29','2019-12-07 07:37:29','','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 07:37:29','2019-12-07 07:37:29','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4068,2,'2019-12-07 09:19:45','2019-12-07 09:19:45','[contact-form-7 id=\"114\" title=\"contact\"]','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 09:19:45','2019-12-07 09:19:45','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4069,2,'2019-12-07 09:26:20','2019-12-07 09:26:20','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>[contact-form-7 id=\"114\" title=\"contact\"]','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 09:26:20','2019-12-07 09:26:20','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4070,2,'2019-12-07 09:28:05','2019-12-07 09:28:05','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>[contact-form-7 id=\"114\" title=\"contact\"]','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 09:28:05','2019-12-07 09:28:05','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4072,2,'2019-12-07 09:55:32','2019-12-07 09:55:32','<p>[contact-form-7 id=\"114\" title=\"contact\"]</p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 09:55:32','2019-12-07 09:55:32','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4074,2,'2019-12-07 09:58:14','2019-12-07 09:58:14','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p><p>[contact-form-7 id=\"114\" title=\"contact\"]</p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 09:58:14','2019-12-07 09:58:14','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4075,2,'2019-12-07 09:59:47','2019-12-07 09:59:47','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n		<p>[contact-form-7 id=\"114\" title=\"contact\"]</p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 09:59:47','2019-12-07 09:59:47','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4076,2,'2019-12-07 10:01:15','2019-12-07 10:01:15','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<p>[contact-form-7 id=\"114\" title=\"contact\"]</p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:01:15','2019-12-07 10:01:15','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4077,2,'2019-12-07 10:02:00','2019-12-07 10:02:00','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<p>[contact-form-7 id=\"114\" title=\"contact\"]</p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:02:00','2019-12-07 10:02:00','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4078,2,'2019-12-07 10:03:07','2019-12-07 10:03:07','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<p>[contact-form-7 id=\"114\" title=\"contact\"]</p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:03:07','2019-12-07 10:03:07','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4079,2,'2019-12-07 10:04:26','2019-12-07 10:04:26','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n<p>[contact-form-7 id=\"114\" title=\"contact\"]</p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:04:26','2019-12-07 10:04:26','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4080,2,'2019-12-07 10:10:44','2019-12-07 10:10:44','<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n								<h3>Quick Contact</h3>						\n[contact-form-7 id=\"114\" title=\"contact\"]','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:10:44','2019-12-07 10:10:44','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4081,2,'2019-12-07 10:12:36','2019-12-07 10:12:36','<h2 style=\"background-color: #292A32;\">Contact Us</h2>\n	<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n								<h3>Quick Contact</h3>						\n[contact-form-7 id=\"114\" title=\"contact\"]','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:12:36','2019-12-07 10:12:36','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4082,2,'2019-12-07 10:15:34','2019-12-07 10:15:34','<h2 style=\"background-color: #292A32;\">Contact Us</h2>\n	<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n	<h2 style=\"background-color: #292A32;\">Quick Contact</h2>\n[contact-form-7 id=\"114\" title=\"contact\"]','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:15:34','2019-12-07 10:15:34','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4083,2,'2019-12-07 10:26:43','2019-12-07 10:26:43','<h2 style=\"background-color: #292A32;\">Contact Us</h2>\n	<h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><br /><br /><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><br /><strong><br /></strong><br /> </p>		\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n	<h2 style=\"background-color: #292A32;\">Quick Contact</h2>\n[contact-form-7 id=\"114\" title=\"contact\"]<p> </p><iframe style=\"border: 0;\" src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" width=\"100%\" height=\"350\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"></iframe><p><!--			</p>\n<p>--></p>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:26:43','2019-12-07 10:26:43','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4084,2,'2019-12-07 10:34:01','2019-12-07 10:34:01','<h2 style=\"background-color: #292a32;\">Contact Us</h2>\r\n<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a>\r\n\r\n</address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong>\r\n</strong>\r\n<h2>Outside from India(Our active team members)</h2>\r\n<h3>Nigeria</h3>\r\n<address><strong>Ms.Rebecca Scolastica Bello</strong>\r\nChief International Representative\r\nMob:+2348036832447/08029137224\r\nEmail: <a>becscola01@gmail.com </a></address>\r\n<h3>Malaysia</h3>\r\n<address>Sivashankari Ramamoorthi,Malaysia Outreach\r\nE-mail : <a>sivashankari2212@gmail.com </a>\r\nMob: 0129353362</address>\r\n<h3>Philippines</h3>\r\n<address>Rodel Estadillo Alo,Philipines Outreach\r\nE-mail : <a>rodel.alo03@gmail.com</a>\r\nMob:0947-376-2202</address>\r\n<h3>Iraq</h3>\r\n<address>Dr.Muslim Dhaher Musa\r\nE-mail : <a>musamoslim@yahoo.com</a>\r\nMob: 009647806674881</address>\r\n<h2 style=\"background-color: #292a32;\">Quick Contact</h2>\r\n[contact-form-7 id=\"114\" title=\"contact\"]\r\n\r\n<iframe style=\"border: 0;\" src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" width=\"100%\" height=\"350\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"></iframe>\r\n\r\n<!--\r\n\r\n-->','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:34:01','2019-12-07 10:34:01','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4086,2,'2019-12-07 10:38:00','2019-12-07 10:38:00','<h3>Quick Contact</h3>		\n		[contact-form-7 id=\"114\" title=\"contact\"]','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:38:00','2019-12-07 10:38:00','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4088,2,'2019-12-07 10:43:19','2019-12-07 10:43:19',' <h3>Corporate office</h3><address>Microbioz India<br />(Corporate Address)<br />J3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br />Mob: +91-9670704431,+91-7827169949,<br />Email: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><p><strong>Connect with Us</strong><br />Facebook: <a>www.facebook.com/MICROBIOZINDIA</a><br />Twitter: <a>www.twitter.com/MICROBIOZINDIA</a></p></address><h3>New Delhi</h3><address>Microbioz India<br />(Branch Office)<br />J3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br />Mob: +91-9670704431,9773585375</address><p><em>Email: </em><a><em>kumar@microbiozindia.com</em></a></p><p><strong> </strong></p><h2>Outside from India(Our active team members)</h2><p> </p><h3>Nigeria</h3><address><strong>Ms.Rebecca Scolastica Bello</strong><br />Chief International Representative<br />Mob:+2348036832447/08029137224<br />Email: <a>becscola01@gmail.com </a></address><h3>Malaysia</h3><address>Sivashankari Ramamoorthi,Malaysia Outreach<br />E-mail : <a>sivashankari2212@gmail.com </a><br />Mob: 0129353362</address><h3>Philippines</h3><address>Rodel Estadillo Alo,Philipines Outreach<br />E-mail : <a>rodel.alo03@gmail.com</a><br />Mob:0947-376-2202</address><h3>Iraq</h3><address>Dr.Muslim Dhaher Musa<br />E-mail : <a>musamoslim@yahoo.com</a><br />Mob: 009647806674881</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:43:19','2019-12-07 10:43:19','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4089,2,'2019-12-07 10:44:25','2019-12-07 10:44:25','&nbsp;\r\n<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a>\r\n\r\n</address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>\r\n<h2>Outside from India(Our active team members)</h2>\r\n<h3>Nigeria</h3>\r\n<address><strong>Ms.Rebecca Scolastica Bello</strong>\r\nChief International Representative\r\nMob:+2348036832447/08029137224\r\nEmail: <a>becscola01@gmail.com </a></address>\r\n<h3>Malaysia</h3>\r\n<address>Sivashankari Ramamoorthi,Malaysia Outreach\r\nE-mail : <a>sivashankari2212@gmail.com </a>\r\nMob: 0129353362</address>\r\n<h3>Philippines</h3>\r\n<address>Rodel Estadillo Alo,Philipines Outreach\r\nE-mail : <a>rodel.alo03@gmail.com</a>\r\nMob:0947-376-2202</address>\r\n<h3>Iraq</h3>\r\n<address>Dr.Muslim Dhaher Musa\r\nE-mail : <a>musamoslim@yahoo.com</a>\r\nMob: 009647806674881</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:44:25','2019-12-07 10:44:25','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4091,2,'2019-12-07 10:51:30','2019-12-07 10:51:30','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:51:30','2019-12-07 10:51:30','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4093,2,'2019-12-07 10:54:33','2019-12-07 10:54:33','&nbsp;\r\n<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>\r\n<h2>Outside from India(Our active team members)</h2>\r\n<h3>Nigeria</h3>\r\n<address><strong>Ms.Rebecca Scolastica Bello</strong>\r\nChief International Representative\r\nMob:+2348036832447/08029137224\r\nEmail: <a>becscola01@gmail.com </a></address>\r\n<h3>Malaysia</h3>\r\n<address>Sivashankari Ramamoorthi,Malaysia Outreach\r\nE-mail : <a>sivashankari2212@gmail.com </a>\r\nMob: 0129353362</address>\r\n<h3>Philippines</h3>\r\n<address>Rodel Estadillo Alo,Philipines Outreach\r\nE-mail : <a>rodel.alo03@gmail.com</a>\r\nMob:0947-376-2202</address>\r\n<h3>Iraq</h3>\r\n<address>Dr.Muslim Dhaher Musa\r\nE-mail : <a>musamoslim@yahoo.com</a>\r\nMob: 009647806674881</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 10:54:33','2019-12-07 10:54:33','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4094,2,'2019-12-07 11:11:35','2019-12-07 11:11:35','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:11:35','2019-12-07 11:11:35','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4095,2,'2019-12-07 11:12:46','2019-12-07 11:12:46','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a>\r\n\r\n<strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong>\r\n</strong>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:12:46','2019-12-07 11:12:46','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4096,2,'2019-12-07 11:14:40','2019-12-07 11:14:40','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a>\r\n\r\n</address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:14:40','2019-12-07 11:14:40','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4097,2,'2019-12-07 11:21:02','2019-12-07 11:21:02','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:21:02','2019-12-07 11:21:02','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4098,2,'2019-12-07 11:21:33','2019-12-07 11:21:33','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:21:33','2019-12-07 11:21:33','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4099,2,'2019-12-07 11:23:53','2019-12-07 11:23:53','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:23:53','2019-12-07 11:23:53','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4100,2,'2019-12-07 11:31:13','2019-12-07 11:31:13','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:31:13','2019-12-07 11:31:13','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4102,2,'2019-12-07 11:33:18','2019-12-07 11:33:18','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:33:18','2019-12-07 11:33:18','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4103,2,'2019-12-07 11:35:16','2019-12-07 11:35:16','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:35:16','2019-12-07 11:35:16','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4104,2,'2019-12-07 11:39:26','2019-12-07 11:39:26','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:39:26','2019-12-07 11:39:26','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4105,2,'2019-12-07 11:40:30','2019-12-07 11:40:30','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:40:30','2019-12-07 11:40:30','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4106,2,'2019-12-07 11:41:01','2019-12-07 11:41:01','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:41:01','2019-12-07 11:41:01','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4107,2,'2019-12-07 11:41:38','2019-12-07 11:41:38','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:41:38','2019-12-07 11:41:38','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4108,2,'2019-12-07 11:44:54','2019-12-07 11:44:54','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n<iframe src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" style=\"border:0\" allowfullscreen=\"\" width=\"100%\" height=\"350\" frameborder=\"0\"></iframe>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:44:54','2019-12-07 11:44:54','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4109,2,'2019-12-07 11:45:01','2019-12-07 11:45:01','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:45:01','2019-12-07 11:45:01','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4111,2,'2019-12-07 11:48:37','2019-12-07 11:48:37','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n<iframe src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" style=\"border:0\" allowfullscreen=\"\" width=\"100%\" height=\"350\" frameborder=\"0\"></iframe>\n<!--			-->\n	<!-- END .panel -->','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:48:37','2019-12-07 11:48:37','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4112,2,'2019-12-07 11:48:37','2019-12-07 11:48:37','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a><strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong> </strong>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:48:37','2019-12-07 11:48:37','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4113,2,'2019-12-07 11:53:09','2019-12-07 11:53:09','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n<iframe src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" style=\"border:0\" allowfullscreen=\"\" width=\"100%\" height=\"350\" frameborder=\"0\"></iframe>\n<!--			-->\n	<!-- END .panel -->','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:53:09','2019-12-07 11:53:09','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4114,2,'2019-12-07 11:53:46','2019-12-07 11:53:46','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n<iframe src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" style=\"border:0\" allowfullscreen=\"\" width=\"100%\" height=\"350\" frameborder=\"0\"></iframe>\n<!--			-->\n	<!-- END .panel -->\n	<!-- END .panel -->','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:53:46','2019-12-07 11:53:46','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4115,2,'2019-12-07 11:55:54','2019-12-07 11:55:54','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>\n<iframe src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" style=\"border:0\" allowfullscreen=\"\" width=\"100%\" height=\"350\" frameborder=\"0\"></iframe>\n<!--			-->\n	<!-- END .panel -->\n	<!-- END .panel -->','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:55:54','2019-12-07 11:55:54','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4116,2,'2019-12-07 11:56:39','2019-12-07 11:56:39','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a>\r\n\r\n<strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong>\r\n</strong>\r\n<h2>Outside from India(Our active team members)</h2>\r\n<h3>Nigeria</h3>\r\n<address><strong>Ms.Rebecca Scolastica Bello</strong>\r\nChief International Representative\r\nMob:+2348036832447/08029137224\r\nEmail: <a>becscola01@gmail.com </a></address>\r\n<h3>Malaysia</h3>\r\n<address>Sivashankari Ramamoorthi,Malaysia Outreach\r\nE-mail : <a>sivashankari2212@gmail.com </a>\r\nMob: 0129353362</address>\r\n<h3>Philippines</h3>\r\n<address>Rodel Estadillo Alo,Philipines Outreach\r\nE-mail : <a>rodel.alo03@gmail.com</a>\r\nMob:0947-376-2202</address>\r\n<h3>Iraq</h3>\r\n<address>Dr.Muslim Dhaher Musa\r\nE-mail : <a>musamoslim@yahoo.com</a>\r\nMob: 009647806674881</address><iframe style=\"border: 0;\" src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" width=\"100%\" height=\"350\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"></iframe>\r\n<!-- -->\r\n<!-- END .panel -->\r\n<!-- END .panel -->','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 11:56:39','2019-12-07 11:56:39','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4118,2,'2019-12-07 12:00:26','2019-12-07 12:00:26','<h3>Corporate office</h3>\n<address>Microbioz India<br>\n(Corporate Address)<br>\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019<br>\nMob: +91-9670704431,+91-7827169949,<br>\nEmail: <a href=\"\">subscription@microbiozindia.com</a>, <a href=\"\">support@microbiozindia.com </a><br>\n<br>\n<strong>Connect with Us</strong><br>\nFacebook:  <a href=\"\">www.facebook.com/MICROBIOZINDIA</a><br>\nTwitter: <a href=\"\">www.twitter.com/MICROBIOZINDIA</a></address>\n<h3>New Delhi</h3>\n<address>Microbioz India<br>\n(Branch Office)<br>\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019<br>\nMob: +91-9670704431,9773585375</address>\n<em>Email: </em><a href=\"\"><em>kumar@microbiozindia.com</em></a>\n<br>\n<strong><br>\n</strong><br>\n&nbsp;\n			<h2>Outside from India(Our active team members)</h2>		\n<h3>Nigeria</h3>\n<address><strong>Ms.Rebecca Scolastica Bello</strong><br>\nChief International Representative<br>\nMob:+2348036832447/08029137224 <br>\nEmail: <a href=\"\">becscola01@gmail.com </a></address>\n<h3>Malaysia</h3>\n<address>Sivashankari Ramamoorthi,Malaysia Outreach<br>\nE-mail : <a href=\"\">sivashankari2212@gmail.com  </a><br>\nMob: 0129353362</address>\n<h3>Philippines</h3>\n<address>Rodel Estadillo Alo,Philipines Outreach<br>\nE-mail : <a href=\"\">rodel.alo03@gmail.com</a><br>\nMob:0947-376-2202</address>\n<h3>Iraq</h3>\n<address>Dr.Muslim Dhaher Musa<br>\nE-mail : <a href=\"\">musamoslim@yahoo.com</a><br>\nMob: 009647806674881</address>','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 12:00:26','2019-12-07 12:00:26','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4119,2,'2019-12-07 12:00:31','2019-12-07 12:00:31','<h3>Corporate office</h3>\r\n<address>Microbioz India\r\n(Corporate Address)\r\nJ3/37,First Floor DDA Flats Kalkaji, Delhi, India-110019\r\nMob: +91-9670704431,+91-7827169949,\r\nEmail: <a>subscription@microbiozindia.com</a>, <a>support@microbiozindia.com </a>\r\n\r\n<strong>Connect with Us</strong>\r\nFacebook: <a>www.facebook.com/MICROBIOZINDIA</a>\r\nTwitter: <a>www.twitter.com/MICROBIOZINDIA</a></address>\r\n<h3>New Delhi</h3>\r\n<address>Microbioz India\r\n(Branch Office)\r\nJ3/37,First Floor,DDA Flats Kalka Ji,New Delhi-110019\r\nMob: +91-9670704431,9773585375</address><em>Email: </em><a><em>kumar@microbiozindia.com</em></a>\r\n\r\n<strong>\r\n</strong>\r\n<h2>Outside from India(Our active team members)</h2>\r\n<h3>Nigeria</h3>\r\n<address><strong>Ms.Rebecca Scolastica Bello</strong>\r\nChief International Representative\r\nMob:+2348036832447/08029137224\r\nEmail: <a>becscola01@gmail.com </a></address>\r\n<h3>Malaysia</h3>\r\n<address>Sivashankari Ramamoorthi,Malaysia Outreach\r\nE-mail : <a>sivashankari2212@gmail.com </a>\r\nMob: 0129353362</address>\r\n<h3>Philippines</h3>\r\n<address>Rodel Estadillo Alo,Philipines Outreach\r\nE-mail : <a>rodel.alo03@gmail.com</a>\r\nMob:0947-376-2202</address>\r\n<h3>Iraq</h3>\r\n<address>Dr.Muslim Dhaher Musa\r\nE-mail : <a>musamoslim@yahoo.com</a>\r\nMob: 009647806674881</address><iframe style=\"border: 0;\" src=\"https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3558.888229262809!2d81.00985931504417!3d26.87529198314374!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x399be2977fe02399%3A0x8050af8fa88f65fe!2sMicrobioz+India!5e0!3m2!1sen!2sin!4v1476263580880\" width=\"100%\" height=\"350\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"></iframe>\r\n<!-- -->\r\n<!-- END .panel -->\r\n<!-- END .panel -->','Contact','','inherit','closed','closed','','62-revision-v1','','','2019-12-07 12:00:31','2019-12-07 12:00:31','',62,'https://microbiozindia.com/uncategorized/62-revision-v1/',0,'revision','',0),(4120,2,'2019-12-07 14:46:08','2019-12-07 14:46:08','Analytik reports on ground-breaking work by the Department of Chemistry at the University of Sheffield using a LV-1 Microfluidizer to create novel oil-in-water Nano emulsions that were subsequently occluded within a calcite crystalline lattice.\r\n\r\nParticle Technology is an important discipline that underpins many industrial sectors, including biomedical applications, latex paints and coatings, engine oil additives, viscosity modifiers and emulsion stabilisation. Steve Armes, Professor of Polymer and Colloid Chemistry at the University of Sheffield, is one of the UK\'s leading experts in particle science and technology, with more than thirty years of research experience in this field. In particular, he designs a wide range of microscopic polymer particles on the nanoscale.\r\n\r\nProfessor Steve Armes said \"It is well known that oil and water do not mix. Similarly, the incorporation of oil droplets within inorganic crystals is highly counter-intuitive because there is a large difference in surface energy for these two components. Our new occlusion protocol, developed using the high-pressure LV-1 microfluidizer, has enabled either oil-soluble dyes or oil-dispersible hydrophobic nanoparticles to be incorporated for the first time within host crystals. This exciting new innovation has considerable potential to be used as a new environmentally-friendly matrix for the microencapsulation and controlled release of a wide range of actives for various commercial applications. In view of this, we have filed a preliminary patent application to protect the IP associated with our work.\r\n\r\nProfessor Ames added: “We are indebted to the excellent technical support provided by Analytik, which has enabled us to fully exploit the high-pressure LV-1 Microfluidizer for the production of well-defined nanoemulsions. We will be seeking their support and advice in the future as we seek to extend our studies to include water-in-oil nanoemulsions”.\r\n\r\nThe LV1 Microfluidizer is a high shear homogeniser which brings outstanding processing capabilities to samples as small as 1 ml. The LV1 has been designed to achieve operating pressures up to 30,000 psi for samples ranging from 1-6 ml. Using proprietary fixed-geometry interaction chamber technology, the LV1 is capable of processing a wide variety of fluids such as oil-in-water emulsions, solids-in-liquid suspensions, and cells, including the most difficult yeasts and plant cells, in as few as 1-2 passes. What\'s more, the process is repeatable and is guaranteed to scale up to pilot and/or production volumes.\r\n\r\nFor further more detailed information on the LV-1 Microfluidizer please visit https://analytik.co.uk/product/nanoemulsions-lv1-microfluidizer/ or contact Analytik on +44-1954-232776 / info@analytik.co.uk. For a copy of the recently published paper ‘Efficient occlusion of oil droplets within calcite crystals’ describing the pioneering work of Professor Armes research group please visit https://pubs.rsc.org/en/content/articlelanding/2019/sc/c9sc03372f#!divAbstract\r\n\r\nFor over 15 years - Analytik has been a trusted supplier of cutting-edge scientific instrumentation to leading organisations throughout the UK and Ireland. In addition to supplying innovative analytical instrumentation from global technology providers, we deliver added value through specialised consultative expertise and comprehensive pre and post sales support to ensure that our customers get the most out of their investment. For further information please visit www.analytik.co.uk.','High-Pressure Microfluidisation Enables Oil Droplets to enter Inorganic Crystals','','publish','open','open','','high-pressure-microfluidisation-enables-oil-droplets-to-enter-inorganic-crystals','','','2019-12-07 14:51:51','2019-12-07 14:51:51','',0,'https://microbiozindia.com/?p=4120',0,'post','',0),(4121,2,'2019-12-07 14:45:54','2019-12-07 14:45:54','','Untitled design (1)','','inherit','open','closed','','untitled-design-1','','','2019-12-07 14:45:54','2019-12-07 14:45:54','',4120,'https://microbiozindia.com/wp-content/uploads/2019/12/Untitled-design-1.png',0,'attachment','image/png',0),(4122,2,'2019-12-07 14:46:08','2019-12-07 14:46:08','Analytik reports on ground-breaking work by the Department of Chemistry at the University of Sheffield using a LV-1 Microfluidizer to create novel oil-in-water Nano emulsions that were subsequently occluded within a calcite crystalline lattice.\r\n\r\nParticle Technology is an important discipline that underpins many industrial sectors, including biomedical applications, latex paints and coatings, engine oil additives, viscosity modifiers and emulsion stabilisation. Steve Armes, Professor of Polymer and Colloid Chemistry at the University of Sheffield, is one of the UK\'s leading experts in particle science and technology, with more than thirty years of research experience in this field. In particular, he designs a wide range of microscopic polymer particles on the nanoscale.\r\n\r\nProfessor Steve Armes said \"It is well known that oil and water do not mix. Similarly, the incorporation of oil droplets within inorganic crystals is highly counter-intuitive because there is a large difference in surface energy for these two components. Our new occlusion protocol, developed using the high-pressure LV-1 microfluidizer, has enabled either oil-soluble dyes or oil-dispersible hydrophobic nanoparticles to be incorporated for the first time within host crystals. This exciting new innovation has considerable potential to be used as a new environmentally-friendly matrix for the microencapsulation and controlled release of a wide range of actives for various commercial applications. In view of this, we have filed a preliminary patent application to protect the IP associated with our work.\r\n\r\nProfessor Ames added: “We are indebted to the excellent technical support provided by Analytik, which has enabled us to fully exploit the high-pressure LV-1 Microfluidizer for the production of well-defined nanoemulsions. We will be seeking their support and advice in the future as we seek to extend our studies to include water-in-oil nanoemulsions”.\r\n\r\nThe LV1 Microfluidizer is a high shear homogeniser which brings outstanding processing capabilities to samples as small as 1 ml. The LV1 has been designed to achieve operating pressures up to 30,000 psi for samples ranging from 1-6 ml. Using proprietary fixed-geometry interaction chamber technology, the LV1 is capable of processing a wide variety of fluids such as oil-in-water emulsions, solids-in-liquid suspensions, and cells, including the most difficult yeasts and plant cells, in as few as 1-2 passes. What\'s more, the process is repeatable and is guaranteed to scale up to pilot and/or production volumes.\r\n\r\nFor further more detailed information on the LV-1 Microfluidizer please visit https://analytik.co.uk/product/nanoemulsions-lv1-microfluidizer/ or contact Analytik on +44-1954-232776 / info@analytik.co.uk. For a copy of the recently published paper ‘Efficient occlusion of oil droplets within calcite crystals’ describing the pioneering work of Professor Armes research group please visit https://pubs.rsc.org/en/content/articlelanding/2019/sc/c9sc03372f#!divAbstract\r\n\r\nFor over 15 years - Analytik has been a trusted supplier of cutting-edge scientific instrumentation to leading organisations throughout the UK and Ireland. In addition to supplying innovative analytical instrumentation from global technology providers, we deliver added value through specialised consultative expertise and comprehensive pre and post sales support to ensure that our customers get the most out of their investment. For further information please visit www.analytik.co.uk.','High-Pressure Microfluidisation Enables Oil Droplets to enter Inorganic Crystals','','inherit','closed','closed','','4120-revision-v1','','','2019-12-07 14:46:08','2019-12-07 14:46:08','',4120,'https://microbiozindia.com/uncategorized/4120-revision-v1/',0,'revision','',0),(4123,2,'2019-12-07 14:48:17','2019-12-07 14:48:17','','HH','','inherit','open','closed','','hh','','','2019-12-07 14:48:17','2019-12-07 14:48:17','',4120,'https://microbiozindia.com/wp-content/uploads/2019/12/HH.png',0,'attachment','image/png',0),(4124,2,'2019-12-07 14:51:51','2019-12-07 14:51:51','Analytik reports on ground-breaking work by the Department of Chemistry at the University of Sheffield using a LV-1 Microfluidizer to create novel oil-in-water Nano emulsions that were subsequently occluded within a calcite crystalline lattice.\r\n\r\nParticle Technology is an important discipline that underpins many industrial sectors, including biomedical applications, latex paints and coatings, engine oil additives, viscosity modifiers and emulsion stabilisation. Steve Armes, Professor of Polymer and Colloid Chemistry at the University of Sheffield, is one of the UK\'s leading experts in particle science and technology, with more than thirty years of research experience in this field. In particular, he designs a wide range of microscopic polymer particles on the nanoscale.\r\n\r\nProfessor Steve Armes said \"It is well known that oil and water do not mix. Similarly, the incorporation of oil droplets within inorganic crystals is highly counter-intuitive because there is a large difference in surface energy for these two components. Our new occlusion protocol, developed using the high-pressure LV-1 microfluidizer, has enabled either oil-soluble dyes or oil-dispersible hydrophobic nanoparticles to be incorporated for the first time within host crystals. This exciting new innovation has considerable potential to be used as a new environmentally-friendly matrix for the microencapsulation and controlled release of a wide range of actives for various commercial applications. In view of this, we have filed a preliminary patent application to protect the IP associated with our work.\r\n\r\nProfessor Ames added: “We are indebted to the excellent technical support provided by Analytik, which has enabled us to fully exploit the high-pressure LV-1 Microfluidizer for the production of well-defined nanoemulsions. We will be seeking their support and advice in the future as we seek to extend our studies to include water-in-oil nanoemulsions”.\r\n\r\nThe LV1 Microfluidizer is a high shear homogeniser which brings outstanding processing capabilities to samples as small as 1 ml. The LV1 has been designed to achieve operating pressures up to 30,000 psi for samples ranging from 1-6 ml. Using proprietary fixed-geometry interaction chamber technology, the LV1 is capable of processing a wide variety of fluids such as oil-in-water emulsions, solids-in-liquid suspensions, and cells, including the most difficult yeasts and plant cells, in as few as 1-2 passes. What\'s more, the process is repeatable and is guaranteed to scale up to pilot and/or production volumes.\r\n\r\nFor further more detailed information on the LV-1 Microfluidizer please visit https://analytik.co.uk/product/nanoemulsions-lv1-microfluidizer/ or contact Analytik on +44-1954-232776 / info@analytik.co.uk. For a copy of the recently published paper ‘Efficient occlusion of oil droplets within calcite crystals’ describing the pioneering work of Professor Armes research group please visit https://pubs.rsc.org/en/content/articlelanding/2019/sc/c9sc03372f#!divAbstract\r\n\r\nFor over 15 years - Analytik has been a trusted supplier of cutting-edge scientific instrumentation to leading organisations throughout the UK and Ireland. In addition to supplying innovative analytical instrumentation from global technology providers, we deliver added value through specialised consultative expertise and comprehensive pre and post sales support to ensure that our customers get the most out of their investment. For further information please visit www.analytik.co.uk.','High-Pressure Microfluidisation Enables Oil Droplets to enter Inorganic Crystals','','inherit','closed','closed','','4120-revision-v1','','','2019-12-07 14:51:51','2019-12-07 14:51:51','',4120,'https://microbiozindia.com/uncategorized/4120-revision-v1/',0,'revision','',0),(4125,2,'2019-12-10 09:05:46','2019-12-10 09:05:46','Ziath has launched a competitively priced starter kit for organizations involved in food research, production and testing to keep track of samples to help improve food safety.\r\n\r\nReflecting the threat of foodborne illnesses and product recalls, food safety is an issue of significant and growing importance to consumers, food manufacturers and research laboratories. Increasingly legislative bodies around the world are pushing for handlers along the entire food supply chain to put in place food \'track and trace\' provisions to prevent catastrophic harm to the health of consumers and avoid food safety related disruption and economic loss to the food industry.\r\n\r\nThe Ziath \'Track and Trace\' starter kit contains everything an organization needs to start up and maintain enhanced food sample integrity, tracking and audit trail.\r\n\r\nThe new starter kit combines top-quality 2D coded sample storage tubes, 48-position SBS format tube racks and a high-performance single tube 2D barcode scanner. Also included within this package is the Ziath Samples&#x2122; sample management software which allows you to organize your food sample inventory, making setting up a traceable record of food samples very straightforward.\r\n\r\nFor further information on the \'Track and Trace\' starter kit please contact Ziath on +44-1223-855021 / +1-858-880-6920 / <a href=\"mailto:david.anstee@ziath.com\">david.anstee@ziath.com</a>.\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com/\">www.ziath.com</a>','Tracking Samples to Improve Food Safety','','publish','open','open','','tracking-samples-to-improve-food-safety','','','2019-12-10 09:05:46','2019-12-10 09:05:46','',0,'https://microbiozindia.com/?p=4125',0,'post','',0),(4126,2,'2019-12-10 09:05:32','2019-12-10 09:05:32','','tt','','inherit','open','closed','','tt','','','2019-12-10 09:05:32','2019-12-10 09:05:32','',4125,'https://microbiozindia.com/wp-content/uploads/2019/12/tt.png',0,'attachment','image/png',0),(4127,2,'2019-12-10 09:05:46','2019-12-10 09:05:46','Ziath has launched a competitively priced starter kit for organizations involved in food research, production and testing to keep track of samples to help improve food safety.\r\n\r\nReflecting the threat of foodborne illnesses and product recalls, food safety is an issue of significant and growing importance to consumers, food manufacturers and research laboratories. Increasingly legislative bodies around the world are pushing for handlers along the entire food supply chain to put in place food \'track and trace\' provisions to prevent catastrophic harm to the health of consumers and avoid food safety related disruption and economic loss to the food industry.\r\n\r\nThe Ziath \'Track and Trace\' starter kit contains everything an organization needs to start up and maintain enhanced food sample integrity, tracking and audit trail.\r\n\r\nThe new starter kit combines top-quality 2D coded sample storage tubes, 48-position SBS format tube racks and a high-performance single tube 2D barcode scanner. Also included within this package is the Ziath Samples&#x2122; sample management software which allows you to organize your food sample inventory, making setting up a traceable record of food samples very straightforward.\r\n\r\nFor further information on the \'Track and Trace\' starter kit please contact Ziath on +44-1223-855021 / +1-858-880-6920 / <a href=\"mailto:david.anstee@ziath.com\">david.anstee@ziath.com</a>.\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com/\">www.ziath.com</a>','Tracking Samples to Improve Food Safety','','inherit','closed','closed','','4125-revision-v1','','','2019-12-10 09:05:46','2019-12-10 09:05:46','',4125,'https://microbiozindia.com/uncategorized/4125-revision-v1/',0,'revision','',0),(4129,2,'2019-12-10 10:48:48','2019-12-10 10:48:48','','header-logo','','inherit','open','closed','','header-logo','','','2019-12-10 10:48:48','2019-12-10 10:48:48','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/header-logo.png',0,'attachment','image/png',0),(4130,2,'2019-12-10 17:35:57','2019-12-10 17:35:57','Testa Analytical Solutions e.K. has launched the new Particle Explorer software suite for its popular BI-200SM light scattering goniometer system.\r\nThe new software suite has been designed to enable even occasional users to simply access the unmatched research grade performance and extensive operational versatility of the BI-200SM in one convenient user interface.\r\nAll Particle Explorer software modules are easily accessible and packed with a plethora of new and exciting features. The new software suite supports Multi-Angle DLS, simultaneous DLS and SLS measurement and a full range of calculation algorithms for this powerful technique. Best of all, Particle Explorer is available as an option for most existing BI-200SM system users with little or no hardware upgrade required.\r\n\r\n<img class=\"alignnone  wp-image-4132\" src=\"https://microbiozindia.com/wp-content/uploads/2019/12/Testapr29-imageA-300x152.jpg\" alt=\"\" width=\"731\" height=\"370\" />\r\nThe Bl-200SM goniometer system is a precision research grade instrument designed for exacting light scattering measurements. Based on a special turntable with precision ball bearings and stepping motor, the Bl-200SM\'s modular, automated design and quality construction guarantee precise measurements due to the wobble-free movement of the detector. As you would expect from a research grade system the BI-200SM can measure light scattering over a wide angular range (8° to 155° with 25 mm cells) and offers fine adjustment of measurement angles to 0.01° directly using a large, fine-control knob. Fine-screw vertical adjustment makes centre of rotation measurement easier when aligning cells. Precise repeatable data is ensured by automated heating and cooling of the sample cell using and standard external recirculating system. Field proven in hundreds of labs around the world the BI-200SM light scattering goniometer system is ideal for even the most demanding macromolecular studies and submicron particle sizing applications.\r\n\r\nFor further information on Particle Explorer software for the BI-200SM research goniometer system please watch the video at <a href=\"http://www.testa-analytical.com/index.html?dc=Videos&amp;sn=11\">www.testa-analytical.com/index.html?dc=Videos&amp;sn=11</a> or contact Testa Analytical Solutions on +49-30-864-24076 / <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>.\r\n\r\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.','Powerful Software Suite for Light Scattering Goniometer','','publish','open','open','','powerful-software-suite-for-light-scattering-goniometer','','','2019-12-10 17:35:57','2019-12-10 17:35:57','',0,'https://microbiozindia.com/?p=4130',0,'post','',0),(4131,2,'2019-12-10 17:33:44','2019-12-10 17:33:44','','A','','inherit','open','closed','','a','','','2019-12-10 17:33:44','2019-12-10 17:33:44','',4130,'https://microbiozindia.com/wp-content/uploads/2019/12/A.png',0,'attachment','image/png',0),(4132,2,'2019-12-10 17:33:49','2019-12-10 17:33:49','','Testapr29-imageA','','inherit','open','closed','','testapr29-imagea','','','2019-12-10 17:33:49','2019-12-10 17:33:49','',4130,'https://microbiozindia.com/wp-content/uploads/2019/12/Testapr29-imageA.jpg',0,'attachment','image/jpeg',0),(4133,2,'2019-12-10 17:35:57','2019-12-10 17:35:57','Testa Analytical Solutions e.K. has launched the new Particle Explorer software suite for its popular BI-200SM light scattering goniometer system.\r\nThe new software suite has been designed to enable even occasional users to simply access the unmatched research grade performance and extensive operational versatility of the BI-200SM in one convenient user interface.\r\nAll Particle Explorer software modules are easily accessible and packed with a plethora of new and exciting features. The new software suite supports Multi-Angle DLS, simultaneous DLS and SLS measurement and a full range of calculation algorithms for this powerful technique. Best of all, Particle Explorer is available as an option for most existing BI-200SM system users with little or no hardware upgrade required.\r\n\r\n<img class=\"alignnone  wp-image-4132\" src=\"https://microbiozindia.com/wp-content/uploads/2019/12/Testapr29-imageA-300x152.jpg\" alt=\"\" width=\"731\" height=\"370\" />\r\nThe Bl-200SM goniometer system is a precision research grade instrument designed for exacting light scattering measurements. Based on a special turntable with precision ball bearings and stepping motor, the Bl-200SM\'s modular, automated design and quality construction guarantee precise measurements due to the wobble-free movement of the detector. As you would expect from a research grade system the BI-200SM can measure light scattering over a wide angular range (8° to 155° with 25 mm cells) and offers fine adjustment of measurement angles to 0.01° directly using a large, fine-control knob. Fine-screw vertical adjustment makes centre of rotation measurement easier when aligning cells. Precise repeatable data is ensured by automated heating and cooling of the sample cell using and standard external recirculating system. Field proven in hundreds of labs around the world the BI-200SM light scattering goniometer system is ideal for even the most demanding macromolecular studies and submicron particle sizing applications.\r\n\r\nFor further information on Particle Explorer software for the BI-200SM research goniometer system please watch the video at <a href=\"http://www.testa-analytical.com/index.html?dc=Videos&amp;sn=11\">www.testa-analytical.com/index.html?dc=Videos&amp;sn=11</a> or contact Testa Analytical Solutions on +49-30-864-24076 / <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>.\r\n\r\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.','Powerful Software Suite for Light Scattering Goniometer','','inherit','closed','closed','','4130-revision-v1','','','2019-12-10 17:35:57','2019-12-10 17:35:57','',4130,'https://microbiozindia.com/uncategorized/4130-revision-v1/',0,'revision','',0),(4134,2,'2019-12-10 17:36:08','2019-12-10 17:36:08','Testa Analytical Solutions e.K. has launched the new Particle Explorer software suite for its popular BI-200SM light scattering goniometer system.\nThe new software suite has been designed to enable even occasional users to simply access the unmatched research grade performance and extensive operational versatility of the BI-200SM in one convenient user interface.\nAll Particle Explorer software modules are easily accessible and packed with a plethora of new and exciting features. The new software suite supports Multi-Angle DLS, simultaneous DLS and SLS measurement and a full range of calculation algorithms for this powerful technique. Best of all, Particle Explorer is available as an option for most existing BI-200SM system users with little or no hardware upgrade required.\n\n<img class=\"alignnone  wp-image-4132\" src=\"https://microbiozindia.com/wp-content/uploads/2019/12/Testapr29-imageA-300x152.jpg\" alt=\"\" width=\"731\" height=\"370\" />\nThe Bl-200SM goniometer system is a precision research grade instrument designed for exacting light scattering measurements. Based on a special turntable with precision ball bearings and stepping motor, the Bl-200SM\'s modular, automated design and quality construction guarantee precise measurements due to the wobble-free movement of the detector. As you would expect from a research grade system the BI-200SM can measure light scattering over a wide angular range (8° to 155° with 25 mm cells) and offers fine adjustment of measurement angles to 0.01° directly using a large, fine-control knob. Fine-screw vertical adjustment makes centre of rotation measurement easier when aligning cells. Precise repeatable data is ensured by automated heating and cooling of the sample cell using and standard external recirculating system. Field proven in hundreds of labs around the world the BI-200SM light scattering goniometer system is ideal for even the most demanding macromolecular studies and submicron particle sizing applications.\n\nFor further information on Particle Explorer software for the BI-200SM research goniometer system please watch the video at <a href=\"http://www.testa-analytical.com/index.html?dc=Videos&amp;sn=11\">www.testa-analytical.com/index.html?dc=Videos&amp;sn=11</a> or contact Testa Analytical Solutions on +49-30-864-24076 / <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>.\n\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.','Powerful Software Suite for Light Scattering Goniometer','','inherit','closed','closed','','4130-autosave-v1','','','2019-12-10 17:36:08','2019-12-10 17:36:08','',4130,'https://microbiozindia.com/uncategorized/4130-autosave-v1/',0,'revision','',0),(4135,2,'2019-12-11 16:04:05','2019-12-11 16:04:05','The MiniVap® Nitrogen Blowdown evaporator from Porvair Sciences is purpose designed for research and development departments where low numbers of individual microplates or vials need drying.\r\n\r\nThe MiniVap® is simple to operate and maintain. Installation requires only connection to a gas supply and standard mains socket. With manual control of the needle depth, gas temperature and flow rate, it allows fine control and quicker drying times than other standard methods.\r\n\r\nPurpose designed for removing solvents from vials and standard ANSI/SLAS format microplates the MiniVap® offer quicker dry down times than traditional methods such as vacuum oven. Typically, the MiniVap® takes less than 6 minutes to remove volatile organic solvents from your HPLC fractions collected in 24- or 96-well microplates.\r\n\r\nCompact in design the affordably priced MiniVap® is simple to install, operate and maintain. Installation just requires connection to a gas supply and standard mains socket. Safety of operation is ensured as the CE marked compact unit fits into all fume cupboards.\r\n\r\nPorvair Sciences evaporators are designed to remove the traditional laboratory ‘bottleneck’ of solvent evaporation from microplates prior to analysis or reconstitution in storage buffer. These evaporators give significant throughput advantages to laboratories looking to optimise microplate sample preparation productivity. Faster than centrifugal evaporation, significant increases in sample throughput are achieved through advanced evaporator head technology and an innovative manifold design, which directly injects heated nitrogen into each individual well of the microplate simultaneously.\r\n\r\nFor further information please visit <a href=\"http://www.microplates.com/blowdown-evaporator-minivap/\">www.microplates.com/blowdown-evaporator-minivap/</a>  or contact Porvair Sciences Ltd on +44-1978-661144 or <a href=\"mailto:enquiries@porvairsciences.com\">enquiries@porvairsciences.com</a>.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.','MiniVap® Nitrogen Blowdown evaporator from Porvair Sciences','','publish','open','open','','minivap-nitrogen-blowdown-evaporator-from-porvair-sciences','','','2019-12-11 16:04:05','2019-12-11 16:04:05','',0,'https://microbiozindia.com/?p=4135',0,'post','',0),(4136,2,'2019-12-11 16:03:47','2019-12-11 16:03:47','','ADD','','inherit','open','closed','','add','','','2019-12-11 16:03:47','2019-12-11 16:03:47','',4135,'https://microbiozindia.com/wp-content/uploads/2019/12/ADD.png',0,'attachment','image/png',0),(4137,2,'2019-12-11 16:04:05','2019-12-11 16:04:05','The MiniVap® Nitrogen Blowdown evaporator from Porvair Sciences is purpose designed for research and development departments where low numbers of individual microplates or vials need drying.\r\n\r\nThe MiniVap® is simple to operate and maintain. Installation requires only connection to a gas supply and standard mains socket. With manual control of the needle depth, gas temperature and flow rate, it allows fine control and quicker drying times than other standard methods.\r\n\r\nPurpose designed for removing solvents from vials and standard ANSI/SLAS format microplates the MiniVap® offer quicker dry down times than traditional methods such as vacuum oven. Typically, the MiniVap® takes less than 6 minutes to remove volatile organic solvents from your HPLC fractions collected in 24- or 96-well microplates.\r\n\r\nCompact in design the affordably priced MiniVap® is simple to install, operate and maintain. Installation just requires connection to a gas supply and standard mains socket. Safety of operation is ensured as the CE marked compact unit fits into all fume cupboards.\r\n\r\nPorvair Sciences evaporators are designed to remove the traditional laboratory ‘bottleneck’ of solvent evaporation from microplates prior to analysis or reconstitution in storage buffer. These evaporators give significant throughput advantages to laboratories looking to optimise microplate sample preparation productivity. Faster than centrifugal evaporation, significant increases in sample throughput are achieved through advanced evaporator head technology and an innovative manifold design, which directly injects heated nitrogen into each individual well of the microplate simultaneously.\r\n\r\nFor further information please visit <a href=\"http://www.microplates.com/blowdown-evaporator-minivap/\">www.microplates.com/blowdown-evaporator-minivap/</a>  or contact Porvair Sciences Ltd on +44-1978-661144 or <a href=\"mailto:enquiries@porvairsciences.com\">enquiries@porvairsciences.com</a>.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.','MiniVap® Nitrogen Blowdown evaporator from Porvair Sciences','','inherit','closed','closed','','4135-revision-v1','','','2019-12-11 16:04:05','2019-12-11 16:04:05','',4135,'https://microbiozindia.com/uncategorized/4135-revision-v1/',0,'revision','',0),(4139,2,'2019-12-12 15:58:05','2019-12-12 15:58:05','According to one of the study, the immune repertoire sequencing market in terms of revenue, is projected to register a CAGR of 7.3% over the forecast period.\r\n\r\nThe immune repertoire sequencing market is segmented based on product type, application, end users and regions. Based on product type, the immune repertoire sequencing market is segmented into assay kits, software and services. The assay kits is expected to be the leading segment in the immune repertoire sequencing market and grow at a CAGR of 7.7% over the forecast period. Based on application, the immune repertoire sequencing market is segmented into cancer immunotherapy, infectious diseases, vaccine development and efficacy, transplant rejection &amp; tolerance, autoimmune disease and biomarker discovery. The cancer immunotherapy segment in the immune repertoire sequencing market is expected to account a high revenue share and grow at a CAGR of 8.7% over the forecast period. Based on end users, the immune repertoire sequencing market is segmented into academic institutes and research centres. The research centres is expected to be the leading segment in the immune repertoire sequencing market over the forecast period, growing at a CAGR of 7.6%.\r\n\r\nThe growth of the immune repertoire sequencing market is primarily driven by increasing prevalence of cancer and other infectious diseases and growing awareness for development of cell-mediated immunotherapies globally. In addition, other factors which is expected to propel the growth of the global Immune Repertoire Sequencing market include increase in healthcare expenditure, demand for genomic based research, increase in sequencing based projects, advancement in sequencing tools (pre-sequencing, bioinformatics solutions and cloud computing). Besides, exceptional developments by China and Japan for integration of new technologies in biomedical research including advancement in genome sequencing is also expected to propel the growth of the immune repertoire sequencing market. The substantial price drop in high throughput sequencing is also expected to contribute to the growth of the immune repertoire sequencing market, particularly in underdeveloped countries of Latin America and MEA.\r\n\r\nThis report assesses the trends that are driving the growth of each segment of the immune repertoire sequencing market on the global as well as regional level, and offers potential takeaways that could prove substantially useful for the manufacturers planning to enter the immune repertoire sequencing market.\r\n\r\nNorth America accounted a high revenue share in 2017, and is expected to be the dominant regional market for immune repertoire sequencing over the forecast period. The U.S. immune repertoire sequencing market is expected to hold a large share in North America and is expected to grow at a CAGR of 6.7% over the forecast period. Large presence of globally renowned companies in high-throughput sequencing and increased scale of sequencing projects in the region is expected to increase the adoption of immune repertoire sequencing. Besides, the leading academic universities and research centers are based in North America, which is also expected to the surge the adoption of immune repertoire sequencing methods. The Europe and Asia Pacific immune repertoire sequencing markets collectively will grow at CAGRs of 7.3% and 9.9 %, respectively, over the forecast period. The Latin America and Middle East and Africa immune repertoire sequencing markets are estimated to expand at CAGRs of 5.8% and 4.8%, respectively, over the forecast period. Consistent investment in development of the healthcare sector in terms of research and services through governmental and private capital funding will drive the demand for immune repertoire sequencing in the region by implication of sequencing tools. High prevalence of infectious and other diseases is one of the key factors expected to drive the growth of the immune repertoire sequencing market in Middle East and Africa.\r\n\r\nExamples of some of the key players covered in the report of the immune repertoire sequencing market are Illumina, Takara Bio Inc, BGI, Thermo Fischer Scientific, and F. Hoffmann-La Roche Ltd, among others. The companies are focusing on developing new software-based platforms and improved assay-based kits for immune repertoire sequencing. However, the high cost associated with certain sequencing platforms and data analytic services are expected to hinder the growth of the immune repertoire sequencing market over the forecast period.\r\n\r\n<em><u>These insights are based on a report on <a href=\"https://www.persistencemarketresearch.com/market-research/immune-repertoire-sequencing-market.asp\">Immune Repertoire Sequencing Market</a> by Persistence Market Research.</u></em>','Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High Throughput Sequencing, Bioinformatics Solutions and Cloud Computing','','publish','open','open','','immune-repertoire-sequencing-market-growth-anticipated-to-be-driven-by-advancements-in-high-throughput-sequencing-bioinformatics-solutions-and-cloud-computing','','','2019-12-12 15:58:32','2019-12-12 15:58:32','',0,'https://microbiozindia.com/?p=4139',0,'post','',0),(4140,2,'2019-12-12 15:57:34','2019-12-12 15:57:34','','ffggf','','inherit','open','closed','','ffggf','','','2019-12-12 15:57:34','2019-12-12 15:57:34','',4139,'https://microbiozindia.com/wp-content/uploads/2019/12/ffggf.png',0,'attachment','image/png',0),(4141,2,'2019-12-12 15:58:05','2019-12-12 15:58:05','According to one of the study, the immune repertoire sequencing market in terms of revenue, is projected to register a CAGR of 7.3% over the forecast period.\r\n\r\nThe immune repertoire sequencing market is segmented based on product type, application, end users and regions. Based on product type, the immune repertoire sequencing market is segmented into assay kits, software and services. The assay kits is expected to be the leading segment in the immune repertoire sequencing market and grow at a CAGR of 7.7% over the forecast period. Based on application, the immune repertoire sequencing market is segmented into cancer immunotherapy, infectious diseases, vaccine development and efficacy, transplant rejection &amp; tolerance, autoimmune disease and biomarker discovery. The cancer immunotherapy segment in the immune repertoire sequencing market is expected to account a high revenue share and grow at a CAGR of 8.7% over the forecast period. Based on end users, the immune repertoire sequencing market is segmented into academic institutes and research centres. The research centres is expected to be the leading segment in the immune repertoire sequencing market over the forecast period, growing at a CAGR of 7.6%.\r\n\r\nThe growth of the immune repertoire sequencing market is primarily driven by increasing prevalence of cancer and other infectious diseases and growing awareness for development of cell-mediated immunotherapies globally. In addition, other factors which is expected to propel the growth of the global Immune Repertoire Sequencing market include increase in healthcare expenditure, demand for genomic based research, increase in sequencing based projects, advancement in sequencing tools (pre-sequencing, bioinformatics solutions and cloud computing). Besides, exceptional developments by China and Japan for integration of new technologies in biomedical research including advancement in genome sequencing is also expected to propel the growth of the immune repertoire sequencing market. The substantial price drop in high throughput sequencing is also expected to contribute to the growth of the immune repertoire sequencing market, particularly in underdeveloped countries of Latin America and MEA.\r\n\r\nThis report assesses the trends that are driving the growth of each segment of the immune repertoire sequencing market on the global as well as regional level, and offers potential takeaways that could prove substantially useful for the manufacturers planning to enter the immune repertoire sequencing market.\r\n\r\nNorth America accounted a high revenue share in 2017, and is expected to be the dominant regional market for immune repertoire sequencing over the forecast period. The U.S. immune repertoire sequencing market is expected to hold a large share in North America and is expected to grow at a CAGR of 6.7% over the forecast period. Large presence of globally renowned companies in high-throughput sequencing and increased scale of sequencing projects in the region is expected to increase the adoption of immune repertoire sequencing. Besides, the leading academic universities and research centers are based in North America, which is also expected to the surge the adoption of immune repertoire sequencing methods. The Europe and Asia Pacific immune repertoire sequencing markets collectively will grow at CAGRs of 7.3% and 9.9 %, respectively, over the forecast period. The Latin America and Middle East and Africa immune repertoire sequencing markets are estimated to expand at CAGRs of 5.8% and 4.8%, respectively, over the forecast period. Consistent investment in development of the healthcare sector in terms of research and services through governmental and private capital funding will drive the demand for immune repertoire sequencing in the region by implication of sequencing tools. High prevalence of infectious and other diseases is one of the key factors expected to drive the growth of the immune repertoire sequencing market in Middle East and Africa.\r\n\r\nExamples of some of the key players covered in the report of the immune repertoire sequencing market are Illumina, Takara Bio Inc, BGI, Thermo Fischer Scientific, and F. Hoffmann-La Roche Ltd, among others. The companies are focusing on developing new software-based platforms and improved assay-based kits for immune repertoire sequencing. However, the high cost associated with certain sequencing platforms and data analytic services are expected to hinder the growth of the immune repertoire sequencing market over the forecast period.\r\n\r\n<em><u>These insights are based on a report on <a href=\"https://www.persistencemarketresearch.com/market-research/immune-repertoire-sequencing-market.asp\">Immune Repertoire Sequencing Market</a> by Persistence Market Research.</u></em>','Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High Throughput Sequencing, Bioinformatics Solutions and Cloud Computing','','inherit','closed','closed','','4139-revision-v1','','','2019-12-12 15:58:05','2019-12-12 15:58:05','',4139,'https://microbiozindia.com/uncategorized/4139-revision-v1/',0,'revision','',0),(4143,2,'2019-12-18 10:10:28','2019-12-18 10:10:28','AMSBIO has expanded its range of cfPure&#x2122; Cell Free DNA Purification Kits for rapid and efficient isolation of circulating cell free DNA (cfDNA).  A new cfPure&#x2122;Max kit is now available for use on samples of 5mLs volume or greater.\r\n\r\nAMSBIO cfPure® kits use silica-coated paramagnetic particles to purify cell free DNA from less than 1 mL to greater than 10 mL of serum or plasma. The buffers were developed to ensure efficient recovery of 100 bp – 500 bp DNA fragments in order to maximize recovery of cell free DNA. The recovered DNA is suitable for a wide range of down-stream applications, such as bisulfite sequencing, NGS, and qPCR.\r\n\r\n<img class=\"alignnone wp-image-4145\" src=\"https://microbiozindia.com/wp-content/uploads/2019/12/amsbiopr258-imageB.bmp\" alt=\"\" width=\"584\" height=\"331\" />\r\n\r\nThe cfPure® protocol is rapid and easy, allowing users to process several samples in an hour or less and making it ideal for biomarker screening. Using proprietary silica-coated magnetic bead technology, cfPure® kits are able to efficiently recover low molecular weight cell free DNA during isolation - a key success factor for successful analysis of cfDNA. Designed for scalability, cfPure® kits enable you to use just the number of beads and amount of reagent that you need for your cfDNA extraction.  This also means that the number of extractions per kit is dependent on the amount of sample you wish to purify DNA from.\r\n\r\nIn addition to being easy to perform, scalable and easy to automate, cfPure® kits allow you to use less magnetic bead solution if you are purifying small amounts of plasma – saving you money. Since cfDNA is typically found at very low concentrations and in a fragmented state, very efficient DNA capture, as provided by AMSBIO\'s cfPure&#x2122; Cell Free DNA Purification Kits, is vital to provide sensitive and reliable results.\r\n\r\nFor further information please visit <a href=\"http://www.amsbio.com/circulating-cell-free-DNA.aspx\">http://www.amsbio.com/circulating-cell-free-DNA.aspx</a> or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / email <a href=\"mailto:info@amsbio.com\">info@amsbio.com</a>','Efficient Isolation of Circulating Cell Free DNA','','publish','open','open','','efficient-isolation-of-circulating-cell-free-dna','','','2019-12-18 10:12:12','2019-12-18 10:12:12','',0,'https://microbiozindia.com/?p=4143',0,'post','',0),(4144,2,'2019-12-18 10:09:33','2019-12-18 10:09:33','','11','','inherit','open','closed','','11','','','2019-12-18 10:09:33','2019-12-18 10:09:33','',4143,'https://microbiozindia.com/wp-content/uploads/2019/12/11.png',0,'attachment','image/png',0),(4145,2,'2019-12-18 10:10:01','2019-12-18 10:10:01','','amsbiopr258-imageB','','inherit','open','closed','','amsbiopr258-imageb','','','2019-12-18 10:10:01','2019-12-18 10:10:01','',4143,'https://microbiozindia.com/wp-content/uploads/2019/12/amsbiopr258-imageB.bmp',0,'attachment','image/bmp',0),(4146,2,'2019-12-18 10:10:28','2019-12-18 10:10:28','AMSBIO has expanded its range of cfPure&#x2122; Cell Free DNA Purification Kits for rapid and efficient isolation of circulating cell free DNA (cfDNA).  A new cfPure&#x2122;Max kit is now available for use on samples of 5mLs volume or greater.\r\n\r\nAMSBIO cfPure® kits use silica-coated paramagnetic particles to purify cell free DNA from less than 1 mL to greater than 10 mL of serum or plasma. The buffers were developed to ensure efficient recovery of 100 bp – 500 bp DNA fragments in order to maximize recovery of cell free DNA. The recovered DNA is suitable for a wide range of down-stream applications, such as bisulfite sequencing, NGS, and qPCR.\r\n\r\n<img class=\"alignnone  wp-image-4145\" src=\"https://microbiozindia.com/wp-content/uploads/2019/12/amsbiopr258-imageB.bmp\" alt=\"\" width=\"584\" height=\"331\" />\r\n\r\nThe cfPure® protocol is rapid and easy, allowing users to process several samples in an hour or less and making it ideal for biomarker screening. Using proprietary silica-coated magnetic bead technology, cfPure® kits are able to efficiently recover low molecular weight cell free DNA during isolation - a key success factor for successful analysis of cfDNA. Designed for scalability, cfPure® kits enable you to use just the number of beads and amount of reagent that you need for your cfDNA extraction.  This also means that the number of extractions per kit is dependent on the amount of sample you wish to purify DNA from.\r\n\r\nIn addition to being easy to perform, scalable and easy to automate, cfPure® kits allow you to use less magnetic bead solution if you are purifying small amounts of plasma – saving you money. Since cfDNA is typically found at very low concentrations and in a fragmented state, very efficient DNA capture, as provided by AMSBIO\'s cfPure&#x2122; Cell Free DNA Purification Kits, is vital to provide sensitive and reliable results.\r\n\r\nFor further information please visit <a href=\"http://www.amsbio.com/circulating-cell-free-DNA.aspx\">http://www.amsbio.com/circulating-cell-free-DNA.aspx</a> or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / email <a href=\"mailto:info@amsbio.com\">info@amsbio.com</a>','Efficient Isolation of Circulating Cell Free DNA','','inherit','closed','closed','','4143-revision-v1','','','2019-12-18 10:10:28','2019-12-18 10:10:28','',4143,'https://microbiozindia.com/uncategorized/4143-revision-v1/',0,'revision','',0),(4148,2,'2019-12-19 04:36:41','2019-12-19 04:36:41','Porvair Sciences has expanded its range of high quality, black microplates that minimise sample degradation by exposure to light, even over long storage periods.\r\n\r\nAvailable in a choice of 48-, 96- and 384-well formats – Porvair Sciences black plates are precisely manufactured to applicable ANSI / SLAS dimensions ensuring complete compatibility with almost all readers and automated equipment.\r\n<img class=\"alignnone  wp-image-3658\" src=\"https://microbiozindia.com/wp-content/uploads/2019/11/PORVAIR22-300x169.jpg\" alt=\"\" width=\"257\" height=\"145\" />\r\nManufactured from polypropylene, the range of black microplates offer excellent heat and solvent resistant qualities. Using only ultra-pure grade polymer means that each black plate has near zero leachates ensuring long-term sample integrity. Porvair Sciences black plates are supplied RNase / DNase free meaning they can be used to store even the most sensitive biological samples.\r\n\r\nTo prevent evaporation, hydration of DMSO solutions and to completely eliminate light from samples - Porvair Sciences additionally offers a selection of Absorb Max light blocking sealing films that may be applied to the top of the black plates. A split backing and edge cut-outs make positioning and applying the sealing film quick and simple.\r\n\r\nThe light-blocking and absorbing properties of Porvair Sciences black microplates, used in conjunction with Absorb Max sealing films (P/N 229520), provides a perfect combination for protecting light-sensitive assays or samples during storage.\r\n\r\nFor further information please visit <a href=\"https://www.microplates.com/solid-bottom/\">https://www.microplates.com/solid-bottom/</a> or contact Porvair Sciences Ltd on +44-1978-661144 or <a href=\"mailto:enquiries@porvairsciences.com\">enquiries@porvairsciences.com</a>.','Black Microplates for Light Sensitive Samples by Porvair Sciences','','publish','open','open','','black-microplates-for-light-sensitive-samples-by-porvair-sciences','','','2020-01-26 18:41:08','2020-01-26 18:41:08','',0,'https://microbiozindia.com/?p=4148',0,'post','',0),(4149,2,'2019-12-19 04:36:00','2019-12-19 04:36:00','','hh','','inherit','open','closed','','hh-2','','','2019-12-19 04:36:00','2019-12-19 04:36:00','',4148,'https://microbiozindia.com/wp-content/uploads/2019/12/hh.png',0,'attachment','image/png',0),(4150,2,'2019-12-19 04:36:41','2019-12-19 04:36:41','Porvair Sciences has expanded its range of high quality, black microplates that minimise sample degradation by exposure to light, even over long storage periods.\r\n\r\nAvailable in a choice of 48-, 96- and 384-well formats – Porvair Sciences black plates are precisely manufactured to applicable ANSI / SLAS dimensions ensuring complete compatibility with almost all readers and automated equipment.\r\n<img class=\"alignnone  wp-image-3658\" src=\"https://microbiozindia.com/wp-content/uploads/2019/11/PORVAIR22-300x169.jpg\" alt=\"\" width=\"257\" height=\"145\" />\r\nManufactured from polypropylene, the range of black microplates offer excellent heat and solvent resistant qualities. Using only ultra-pure grade polymer means that each black plate has near zero leachates ensuring long-term sample integrity. Porvair Sciences black plates are supplied RNase / DNase free meaning they can be used to store even the most sensitive biological samples.\r\n\r\nTo prevent evaporation, hydration of DMSO solutions and to completely eliminate light from samples - Porvair Sciences additionally offers a selection of Absorb Max light blocking sealing films that may be applied to the top of the black plates. A split backing and edge cut-outs make positioning and applying the sealing film quick and simple.\r\n\r\nThe light-blocking and absorbing properties of Porvair Sciences black microplates, used in conjunction with Absorb Max sealing films (P/N 229520), provides a perfect combination for protecting light-sensitive assays or samples during storage.\r\n\r\nFor further information please visit <a href=\"https://www.microplates.com/solid-bottom/\">https://www.microplates.com/solid-bottom/</a> or contact Porvair Sciences Ltd on +44-1978-661144 or <a href=\"mailto:enquiries@porvairsciences.com\">enquiries@porvairsciences.com</a>.','Black Microplates for Light Sensitive Samples by Porvair Sciences','','inherit','closed','closed','','4148-revision-v1','','','2019-12-19 04:36:41','2019-12-19 04:36:41','',4148,'https://microbiozindia.com/uncategorized/4148-revision-v1/',0,'revision','',0),(4151,2,'2019-12-19 10:20:48','2019-12-19 10:20:48','Sartorius, a leading international partner of life science research and the biopharmaceutical industry, and the German Research Center for Artificial Intelligence (<a href=\"https://www.dfki.de/en/web/\" target=\"_blank\" rel=\"noopener noreferrer\">DFKI</a>) have established the Sartorius AI Lab (SAIL) research laboratory. On the DFKI campus in Kaiserslautern, the use of artificial intelligence (AI) in Sartorius products and platform solutions is being experimentally tested and further developed at SAIL.\r\n\r\n“So far, advanced methods of data analysis have been used only to a very limited extent in the biopharmaceutical industry, in drug research and in production. This is one of the reasons that development timelines and costs for medical drugs are ever increasing. Better use of data through AI is a particularly promising approach for making significant progress in this area. Many customers are already using the powerful software we have been offering for two and a half years through our Data Analytics unit for specific applications in biopharmaceutical production. We aim to strongly expand this business activity and are therefore glad to have found DFKI, one of the most important international centers of excellence for AI and deep learning with more than 1,000 scientists, as strong partners to join us in developing such solutions,”<strong><span style=\"font-family: \'Arial\',sans-serif;\"> said CEO Dr. Joachim Kreuzburg.</span></strong>\r\n\r\nSAIL is assigned to the DFKI research department of Smart Data &amp; Knowledge Services headed by Professor Andreas Dengel and uses DFKI\'s deep learning hardware and expertise, which is unique throughout Europe. As a protected data room and independent data laboratory, SAIL is also open to Sartorius partners and customers as part of cooperation agreements, and the first projects have already been initiated. In addition, Sartorius and DFKI will use SAIL for training purposes, and DFKI employees will also be able to further their education in life science applications at Sartorius research sites.\r\n\r\n<strong><span style=\"font-family: \'Arial\',sans-serif;\">Prof. Oscar-Werner Reif, Chief Technology Officer at Sartorius, emphasized:</span></strong> “Within the framework of this cooperation, we are creating the foundations for developing digital tools and methods based on AI. The results obtained will be incorporated into the further development of Sartorius products so that our application solutions become more and more adaptive and powerful. Our aim is to use better methods of data analysis and the increasing computer capacities to map and simulate the development and production of biopharmaceuticals in computers in the future. As a result, development times and costs for new therapies will improve dramatically by an accelerated timeline from idea to patient. In addition, we are pleased to offer Sartorius employees and DFKI students and scientists the opportunity to exchange ideas and gain further qualifications in AI and life science applications.”\r\n\r\n<strong><span style=\"font-family: \'Arial\',sans-serif;\">Prof. Andreas Dengel, DFKI site manager in Kaiserslautern, said:</span></strong> \"The DFKI transfer labs are developing new service modules with artificial intelligence for various markets and target groups. For two years, we have been using our AI hardware equipment, which is unique in Europe, for application-oriented research we conduct together with renowned companies such as Allianz, Continental, Hitachi and IAV. I am very pleased that we are entering the life science tools market as a partner with the global player Sartorius.\"','Sartorius joints hands with German Research Center for Artificial Intelligence to open Joint Research Laboratory','','publish','open','open','','sartorius-joints-hands-with-german-research-center-for-artificial-intelligence-to-open-joint-research-laboratory','','','2019-12-19 10:27:41','2019-12-19 10:27:41','',0,'https://microbiozindia.com/?p=4151',0,'post','',0),(4152,2,'2019-12-19 10:20:35','2019-12-19 10:20:35','','SARTORIUS','','inherit','open','closed','','sartorius','','','2019-12-19 10:20:35','2019-12-19 10:20:35','',4151,'https://microbiozindia.com/wp-content/uploads/2019/12/SARTORIUS.png',0,'attachment','image/png',0),(4153,2,'2019-12-19 10:20:48','2019-12-19 10:20:48','<a href=\"https://www.sartorius.com/en\" target=\"_blank\" rel=\"noopener noreferrer\">Sartorius</a>, a leading international partner of life science research and the biopharmaceutical industry, and the German Research Center for Artificial Intelligence (<a href=\"https://www.dfki.de/en/web/\" target=\"_blank\" rel=\"noopener noreferrer\">DFKI</a>) have established the Sartorius AI Lab (SAIL) research laboratory. On the DFKI campus in Kaiserslautern, the use of artificial intelligence (AI) in Sartorius products and platform solutions is being experimentally tested and further developed at SAIL.\r\n\r\n“So far, advanced methods of data analysis have been used only to a very limited extent in the biopharmaceutical industry, in drug research and in production. This is one of the reasons that development timelines and costs for medical drugs are ever increasing. Better use of data through AI is a particularly promising approach for making significant progress in this area. Many customers are already using the powerful software we have been offering for two and a half years through our Data Analytics unit for specific applications in biopharmaceutical production. We aim to strongly expand this business activity and are therefore glad to have found DFKI, one of the most important international centers of excellence for AI and deep learning with more than 1,000 scientists, as strong partners to join us in developing such solutions,”<strong><span style=\"font-family: \'Arial\',sans-serif;\"> said CEO Dr. Joachim Kreuzburg.</span></strong>\r\n\r\nSAIL is assigned to the DFKI research department of Smart Data &amp; Knowledge Services headed by Professor Andreas Dengel and uses DFKI\'s deep learning hardware and expertise, which is unique throughout Europe. As a protected data room and independent data laboratory, SAIL is also open to Sartorius partners and customers as part of cooperation agreements, and the first projects have already been initiated. In addition, Sartorius and DFKI will use SAIL for training purposes, and DFKI employees will also be able to further their education in life science applications at Sartorius research sites.\r\n\r\n<strong><span style=\"font-family: \'Arial\',sans-serif;\">Prof. Oscar-Werner Reif, Chief Technology Officer at Sartorius, emphasized:</span></strong> “Within the framework of this cooperation, we are creating the foundations for developing digital tools and methods based on AI. The results obtained will be incorporated into the further development of Sartorius products so that our application solutions become more and more adaptive and powerful. Our aim is to use better methods of data analysis and the increasing computer capacities to map and simulate the development and production of biopharmaceuticals in computers in the future. As a result, development times and costs for new therapies will improve dramatically by an accelerated timeline from idea to patient. In addition, we are pleased to offer Sartorius employees and DFKI students and scientists the opportunity to exchange ideas and gain further qualifications in AI and life science applications.”\r\n\r\n<strong><span style=\"font-family: \'Arial\',sans-serif;\">Prof. Andreas Dengel, DFKI site manager in Kaiserslautern, said:</span></strong> \"The DFKI transfer labs are developing new service modules with artificial intelligence for various markets and target groups. For two years, we have been using our AI hardware equipment, which is unique in Europe, for application-oriented research we conduct together with renowned companies such as Allianz, Continental, Hitachi and IAV. I am very pleased that we are entering the life science tools market as a partner with the global player Sartorius.\"','Sartorius joints hands with German Research Center for Artificial Intelligence to open Joint Research Laboratory','','inherit','closed','closed','','4151-revision-v1','','','2019-12-19 10:20:48','2019-12-19 10:20:48','',4151,'https://microbiozindia.com/uncategorized/4151-revision-v1/',0,'revision','',0),(4154,2,'2019-12-19 10:27:41','2019-12-19 10:27:41','Sartorius, a leading international partner of life science research and the biopharmaceutical industry, and the German Research Center for Artificial Intelligence (<a href=\"https://www.dfki.de/en/web/\" target=\"_blank\" rel=\"noopener noreferrer\">DFKI</a>) have established the Sartorius AI Lab (SAIL) research laboratory. On the DFKI campus in Kaiserslautern, the use of artificial intelligence (AI) in Sartorius products and platform solutions is being experimentally tested and further developed at SAIL.\r\n\r\n“So far, advanced methods of data analysis have been used only to a very limited extent in the biopharmaceutical industry, in drug research and in production. This is one of the reasons that development timelines and costs for medical drugs are ever increasing. Better use of data through AI is a particularly promising approach for making significant progress in this area. Many customers are already using the powerful software we have been offering for two and a half years through our Data Analytics unit for specific applications in biopharmaceutical production. We aim to strongly expand this business activity and are therefore glad to have found DFKI, one of the most important international centers of excellence for AI and deep learning with more than 1,000 scientists, as strong partners to join us in developing such solutions,”<strong><span style=\"font-family: \'Arial\',sans-serif;\"> said CEO Dr. Joachim Kreuzburg.</span></strong>\r\n\r\nSAIL is assigned to the DFKI research department of Smart Data &amp; Knowledge Services headed by Professor Andreas Dengel and uses DFKI\'s deep learning hardware and expertise, which is unique throughout Europe. As a protected data room and independent data laboratory, SAIL is also open to Sartorius partners and customers as part of cooperation agreements, and the first projects have already been initiated. In addition, Sartorius and DFKI will use SAIL for training purposes, and DFKI employees will also be able to further their education in life science applications at Sartorius research sites.\r\n\r\n<strong><span style=\"font-family: \'Arial\',sans-serif;\">Prof. Oscar-Werner Reif, Chief Technology Officer at Sartorius, emphasized:</span></strong> “Within the framework of this cooperation, we are creating the foundations for developing digital tools and methods based on AI. The results obtained will be incorporated into the further development of Sartorius products so that our application solutions become more and more adaptive and powerful. Our aim is to use better methods of data analysis and the increasing computer capacities to map and simulate the development and production of biopharmaceuticals in computers in the future. As a result, development times and costs for new therapies will improve dramatically by an accelerated timeline from idea to patient. In addition, we are pleased to offer Sartorius employees and DFKI students and scientists the opportunity to exchange ideas and gain further qualifications in AI and life science applications.”\r\n\r\n<strong><span style=\"font-family: \'Arial\',sans-serif;\">Prof. Andreas Dengel, DFKI site manager in Kaiserslautern, said:</span></strong> \"The DFKI transfer labs are developing new service modules with artificial intelligence for various markets and target groups. For two years, we have been using our AI hardware equipment, which is unique in Europe, for application-oriented research we conduct together with renowned companies such as Allianz, Continental, Hitachi and IAV. I am very pleased that we are entering the life science tools market as a partner with the global player Sartorius.\"','Sartorius joints hands with German Research Center for Artificial Intelligence to open Joint Research Laboratory','','inherit','closed','closed','','4151-revision-v1','','','2019-12-19 10:27:41','2019-12-19 10:27:41','',4151,'https://microbiozindia.com/uncategorized/4151-revision-v1/',0,'revision','',0),(4155,2,'2019-12-20 04:26:10','0000-00-00 00:00:00','Eribulin will be available in India at approximately 40% cost of the innovator brand\n\nEmcure Pharmaceuticals, a leading integrated global pharmaceutical company from India today announced the launch of the world’s first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) for the treatment of metastatic breast cancer (MBC). Emcure will be marketing the drug under brand name ‘Eribilin’, with an aim to offer high-quality and cost-effective treatment option to breast cancer patients in India.\n\nAs per reports from the Indian Council of Medical Research &amp; Population Based Cancer Registry (ICMR-PBCR) Breast cancer is the commonest occurring cancer in urban Indian women and the second commonest in rural women. Although world class breast cancer treatment is available in India, majority of the patients are unable to access it due to lack of quality infrastructure, skills and above all financial resources.\n\n‘Incidence of breast cancer is on the rise in India and being a price sensitive market with low awareness, with the launch of Eribilin we aim to provide a proven and cost-effective treatment of high quality and efficacy as offered by the innovator brand. It is a proud moment for Emcure to launch Eribilin, the world’s first generic version of the innovator brand that will break the price barrier making it a cost-effective option for patients,” said Mr. Sainath Iyer, President – Business Strategy &amp; Specialty Business – Emcure Pharmaceuticals Ltd\n\nVarious Indian studies suggest that about 20% of breast cancers are triple-negative breast cancers. Triple-negative breast cancer (TNBC) is cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. It means that the growth of the cancer is not fuelled by the hormones estrogen and progesterone, or by the HER2 protein. Even though chemotherapy may work well for this type of breast cancer, the chance of relapse is high and overall prognosis is poor than the other types of breast cancer.\n\nEmcure’s Eribilin has been approved by DCGI to be marketed in India. ‘Breast cancer is the most common type of cancer affecting women in India and its incidence is on the rise. Currently available treatment for triple negative breast cancer in India is out of reach of most patients due to its high cost. Emcure’s Eribilin will change this scenario by offering a world-class, high quality drug at a reasonable price to the patients in India” said Mr. Sainath Iyer, President – Business Strategy &amp; Specialty Business – Emcure Pharmaceuticals Ltd\n\nEribulin is a non-taxane inhibitor of microtubule dynamics and remains effective in MBC previously treated with an anthracycline and a taxane. Eribulin is a complex API derived from a marine natural product called Halocondrin B. ‘Emcure’s R&amp;D resources are equipped with technical competence and state-of-the-art development facility to develop such complex generics. Generic Eribulin is a landmark achievement of Emcure’s R&amp;D efforts both in API manufacturing and formulation,” said Dr. Mukund Gurjar, Chief Scientific Officer, Emcure Pharmaceuticals.\n\nEmcure will manufacture generic Eribulin at its state of the art plant at Hinjewadi in Pune and market it at a cost which will be approximately 40% less than the innovator brand bringing hope to millions of breast cancer patients in India. The drug would currently be marketed in India, however Emcure plans to register the brand in international markets as well, wherever the drug is about to go off-patent.\n\n<strong>About Eribilin:</strong>\n\nEribilin is world’s first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) for the treatment of metastatic breast cancer (MBC). Eribulin is a mechanistically unique inhibitor of microtubule dynamics and binds predominantly to a small number of high affinity sites through both cytotoxic and non-cytotoxic mechanisms. It eliminates cancer cells through prolonged and irreversible mitotic blockade. The parent molecule is a potent, naturally occurring mitotic inhibitor found in the sponge genus Halichondria. ERIBILIN has been developed indigenously by Emcure Pharmaceuticals and offers the same quality and efficacy as the original brand. ERIBILIN will be manufactured in Emcure’s plant at Hinjewadi, Pune.','Emcure launches worlds first generic Eribulin for treatment of metastatic breast cancer','','draft','open','open','','','','','2019-12-20 04:26:10','2019-12-20 04:26:10','',0,'https://microbiozindia.com/?p=4155',0,'post','',0),(4156,2,'2019-12-27 07:43:02','2019-12-27 07:43:02','Ami Polymer Pvt. Ltd. Pleased to announce that on 18<sup>th</sup> Nov. 2019 International Distribution Network was offered by signing an exclusive master distribution agreement with Foxx Life Sciences offering a service to customer in North America, Mexico and Canada by quick access to the company products.\r\n\r\n“Foxx Life Sciences” Global leader in single-use technology having a strong presence in the Bioprocess market, through strategic planning and acquisition, commitment, and hard work, Foxx has developed an unparalleled reputation for technical expertise, quality and value.\r\n\r\n“Ami Polymer Pvt. Ltd.” is leader in rubber product manufacturing for food, pharma, Medical, and heavy engineering industries. Ami is enjoying the business growth through offering products with excellence in quality, ultimate customer satisfaction and being in business with ethics.\r\n\r\n“This Imperative addition will allow Foxx Life Sciences to become a key global supplier to the pharmaceutical and biotech markets and for that our strategic Partnership will help businesses to create business plans that provide profitable, sustainable results” said by President and CEO of Foxx life sciences Thomas Taylor\r\n\r\n“For the first time Ami is going to do long term business partnership. Ami is super excited to take a step forward with team Foxx and it will enhanced the wide business opportunities in pharma sector with technological advancement and Customer Satisfaction “ said by Managing Director of Ami Polymer Pvt. Ltd. Mr. Alpesh Gandhi.\r\n\r\n“An organization that helps business to develop strong leaders while creating a culture where self-improvement is an intrinsic part of the organization’s value system” – Combined motive of “Foxx” and “Ami”\r\n\r\nThe Network allows full coverage of specialized Pharma Tubings (Platinum cured Silicone, TPE, FKM, and FEP tubings), O-rings, Manifolds, and Sanitary Gaskets for the markets such as Bio pharma, Medical and Lifesciences.\r\n\r\n<em>Established in 1996 at Mumbai (Maharashtra, India), Ami Polymer Pvt. Ltd. is an ISO 9001:2015, ISO 14001:2015 and OHSAS 18001: 2007 TUV Nord certified company having 375 employees (25+ polymer technologists) devoted to manufacturing and supplying the finest quality range of biopharmaceuticals grade elastomer tubing, reinforced hose, inflatable gaskets and all types of extruded &amp; molded components. our product range is designed </em><em>,</em><em>fabricated and</em><em> distributed among 5000+ customers of various </em><em>industrial sectors including; pharmaceutical, biotech, food processing, medical, solar, aerospace, engineering, textile, steel etc...For more information visit </em><a href=\"https://www.amipolymer.com/\"><em>amipolymer.com</em></a><em>. </em>\r\n\r\n<em>Ami polymer is having </em><em>15 registered product brands with </em><em>7 Drug master file</em><em>s</em> <em>for </em><em>USFDA and NSF-51 USA certifications on the products.</em>\r\n\r\n<em>Located just 50 kilometers north of Boston, Foxx Life Sciences is a privately held world leader in custom single-use systems (SUS) including tubing, bag, bottle, flask and carboy assemblies, filtration, fluid management, laboratory safety products, and lab glassware for the research, biotech, and pharmaceutical industries. In addition to the Foxx Product line, the company distributes over 1,000 products from Borosil, Ami Polymer, and CPC.  The company is Quality focused with ISO 13485: 2016 certified since 2010, ISO Class 7 cleanrooms, and three locations. For more information, call 617-320-1138 or visit </em><a href=\"https://www.foxxlifesciences.com/\"><em>FoxxLifeSciences.com</em></a><em>  </em>\r\n\r\n&nbsp;','Ami Polymer Pvt. Ltd. Signs Master Distribution Agreement with Foxx Life Sciences','','publish','open','open','','ami-polymer-pvt-ltd-signs-master-distribution-agreement-with-foxx-life-sciences','','','2019-12-27 07:43:02','2019-12-27 07:43:02','',0,'https://microbiozindia.com/?p=4156',0,'post','',0),(4157,2,'2019-12-27 07:42:48','2019-12-27 07:42:48','','AAA','','inherit','open','closed','','aaa','','','2019-12-27 07:42:48','2019-12-27 07:42:48','',4156,'https://microbiozindia.com/wp-content/uploads/2019/12/AAA.png',0,'attachment','image/png',0),(4158,2,'2019-12-27 07:43:02','2019-12-27 07:43:02','Ami Polymer Pvt. Ltd. Pleased to announce that on 18<sup>th</sup> Nov. 2019 International Distribution Network was offered by signing an exclusive master distribution agreement with Foxx Life Sciences offering a service to customer in North America, Mexico and Canada by quick access to the company products.\r\n\r\n“Foxx Life Sciences” Global leader in single-use technology having a strong presence in the Bioprocess market, through strategic planning and acquisition, commitment, and hard work, Foxx has developed an unparalleled reputation for technical expertise, quality and value.\r\n\r\n“Ami Polymer Pvt. Ltd.” is leader in rubber product manufacturing for food, pharma, Medical, and heavy engineering industries. Ami is enjoying the business growth through offering products with excellence in quality, ultimate customer satisfaction and being in business with ethics.\r\n\r\n“This Imperative addition will allow Foxx Life Sciences to become a key global supplier to the pharmaceutical and biotech markets and for that our strategic Partnership will help businesses to create business plans that provide profitable, sustainable results” said by President and CEO of Foxx life sciences Thomas Taylor\r\n\r\n“For the first time Ami is going to do long term business partnership. Ami is super excited to take a step forward with team Foxx and it will enhanced the wide business opportunities in pharma sector with technological advancement and Customer Satisfaction “ said by Managing Director of Ami Polymer Pvt. Ltd. Mr. Alpesh Gandhi.\r\n\r\n“An organization that helps business to develop strong leaders while creating a culture where self-improvement is an intrinsic part of the organization’s value system” – Combined motive of “Foxx” and “Ami”\r\n\r\nThe Network allows full coverage of specialized Pharma Tubings (Platinum cured Silicone, TPE, FKM, and FEP tubings), O-rings, Manifolds, and Sanitary Gaskets for the markets such as Bio pharma, Medical and Lifesciences.\r\n\r\n<em>Established in 1996 at Mumbai (Maharashtra, India), Ami Polymer Pvt. Ltd. is an ISO 9001:2015, ISO 14001:2015 and OHSAS 18001: 2007 TUV Nord certified company having 375 employees (25+ polymer technologists) devoted to manufacturing and supplying the finest quality range of biopharmaceuticals grade elastomer tubing, reinforced hose, inflatable gaskets and all types of extruded &amp; molded components. our product range is designed </em><em>,</em><em>fabricated and</em><em> distributed among 5000+ customers of various </em><em>industrial sectors including; pharmaceutical, biotech, food processing, medical, solar, aerospace, engineering, textile, steel etc...For more information visit </em><a href=\"https://www.amipolymer.com/\"><em>amipolymer.com</em></a><em>. </em>\r\n\r\n<em>Ami polymer is having </em><em>15 registered product brands with </em><em>7 Drug master file</em><em>s</em> <em>for </em><em>USFDA and NSF-51 USA certifications on the products.</em>\r\n\r\n<em>Located just 50 kilometers north of Boston, Foxx Life Sciences is a privately held world leader in custom single-use systems (SUS) including tubing, bag, bottle, flask and carboy assemblies, filtration, fluid management, laboratory safety products, and lab glassware for the research, biotech, and pharmaceutical industries. In addition to the Foxx Product line, the company distributes over 1,000 products from Borosil, Ami Polymer, and CPC.  The company is Quality focused with ISO 13485: 2016 certified since 2010, ISO Class 7 cleanrooms, and three locations. For more information, call 617-320-1138 or visit </em><a href=\"https://www.foxxlifesciences.com/\"><em>FoxxLifeSciences.com</em></a><em>  </em>\r\n\r\n&nbsp;','Ami Polymer Pvt. Ltd. Signs Master Distribution Agreement with Foxx Life Sciences','','inherit','closed','closed','','4156-revision-v1','','','2019-12-27 07:43:02','2019-12-27 07:43:02','',4156,'https://microbiozindia.com/uncategorized/4156-revision-v1/',0,'revision','',0),(4159,2,'2019-12-27 16:40:31','2019-12-27 16:40:31','','microbioz india ad_micro_352x286[h]px_2_high res_RGB-01','','inherit','open','closed','','microbioz-india-ad_micro_352x286hpx_2_high-res_rgb-01','','','2019-12-27 16:40:31','2019-12-27 16:40:31','',26,'https://microbiozindia.com/wp-content/uploads/2019/11/microbioz-india-ad_micro_352x286hpx_2_high-res_RGB-01.jpg',0,'attachment','image/jpeg',0),(4160,2,'2019-12-27 16:40:34','2019-12-27 16:40:34','','microbioz india ad_micro_798x103[h]px_3_high res_RGB-01','','inherit','open','closed','','microbioz-india-ad_micro_798x103hpx_3_high-res_rgb-01','','','2019-12-27 16:40:34','2019-12-27 16:40:34','',26,'https://microbiozindia.com/wp-content/uploads/2019/11/microbioz-india-ad_micro_798x103hpx_3_high-res_RGB-01.jpg',0,'attachment','image/jpeg',0),(4161,2,'2019-12-30 10:05:32','2019-12-30 10:05:32','Hyderabad, India and Princeton, NJ, USA. December 30, 2019— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® (sodium nitroprusside) Injection, 50 mg/2mL vial, approved by the U.S. Food and Drug Administration (USFDA).\r\n\r\nThe Nitropress® brand and generics had U.S. sales of approximately $8 million MAT for the most recent twelve months ending in October 2019 according to IQVIA Health*.\r\n\r\nDr. Reddy’s Sodium Nitroprusside Injection is available in single-dose 50 mg/2 mL (25 mg/mL) vials.\r\n\r\nNitropress® is a trademark of Hospira, Inc.\r\n\r\n<strong>Warnings !!</strong>\r\n\r\nSodium Nitroprusside Injection is not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion.\r\n\r\nSodium Nitroprusside can cause precipitous decreases in blood pressure (see DOSAGE AND ADMINISTRATION). In patients not properly monitored, these decreases can lead to irreversible ischemic injuries or death. Sodium nitroprusside should be used only when available equipment and personnel allow blood pressure to be continuously monitored.\r\n\r\nExcept when used briefly or at low (&lt; 2 mcg/kg/min) infusion rates, sodium nitroprusside gives rise to important quantities of cyanide ion, which can reach toxic, potentially lethal levels (see WARNINGS). The usual dose rate is 0.5 to10 mcg/kg/min, but infusion at the maximum dose rate should never last more than 10 minutes. If blood pressure has not been adequately controlled after 10 minutes of infusion at the maximum rate, administration of sodium nitroprusside should be terminated immediately.\r\n\r\nAlthough acid-base balance and venous oxygen concentration should be monitored and may indicate cyanide toxicity, these laboratory tests provide imperfect guidance.\r\n\r\n<em>*IQIA Retail and Non-Retail MAT October 2019</em>\r\n\r\n<strong>About Dr.Reddy\'s:</strong>\r\n\r\n<span style=\"font-size: 10pt;\">Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &amp; Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilar and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia &amp; CIS countries, and Europe. </span>','Dr. Reddy\'s Laboratories announces the launch of  Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market','','publish','open','open','','dr-reddys-laboratories-announces-the-launch-of-sodium-nitroprusside-injection-50-mg-2-ml-25-mg-ml-single-dose-vial-in-the-u-s-market','','','2019-12-30 10:08:06','2019-12-30 10:08:06','',0,'https://microbiozindia.com/?p=4161',0,'post','',0),(4162,2,'2019-12-30 10:05:13','2019-12-30 10:05:13','','ART','','inherit','open','closed','','art','','','2019-12-30 10:05:13','2019-12-30 10:05:13','',4161,'https://microbiozindia.com/wp-content/uploads/2019/12/ART.png',0,'attachment','image/png',0),(4163,2,'2019-12-30 10:05:32','2019-12-30 10:05:32','Hyderabad, India and Princeton, NJ, USA. December 30, 2019— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® (sodium nitroprusside) Injection, 50 mg/2mL vial, approved by the U.S. Food and Drug Administration (USFDA).\r\n\r\nThe Nitropress® brand and generics had U.S. sales of approximately $8 million MAT for the most recent twelve months ending in October 2019 according to IQVIA Health*.\r\n\r\nDr. Reddy’s Sodium Nitroprusside Injection is available in single-dose 50 mg/2 mL (25 mg/mL) vials.\r\n\r\nNitropress® is a trademark of Hospira, Inc.\r\n\r\n<strong>Warnings !!</strong>\r\n\r\nSodium Nitroprusside Injection is not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion.\r\n\r\nSodium Nitroprusside can cause precipitous decreases in blood pressure (see DOSAGE AND ADMINISTRATION). In patients not properly monitored, these decreases can lead to irreversible ischemic injuries or death. Sodium nitroprusside should be used only when available equipment and personnel allow blood pressure to be continuously monitored.\r\n\r\nExcept when used briefly or at low (&lt; 2 mcg/kg/min) infusion rates, sodium nitroprusside gives rise to important quantities of cyanide ion, which can reach toxic, potentially lethal levels (see WARNINGS). The usual dose rate is 0.5 to10 mcg/kg/min, but infusion at the maximum dose rate should never last more than 10 minutes. If blood pressure has not been adequately controlled after 10 minutes of infusion at the maximum rate, administration of sodium nitroprusside should be terminated immediately.\r\n\r\nAlthough acid-base balance and venous oxygen concentration should be monitored and may indicate cyanide toxicity, these laboratory tests provide imperfect guidance.','Dr. Reddy\'s Laboratories announces the launch of  Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market','','inherit','closed','closed','','4161-revision-v1','','','2019-12-30 10:05:32','2019-12-30 10:05:32','',4161,'https://microbiozindia.com/uncategorized/4161-revision-v1/',0,'revision','',0),(4164,2,'2019-12-30 10:08:00','2019-12-30 10:08:00','Hyderabad, India and Princeton, NJ, USA. December 30, 2019— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® (sodium nitroprusside) Injection, 50 mg/2mL vial, approved by the U.S. Food and Drug Administration (USFDA).\n\nThe Nitropress® brand and generics had U.S. sales of approximately $8 million MAT for the most recent twelve months ending in October 2019 according to IQVIA Health*.\n\nDr. Reddy’s Sodium Nitroprusside Injection is available in single-dose 50 mg/2 mL (25 mg/mL) vials.\n\nNitropress® is a trademark of Hospira, Inc.\n\n<strong>Warnings !!</strong>\n\nSodium Nitroprusside Injection is not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion.\n\nSodium Nitroprusside can cause precipitous decreases in blood pressure (see DOSAGE AND ADMINISTRATION). In patients not properly monitored, these decreases can lead to irreversible ischemic injuries or death. Sodium nitroprusside should be used only when available equipment and personnel allow blood pressure to be continuously monitored.\n\nExcept when used briefly or at low (&lt; 2 mcg/kg/min) infusion rates, sodium nitroprusside gives rise to important quantities of cyanide ion, which can reach toxic, potentially lethal levels (see WARNINGS). The usual dose rate is 0.5 to10 mcg/kg/min, but infusion at the maximum dose rate should never last more than 10 minutes. If blood pressure has not been adequately controlled after 10 minutes of infusion at the maximum rate, administration of sodium nitroprusside should be terminated immediately.\n\nAlthough acid-base balance and venous oxygen concentration should be monitored and may indicate cyanide toxicity, these laboratory tests provide imperfect guidance.\n\n<em>*IQIA Retail and Non-Retail MAT October 2019</em>\n\n<strong>About Dr.Redd:</strong>\n\n<span style=\"font-size: 10pt;\">Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &amp; Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilar and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia &amp; CIS countries, and Europe. </span>','Dr. Reddy\'s Laboratories announces the launch of  Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market','','inherit','closed','closed','','4161-autosave-v1','','','2019-12-30 10:08:00','2019-12-30 10:08:00','',4161,'https://microbiozindia.com/uncategorized/4161-autosave-v1/',0,'revision','',0),(4165,2,'2019-12-30 10:08:06','2019-12-30 10:08:06','Hyderabad, India and Princeton, NJ, USA. December 30, 2019— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® (sodium nitroprusside) Injection, 50 mg/2mL vial, approved by the U.S. Food and Drug Administration (USFDA).\r\n\r\nThe Nitropress® brand and generics had U.S. sales of approximately $8 million MAT for the most recent twelve months ending in October 2019 according to IQVIA Health*.\r\n\r\nDr. Reddy’s Sodium Nitroprusside Injection is available in single-dose 50 mg/2 mL (25 mg/mL) vials.\r\n\r\nNitropress® is a trademark of Hospira, Inc.\r\n\r\n<strong>Warnings !!</strong>\r\n\r\nSodium Nitroprusside Injection is not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion.\r\n\r\nSodium Nitroprusside can cause precipitous decreases in blood pressure (see DOSAGE AND ADMINISTRATION). In patients not properly monitored, these decreases can lead to irreversible ischemic injuries or death. Sodium nitroprusside should be used only when available equipment and personnel allow blood pressure to be continuously monitored.\r\n\r\nExcept when used briefly or at low (&lt; 2 mcg/kg/min) infusion rates, sodium nitroprusside gives rise to important quantities of cyanide ion, which can reach toxic, potentially lethal levels (see WARNINGS). The usual dose rate is 0.5 to10 mcg/kg/min, but infusion at the maximum dose rate should never last more than 10 minutes. If blood pressure has not been adequately controlled after 10 minutes of infusion at the maximum rate, administration of sodium nitroprusside should be terminated immediately.\r\n\r\nAlthough acid-base balance and venous oxygen concentration should be monitored and may indicate cyanide toxicity, these laboratory tests provide imperfect guidance.\r\n\r\n<em>*IQIA Retail and Non-Retail MAT October 2019</em>\r\n\r\n<strong>About Dr.Reddy\'s:</strong>\r\n\r\n<span style=\"font-size: 10pt;\">Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &amp; Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilar and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia &amp; CIS countries, and Europe. </span>','Dr. Reddy\'s Laboratories announces the launch of  Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market','','inherit','closed','closed','','4161-revision-v1','','','2019-12-30 10:08:06','2019-12-30 10:08:06','',4161,'https://microbiozindia.com/uncategorized/4161-revision-v1/',0,'revision','',0),(4166,2,'2019-12-24 09:25:44','2019-12-24 09:25:44','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the December 2019 an annual edition of Microbioz India magazine, supported by the cover story entitled “Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High <em>Throughput Sequencing, Bioinformatics Solutions and Cloud Computing”</em> an insights <em>based on a report on </em><a href=\"https://www.persistencemarketresearch.com/market-research/immune-repertoire-sequencing-market.asp\"><em>Immune Repertoire Sequencing Market</em></a><em> by Persistence Market Research.</em> <em>The immune repertoire sequencing market in terms of revenue, is projected to register a CAGR of 7.3% over the forecast period. The immune repertoire sequencing market is segmented based on product type, application, end users and regions. Based on product type, the immune repertoire sequencing market is segmented into assay kits, software and services.</em>','Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High Throughput Sequencing, Bioinformatics Solutions and Cloud Computing','','publish','closed','closed','','immune-repertoire-sequencing-market-growth-anticipated-to-be-driven-by-advancements-in-high-throughput-sequencing-bioinformatics-solutions-and-cloud-computing','','','2020-01-04 09:53:25','2020-01-04 09:53:25','',0,'https://microbiozindia.com/?post_type=magazines&#038;p=4166',0,'magazines','',0),(4167,2,'2020-01-04 09:28:16','2020-01-04 09:28:16','','MAGCVR (2)','','inherit','open','closed','','magcvr-2','','','2020-01-04 09:28:16','2020-01-04 09:28:16','',4166,'https://microbiozindia.com/wp-content/uploads/2020/01/MAGCVR-2.png',0,'attachment','image/png',0),(4168,2,'2020-01-04 09:34:03','2020-01-04 09:34:03','','WEBCBR (1)','','inherit','open','closed','','webcbr-1','','','2020-01-04 09:34:03','2020-01-04 09:34:03','',4166,'https://microbiozindia.com/wp-content/uploads/2020/01/WEBCBR-1.png',0,'attachment','image/png',0),(4169,2,'2020-01-04 09:34:05','2020-01-04 09:34:05','','WEBCBR (2)','','inherit','open','closed','','webcbr-2','','','2020-01-04 09:34:05','2020-01-04 09:34:05','',4166,'https://microbiozindia.com/wp-content/uploads/2020/01/WEBCBR-2.png',0,'attachment','image/png',0),(4170,2,'2020-01-04 09:34:06','2020-01-04 09:34:06','','WEBCBR (3)','','inherit','open','closed','','webcbr-3','','','2020-01-04 09:34:06','2020-01-04 09:34:06','',4166,'https://microbiozindia.com/wp-content/uploads/2020/01/WEBCBR-3.png',0,'attachment','image/png',0),(4171,2,'2020-01-04 09:34:06','2020-01-04 09:34:06','','WEBCBR (4)','','inherit','open','closed','','webcbr-4','','','2020-01-04 09:34:06','2020-01-04 09:34:06','',4166,'https://microbiozindia.com/wp-content/uploads/2020/01/WEBCBR-4.png',0,'attachment','image/png',0),(4172,2,'2020-01-04 09:50:46','2020-01-04 09:50:46','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the December 2019 an annual edition of Microbioz India magazine, supported by the cover story entitled “Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High <em>Throughput Sequencing, Bioinformatics Solutions and Cloud Computing”</em> an insights <em>based on a report on </em><a href=\"https://www.persistencemarketresearch.com/market-research/immune-repertoire-sequencing-market.asp\"><em>Immune Repertoire Sequencing Market</em></a><em> by Persistence Market Research.</em> <em>The immune repertoire sequencing market in terms of revenue, is projected to register a CAGR of 7.3% over the forecast period. The immune repertoire sequencing market is segmented based on product type, application, end users and regions. Based on product type, the immune repertoire sequencing market is segmented into assay kits, software and services.</em>','Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High Throughput Sequencing, Bioinformatics Solutions and Cloud Computing','','inherit','closed','closed','','4166-revision-v1','','','2020-01-04 09:50:46','2020-01-04 09:50:46','',4166,'https://microbiozindia.com/uncategorized/4166-revision-v1/',0,'revision','',0),(4173,2,'2020-01-04 09:53:25','2020-01-04 09:53:25','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the December 2019 an annual edition of Microbioz India magazine, supported by the cover story entitled “Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High <em>Throughput Sequencing, Bioinformatics Solutions and Cloud Computing”</em> an insights <em>based on a report on </em><a href=\"https://www.persistencemarketresearch.com/market-research/immune-repertoire-sequencing-market.asp\"><em>Immune Repertoire Sequencing Market</em></a><em> by Persistence Market Research.</em> <em>The immune repertoire sequencing market in terms of revenue, is projected to register a CAGR of 7.3% over the forecast period. The immune repertoire sequencing market is segmented based on product type, application, end users and regions. Based on product type, the immune repertoire sequencing market is segmented into assay kits, software and services.</em>','Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High Throughput Sequencing, Bioinformatics Solutions and Cloud Computing','','inherit','closed','closed','','4166-revision-v1','','','2020-01-04 09:53:25','2020-01-04 09:53:25','',4166,'https://microbiozindia.com/uncategorized/4166-revision-v1/',0,'revision','',0),(4174,2,'2020-01-09 10:48:02','2020-01-09 10:48:02','Testa Analytical Solutions e.K, a leading developer of high-performance GPC / SEC instruments and detectors for polymer characterization will showcase its OEM design and manufacture capabilities at Analytica 2020.\r\n\r\nBacked by decades of experience, Testa Analytical has created, for a growing number of leading international laboratory and process instrument companies, fully optimised high-performance GPC/SEC detectors, GPC/SEC Pumps, accessories and software products customizable to meet their exact needs.\r\n\r\nVisitors to Analytica Booth A2-429 will be able to meet Testa Analytical\'s team of knowledgeable technical and engineering staff to discuss your product development needs and to learn how they can provide seamless integration of their proprietary technology into your existing or new product.\r\n\r\n<img class=\"alignnone wp-image-4175\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/TestaPR30-image-300x242.jpg\" alt=\"\" width=\"484\" height=\"391\" />\r\n\r\nAlso, on display will be a full range of state-of-the-art scientific instruments that use scattered light to measure zeta potential, particle size, and molecular weight. Testa Analytical are dedicated to supplying the most accurate, reliable, and easy-to-use particle characterization instruments on the market. Our modular instrument design allows us to fully customize every aspect of our products, ensuring that our customers receive precisely what they need to meet their research goals. The Testa Analytical commitment to its customers continues long after a sale is made. Our knowledgeable\r\nteam of technical staff is standing by to assist you with your toughest application challenges.\r\n\r\nFor further information on please visit <a href=\"http://www.testa-analytical.com/\">www.testa-analytical.com</a> or contact Testa Analytical Solutions on +49-30-864-24076 / <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>.\r\n\r\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.\r\n\r\n---------------------\r\n\r\n<strong>Worldwide HQ </strong>\r\n\r\nTesta Analytical Solutions e.K.\r\n\r\nSophienstraße 5\r\n12203 Berlin\r\n\r\nGermany\r\n\r\nTel:     +49-30-864-24076\r\n\r\nEmail: <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>\r\nWeb   <a href=\"http://www.testa-analytical.com\">www.testa-analytical.com</a>','Optimized Instruments for Polymer Characterization & Particle Sizing','','publish','open','open','','optimized-instruments-for-polymer-characterization-particle-sizing','','','2020-01-09 10:49:00','2020-01-09 10:49:00','',0,'https://microbiozindia.com/?p=4174',0,'post','',0),(4175,2,'2020-01-09 10:38:57','2020-01-09 10:38:57','','TestaPR30-image','','inherit','open','closed','','testapr30-image','','','2020-01-09 10:38:57','2020-01-09 10:38:57','',4174,'https://microbiozindia.com/wp-content/uploads/2020/01/TestaPR30-image.jpg',0,'attachment','image/jpeg',0),(4176,2,'2020-01-09 10:39:10','2020-01-09 10:39:10','','ziathpr12-image','','inherit','open','closed','','ziathpr12-image','','','2020-01-09 10:39:10','2020-01-09 10:39:10','',4174,'https://microbiozindia.com/wp-content/uploads/2020/01/ziathpr12-image.jpg',0,'attachment','image/jpeg',0),(4177,2,'2020-01-09 10:41:45','2020-01-09 10:41:45','','AAA','','inherit','open','closed','','aaa-2','','','2020-01-09 10:41:45','2020-01-09 10:41:45','',4174,'https://microbiozindia.com/wp-content/uploads/2020/01/AAA.png',0,'attachment','image/png',0),(4178,2,'2020-01-09 10:41:48','2020-01-09 10:41:48','','ZIATH','','inherit','open','closed','','ziath','','','2020-01-09 10:41:48','2020-01-09 10:41:48','',4174,'https://microbiozindia.com/wp-content/uploads/2020/01/ZIATH.png',0,'attachment','image/png',0),(4179,2,'2020-01-09 10:48:02','2020-01-09 10:48:02','Testa Analytical Solutions e.K, a leading developer of high-performance GPC / SEC instruments and detectors for polymer characterization will showcase its OEM design and manufacture capabilities at Analytica 2020.\r\n\r\nBacked by decades of experience, Testa Analytical has created, for a growing number of leading international laboratory and process instrument companies, fully optimised high-performance GPC/SEC detectors, GPC/SEC Pumps, accessories and software products customizable to meet their exact needs.\r\n\r\nVisitors to Analytica Booth A2-429 will be able to meet Testa Analytical\'s team of knowledgeable technical and engineering staff to discuss your product development needs and to learn how they can provide seamless integration of their proprietary technology into your existing or new product.\r\n\r\n<img class=\"alignnone  wp-image-4175\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/TestaPR30-image-300x242.jpg\" alt=\"\" width=\"484\" height=\"391\" />\r\n\r\nAlso, on display will be a full range of state-of-the-art scientific instruments that use scattered light to measure zeta potential, particle size, and molecular weight. Testa Analytical are dedicated to supplying the most accurate, reliable, and easy-to-use particle characterization instruments on the market. Our modular instrument design allows us to fully customize every aspect of our products, ensuring that our customers receive precisely what they need to meet their research goals. The Testa Analytical commitment to its customers continues long after a sale is made. Our knowledgeable\r\nteam of technical staff is standing by to assist you with your toughest application challenges.\r\n\r\nFor further information on please visit <a href=\"http://www.testa-analytical.com/\">www.testa-analytical.com</a> or contact Testa Analytical Solutions on +49-30-864-24076 / <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>.\r\n\r\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.\r\n\r\n---------------------\r\n\r\n<strong>Worldwide HQ </strong><strong>\r\n\r\nTesta Analytical Solutions e.K.</strong>\r\n\r\nSophienstraße 5\r\n12203 Berlin\r\n\r\nGermany\r\n\r\nTel:     +49-30-864-24076\r\n\r\nEmail: <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>\r\nWeb   <a href=\"http://www.testa-analytical.com\">www.testa-analytical.com</a>','Optimized Instruments for Polymer Characterization & Particle Sizing','','inherit','closed','closed','','4174-revision-v1','','','2020-01-09 10:48:02','2020-01-09 10:48:02','',4174,'https://microbiozindia.com/uncategorized/4174-revision-v1/',0,'revision','',0),(4180,2,'2020-01-09 10:49:00','2020-01-09 10:49:00','Testa Analytical Solutions e.K, a leading developer of high-performance GPC / SEC instruments and detectors for polymer characterization will showcase its OEM design and manufacture capabilities at Analytica 2020.\r\n\r\nBacked by decades of experience, Testa Analytical has created, for a growing number of leading international laboratory and process instrument companies, fully optimised high-performance GPC/SEC detectors, GPC/SEC Pumps, accessories and software products customizable to meet their exact needs.\r\n\r\nVisitors to Analytica Booth A2-429 will be able to meet Testa Analytical\'s team of knowledgeable technical and engineering staff to discuss your product development needs and to learn how they can provide seamless integration of their proprietary technology into your existing or new product.\r\n\r\n<img class=\"alignnone wp-image-4175\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/TestaPR30-image-300x242.jpg\" alt=\"\" width=\"484\" height=\"391\" />\r\n\r\nAlso, on display will be a full range of state-of-the-art scientific instruments that use scattered light to measure zeta potential, particle size, and molecular weight. Testa Analytical are dedicated to supplying the most accurate, reliable, and easy-to-use particle characterization instruments on the market. Our modular instrument design allows us to fully customize every aspect of our products, ensuring that our customers receive precisely what they need to meet their research goals. The Testa Analytical commitment to its customers continues long after a sale is made. Our knowledgeable\r\nteam of technical staff is standing by to assist you with your toughest application challenges.\r\n\r\nFor further information on please visit <a href=\"http://www.testa-analytical.com/\">www.testa-analytical.com</a> or contact Testa Analytical Solutions on +49-30-864-24076 / <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>.\r\n\r\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.\r\n\r\n---------------------\r\n\r\n<strong>Worldwide HQ </strong>\r\n\r\nTesta Analytical Solutions e.K.\r\n\r\nSophienstraße 5\r\n12203 Berlin\r\n\r\nGermany\r\n\r\nTel:     +49-30-864-24076\r\n\r\nEmail: <a href=\"mailto:info@testa-analytical.com\">info@testa-analytical.com</a>\r\nWeb   <a href=\"http://www.testa-analytical.com\">www.testa-analytical.com</a>','Optimized Instruments for Polymer Characterization & Particle Sizing','','inherit','closed','closed','','4174-revision-v1','','','2020-01-09 10:49:00','2020-01-09 10:49:00','',4174,'https://microbiozindia.com/uncategorized/4174-revision-v1/',0,'revision','',0),(4181,2,'2020-01-09 10:51:37','2020-01-09 10:51:37','Ziath has announced that it will launch a revolutionary web-based 2D-barcoded tube identification product - Datapaq 5 at SLAS 2020** in San Diego, USA.\r\n\r\nIn modern laboratories - samples are typically stored in large -80°C freezers, liquid nitrogen tanks or fully automated stores that are often inconveniently situated in an outbuilding or a basement. Datapaq 5 is the first of a new generation of digital sample management tools being developed by Ziath to allow sample management technicians to quickly and accurately log sample identity at the point of storage or retrieval.\r\n<img class=\"alignnone wp-image-4176\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/ziathpr12-image-300x168.jpg\" alt=\"\" width=\"518\" height=\"290\" />\r\nDatapaq 5 will run from any computer on a local network or over the internet if your IT rules allow, using a web-based highly intuitive graphical user interface. Datapaq 5 provides visual confirmation of tube identity and individual tube image inspection. From launch, this exciting new product will be available on Ziath\'s popular camera-based 2D barcoded scanners the Mirage, Express and the Cube.\r\n\r\nDatapaq 5 offers a convenient way to use a 2D barcoded tube or rack scanner anywhere across a laboratory or an organisation’s site where a suitable laptop or computer is available. Thanks to its web-based interface, Datapaq 5’s user interface will run on both Microsoft and Apple operating systems.\r\n\r\nThe new web-based software includes a host of features designed to streamline the collection of tube information for subsequent processing in inventory management software, such as Ziath’s popular Samples program.\r\n\r\nIn a further development - Ziath are also debuting an Android app that can run their rack scanners from a mobile device directly, in addition to using a web interface. This will put tube identification directly into the technician’s hands as they access their samples, wherever they may be stored.\r\n\r\nFor further information on Datapaq 5 please visit SLAS Booth 1548 or contact Ziath on +44 (0)1223 855021 or +1 858-880-6920 and via email to <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com/\">www.ziath.com</a>.\r\n\r\n**  SLAS 2020 will take place from January 25 – 29 2020 (see <a href=\"https://www.slas2020.org/\">https://www.slas2020.org/</a>)\r\n\r\n<strong><u>Worldwide HQ</u></strong><strong> </strong>\r\n\r\nZiath Ltd\r\nUnit 2a, Solopark Trading Estate\r\n\r\nStation Road\r\n\r\nPapisford\r\n\r\nCambridge CB22 3HB\r\nUK\r\nTel:     +44 1223 855021\r\n\r\nEmail: <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\nWeb    <a href=\"http://www.ziath.com\">www.ziath.com</a>','Reading 2D Barcoded Tubes Directly at the Point of Storage or Retrieval','','publish','open','open','','reading-2d-barcoded-tubes-directly-at-the-point-of-storage-or-retrieval','','','2020-02-01 13:51:50','2020-02-01 13:51:50','',0,'https://microbiozindia.com/?p=4181',0,'post','',0),(4182,2,'2020-01-09 10:51:37','2020-01-09 10:51:37','Ziath has announced that it will launch a <em>revolutionary web-based 2D-barcoded tube identification product </em>- Datapaq 5 at SLAS 2020** in San Diego, USA.\r\n\r\nIn modern laboratories - samples are typically stored in large -80°C freezers, liquid nitrogen tanks or fully automated stores that are often inconveniently situated in an outbuilding or a basement. Datapaq 5 is the first of a new generation of digital sample management tools being developed by Ziath to allow sample management technicians to quickly and accurately log sample identity at the point of storage or retrieval.\r\n<img class=\"alignnone size-medium wp-image-4176\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/ziathpr12-image-300x168.jpg\" alt=\"\" width=\"300\" height=\"168\" />\r\nDatapaq 5 will run from any computer on a local network or over the internet if your IT rules allow, using a web-based highly intuitive graphical user interface. Datapaq 5 provides visual confirmation of tube identity and individual tube image inspection. From launch, this exciting new product will be available on Ziath\'s popular camera-based 2D barcoded scanners the Mirage, Express and the Cube.\r\n\r\nDatapaq 5 offers a convenient way to use a 2D barcoded tube or rack scanner anywhere across a laboratory or an organisation’s site where a suitable laptop or computer is available. Thanks to its web-based interface, Datapaq 5’s user interface will run on both Microsoft and Apple operating systems.\r\n\r\nThe new web-based software includes a host of features designed to streamline the collection of tube information for subsequent processing in inventory management software, such as Ziath’s popular Samples program.\r\n\r\nIn a further development - Ziath are also debuting an Android app that can run their rack scanners from a mobile device directly, in addition to using a web interface. This will put tube identification directly into the technician’s hands as they access their samples, wherever they may be stored.\r\n\r\nFor further information on Datapaq 5 please visit SLAS Booth 1548 or contact Ziath on +44 (0)1223 855021 or +1 858-880-6920 and via email to <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com/\">www.ziath.com</a>.\r\n\r\n**  SLAS 2020 will take place from January 25 – 29 2020 (see <a href=\"https://www.slas2020.org/\">https://www.slas2020.org/</a>)\r\n\r\n<strong><u>Worldwide HQ</u></strong><strong> </strong><strong>\r\n\r\nZiath Ltd\r\n</strong>Unit 2a, Solopark Trading Estate\r\n\r\nStation Road\r\n\r\nPapisford\r\n\r\nCambridge CB22 3HB\r\nUK\r\nTel:     +44 1223 855021\r\n\r\nEmail: <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\nWeb    <a href=\"http://www.ziath.com\">www.ziath.com</a>\r\n\r\n&nbsp;','Reading 2D-Barcoded Tubes Directly at the Point of Storage or Retrieval','','inherit','closed','closed','','4181-revision-v1','','','2020-01-09 10:51:37','2020-01-09 10:51:37','',4181,'https://microbiozindia.com/uncategorized/4181-revision-v1/',0,'revision','',0),(4183,2,'2020-01-09 10:52:42','2020-01-09 10:52:42','Ziath has announced that it will launch a <em>revolutionary web-based 2D-barcoded tube identification product </em>- Datapaq 5 at SLAS 2020** in San Diego, USA.\n\nIn modern laboratories - samples are typically stored in large -80°C freezers, liquid nitrogen tanks or fully automated stores that are often inconveniently situated in an outbuilding or a basement. Datapaq 5 is the first of a new generation of digital sample management tools being developed by Ziath to allow sample management technicians to quickly and accurately log sample identity at the point of storage or retrieval.\n<img class=\"alignnone size-medium wp-image-4176\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/ziathpr12-image-300x168.jpg\" alt=\"\" width=\"300\" height=\"168\" />\nDatapaq 5 will run from any computer on a local network or over the internet if your IT rules allow, using a web-based highly intuitive graphical user interface. Datapaq 5 provides visual confirmation of tube identity and individual tube image inspection. From launch, this exciting new product will be available on Ziath\'s popular camera-based 2D barcoded scanners the Mirage, Express and the Cube.\n\nDatapaq 5 offers a convenient way to use a 2D barcoded tube or rack scanner anywhere across a laboratory or an organisation’s site where a suitable laptop or computer is available. Thanks to its web-based interface, Datapaq 5’s user interface will run on both Microsoft and Apple operating systems.\n\nThe new web-based software includes a host of features designed to streamline the collection of tube information for subsequent processing in inventory management software, such as Ziath’s popular Samples program.\n\nIn a further development - Ziath are also debuting an Android app that can run their rack scanners from a mobile device directly, in addition to using a web interface. This will put tube identification directly into the technician’s hands as they access their samples, wherever they may be stored.\n\nFor further information on Datapaq 5 please visit SLAS Booth 1548 or contact Ziath on +44 (0)1223 855021 or +1 858-880-6920 and via email to <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\n\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com/\">www.ziath.com</a>.\n\n**  SLAS 2020 will take place from January 25 – 29 2020 (see <a href=\"https://www.slas2020.org/\">https://www.slas2020.org/</a>)\n\n<strong><u>Worldwide HQ</u></strong><strong> </strong>\n\nZiath Ltd\nUnit 2a, Solopark Trading Estate\n\nStation Road\n\nPapisford\n\nCambridge CB22 3HB\nUK\nTel:     +44 1223 855021\n\nEmail: <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\nWeb    <a href=\"http://www.ziath.com\">www.ziath.com</a>','Reading 2D-Barcoded Tubes Directly at the Point of Storage or Retrieval','','inherit','closed','closed','','4181-autosave-v1','','','2020-01-09 10:52:42','2020-01-09 10:52:42','',4181,'https://microbiozindia.com/uncategorized/4181-autosave-v1/',0,'revision','',0),(4184,2,'2020-01-09 10:53:10','2020-01-09 10:53:10','Ziath has announced that it will launch a <em>revolutionary web-based 2D-barcoded tube identification product </em>- Datapaq 5 at SLAS 2020** in San Diego, USA.\r\n\r\nIn modern laboratories - samples are typically stored in large -80°C freezers, liquid nitrogen tanks or fully automated stores that are often inconveniently situated in an outbuilding or a basement. Datapaq 5 is the first of a new generation of digital sample management tools being developed by Ziath to allow sample management technicians to quickly and accurately log sample identity at the point of storage or retrieval.\r\n<img class=\"alignnone  wp-image-4176\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/ziathpr12-image-300x168.jpg\" alt=\"\" width=\"518\" height=\"290\" />\r\nDatapaq 5 will run from any computer on a local network or over the internet if your IT rules allow, using a web-based highly intuitive graphical user interface. Datapaq 5 provides visual confirmation of tube identity and individual tube image inspection. From launch, this exciting new product will be available on Ziath\'s popular camera-based 2D barcoded scanners the Mirage, Express and the Cube.\r\n\r\nDatapaq 5 offers a convenient way to use a 2D barcoded tube or rack scanner anywhere across a laboratory or an organisation’s site where a suitable laptop or computer is available. Thanks to its web-based interface, Datapaq 5’s user interface will run on both Microsoft and Apple operating systems.\r\n\r\nThe new web-based software includes a host of features designed to streamline the collection of tube information for subsequent processing in inventory management software, such as Ziath’s popular Samples program.\r\n\r\nIn a further development - Ziath are also debuting an Android app that can run their rack scanners from a mobile device directly, in addition to using a web interface. This will put tube identification directly into the technician’s hands as they access their samples, wherever they may be stored.\r\n\r\nFor further information on Datapaq 5 please visit SLAS Booth 1548 or contact Ziath on +44 (0)1223 855021 or +1 858-880-6920 and via email to <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com/\">www.ziath.com</a>.\r\n\r\n**  SLAS 2020 will take place from January 25 – 29 2020 (see <a href=\"https://www.slas2020.org/\">https://www.slas2020.org/</a>)\r\n\r\n<strong><u>Worldwide HQ</u></strong><strong> </strong>\r\n\r\nZiath Ltd\r\nUnit 2a, Solopark Trading Estate\r\n\r\nStation Road\r\n\r\nPapisford\r\n\r\nCambridge CB22 3HB\r\nUK\r\nTel:     +44 1223 855021\r\n\r\nEmail: <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\nWeb    <a href=\"http://www.ziath.com\">www.ziath.com</a>','Reading 2D Barcoded Tubes Directly at the Point of Storage or Retrieval','','inherit','closed','closed','','4181-revision-v1','','','2020-01-09 10:53:10','2020-01-09 10:53:10','',4181,'https://microbiozindia.com/uncategorized/4181-revision-v1/',0,'revision','',0),(4185,2,'2020-01-09 11:43:09','2020-01-09 11:43:09','Gas chromatography is a mass analytics method applied in all domains of human activities – from ecology, healthcare, and agriculture… to petro chemistry and nuclear energy, as well as many modern scientific applications. And thanks to its high sensitivity and the ability to tailor analysis for specific compounds, gas chromatography occupies a special place among the other instrumental analysis methods.\r\n\r\nToday, analytical monitoring for contaminants to ensure they do not exceed health and safety limits, as well as food quality control, toxicological diagnostics, process control in production facilities, and material quality control… are unimaginable without gas chromatography.\r\n\r\nThe Chromatec Crystal 9000 Gas Chromatography system with a high endanalytical Capability with fully automated, flexible and versatile tool with a wide range of detectors, sample introduction devises and external automatic samplers. This system is always at the service of science and technology Providing highest Sensitivity and efficiency in analytical problems solving of different applications in the segments of<strong> ;</strong>\r\n\r\n<img class=\"alignnone wp-image-4186\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/GC-MS-Crystal-9000-300x267.jpg\" alt=\"\" width=\"317\" height=\"282\" />\r\n\r\n<strong>1:-Oil &amp; Gas</strong> for analyzing the most demand applications for Natural, refinery and Liquefied Gas and crude Oil and Petroleum Products\r\n\r\n2:-Adding MSD in obtaining high limit of detection for determination of harmful pollutants such as pesticides, herbicides and chemical contamination to guarantee Air Quality and safe Nature\r\n\r\n3:-Is used as powerful tool to exam the products and raw material for all needs of Petrochemical, chemical, biotechnology and mining industries\r\n\r\n4:-Plays a vital role in Forensic adding MSD it is very accurate and precise tool to detect and specify drugs of abuse, toxic d explosive materials and also in many criminalistics laboratories\r\n\r\n5:-Accuracy and Validity are key factors in Pharmaceutical industry and Chromatec Crystal 9000 GC has been designed to meet these requirements in the highest Performance complying to its validation documents\r\n\r\n6:-An Integral Part of GC is Detector and chromatec Crystal 9000 is capable of accepting 4 detectors simultaneously with Vide range of Detectors\r\n\r\n7:-Having understood the concept of meeting compliance, chromatec GC Crystal 9000 comply FDA 21 CFR Part 11 According to GLP/GMP requirements\r\n\r\n8:-In case of upgradation Chromatec Crystal 9000 can be upgraded to MS by simply adding MS Detector which is Quadruple for determination of wide range of compounds with identification via mass spectrum libraries\r\n\r\n9:-Possibility to install a wide range of capillary pneumatic control accessories like Dean’s switch micro fluidic module and other low-dead volume collectors for capillary columns switching. Fully controlled by PC software or by optional external keyboard/display. Optional 7 inch Touch Screen LCD makes the operational more easily and helps to get fast information about instrument status\r\n\r\n10:-You are looking for system trails or demonstration the capability of GC, please contact immediately <strong>Smart LabtechApplication Excellency Lab</strong> and are pleased to offer you our services\r\n\r\n<strong>For more details contact:</strong>\r\n\r\nP.Indraneel,\r\n\r\n9848444237,\r\n\r\nmarketing@smartlabtech.net,\r\n\r\n<a href=\"http://smartlabtech.com/\">Smart Labtech Pvt Ltd,</a>\r\n\r\nHyderabad.','GAS CHROMATOGRAPHY- Best Choice for every Laboratory','','publish','open','open','','gas-chromatography-best-choice-for-every-laboratory','','','2020-01-09 11:48:34','2020-01-09 11:48:34','',0,'https://microbiozindia.com/?p=4185',0,'post','',0),(4186,2,'2020-01-09 11:40:58','2020-01-09 11:40:58','','GC MS Crystal 9000','','inherit','open','closed','','gc-ms-crystal-9000','','','2020-01-09 11:40:58','2020-01-09 11:40:58','',4185,'https://microbiozindia.com/wp-content/uploads/2020/01/GC-MS-Crystal-9000.jpg',0,'attachment','image/jpeg',0),(4187,2,'2020-01-09 11:41:04','2020-01-09 11:41:04','','aaakl','','inherit','open','closed','','aaakl','','','2020-01-09 11:41:04','2020-01-09 11:41:04','',4185,'https://microbiozindia.com/wp-content/uploads/2020/01/aaakl.png',0,'attachment','image/png',0),(4188,2,'2020-01-09 11:43:09','2020-01-09 11:43:09','Gas chromatography is a mass analytics method applied in all domains of human activities – from ecology, healthcare, and agriculture… to petro chemistry and nuclear energy, as well as many modern scientific applications. And thanks to its high sensitivity and the ability to tailor analysis for specific compounds, gas chromatography occupies a special place among the other instrumental analysis methods.\r\n\r\nToday, analytical monitoring for contaminants to ensure they do not exceed health and safety limits, as well as food quality control, toxicological diagnostics, process control in production facilities, and material quality control… are unimaginable without gas chromatography.\r\n\r\nThe Chromatec Crystal 9000 Gas Chromatography system with a high endanalytical Capability with fully automated, flexible and versatile tool with a wide range of detectors, sample introduction devises and external automatic samplers. This system is always at the service of science and technology Providing highest Sensitivity and efficiency in analytical problems solving of different applications in the segments of<strong> ;</strong>\r\n\r\n<img class=\"alignnone  wp-image-4186\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/GC-MS-Crystal-9000-300x267.jpg\" alt=\"\" width=\"317\" height=\"282\" />\r\n<ul>\r\n 	<li><strong>Oil &amp; Gas</strong> for analyzing the most demand applications for Natural, refinery and Liquefied Gas and crude Oil and Petroleum Products</li>\r\n 	<li>Adding MSD in obtaining high limit of detection for determination of harmful pollutants such as pesticides, herbicides and chemical contamination to guarantee Air Quality and safe Nature</li>\r\n 	<li>Is used as powerful tool to exam the products and raw material for all needs of Petrochemical, chemical, biotechnology and mining industries</li>\r\n 	<li>Plays a vital role in Forensic adding MSD it is very accurate and precise tool to detect and specify drugs of abuse, toxic d explosive materials and also in many criminalistics laboratories</li>\r\n 	<li>Accuracy and Validity are key factors in Pharmaceutical industry and Chromatec Crystal 9000 GC has been designed to meet these requirements in the highest Performance complying to its validation documents</li>\r\n 	<li>An Integral Part of GC is Detector and chromatec Crystal 9000 is capable of accepting 4 detectors simultaneously with Vide range of Detectors</li>\r\n 	<li>Having understood the concept of meeting compliance, chromatec GC Crystal 9000 comply FDA 21 CFR Part 11 According to GLP/GMP requirements</li>\r\n 	<li>In case of upgradation Chromatec Crystal 9000 can be upgraded to MS by simply adding MS Detector which is Quadruple for determination of wide range of compounds with identification via mass spectrum libraries</li>\r\n 	<li>Possibility to install a wide range of capillary pneumatic control accessories like Dean’s switch micro fluidic module and other low-dead volume collectors for capillary columns switching. Fully controlled by PC software or by optional external keyboard/display. Optional 7 inch Touch Screen LCD makes the operational more easily and helps to get fast information about instrument status</li>\r\n</ul>\r\nYou are looking for system trails or demonstration the capability of GC, please contact immediately <strong>Smart LabtechApplication Excellency Lab</strong> and are pleased to offer you our services\r\n\r\n<strong>For more details contact:</strong>\r\n\r\nP.Indraneel,\r\n\r\n9848444237,\r\n\r\nmarketing@smartlabtech.net,\r\n\r\nSmart Labtech Pvt Ltd,\r\n\r\nHyderabad.','GAS CHROMATOGRAPHY- Best Choice for every Laboratory','','inherit','closed','closed','','4185-revision-v1','','','2020-01-09 11:43:09','2020-01-09 11:43:09','',4185,'https://microbiozindia.com/uncategorized/4185-revision-v1/',0,'revision','',0),(4189,2,'2020-01-09 11:44:59','2020-01-09 11:44:59','Gas chromatography is a mass analytics method applied in all domains of human activities – from ecology, healthcare, and agriculture… to petro chemistry and nuclear energy, as well as many modern scientific applications. And thanks to its high sensitivity and the ability to tailor analysis for specific compounds, gas chromatography occupies a special place among the other instrumental analysis methods.\r\n\r\nToday, analytical monitoring for contaminants to ensure they do not exceed health and safety limits, as well as food quality control, toxicological diagnostics, process control in production facilities, and material quality control… are unimaginable without gas chromatography.\r\n\r\nThe Chromatec Crystal 9000 Gas Chromatography system with a high endanalytical Capability with fully automated, flexible and versatile tool with a wide range of detectors, sample introduction devises and external automatic samplers. This system is always at the service of science and technology Providing highest Sensitivity and efficiency in analytical problems solving of different applications in the segments of<strong> ;</strong>\r\n\r\n<img class=\"alignnone wp-image-4186\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/GC-MS-Crystal-9000-300x267.jpg\" alt=\"\" width=\"317\" height=\"282\" />\r\n<ol style=\"list-style-type: lower-alpha;\">\r\n 	<li><strong>Oil &amp; Gas</strong> for analyzing the most demand applications for Natural, refinery and Liquefied Gas and crude Oil and Petroleum Products</li>\r\n 	<li>Adding MSD in obtaining high limit of detection for determination of harmful pollutants such as pesticides, herbicides and chemical contamination to guarantee Air Quality and safe Nature</li>\r\n 	<li>Is used as powerful tool to exam the products and raw material for all needs of Petrochemical, chemical, biotechnology and mining industries</li>\r\n 	<li>Plays a vital role in Forensic adding MSD it is very accurate and precise tool to detect and specify drugs of abuse, toxic d explosive materials and also in many criminalistics laboratories</li>\r\n 	<li>Accuracy and Validity are key factors in Pharmaceutical industry and Chromatec Crystal 9000 GC has been designed to meet these requirements in the highest Performance complying to its validation documents</li>\r\n 	<li>An Integral Part of GC is Detector and chromatec Crystal 9000 is capable of accepting 4 detectors simultaneously with Vide range of Detectors</li>\r\n 	<li>Having understood the concept of meeting compliance, chromatec GC Crystal 9000 comply FDA 21 CFR Part 11 According to GLP/GMP requirements</li>\r\n 	<li>In case of upgradation Chromatec Crystal 9000 can be upgraded to MS by simply adding MS Detector which is Quadruple for determination of wide range of compounds with identification via mass spectrum libraries</li>\r\n 	<li>Possibility to install a wide range of capillary pneumatic control accessories like Dean’s switch micro fluidic module and other low-dead volume collectors for capillary columns switching. Fully controlled by PC software or by optional external keyboard/display. Optional 7 inch Touch Screen LCD makes the operational more easily and helps to get fast information about instrument status</li>\r\n</ol>\r\nYou are looking for system trails or demonstration the capability of GC, please contact immediately <strong>Smart LabtechApplication Excellency Lab</strong> and are pleased to offer you our services\r\n\r\n<strong>For more details contact:</strong>\r\n\r\nP.Indraneel,\r\n\r\n9848444237,\r\n\r\nmarketing@smartlabtech.net,\r\n\r\nSmart Labtech Pvt Ltd,\r\n\r\nHyderabad.','GAS CHROMATOGRAPHY- Best Choice for every Laboratory','','inherit','closed','closed','','4185-revision-v1','','','2020-01-09 11:44:59','2020-01-09 11:44:59','',4185,'https://microbiozindia.com/uncategorized/4185-revision-v1/',0,'revision','',0),(4190,2,'2020-01-09 11:48:03','2020-01-09 11:48:03','Gas chromatography is a mass analytics method applied in all domains of human activities – from ecology, healthcare, and agriculture… to petro chemistry and nuclear energy, as well as many modern scientific applications. And thanks to its high sensitivity and the ability to tailor analysis for specific compounds, gas chromatography occupies a special place among the other instrumental analysis methods.\n\nToday, analytical monitoring for contaminants to ensure they do not exceed health and safety limits, as well as food quality control, toxicological diagnostics, process control in production facilities, and material quality control… are unimaginable without gas chromatography.\n\nThe Chromatec Crystal 9000 Gas Chromatography system with a high endanalytical Capability with fully automated, flexible and versatile tool with a wide range of detectors, sample introduction devises and external automatic samplers. This system is always at the service of science and technology Providing highest Sensitivity and efficiency in analytical problems solving of different applications in the segments of<strong> ;</strong>\n\n<img class=\"alignnone wp-image-4186\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/GC-MS-Crystal-9000-300x267.jpg\" alt=\"\" width=\"317\" height=\"282\" />\n\n<strong>1:-Oil &amp; Gas</strong> for analyzing the most demand applications for Natural, refinery and Liquefied Gas and crude Oil and Petroleum Products\n\n2:-Adding MSD in obtaining high limit of detection for determination of harmful pollutants such as pesticides, herbicides and chemical contamination to guarantee Air Quality and safe Nature\n\n3:-Is used as powerful tool to exam the products and raw material for all needs of Petrochemical, chemical, biotechnology and mining industries\n\n4:-Plays a vital role in Forensic adding MSD it is very accurate and precise tool to detect and specify drugs of abuse, toxic d explosive materials and also in many criminalistics laboratories\n\n5:-Accuracy and Validity are key factors in Pharmaceutical industry and Chromatec Crystal 9000 GC has been designed to meet these requirements in the highest Performance complying to its validation documents\n\n6:-An Integral Part of GC is Detector and chromatec Crystal 9000 is capable of accepting 4 detectors simultaneously with Vide range of Detectors\n\n7:-Having understood the concept of meeting compliance, chromatec GC Crystal 9000 comply FDA 21 CFR Part 11 According to GLP/GMP requirements\n\n8:-In case of upgradation Chromatec Crystal 9000 can be upgraded to MS by simply adding MS Detector which is Quadruple for determination of wide range of compounds with identification via mass spectrum libraries\n\n9:-Possibility to install a wide range of capillary pneumatic control accessories like Dean’s switch micro fluidic module and other low-dead volume collectors for capillary columns switching. Fully controlled by PC software or by optional external keyboard/display. Optional 7 inch Touch Screen LCD makes the operational more easily and helps to get fast information about instrument status\n\n10:-You are looking for system trails or demonstration the capability of GC, please contact immediately <strong>Smart LabtechApplication Excellency Lab</strong> and are pleased to offer you our services\n\n<strong>For more details contact:</strong>\n\nP.Indraneel,\n\n9848444237,\n\nmarketing@smartlabtech.net,\n\n<a href=\"http://smartlabtech.com/\">Smart Labtech Pvt Ltd,</a>\n\nHyderabad.','GAS CHROMATOGRAPHY- Best Choice for every Laboratory','','inherit','closed','closed','','4185-autosave-v1','','','2020-01-09 11:48:03','2020-01-09 11:48:03','',4185,'https://microbiozindia.com/uncategorized/4185-autosave-v1/',0,'revision','',0),(4191,2,'2020-01-09 11:48:34','2020-01-09 11:48:34','Gas chromatography is a mass analytics method applied in all domains of human activities – from ecology, healthcare, and agriculture… to petro chemistry and nuclear energy, as well as many modern scientific applications. And thanks to its high sensitivity and the ability to tailor analysis for specific compounds, gas chromatography occupies a special place among the other instrumental analysis methods.\r\n\r\nToday, analytical monitoring for contaminants to ensure they do not exceed health and safety limits, as well as food quality control, toxicological diagnostics, process control in production facilities, and material quality control… are unimaginable without gas chromatography.\r\n\r\nThe Chromatec Crystal 9000 Gas Chromatography system with a high endanalytical Capability with fully automated, flexible and versatile tool with a wide range of detectors, sample introduction devises and external automatic samplers. This system is always at the service of science and technology Providing highest Sensitivity and efficiency in analytical problems solving of different applications in the segments of<strong> ;</strong>\r\n\r\n<img class=\"alignnone wp-image-4186\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/GC-MS-Crystal-9000-300x267.jpg\" alt=\"\" width=\"317\" height=\"282\" />\r\n\r\n<strong>1:-Oil &amp; Gas</strong> for analyzing the most demand applications for Natural, refinery and Liquefied Gas and crude Oil and Petroleum Products\r\n\r\n2:-Adding MSD in obtaining high limit of detection for determination of harmful pollutants such as pesticides, herbicides and chemical contamination to guarantee Air Quality and safe Nature\r\n\r\n3:-Is used as powerful tool to exam the products and raw material for all needs of Petrochemical, chemical, biotechnology and mining industries\r\n\r\n4:-Plays a vital role in Forensic adding MSD it is very accurate and precise tool to detect and specify drugs of abuse, toxic d explosive materials and also in many criminalistics laboratories\r\n\r\n5:-Accuracy and Validity are key factors in Pharmaceutical industry and Chromatec Crystal 9000 GC has been designed to meet these requirements in the highest Performance complying to its validation documents\r\n\r\n6:-An Integral Part of GC is Detector and chromatec Crystal 9000 is capable of accepting 4 detectors simultaneously with Vide range of Detectors\r\n\r\n7:-Having understood the concept of meeting compliance, chromatec GC Crystal 9000 comply FDA 21 CFR Part 11 According to GLP/GMP requirements\r\n\r\n8:-In case of upgradation Chromatec Crystal 9000 can be upgraded to MS by simply adding MS Detector which is Quadruple for determination of wide range of compounds with identification via mass spectrum libraries\r\n\r\n9:-Possibility to install a wide range of capillary pneumatic control accessories like Dean’s switch micro fluidic module and other low-dead volume collectors for capillary columns switching. Fully controlled by PC software or by optional external keyboard/display. Optional 7 inch Touch Screen LCD makes the operational more easily and helps to get fast information about instrument status\r\n\r\n10:-You are looking for system trails or demonstration the capability of GC, please contact immediately <strong>Smart LabtechApplication Excellency Lab</strong> and are pleased to offer you our services\r\n\r\n<strong>For more details contact:</strong>\r\n\r\nP.Indraneel,\r\n\r\n9848444237,\r\n\r\nmarketing@smartlabtech.net,\r\n\r\n<a href=\"http://smartlabtech.com/\">Smart Labtech Pvt Ltd,</a>\r\n\r\nHyderabad.','GAS CHROMATOGRAPHY- Best Choice for every Laboratory','','inherit','closed','closed','','4185-revision-v1','','','2020-01-09 11:48:34','2020-01-09 11:48:34','',4185,'https://microbiozindia.com/uncategorized/4185-revision-v1/',0,'revision','',0),(4192,2,'2020-01-09 16:19:50','2020-01-09 16:19:50','The DrySyn Scholar Kit from Asynt has been designed to meet, without compromise, the safety requirements required in academic laboratories for the heating and stirring of round bottom flasks, whilst maintaining ease of set up and use.\r\n\r\nThe DrySyn Scholar combines robustness, affordability and enhanced operator safety features making it the ultimate \'student friendly\' heating block system.\r\n<img class=\"alignnone  wp-image-4194\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/asyntpr101-imageA-300x225.jpg\" alt=\"\" width=\"323\" height=\"242\" />\r\nSpecifically designed for safety conscious teaching laboratories - the DrySyn Scholar kit enables the heating of single 100 mL and 250 mL round bottom flasks, without the mess or inherent safety hazards of a hot oil bath or heating mantle.  Prominent lifting handles ensure moving even hot reaction blocks is easy, fast and safe. Options are available to further expand the use of the DrySyn Scholar base for reactions in 25 mL and 50 mL flasks.\r\n\r\nCompatible with almost any magnetic hotplate stirrer, thanks to a set of adjustable feet, the low thermal mass design of the DrySyn Scholar delivers fast heating and low power consumption while maintaining accurate and precise temperature control.\r\n\r\nTo watch a video introduction to the DrySyn Scholar please visit <a href=\"https://www.youtube.com/watch?v=QBPiO98Priw\">https://www.youtube.com/watch?v=QBPiO98Priw</a><u>.</u> For further information\r\nplease visit <a href=\"https://www.asynt.com/product/integrity-10-high-pressure-module/\">https://www.asynt.com/product/drysyn-scholar/</a> or contact Asynt on +44-1638-781709 / <a href=\"mailto:enquiries@asynt.com\">enquiries@asynt.com</a>.','Laboratory Scale Kit for Safe Heating of Round Bottom Flasks','','publish','open','open','','laboratory-scale-kit-for-safe-heating-of-round-bottom-flasks','','','2020-01-09 16:19:50','2020-01-09 16:19:50','',0,'https://microbiozindia.com/?p=4192',0,'post','',0),(4193,2,'2020-01-09 16:18:29','2020-01-09 16:18:29','','ASYNT','','inherit','open','closed','','asynt','','','2020-01-09 16:18:29','2020-01-09 16:18:29','',4192,'https://microbiozindia.com/wp-content/uploads/2020/01/ASYNT.png',0,'attachment','image/png',0),(4194,2,'2020-01-09 16:18:31','2020-01-09 16:18:31','','asyntpr101-imageA','','inherit','open','closed','','asyntpr101-imagea','','','2020-01-09 16:18:31','2020-01-09 16:18:31','',4192,'https://microbiozindia.com/wp-content/uploads/2020/01/asyntpr101-imageA.jpg',0,'attachment','image/jpeg',0),(4195,2,'2020-01-09 16:19:50','2020-01-09 16:19:50','The DrySyn Scholar Kit from Asynt has been designed to meet, without compromise, the safety requirements required in academic laboratories for the heating and stirring of round bottom flasks, whilst maintaining ease of set up and use.\r\n\r\nThe DrySyn Scholar combines robustness, affordability and enhanced operator safety features making it the ultimate \'student friendly\' heating block system.\r\n<img class=\"alignnone  wp-image-4194\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/asyntpr101-imageA-300x225.jpg\" alt=\"\" width=\"323\" height=\"242\" />\r\nSpecifically designed for safety conscious teaching laboratories - the DrySyn Scholar kit enables the heating of single 100 mL and 250 mL round bottom flasks, without the mess or inherent safety hazards of a hot oil bath or heating mantle.  Prominent lifting handles ensure moving even hot reaction blocks is easy, fast and safe. Options are available to further expand the use of the DrySyn Scholar base for reactions in 25 mL and 50 mL flasks.\r\n\r\nCompatible with almost any magnetic hotplate stirrer, thanks to a set of adjustable feet, the low thermal mass design of the DrySyn Scholar delivers fast heating and low power consumption while maintaining accurate and precise temperature control.\r\n\r\nTo watch a video introduction to the DrySyn Scholar please visit <a href=\"https://www.youtube.com/watch?v=QBPiO98Priw\">https://www.youtube.com/watch?v=QBPiO98Priw</a><u>.</u> For further information\r\nplease visit <a href=\"https://www.asynt.com/product/integrity-10-high-pressure-module/\">https://www.asynt.com/product/drysyn-scholar/</a> or contact Asynt on +44-1638-781709 / <a href=\"mailto:enquiries@asynt.com\">enquiries@asynt.com</a>.','Laboratory Scale Kit for Safe Heating of Round Bottom Flasks','','inherit','closed','closed','','4192-revision-v1','','','2020-01-09 16:19:50','2020-01-09 16:19:50','',4192,'https://microbiozindia.com/uncategorized/4192-revision-v1/',0,'revision','',0),(4196,2,'2020-01-10 10:11:35','2020-01-10 10:11:35','FLIR Systems patented MSX® (Multi-Spectral Dynamic Imaging) technology adds visible light details to thermal images in real time delivering greater clarity, embedding edge and outline detail onto thermal readings. Based on FLIR’s unique onboard processor, this innovative technology uses an internal digital camera to enhance thermal images in real time.\r\n\r\nKey details apparent to the naked eye can sometimes get lost in a regular thermal image, requiring a separate digital photo to reference the location of the thermal issue being investigated. A regular thermal image only displays heat signatures, which can cause details to get lost in the haze if they represent a similar temperature. To overcome this, FLIR thermal cameras with MSX® technology use an internal digital camera to enhance the thermal image.\r\n\r\nMSX® uses a high-contrast visual image to emboss key aspects of the scene on top of a full thermal image. Unlike image fusing (merging of a visible light and thermal image), MSX® does not dilute the thermal image or decrease thermal transparency.\r\n\r\nMSX® technology ensures easier target identification without compromising radiometric data thereby ensuring the quality of your thermal images is routinely excellent.\r\n\r\nFLIR Systems T530 and T540 thermal imaging cameras are designed to support advanced thermographers and IR service consultants by focusing on resolution, speed, and ergonomics. With the 180° rotating optical block, vibrant LCD display, and streamlined form factor, the T500-Series offers inspectors the necessary tools to support comprehensive inspections in challenging conditions, especially when equipment is obstructed from view or difficult to access.\r\n\r\nFor further information on the T-500 series cameras with FLIR’s MSX® (Multi-Spectral Dynamic Imaging) technology please visit <a href=\"https://www.flir.co.uk/discover/professional-tools/what-is-msx/\">https://www.flir.co.uk/discover/professional-tools/what-is-msx/</a> or contact FLIR Systems on <a href=\"mailto:research@flir.com\">research@flir.com</a> or +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems’ vision is to be “The World’s Sixth Sense,” creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit <a href=\"https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.flir.com%2F&amp;data=02%7C01%7Cjessica.pratten%40ioppublishing.org%7C5fb1e88b230c472e047808d6f87aec51%7Cf9ee42e6bad04e639115f704f9ccceed%7C0%7C0%7C636969604162461222&amp;sdata=3K3yIvZFFvmSa6WQDPqaFK7tM6rUE60uthkyaamdon4%3D&amp;reserved=0\">www.flir.com</a> and follow <a href=\"https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2Fflir%3Fref_src%3Dtwsrc%255Egoogle%257Ctwcamp%255Eserp%257Ctwgr%255Eauthor&amp;data=02%7C01%7Cjessica.pratten%40ioppublishing.org%7C5fb1e88b230c472e047808d6f87aec51%7Cf9ee42e6bad04e639115f704f9ccceed%7C0%7C0%7C636969604162471214&amp;sdata=1yx1qe4%2FeD%2FcNnyC8i2JsuW7bXv%2BaaF69ZARnNnjCck%3D&amp;reserved=0\">@flir.</a>\r\n\r\n&nbsp;','Innovative Multi-Spectral Dynamic Imaging Enhances Thermal Inspection','','publish','open','open','','innovative-multi-spectral-dynamic-imaging-enhances-thermal-inspection','','','2020-01-10 10:13:28','2020-01-10 10:13:28','',0,'https://microbiozindia.com/?p=4196',0,'post','',0),(4197,2,'2020-01-10 10:11:19','2020-01-10 10:11:19','','ddd','','inherit','open','closed','','ddd','','','2020-01-10 10:11:19','2020-01-10 10:11:19','',4196,'https://microbiozindia.com/wp-content/uploads/2020/01/ddd.png',0,'attachment','image/png',0),(4198,2,'2020-01-10 10:11:35','2020-01-10 10:11:35','FLIR Systems patented MSX® (Multi-Spectral Dynamic Imaging) technology adds visible light details to thermal images in real time delivering greater clarity, embedding edge and outline detail onto thermal readings. Based on FLIR’s unique onboard processor, this innovative technology uses an internal digital camera to enhance thermal images in real time.\r\n\r\nKey details apparent to the naked eye can sometimes get lost in a regular thermal image, requiring a separate digital photo to reference the location of the thermal issue being investigated. A regular thermal image only displays heat signatures, which can cause details to get lost in the haze if they represent a similar temperature. To overcome this, FLIR thermal cameras with MSX® technology use an internal digital camera to enhance the thermal image.\r\n\r\nMSX® uses a high-contrast visual image to emboss key aspects of the scene on top of a full thermal image. Unlike image fusing (merging of a visible light and thermal image), MSX® does not dilute the thermal image or decrease thermal transparency.\r\n\r\nMSX® technology ensures easier target identification without compromising radiometric data thereby ensuring the quality of your thermal images is routinely excellent.\r\n\r\nFLIR Systems T530 and T540 thermal imaging cameras are designed to support advanced thermographers and IR service consultants by focusing on resolution, speed, and ergonomics. With the 180° rotating optical block, vibrant LCD display, and streamlined form factor, the T500-Series offers inspectors the necessary tools to support comprehensive inspections in challenging conditions, especially when equipment is obstructed from view or difficult to access.\r\n\r\nFor further information on the T-500 series cameras with FLIR’s MSX® (Multi-Spectral Dynamic Imaging) technology please visit <a href=\"https://www.flir.co.uk/discover/professional-tools/what-is-msx/\">https://www.flir.co.uk/discover/professional-tools/what-is-msx/</a> or contact FLIR Systems on <a href=\"mailto:research@flir.com\">research@flir.com</a> or +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems’ vision is to be “The World’s Sixth Sense,” creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit <a href=\"https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.flir.com%2F&amp;data=02%7C01%7Cjessica.pratten%40ioppublishing.org%7C5fb1e88b230c472e047808d6f87aec51%7Cf9ee42e6bad04e639115f704f9ccceed%7C0%7C0%7C636969604162461222&amp;sdata=3K3yIvZFFvmSa6WQDPqaFK7tM6rUE60uthkyaamdon4%3D&amp;reserved=0\">www.flir.com</a> and follow <a href=\"https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2Fflir%3Fref_src%3Dtwsrc%255Egoogle%257Ctwcamp%255Eserp%257Ctwgr%255Eauthor&amp;data=02%7C01%7Cjessica.pratten%40ioppublishing.org%7C5fb1e88b230c472e047808d6f87aec51%7Cf9ee42e6bad04e639115f704f9ccceed%7C0%7C0%7C636969604162471214&amp;sdata=1yx1qe4%2FeD%2FcNnyC8i2JsuW7bXv%2BaaF69ZARnNnjCck%3D&amp;reserved=0\">@flir.</a>\r\n\r\n&nbsp;','Innovative Multi-Spectral Dynamic Imaging Enhances Thermal Inspection','','inherit','closed','closed','','4196-revision-v1','','','2020-01-10 10:11:35','2020-01-10 10:11:35','',4196,'https://microbiozindia.com/uncategorized/4196-revision-v1/',0,'revision','',0),(4199,2,'2020-01-14 12:06:46','2020-01-14 12:06:46','The new UltraVap Mistral XT 150 from Porvair Sciences provides unmatched automated dry down of organic solvent-based samples in tubes and microplates up to 150mm in length.\r\n\r\nDesigned for easy integration with linear laboratory robots, the UltraVap Mistral XT 150 uses a sample shuttle which can serve and retrieve long tubes or microplates from the deck of Perkin Elmer, Tecan, Hamilton, and Beckman liquid handlers. Controlled via an intuitive colour touchscreen, the UltraVap Mistral 150 accepts tubes up to 150mm in length and comes complete with clear safety side screens and full integral fume management within the unit.\r\n\r\nProven to remove the traditional laboratory ‘bottleneck’ of solvent removal, the UltraVap Mistral XT 150 offers significant throughput advantages to laboratories looking to optimise sample preparation of single microplates or smaller numbers of tubes.\r\n\r\nInstallation of the UltraVap Mistral XT 150 requires only connection to a gas supply and mains electricity. Safety of solvent removal operation is ensured as this compact CE marked unit fits into all fume cupboards.\r\n\r\nFor further information on the UltraVap Mistral XT 150 visit <a href=\"http://www.microplates.com/blowdown-evaporator-ultravap-mistral/\">www.microplates.com/blowdown-evaporator-ultravap-mistral/</a>  or contact Porvair Sciences on +44-1978-666222 / <a href=\"mailto:int.sales@porvairsciences.com\">int.sales@porvairsciences.com</a>.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.\r\n\r\n<strong>\r\nPorvair Sciences Ltd\r\n</strong>Clywedog Rd South\r\nWrexham Industrial Estate\r\nWales LL13 9XS\r\nUK\r\nTel:     +44 1978 661144\r\n\r\nEmail: <a href=\"mailto:int.sales@porvair-sciences.com\">int.sales@porvair-sciences.com</a>\r\nWeb    <a href=\"http://www.porvair-sciences.com/\">www.porvair-sciences.com</a>\r\n\r\n&nbsp;','Robot Compatible Solvent Removal Workstation','','publish','open','open','','robot-compatible-solvent-removal-workstation','','','2020-01-14 12:06:46','2020-01-14 12:06:46','',0,'https://microbiozindia.com/?p=4199',0,'post','',0),(4200,2,'2020-01-14 12:06:09','2020-01-14 12:06:09','','AA','','inherit','open','closed','','aa','','','2020-01-14 12:06:09','2020-01-14 12:06:09','',4199,'https://microbiozindia.com/wp-content/uploads/2020/01/AA.png',0,'attachment','image/png',0),(4201,2,'2020-01-14 12:06:46','2020-01-14 12:06:46','The new UltraVap Mistral XT 150 from Porvair Sciences provides unmatched automated dry down of organic solvent-based samples in tubes and microplates up to 150mm in length.\r\n\r\nDesigned for easy integration with linear laboratory robots, the UltraVap Mistral XT 150 uses a sample shuttle which can serve and retrieve long tubes or microplates from the deck of Perkin Elmer, Tecan, Hamilton, and Beckman liquid handlers. Controlled via an intuitive colour touchscreen, the UltraVap Mistral 150 accepts tubes up to 150mm in length and comes complete with clear safety side screens and full integral fume management within the unit.\r\n\r\nProven to remove the traditional laboratory ‘bottleneck’ of solvent removal, the UltraVap Mistral XT 150 offers significant throughput advantages to laboratories looking to optimise sample preparation of single microplates or smaller numbers of tubes.\r\n\r\nInstallation of the UltraVap Mistral XT 150 requires only connection to a gas supply and mains electricity. Safety of solvent removal operation is ensured as this compact CE marked unit fits into all fume cupboards.\r\n\r\nFor further information on the UltraVap Mistral XT 150 visit <a href=\"http://www.microplates.com/blowdown-evaporator-ultravap-mistral/\">www.microplates.com/blowdown-evaporator-ultravap-mistral/</a>  or contact Porvair Sciences on +44-1978-666222 / <a href=\"mailto:int.sales@porvairsciences.com\">int.sales@porvairsciences.com</a>.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.\r\n\r\n<strong>\r\nPorvair Sciences Ltd\r\n</strong>Clywedog Rd South\r\nWrexham Industrial Estate\r\nWales LL13 9XS\r\nUK\r\nTel:     +44 1978 661144\r\n\r\nEmail: <a href=\"mailto:int.sales@porvair-sciences.com\">int.sales@porvair-sciences.com</a>\r\nWeb    <a href=\"http://www.porvair-sciences.com/\">www.porvair-sciences.com</a>\r\n\r\n&nbsp;','Robot Compatible Solvent Removal Workstation','','inherit','closed','closed','','4199-revision-v1','','','2020-01-14 12:06:46','2020-01-14 12:06:46','',4199,'https://microbiozindia.com/uncategorized/4199-revision-v1/',0,'revision','',0),(4202,2,'2020-01-15 10:06:21','2020-01-15 10:06:21','Specialised Imaging reports that the Institute of Heat and Mass Transfer at RWTH Aachen University (Germany) has invested in a Kirana Ultra High-Speed camera to undertake fundamental research that underpins the development of bio-hybrid fuels for the next generation of sustainable transportation.\r\n\r\nGroundbreaking research at the University of Aachen Fuel Science Center (FSC) aims to develop high-density liquid energy carriers (“bio-hybrid fuels”), for highly efficient and clean combustion engine concepts. The FSC is also investigating the fundamental processes behind the electro-catalytic production of renewable fuels for automotive engines as this technology is an important enabler for the development of these next generation energy carriers.\r\n\r\nThe researchers intend to use the Kirana Ultra High-Speed camera to visualize the transient processes behind the electro-catalytic injection, mixture formation and combustion of bio-hybrid fuels.\r\n\r\nConventional high-speed imaging techniques are already well-established in automotive fuel combustion research, but are not able to resolve very fast processes such as spray fluctuations or the injector opening in high spatial resolution, as the fuel leaving the nozzle can travel at many hundreds of metres per second.\r\n\r\nThe Kirana Ultra High-Speed camera from Specialised Imaging sets a new standard for what is possible, being able to take 180 consecutive high quality images at frame rates of up to 5 MHz.\r\n\r\nThe full resolution of the Kirana camera is maintained independently of its frame rate, enabling it to acheive high spatial and temporal resolution at the same time.\r\n\r\nThe compact Kirana ultra high speed video camera can deliver high resolution and high speed (up to 5 million frames per second) in a no-compromise design. The full resolution of this video camera is maintained at all speeds. Comprehensive triggering facilities, highly accurate timing control and a wide range of output signals, coupled with a software package, simplifies image capture and analysis. Full remote operation using Ethernet connectivity comes standard enabling the Kirana to be easily integrated into almost any environment. The Kirana offers the performance, ease-of-use and operational flexibility that enables users to record and deliver impressive slow-motion video images in just about any material scientific research application.\r\n\r\nFor further information on the Kirana ultra high speed camera please visit <a href=\"https://www.specialised-imaging.com/products/video-cameras/kirana\">www.specialised-imaging.com/products/video-cameras/kirana</a> or contact Specialised Imaging on +44-1442-827728 (UK) / +1-951-296-6406 (USA) / +49-8141-666-8950 (Germany) / +86-1068-651-769 (China) / <a href=\"mailto:info@specialised-imaging.com\">info@specialised-imaging.com</a>.\r\n\r\nFor further information on the work of the FSC at RWTH Aachen University please visit <a href=\"https://www.wsa.rwth-aachen.de/cms/WSA/Forschung/Forschungsprojekte/~scpu/DFG-EXC2186-FSC/lidx/1/\">www.wsa.rwth-aachen.de/cms/WSA/Forschung/Forschungsprojekte/~scpu/DFG-EXC2186-FSC/lidx/1/</a>.\r\n\r\nSpecialised Imaging is a knowledgeable, dynamic company focused upon design, manufacture, service and supply of ultra high-speed imaging systems and components for industrial, defence and scientific applications.  The company\'s continuing policy is to invest in the development of innovative imaging solutions, incorporate the latest technological advances and use improved components wherever possible. A total commitment to quality and a thorough understanding of applications are held as the keys  to the future.','High Speed Camera Advances Bio-Hybrid Fuel Research','','publish','open','open','','high-speed-camera-advances-bio-hybrid-fuel-research','','','2020-01-15 10:06:21','2020-01-15 10:06:21','',0,'https://microbiozindia.com/?p=4202',0,'post','',0),(4203,2,'2020-01-15 10:06:03','2020-01-15 10:06:03','','AAA','','inherit','open','closed','','aaa-3','','','2020-01-15 10:06:03','2020-01-15 10:06:03','',4202,'https://microbiozindia.com/wp-content/uploads/2020/01/AAA-1.png',0,'attachment','image/png',0),(4204,2,'2020-01-15 10:06:21','2020-01-15 10:06:21','Specialised Imaging reports that the Institute of Heat and Mass Transfer at RWTH Aachen University (Germany) has invested in a Kirana Ultra High-Speed camera to undertake fundamental research that underpins the development of bio-hybrid fuels for the next generation of sustainable transportation.\r\n\r\nGroundbreaking research at the University of Aachen Fuel Science Center (FSC) aims to develop high-density liquid energy carriers (“bio-hybrid fuels”), for highly efficient and clean combustion engine concepts. The FSC is also investigating the fundamental processes behind the electro-catalytic production of renewable fuels for automotive engines as this technology is an important enabler for the development of these next generation energy carriers.\r\n\r\nThe researchers intend to use the Kirana Ultra High-Speed camera to visualize the transient processes behind the electro-catalytic injection, mixture formation and combustion of bio-hybrid fuels.\r\n\r\nConventional high-speed imaging techniques are already well-established in automotive fuel combustion research, but are not able to resolve very fast processes such as spray fluctuations or the injector opening in high spatial resolution, as the fuel leaving the nozzle can travel at many hundreds of metres per second.\r\n\r\nThe Kirana Ultra High-Speed camera from Specialised Imaging sets a new standard for what is possible, being able to take 180 consecutive high quality images at frame rates of up to 5 MHz.\r\n\r\nThe full resolution of the Kirana camera is maintained independently of its frame rate, enabling it to acheive high spatial and temporal resolution at the same time.\r\n\r\nThe compact Kirana ultra high speed video camera can deliver high resolution and high speed (up to 5 million frames per second) in a no-compromise design. The full resolution of this video camera is maintained at all speeds. Comprehensive triggering facilities, highly accurate timing control and a wide range of output signals, coupled with a software package, simplifies image capture and analysis. Full remote operation using Ethernet connectivity comes standard enabling the Kirana to be easily integrated into almost any environment. The Kirana offers the performance, ease-of-use and operational flexibility that enables users to record and deliver impressive slow-motion video images in just about any material scientific research application.\r\n\r\nFor further information on the Kirana ultra high speed camera please visit <a href=\"https://www.specialised-imaging.com/products/video-cameras/kirana\">www.specialised-imaging.com/products/video-cameras/kirana</a> or contact Specialised Imaging on +44-1442-827728 (UK) / +1-951-296-6406 (USA) / +49-8141-666-8950 (Germany) / +86-1068-651-769 (China) / <a href=\"mailto:info@specialised-imaging.com\">info@specialised-imaging.com</a>.\r\n\r\nFor further information on the work of the FSC at RWTH Aachen University please visit <a href=\"https://www.wsa.rwth-aachen.de/cms/WSA/Forschung/Forschungsprojekte/~scpu/DFG-EXC2186-FSC/lidx/1/\">www.wsa.rwth-aachen.de/cms/WSA/Forschung/Forschungsprojekte/~scpu/DFG-EXC2186-FSC/lidx/1/</a>.\r\n\r\nSpecialised Imaging is a knowledgeable, dynamic company focused upon design, manufacture, service and supply of ultra high-speed imaging systems and components for industrial, defence and scientific applications.  The company\'s continuing policy is to invest in the development of innovative imaging solutions, incorporate the latest technological advances and use improved components wherever possible. A total commitment to quality and a thorough understanding of applications are held as the keys  to the future.','High Speed Camera Advances Bio-Hybrid Fuel Research','','inherit','closed','closed','','4202-revision-v1','','','2020-01-15 10:06:21','2020-01-15 10:06:21','',4202,'https://microbiozindia.com/uncategorized/4202-revision-v1/',0,'revision','',0),(4205,2,'2020-01-16 11:13:11','2020-01-16 11:13:11','World Association for Small and Medium Enterprises (WASME) is a global non-profit organization, that has been spearheading the cause and development of Small and Medium Enterprises (SMEs) world over since its inception in 1980.\r\n\r\nWarehousing and logistics are crucial factors for companies to gain a competitive edge. With the advent of modern manufacturing, which combines smart and effective products with advanced and innovative technologies, the very definition of warehousing and logistics has evolved to a much larger and integral concept.\r\n\r\nGandhi Automations range of Entrance Automation and Loading bay range of products have changed the evolution in traditional warehousing powered by advanced engineering technology that is not only impacting logistics but the supply chain as a whole. Thus, Gandhi Automations Pvt Ltd once again bags the INNOVATION AWARD for advanced tech innovation as the logistics and manufacturing sectors move beyond the rudimentary manual operations in the supply chain.\r\n\r\nGandhi Automations has successfully evolved into an innovative company catering to all kinds of needs. We have an extremely talented in-house research and development team which designs customized solutions for our customers. Our product engineering team uses the latest software in combination with technologically advanced machinery to provide our customers with an unmatched experience in entrance automation and loading bay equipment\r\n\r\nWe have made significant improvisations and innovations to our loading bay equipment range of products as well as high speed doors. Our new Forklift Roll-off Barrier lip Dock Leveler, Prime Cold Reset, High Speed Doors- Prime Reset, High Speed Doors- Prime Internal Doors, Industrial Sectional Overhead Doors, Dock Levelers, and Isotherm Rolling Shutters are some of the most fast moving innovations and products that have changed the landscape of logistics and warehousing automation.\r\n\r\nQuality is a key driver of progress for us and is an integral part of every process we undertake, from R&amp;D to product delivery. Our quality policies are constantly upgraded to exceed our customer’s requirements and expectations. Gandhi Automations is committed to delivering high-quality products and services to its customers and continuously strives to improve in all aspects. Our products and services are geared towards ensuring that every delivery to the client passes through our stringent quality measures. This policy has engendered a work culture that exhibits a no-compromise attitude towards quality.\r\n\r\nGandhi Automations is known for its research and development, quality and commitment towards customers. The material handling industry is responding with new equipment, technology, and systems that enable complete supply chain visibility, thus allowing customers to see how their investments are impacting their overall operation. The demand for material handling automation and equipment has increased exponentially over the past few years. It is because of the increasing production capacity, reducing man hours and meeting deadlines. Now with more and more companies streamlining their processes, use of material handling equipment for any industry is a must. Demand for such automation is the need for the hour; and also, to deliver faster, hassle free loading / unloading functions to reduce supply chain operating costs.\r\n\r\nTo know more about Gandhi Automations products, visit: www.geapl.co.in','State Health Minister presents WASME Award of Warehouse & Logistic Innovation Award to Gandhi Automations','','publish','open','open','','state-health-minister-presents-wasme-award-of-warehouse-logistic-innovation-award-to-gandhi-automations','','','2020-01-16 11:13:11','2020-01-16 11:13:11','',0,'https://microbiozindia.com/?p=4205',0,'post','',0),(4206,2,'2020-01-16 11:12:55','2020-01-16 11:12:55','','AA','','inherit','open','closed','','aa-2','','','2020-01-16 11:12:55','2020-01-16 11:12:55','',4205,'https://microbiozindia.com/wp-content/uploads/2020/01/AA-1.png',0,'attachment','image/png',0),(4207,2,'2020-01-16 11:13:11','2020-01-16 11:13:11','World Association for Small and Medium Enterprises (WASME) is a global non-profit organization, that has been spearheading the cause and development of Small and Medium Enterprises (SMEs) world over since its inception in 1980.\r\n\r\nWarehousing and logistics are crucial factors for companies to gain a competitive edge. With the advent of modern manufacturing, which combines smart and effective products with advanced and innovative technologies, the very definition of warehousing and logistics has evolved to a much larger and integral concept.\r\n\r\nGandhi Automations range of Entrance Automation and Loading bay range of products have changed the evolution in traditional warehousing powered by advanced engineering technology that is not only impacting logistics but the supply chain as a whole. Thus, Gandhi Automations Pvt Ltd once again bags the INNOVATION AWARD for advanced tech innovation as the logistics and manufacturing sectors move beyond the rudimentary manual operations in the supply chain.\r\n\r\nGandhi Automations has successfully evolved into an innovative company catering to all kinds of needs. We have an extremely talented in-house research and development team which designs customized solutions for our customers. Our product engineering team uses the latest software in combination with technologically advanced machinery to provide our customers with an unmatched experience in entrance automation and loading bay equipment\r\n\r\nWe have made significant improvisations and innovations to our loading bay equipment range of products as well as high speed doors. Our new Forklift Roll-off Barrier lip Dock Leveler, Prime Cold Reset, High Speed Doors- Prime Reset, High Speed Doors- Prime Internal Doors, Industrial Sectional Overhead Doors, Dock Levelers, and Isotherm Rolling Shutters are some of the most fast moving innovations and products that have changed the landscape of logistics and warehousing automation.\r\n\r\nQuality is a key driver of progress for us and is an integral part of every process we undertake, from R&amp;D to product delivery. Our quality policies are constantly upgraded to exceed our customer’s requirements and expectations. Gandhi Automations is committed to delivering high-quality products and services to its customers and continuously strives to improve in all aspects. Our products and services are geared towards ensuring that every delivery to the client passes through our stringent quality measures. This policy has engendered a work culture that exhibits a no-compromise attitude towards quality.\r\n\r\nGandhi Automations is known for its research and development, quality and commitment towards customers. The material handling industry is responding with new equipment, technology, and systems that enable complete supply chain visibility, thus allowing customers to see how their investments are impacting their overall operation. The demand for material handling automation and equipment has increased exponentially over the past few years. It is because of the increasing production capacity, reducing man hours and meeting deadlines. Now with more and more companies streamlining their processes, use of material handling equipment for any industry is a must. Demand for such automation is the need for the hour; and also, to deliver faster, hassle free loading / unloading functions to reduce supply chain operating costs.\r\n\r\nTo know more about Gandhi Automations products, visit: www.geapl.co.in','State Health Minister presents WASME Award of Warehouse & Logistic Innovation Award to Gandhi Automations','','inherit','closed','closed','','4205-revision-v1','','','2020-01-16 11:13:11','2020-01-16 11:13:11','',4205,'https://microbiozindia.com/uncategorized/4205-revision-v1/',0,'revision','',0),(4208,2,'2020-01-16 13:17:30','2020-01-16 13:17:30','','dd','','inherit','open','closed','','dd','','','2020-01-16 13:17:30','2020-01-16 13:17:30','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/dd.png',0,'attachment','image/png',0),(4209,2,'2020-01-16 13:23:37','2020-01-16 13:23:37','','BVHBCVHGCH,,','','inherit','open','closed','','bvhbcvhgch','','','2020-01-16 13:23:37','2020-01-16 13:23:37','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/BVHBCVHGCH.png',0,'attachment','image/png',0),(4210,2,'2020-01-16 13:25:04','2020-01-16 13:25:04','','BVHBCVHGCHvvv','','inherit','open','closed','','bvhbcvhgchvvv','','','2020-01-16 13:25:04','2020-01-16 13:25:04','',0,'https://microbiozindia.com/wp-content/uploads/2019/12/BVHBCVHGCHvvv.png',0,'attachment','image/png',0),(4211,2,'2020-01-21 10:22:16','2020-01-21 10:22:16','An informative white paper from Postnova Analytics demonstrates how its novel Electrical and Asymmetrical Field Flow Fractionation (EAF4) technology can be used to separate a wide variety of nano-sized materials while simultaneously determining surface charge.\r\n\r\nDrawing upon this proprietary technology, the Postnova Analytics EAF2000 is the only field-proven system that combines the principle of Electrical and Asymmetrical Field Flow Fractionation in a single platform. In an EAF2000 system, Electrical and Cross Flow Fields are applied together across the FFF channel enabling separation by size and simultaneous measurement of particle charge based on electrophoretic mobility. Combining these two powerful separation techniques in a single platform opens the door to characterizing complex samples that have proven impossible using other techniques.\r\n<img class=\"alignnone wp-image-4213\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/postnovapr37-imageB-300x164.jpg\" alt=\"\" width=\"391\" height=\"214\" />\r\nWith installed systems in leading academic and government research institutions as well as major pharmaceutical laboratories in Asia, Europe and North America - Postnova Analytics\' pioneering EAF2000 system is proven to separate and characterize complex proteins, antibodies and viruses as well as charged nanoparticles, colloids and polymers.\r\n\r\nWhile traditional Flow Field Flow Fractionation instruments are well known to provide particle size or molar mass distribution data, using an EAF2000 system allows identifying charge heterogeneities which might be present inside the different size and molar mass fractions. As particle or molecule charge plays a large role in many applications, including protein aggregation, polymer flocculation, and particle agglomeration, the EAF2000 opens completely new ways for a significantly better understanding of these phenomena and will quickly help to establish more efficient product development and QC processes.\r\n\r\nFor a copy of the white paper please visit <a href=\"https://info.postnova.com/electrical-asymmetrical-flow-field-flow-fractionation/\">https://info.postnova.com/electrical-asymmetrical-flow-field-flow-fractionation/</a> or contact Postnova Analytics on +49-8191-985-6880 / +44-1885-475007 / +1-801-521-2004 or <a href=\"mailto:info@postnova.com\">info@postnova.com</a>.\r\n\r\nFounded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company\'s growing product portfolio also includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS.  Postnova (<a href=\"http://www.postnova.com\">www.postnova.com</a>) is located and headquartered in Landsberg am Lech (Germany) and has subsidiaries in the USA, UK and Finland. These offices, in conjunction with a highly qualified and trained distribution network, provide informed local support to customers worldwide.\r\n\r\n<em>Image captions:  A: EAF2000 system ; B: Separation of a two-particle polystyrene mixture and determination of their electrophoretic mobility</em>\r\n\r\nFor more information:\r\n\r\n<strong>Postnova Analytics GmbH</strong>\r\n\r\nMax-Planck-Straße 14\r\n86899 Landsberg am Lech\r\n\r\nGermany\r\n\r\nTel:     +49-8191-985-6880\r\n\r\nEmail: <a href=\"mailto:info@postnova.com\">info@postnova.com</a>\r\nWeb    <a href=\"http://www.postnova.com/\">www.postnova.com</a>','White Paper Demonstrates Benefits of Electrical Asymmetrical Field Flow Fractionation','','publish','open','open','','white-paper-demonstrates-benefits-of-electrical-asymmetrical-field-flow-fractionation','','','2020-01-21 10:23:22','2020-01-21 10:23:22','',0,'https://microbiozindia.com/?p=4211',0,'post','',0),(4212,2,'2020-01-21 10:18:05','2020-01-21 10:18:05','','ggg','','inherit','open','closed','','ggg','','','2020-01-21 10:18:05','2020-01-21 10:18:05','',4211,'https://microbiozindia.com/wp-content/uploads/2020/01/ggg.png',0,'attachment','image/png',0),(4213,2,'2020-01-21 10:18:06','2020-01-21 10:18:06','','postnovapr37-imageB','','inherit','open','closed','','postnovapr37-imageb','','','2020-01-21 10:18:06','2020-01-21 10:18:06','',4211,'https://microbiozindia.com/wp-content/uploads/2020/01/postnovapr37-imageB.jpg',0,'attachment','image/jpeg',0),(4214,2,'2020-01-21 10:22:16','2020-01-21 10:22:16','An informative white paper from Postnova Analytics demonstrates how its novel Electrical and Asymmetrical Field Flow Fractionation (EAF4) technology can be used to separate a wide variety of nano-sized materials while simultaneously determining surface charge.\r\n\r\nDrawing upon this proprietary technology, the Postnova Analytics EAF2000 is the only field-proven system that combines the principle of Electrical and Asymmetrical Field Flow Fractionation in a single platform. In an EAF2000 system, Electrical and Cross Flow Fields are applied together across the FFF channel enabling separation by size and simultaneous measurement of particle charge based on electrophoretic mobility. Combining these two powerful separation techniques in a single platform opens the door to characterizing complex samples that have proven impossible using other techniques.\r\n<img class=\"alignnone  wp-image-4213\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/postnovapr37-imageB-300x164.jpg\" alt=\"\" width=\"391\" height=\"214\" />\r\nWith installed systems in leading academic and government research institutions as well as major pharmaceutical laboratories in Asia, Europe and North America - Postnova Analytics\' pioneering EAF2000 system is proven to separate and characterize complex proteins, antibodies and viruses as well as charged nanoparticles, colloids and polymers.\r\n\r\nWhile traditional Flow Field Flow Fractionation instruments are well known to provide particle size or molar mass distribution data, using an EAF2000 system allows identifying charge heterogeneities which might be present inside the different size and molar mass fractions. As particle or molecule charge plays a large role in many applications, including protein aggregation, polymer flocculation, and particle agglomeration, the EAF2000 opens completely new ways for a significantly better understanding of these phenomena and will quickly help to establish more efficient product development and QC processes.\r\n\r\nFor a copy of the white paper please visit <a href=\"https://info.postnova.com/electrical-asymmetrical-flow-field-flow-fractionation/\">https://info.postnova.com/electrical-asymmetrical-flow-field-flow-fractionation/</a> or contact Postnova Analytics on +49-8191-985-6880 / +44-1885-475007 / +1-801-521-2004 or <a href=\"mailto:info@postnova.com\">info@postnova.com</a>.\r\n\r\nFounded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company\'s growing product portfolio also includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS.  Postnova (<a href=\"http://www.postnova.com\">www.postnova.com</a>) is located and headquartered in Landsberg am Lech (Germany) and has subsidiaries in the USA, UK and Finland. These offices, in conjunction with a highly qualified and trained distribution network, provide informed local support to customers worldwide.\r\n\r\n<em>Image captions:  A: EAF2000 system ; B: Separation of a two-particle polystyrene mixture and determination of their electrophoretic mobility</em>\r\n\r\nFor more information:\r\n\r\n<strong>Postnova Analytics GmbH</strong>\r\n\r\nMax-Planck-Straße 14\r\n86899 Landsberg am Lech\r\n\r\nGermany\r\n\r\nTel:     +49-8191-985-6880\r\n\r\nEmail: <a href=\"mailto:info@postnova.com\">info@postnova.com</a>\r\nWeb    <a href=\"http://www.postnova.com/\">www.postnova.com</a>','White Paper Demonstrates Benefits of Electrical Asymmetrical Field Flow Fractionation','','inherit','closed','closed','','4211-revision-v1','','','2020-01-21 10:22:16','2020-01-21 10:22:16','',4211,'https://microbiozindia.com/uncategorized/4211-revision-v1/',0,'revision','',0),(4215,2,'2020-01-25 23:28:21','2020-01-25 23:28:21','Coronaviruses are a group of viruses that cause diseases in mammals and birds that include diarrhea in cows and pigs, and upper respiratory disease in chickens. The virus mainly causes infection in your nose, <a href=\"https://www.webmd.com/allergies/picture-of-the-sinuses\">sinuses</a>, or upper throat. Most coronaviruses are not dangerous. Some types of them are serious, though.\r\n\r\nThe country is facing a \"grave situation\" Mr <strong>Xi Jinping </strong>told senior officials.\r\n\r\nAccording to sources the coronavirus has killed at least 42 people and infected some 1,400 since its discovery in the city of Wuhan. Meanwhile, UK-based researchers have warned of a real possibility that China will not be able to contain the virus.\r\n\r\nThe virus is spreading from China to rest of the world, Dr. Om Srivastava, Infectious Disease specialist said that, “It is too early to say whether the novel coronavirus 2019 will become endemic in India.” There are no reported cases in India at this time, but there is a need of caution he said.\r\n\r\n<strong>Precaution of infection:</strong>\r\n\r\nThere are currently no vaccines available to protect you against human coronavirus infection. You may be able to reduce your risk of infection by doing the following\r\n\r\n1: Wash your hands often with soap and water for at least 20 seconds\r\n\r\n2: Avoid touching your eyes, nose, or mouth with unwashed hands\r\n\r\n3: Avoid close contact with people who are sick','China’s president warns over Coronavirus spread','','publish','open','open','','chinas-president-warns-over-coronavirus-spread','','','2020-01-26 18:40:01','2020-01-26 18:40:01','',0,'https://microbiozindia.com/?p=4215',0,'post','',0),(4216,2,'2020-01-25 23:28:06','2020-01-25 23:28:06','','hhh','','inherit','open','closed','','hhh-2','','','2020-01-25 23:28:06','2020-01-25 23:28:06','',4215,'https://microbiozindia.com/wp-content/uploads/2020/01/hhh.png',0,'attachment','image/png',0),(4217,2,'2020-01-25 23:28:21','2020-01-25 23:28:21','Coronaviruses are a group of viruses that cause diseases in mammals and birds that include diarrhea in cows and pigs, and upper respiratory disease in chickens. The virus mainly causes infection in your nose, <a href=\"https://www.webmd.com/allergies/picture-of-the-sinuses\">sinuses</a>, or upper throat. Most coronaviruses are not dangerous. Some types of them are serious, though.\r\n\r\nThe country is facing a \"grave situation\" Mr <strong>Xi Jinping </strong>told senior officials.\r\n\r\nAccording to sources the coronavirus has killed at least 42 people and infected some 1,400 since its discovery in the city of Wuhan. Meanwhile, UK-based researchers have warned of a real possibility that China will not be able to contain the virus.\r\n\r\nThe virus is spreading from China to rest of the world, Dr. Om Srivastava, Infectious Disease specialist said that, “It is too early to say whether the novel coronavirus 2019 will become endemic in India.” There are no reported cases in India at this time, but there is a need of caution he said.\r\n\r\nPrecaution of infection:\r\n\r\nThere are currently no vaccines available to protect you against human coronavirus infection. You may be able to reduce your risk of infection by doing the following\r\n<ul>\r\n 	<li>Wash your hands often with soap and water for at least 20 seconds</li>\r\n 	<li>Avoid touching your eyes, nose, or mouth with unwashed hands</li>\r\n 	<li>Avoid close contact with people who are sick</li>\r\n</ul>','China’s president warns over Coronavirus spread','','inherit','closed','closed','','4215-revision-v1','','','2020-01-25 23:28:21','2020-01-25 23:28:21','',4215,'https://microbiozindia.com/uncategorized/4215-revision-v1/',0,'revision','',0),(4218,2,'2020-01-25 23:29:01','2020-01-25 23:29:01','<a href=\"https://en.wikipedia.org/wiki/Coronavirus\">Coronaviruses</a> are a group of viruses that cause diseases in mammals and birds that include diarrhea in cows and pigs, and upper respiratory disease in chickens. The virus mainly causes infection in your nose, <a href=\"https://www.webmd.com/allergies/picture-of-the-sinuses\">sinuses</a>, or upper throat. Most coronaviruses are not dangerous. Some types of them are serious, though.\r\n\r\nThe country is facing a \"grave situation\" Mr <strong>Xi Jinping </strong>told senior officials.\r\n\r\nAccording to sources the coronavirus has killed at least 42 people and infected some 1,400 since its discovery in the city of Wuhan. Meanwhile, UK-based researchers have warned of a real possibility that China will not be able to contain the virus.\r\n\r\nThe virus is spreading from China to rest of the world, Dr. Om Srivastava, Infectious Disease specialist said that, “It is too early to say whether the novel coronavirus 2019 will become endemic in India.” There are no reported cases in India at this time, but there is a need of caution he said.\r\n\r\nPrecaution of infection:\r\n\r\nThere are currently no vaccines available to protect you against human coronavirus infection. You may be able to reduce your risk of infection by doing the following\r\n<ul>\r\n 	<li>Wash your hands often with soap and water for at least 20 seconds</li>\r\n 	<li>Avoid touching your eyes, nose, or mouth with unwashed hands</li>\r\n 	<li>Avoid close contact with people who are sick</li>\r\n</ul>','China’s president warns over Coronavirus spread','','inherit','closed','closed','','4215-revision-v1','','','2020-01-25 23:29:01','2020-01-25 23:29:01','',4215,'https://microbiozindia.com/uncategorized/4215-revision-v1/',0,'revision','',0),(4219,2,'2020-01-25 23:29:32','2020-01-25 23:29:32','Coronaviruses are a group of viruses that cause diseases in mammals and birds that include diarrhea in cows and pigs, and upper respiratory disease in chickens. The virus mainly causes infection in your nose, <a href=\"https://www.webmd.com/allergies/picture-of-the-sinuses\">sinuses</a>, or upper throat. Most coronaviruses are not dangerous. Some types of them are serious, though.\r\n\r\nThe country is facing a \"grave situation\" Mr <strong>Xi Jinping </strong>told senior officials.\r\n\r\nAccording to sources the coronavirus has killed at least 42 people and infected some 1,400 since its discovery in the city of Wuhan. Meanwhile, UK-based researchers have warned of a real possibility that China will not be able to contain the virus.\r\n\r\nThe virus is spreading from China to rest of the world, Dr. Om Srivastava, Infectious Disease specialist said that, “It is too early to say whether the novel coronavirus 2019 will become endemic in India.” There are no reported cases in India at this time, but there is a need of caution he said.\r\n\r\nPrecaution of infection:\r\n\r\nThere are currently no vaccines available to protect you against human coronavirus infection. You may be able to reduce your risk of infection by doing the following\r\n<ul>\r\n 	<li>Wash your hands often with soap and water for at least 20 seconds</li>\r\n 	<li>Avoid touching your eyes, nose, or mouth with unwashed hands</li>\r\n 	<li>Avoid close contact with people who are sick</li>\r\n</ul>','China’s president warns over Coronavirus spread','','inherit','closed','closed','','4215-revision-v1','','','2020-01-25 23:29:32','2020-01-25 23:29:32','',4215,'https://microbiozindia.com/uncategorized/4215-revision-v1/',0,'revision','',0),(4220,2,'2020-01-25 23:31:49','2020-01-25 23:31:49','Coronaviruses are a group of viruses that cause diseases in mammals and birds that include diarrhea in cows and pigs, and upper respiratory disease in chickens. The virus mainly causes infection in your nose, <a href=\"https://www.webmd.com/allergies/picture-of-the-sinuses\">sinuses</a>, or upper throat. Most coronaviruses are not dangerous. Some types of them are serious, though.\r\n\r\nThe country is facing a \"grave situation\" Mr <strong>Xi Jinping </strong>told senior officials.\r\n\r\nAccording to sources the coronavirus has killed at least 42 people and infected some 1,400 since its discovery in the city of Wuhan. Meanwhile, UK-based researchers have warned of a real possibility that China will not be able to contain the virus.\r\n\r\nThe virus is spreading from China to rest of the world, Dr. Om Srivastava, Infectious Disease specialist said that, “It is too early to say whether the novel coronavirus 2019 will become endemic in India.” There are no reported cases in India at this time, but there is a need of caution he said.\r\n\r\n<strong>Precaution of infection:</strong>\r\n\r\nThere are currently no vaccines available to protect you against human coronavirus infection. You may be able to reduce your risk of infection by doing the following\r\n\r\n1: Wash your hands often with soap and water for at least 20 seconds\r\n\r\n2: Avoid touching your eyes, nose, or mouth with unwashed hands\r\n\r\n3: Avoid close contact with people who are sick','China’s president warns over Coronavirus spread','','inherit','closed','closed','','4215-revision-v1','','','2020-01-25 23:31:49','2020-01-25 23:31:49','',4215,'https://microbiozindia.com/uncategorized/4215-revision-v1/',0,'revision','',0),(4221,2,'2020-01-27 17:03:28','2020-01-27 17:03:28','Analytik has published a white paper that provides an informative introduction to particle size characterisation using the Differential Centrifugal Sedimentation (DCS) technique.\r\n\r\nDifferential Centrifugal Sedimentation is an extremely powerful tool for high resolution particle characterisation, especially in the size range 0.002 micron (2nm) to 10 microns. It enables very narrow distributions of particles differing in size by less than 2 per cent to be resolved, and hence extremely small differences, changes or shifts in particle size to be accurately and reproducibly detected and measured. The accuracy and reliability of DCS data also enables the technique to be used quantitatively to derive weight and number distributions. Beneficially DCS also produces particle sizing results that are comparable to data resulting from Optical and Scanning Electron Microscopic analyses.\r\n\r\nAfter providing a useful introduction to the theory behind Differential Centrifugal Sedimentation - the white paper discusses different instrumental designs, operational considerations and includes results data from applications that can benefit from the technique. The white paper also introduces a new DCS method for measurement of low density, neutral buoyancy particles, a previous technical limitation of the technique.\r\n\r\nThe white paper concludes that recent advances in Differential Centrifugal Sedimentation instrumentation have improved the technique with respect to ease of use, speed of analysis, accuracy and multiple sample measurement.\r\n\r\nTo learn more about Differential Centrifugal Sedimentation and download a copy of the white paper please visit <a href=\"https://analytik.co.uk/particle-size-characterisation-by-dcs/\">https://analytik.co.uk/particle-size-characterisation-by-dcs/</a>.\r\n\r\nTo learn more about the CPS DC24000 ultra high-resolution particle size analyser that is based upon DCS technology please contact Analytik on +44-1954-232776 / <a href=\"mailto:info@analytik.co.uk\">info@analytik.co.uk</a>.\r\n\r\nFor over 15 years - Analytik has been a trusted supplier of cutting-edge scientific instrumentation to leading organisations throughout the UK and Ireland. In addition to supplying innovative analytical instrumentation from <a href=\"https://analytik.co.uk/product-category/partners/\">global technology providers</a>, we deliver added value through specialised consultative expertise and <a href=\"https://analytik.co.uk/support/\">comprehensive pre and post-sales support</a> to ensure that our customers get the most out of their investment. For further information please visit <a href=\"http://www.analytik.co.uk/\">www.analytik.co.uk</a>.\r\n\r\n<strong>For more Information:</strong>\r\n\r\n<strong>Analytik Ltd</strong>\r\nBarn B, 2 Cygnus Business Park\r\nMiddle Watch, Swavesey\r\nCambridgeshire CB24 4AA\r\nUK\r\ntel: +44-1954-232776\r\nemail: <a href=\"mailto:info@analytik.co.uk\">info@analytik.co.uk</a>\r\nweb:   <a href=\"http://www.analytik.co.uk\">www.analytik.co.uk</a>','Ultra-High-Resolution Particle Characterisation','','publish','open','open','','ultra-high-resolution-particle-characterisation','','','2020-01-27 17:03:28','2020-01-27 17:03:28','',0,'https://microbiozindia.com/?p=4221',0,'post','',0),(4222,2,'2020-01-27 17:03:16','2020-01-27 17:03:16','','ggg','','inherit','open','closed','','ggg-2','','','2020-01-27 17:03:16','2020-01-27 17:03:16','',4221,'https://microbiozindia.com/wp-content/uploads/2020/01/ggg-1.png',0,'attachment','image/png',0),(4223,2,'2020-01-27 17:03:28','2020-01-27 17:03:28','Analytik has published a white paper that provides an informative introduction to particle size characterisation using the Differential Centrifugal Sedimentation (DCS) technique.\r\n\r\nDifferential Centrifugal Sedimentation is an extremely powerful tool for high resolution particle characterisation, especially in the size range 0.002 micron (2nm) to 10 microns. It enables very narrow distributions of particles differing in size by less than 2 per cent to be resolved, and hence extremely small differences, changes or shifts in particle size to be accurately and reproducibly detected and measured. The accuracy and reliability of DCS data also enables the technique to be used quantitatively to derive weight and number distributions. Beneficially DCS also produces particle sizing results that are comparable to data resulting from Optical and Scanning Electron Microscopic analyses.\r\n\r\nAfter providing a useful introduction to the theory behind Differential Centrifugal Sedimentation - the white paper discusses different instrumental designs, operational considerations and includes results data from applications that can benefit from the technique. The white paper also introduces a new DCS method for measurement of low density, neutral buoyancy particles, a previous technical limitation of the technique.\r\n\r\nThe white paper concludes that recent advances in Differential Centrifugal Sedimentation instrumentation have improved the technique with respect to ease of use, speed of analysis, accuracy and multiple sample measurement.\r\n\r\nTo learn more about Differential Centrifugal Sedimentation and download a copy of the white paper please visit <a href=\"https://analytik.co.uk/particle-size-characterisation-by-dcs/\">https://analytik.co.uk/particle-size-characterisation-by-dcs/</a>.\r\n\r\nTo learn more about the CPS DC24000 ultra high-resolution particle size analyser that is based upon DCS technology please contact Analytik on +44-1954-232776 / <a href=\"mailto:info@analytik.co.uk\">info@analytik.co.uk</a>.\r\n\r\nFor over 15 years - Analytik has been a trusted supplier of cutting-edge scientific instrumentation to leading organisations throughout the UK and Ireland. In addition to supplying innovative analytical instrumentation from <a href=\"https://analytik.co.uk/product-category/partners/\">global technology providers</a>, we deliver added value through specialised consultative expertise and <a href=\"https://analytik.co.uk/support/\">comprehensive pre and post-sales support</a> to ensure that our customers get the most out of their investment. For further information please visit <a href=\"http://www.analytik.co.uk/\">www.analytik.co.uk</a>.\r\n\r\n<strong>For more Information:</strong>\r\n\r\n<strong>Analytik Ltd</strong>\r\nBarn B, 2 Cygnus Business Park\r\nMiddle Watch, Swavesey\r\nCambridgeshire CB24 4AA\r\nUK\r\ntel: +44-1954-232776\r\nemail: <a href=\"mailto:info@analytik.co.uk\">info@analytik.co.uk</a>\r\nweb:   <a href=\"http://www.analytik.co.uk\">www.analytik.co.uk</a>','Ultra-High-Resolution Particle Characterisation','','inherit','closed','closed','','4221-revision-v1','','','2020-01-27 17:03:28','2020-01-27 17:03:28','',4221,'https://microbiozindia.com/uncategorized/4221-revision-v1/',0,'revision','',0),(4224,2,'2020-01-28 15:47:39','2020-01-28 15:47:39','Porvair Sciences announce Microluteä PLR - a new benchmark product for <strong>phospholipid removal</strong>. The 96-well microplate provides effective removal (&gt;99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes.\r\nPhospholipid-based matrix effects are a major source of variability and inaccuracy in bioanalytical mass spectrometry (MS) analysis. Popular sample preparation techniques like protein precipitation, dilute and shoot or liquid-liquid extraction methods do not completely remove phospholipids. Microlute PLR is the only product that ensures minimal enhancement or suppression of analyte response by truly eliminating the source of matrix effects and not just masking the problem.\r\nPorvair Sciences phospholipid removal technology differs from conventional methods. Instead of a loose-filled base product,  Microlute PLR is composed of a solid interconnected network of evenly distributed pores that allow biological fluids to flow smoothly and consistently throughout the active media. This proprietary feature overcomes common channelling and breakthrough issues by enhancing the flow of samples throughout the filter thereby maximising the recovery of analytes with unrivalled reproducibility and improving the overall performance of phospholipid removal.\r\nProven in comparative tests with competitive products to provide the most efficient removal of the widest range of phospholipids from plasma and serum samples - Microlute PLR microplates enable you to increase the sensitivity and integrity of your UHPLC/HPLC methods.\r\nBenefiting from an easy-to-use protocol, Microlute PLR microplates ensure you get consistent phospholipid removal and analyte recovery from well-to-well and batch-to-batch first time and every time. As a result, high-throughput studies will benefit from a reproducible, high performing sample preparation workflow.\r\n\r\nFor further information on the Microlute PLR microplate, and details of the comparative testing study, please visit <a href=\"http://www.microplates.com/microlute-plr\">www.microplates.com/microlute-plr</a> or contact Porvair Sciences on +44-1978-666222 / +1-856-696-3605 / <a href=\"mailto:int.sales@porvairsciences.com\">int.sales@porvairsciences.com</a>.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.\r\n\r\n<strong>For more information:</strong>\r\n\r\n<strong>Porvair Sciences Ltd\r\n</strong>Clywedog Rd South\r\nWrexham Industrial Estate\r\nWales LL13 9XS,UK\r\nTel:     +44 1978 661144\r\n\r\nEmail: <a href=\"mailto:int.sales@porvair-sciences.com\">int.sales@porvair-sciences.com</a>\r\nWeb    <a href=\"http://www.porvair-sciences.com/\">www.porvair-sciences.com</a>','Next Generation Phospholipid Removal Microplate','','publish','open','open','','next-generation-phospholipid-removal-microplate','','','2020-01-28 15:47:39','2020-01-28 15:47:39','',0,'https://microbiozindia.com/?p=4224',0,'post','',0),(4225,2,'2020-01-28 15:47:11','2020-01-28 15:47:11','','AAA','','inherit','open','closed','','aaa-4','','','2020-01-28 15:47:11','2020-01-28 15:47:11','',4224,'https://microbiozindia.com/wp-content/uploads/2020/01/AAA-2.png',0,'attachment','image/png',0),(4226,2,'2020-01-28 15:47:39','2020-01-28 15:47:39','Porvair Sciences announce Microluteä PLR - a new benchmark product for <strong>phospholipid removal</strong>. The 96-well microplate provides effective removal (&gt;99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes.\r\nPhospholipid-based matrix effects are a major source of variability and inaccuracy in bioanalytical mass spectrometry (MS) analysis. Popular sample preparation techniques like protein precipitation, dilute and shoot or liquid-liquid extraction methods do not completely remove phospholipids. Microlute PLR is the only product that ensures minimal enhancement or suppression of analyte response by truly eliminating the source of matrix effects and not just masking the problem.\r\nPorvair Sciences phospholipid removal technology differs from conventional methods. Instead of a loose-filled base product,  Microlute PLR is composed of a solid interconnected network of evenly distributed pores that allow biological fluids to flow smoothly and consistently throughout the active media. This proprietary feature overcomes common channelling and breakthrough issues by enhancing the flow of samples throughout the filter thereby maximising the recovery of analytes with unrivalled reproducibility and improving the overall performance of phospholipid removal.\r\nProven in comparative tests with competitive products to provide the most efficient removal of the widest range of phospholipids from plasma and serum samples - Microlute PLR microplates enable you to increase the sensitivity and integrity of your UHPLC/HPLC methods.\r\nBenefiting from an easy-to-use protocol, Microlute PLR microplates ensure you get consistent phospholipid removal and analyte recovery from well-to-well and batch-to-batch first time and every time. As a result, high-throughput studies will benefit from a reproducible, high performing sample preparation workflow.\r\n\r\nFor further information on the Microlute PLR microplate, and details of the comparative testing study, please visit <a href=\"http://www.microplates.com/microlute-plr\">www.microplates.com/microlute-plr</a> or contact Porvair Sciences on +44-1978-666222 / +1-856-696-3605 / <a href=\"mailto:int.sales@porvairsciences.com\">int.sales@porvairsciences.com</a>.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.\r\n\r\n<strong>For more information:</strong>\r\n\r\n<strong>Porvair Sciences Ltd\r\n</strong>Clywedog Rd South\r\nWrexham Industrial Estate\r\nWales LL13 9XS,UK\r\nTel:     +44 1978 661144\r\n\r\nEmail: <a href=\"mailto:int.sales@porvair-sciences.com\">int.sales@porvair-sciences.com</a>\r\nWeb    <a href=\"http://www.porvair-sciences.com/\">www.porvair-sciences.com</a>','Next Generation Phospholipid Removal Microplate','','inherit','closed','closed','','4224-revision-v1','','','2020-01-28 15:47:39','2020-01-28 15:47:39','',4224,'https://microbiozindia.com/uncategorized/4224-revision-v1/',0,'revision','',0),(4227,2,'2020-01-28 17:49:42','2020-01-28 17:49:42','<strong>Asynt</strong> reports on how chemistry labs, seeking to minimise water wastage, are electing to replace Liebig-style water condensers with their <strong>CondenSyn waterless air condenser</strong>, for both reflux and distillation reactions.\r\n\r\nSynthetic experiments often include reflux and distillation steps, making a reflux condenser an essential tool for both research and teaching chemistry. Traditional condensers, cooled by a circulating fluid, are effective and widely used, however they are often operated directly with tap water. This not only creates an environmental and cost issue but also increases the risk of a laboratory flood. The use of an Asynt CondenSyn air condenser negates the need for any recirculating coolant during standard reflux and distillation conditions, saving time, money and water.\r\n\r\nDr Ffion McKeague - Technology Manager at Asynt commented \"Our CondenSyn waterless condensers are rapidly becoming a necessity in laboratories all over the world, driven by their ease of use and massive associated water savings benefits compared to using traditional water condensers\". She added \"Not only has the CondenSyn proved itself as a sustainable alternative for reflux reactions but increasingly also for distillation experiments using the <strong>CondenSyn Distillation Adapter</strong>. A typical Chemistry laboratory replacing their standard water condensers with CondenSyn units can expect to see a return on its investment in as little as 6 months\".\r\n\r\nThe CondenSyn waterless air condenser\'s unique design uses a special borosilicate glass manufacturing technique and this, together with a proprietary multiple hyperbolic profile, ensures optimum heat removal as vapors pass along its length. Offering clear visibility of ongoing experimental reflux, the Asynt CondenSyn is also easy to clean and maintain, whilst the incorporation of a non-roll feature helps prevent accidents if left on a lab bench. Asynt offers a range of CondenSyn to optimally suit different capacity round bottom flasks.\r\n\r\nFor further information on CondenSyn please visit <u><a href=\"https://www.asynt.com/product/asynt-condensyn-air-condenser/\">https://www.asynt.com/product/asynt-condensyn-air-condenser/</a></u> or contact Asynt on +44-1638-781709 / <a href=\"mailto:enquiries@asynt.com\">enquiries@asynt.com</a>.\r\n\r\nAsynt is a leading supplier of affordable products, consumables and services for chemists in industry and academia.  With staff of trained chemists - Asynt can draw upon this in-depth applications knowledge to provide a high level of customer support for its DrySyn Heating Blocks, Controlled Lab Reactors, Synthesis Tools, Evaporators, Circulators, Temperature Control Systems, Vacuum Pumps and Lab Safety Equipment.\r\n\r\nFor more information:<strong>\r\nAsynt Ltd</strong>\r\nUnit 29, Hall Barn Industrial Estate\r\nIsleham\r\nCambridgeshire CB7 5RJ\r\nUK\r\ntel: +44-1638-781709\r\nemail: <a href=\"mailto:enquiries@asynt.com\">enquiries@asynt.com</a>\r\nweb: <a href=\"http://www.asynt.com/\">www.asynt.com</a>','Improved Sustainability for Chemistry Laboratories','','publish','open','open','','improved-sustainability-for-chemistry-laboratories','','','2020-01-28 17:49:42','2020-01-28 17:49:42','',0,'https://microbiozindia.com/?p=4227',0,'post','',0),(4228,2,'2020-01-28 17:49:23','2020-01-28 17:49:23','','AAAA','','inherit','open','closed','','aaaa','','','2020-01-28 17:49:23','2020-01-28 17:49:23','',4227,'https://microbiozindia.com/wp-content/uploads/2020/01/AAAA.png',0,'attachment','image/png',0),(4229,2,'2020-01-28 17:49:42','2020-01-28 17:49:42','<strong>Asynt</strong> reports on how chemistry labs, seeking to minimise water wastage, are electing to replace Liebig-style water condensers with their <strong>CondenSyn waterless air condenser</strong>, for both reflux and distillation reactions.\r\n\r\nSynthetic experiments often include reflux and distillation steps, making a reflux condenser an essential tool for both research and teaching chemistry. Traditional condensers, cooled by a circulating fluid, are effective and widely used, however they are often operated directly with tap water. This not only creates an environmental and cost issue but also increases the risk of a laboratory flood. The use of an Asynt CondenSyn air condenser negates the need for any recirculating coolant during standard reflux and distillation conditions, saving time, money and water.\r\n\r\nDr Ffion McKeague - Technology Manager at Asynt commented \"Our CondenSyn waterless condensers are rapidly becoming a necessity in laboratories all over the world, driven by their ease of use and massive associated water savings benefits compared to using traditional water condensers\". She added \"Not only has the CondenSyn proved itself as a sustainable alternative for reflux reactions but increasingly also for distillation experiments using the <strong>CondenSyn Distillation Adapter</strong>. A typical Chemistry laboratory replacing their standard water condensers with CondenSyn units can expect to see a return on its investment in as little as 6 months\".\r\n\r\nThe CondenSyn waterless air condenser\'s unique design uses a special borosilicate glass manufacturing technique and this, together with a proprietary multiple hyperbolic profile, ensures optimum heat removal as vapors pass along its length. Offering clear visibility of ongoing experimental reflux, the Asynt CondenSyn is also easy to clean and maintain, whilst the incorporation of a non-roll feature helps prevent accidents if left on a lab bench. Asynt offers a range of CondenSyn to optimally suit different capacity round bottom flasks.\r\n\r\nFor further information on CondenSyn please visit <u><a href=\"https://www.asynt.com/product/asynt-condensyn-air-condenser/\">https://www.asynt.com/product/asynt-condensyn-air-condenser/</a></u> or contact Asynt on +44-1638-781709 / <a href=\"mailto:enquiries@asynt.com\">enquiries@asynt.com</a>.\r\n\r\nAsynt is a leading supplier of affordable products, consumables and services for chemists in industry and academia.  With staff of trained chemists - Asynt can draw upon this in-depth applications knowledge to provide a high level of customer support for its DrySyn Heating Blocks, Controlled Lab Reactors, Synthesis Tools, Evaporators, Circulators, Temperature Control Systems, Vacuum Pumps and Lab Safety Equipment.\r\n\r\nFor more information:<strong>\r\nAsynt Ltd</strong>\r\nUnit 29, Hall Barn Industrial Estate\r\nIsleham\r\nCambridgeshire CB7 5RJ\r\nUK\r\ntel: +44-1638-781709\r\nemail: <a href=\"mailto:enquiries@asynt.com\">enquiries@asynt.com</a>\r\nweb: <a href=\"http://www.asynt.com/\">www.asynt.com</a>','Improved Sustainability for Chemistry Laboratories','','inherit','closed','closed','','4227-revision-v1','','','2020-01-28 17:49:42','2020-01-28 17:49:42','',4227,'https://microbiozindia.com/uncategorized/4227-revision-v1/',0,'revision','',0),(4230,2,'2020-01-29 12:52:28','2020-01-29 12:52:28','Pune, January 29<sup>th</sup>, 2020: In continuance of its efforts to advance quality education and promote industry-academia collaboration, Cipla Foundation, the social responsibility arm of Cipla Ltd, has funded the set-up of a world class chemistry research laboratory at the Indian Institute of Science Education and Research (IISER) Pune.\r\n\r\nThe lab aims to provide practical training in Chemistry to undergraduates and researchers in the varsity campus along with support to the national outreach programme for school children.  The centre and the labs will help strengthen science education in India by engaging with various stakeholders, including students, academicians, scientists, teachers of schools and undergraduate level science and mathematics.\r\n\r\nDr. Y. K. Hamied, Chairman, Cipla, Ms. Rumana Hamied, Managing Trustee, Cipla Foundation and Prof. Jayant B Udgaonkar, Director, IISER Pune were present at the campus for the unveiling of the facility along with senior leaders from Cipla and IISER Pune.\r\n\r\nThe expansive 27,000 square feet, ground plus two floor facility has been constructed in an eco-friendly zone in adherence with the green building GRIHA standards. In line with the international standards of chemistry practicals, four state-of-the-art four laboratories have been set up, each appointed with best-in-class equipment including virtual reality functionalities, interactive gadgets, demonstration facilities and more. In addition to academic learning, the facilities will also be utilized for real-life industry driven research projects and contribute to the latest scientific innovation taking place in the country.\r\n\r\nGiven the absence of adequate infrastructure for chemistry laboratories in surrounding Pune Municipal Corporation schools and other colleges, lesser privileged students and teachers from these institutions will also be granted access to this facility. The outreach programme will help impart pedagogy training to teachers as well as hands on science education to teachers and students from schools, colleges and universities and ignite passion for science. Over 1000 teachers and 5000 students will be reached out to each year.\r\n\r\nAt the event, Dr. Y K Hamied, Chairman Cipla Ltd. said, “India has the potential to be at the frontier of research and innovation, particularly in the areas of chemistry, healthcare and life-sciences. IISER, Pune will certainly contribute to this achievement with the help of of ‘state-of-the-art’ facilities and this means increased responsibility for both the staff and the students to excel”\r\n\r\nProf Jayant, Director of IISER Pune shared, “This is the first industry and academic interaction with IISER and Cipla and I am sure that this is just the beginning. This collaboration will be more fruitful in the areas of pharma research in the years to come”. He also mentioned about the expansion of the outreach programme especially in training of secondary school students and most importantly, the teachers.','Cipla Foundation sets up a dedicated state-of-the-art chemistry laboratory at IISER Pune','','publish','open','open','','cipla-foundation-sets-up-a-dedicated-state-of-the-art-chemistry-laboratory-at-iiser-pune','','','2020-01-29 13:00:04','2020-01-29 13:00:04','',0,'https://microbiozindia.com/?p=4230',0,'post','',0),(4231,2,'2020-01-29 12:51:18','2020-01-29 12:51:18','','SAAA','','inherit','open','closed','','saaa','','','2020-01-29 12:51:18','2020-01-29 12:51:18','',4230,'https://microbiozindia.com/wp-content/uploads/2020/01/SAAA.png',0,'attachment','image/png',0),(4232,2,'2020-01-29 12:52:28','2020-01-29 12:52:28','<strong>Pune, January 29<sup>th</sup>, 2020</strong>: In continuance of its efforts to advance quality education and promote industry-academia collaboration, Cipla Foundation, the social responsibility arm of Cipla Ltd, has funded the set-up of a world class chemistry research laboratory at the Indian Institute of Science Education and Research (IISER) Pune.\r\n\r\nThe lab aims to provide practical training in Chemistry to undergraduates and researchers in the varsity campus along with support to the national outreach programme for school children.  The centre and the labs will help strengthen science education in India by engaging with various stakeholders, including students, academicians, scientists, teachers of schools and undergraduate level science and mathematics.\r\n\r\nDr. Y. K. Hamied, Chairman, Cipla, Ms. Rumana Hamied, Managing Trustee, Cipla Foundation and Prof. Jayant B Udgaonkar, Director, IISER Pune were present at the campus for the unveiling of the facility along with senior leaders from Cipla and IISER Pune.\r\n\r\nThe expansive 27,000 square feet, ground plus two floor facility has been constructed in an eco-friendly zone in adherence with the green building GRIHA standards. In line with the international standards of chemistry practicals, four state-of-the-art four laboratories have been set up, each appointed with best-in-class equipment including virtual reality functionalities, interactive gadgets, demonstration facilities and more. In addition to academic learning, the facilities will also be utilized for real-life industry driven research projects and contribute to the latest scientific innovation taking place in the country.\r\n\r\nGiven the absence of adequate infrastructure for chemistry laboratories in surrounding Pune Municipal Corporation schools and other colleges, lesser privileged students and teachers from these institutions will also be granted access to this facility. The outreach programme will help impart pedagogy training to teachers as well as hands on science education to teachers and students from schools, colleges and universities and ignite passion for science. Over 1000 teachers and 5000 students will be reached out to each year.\r\n\r\nAt the event, Dr. Y K Hamied, Chairman Cipla Ltd. said, “India has the potential to be at the frontier of research and innovation, particularly in the areas of chemistry, healthcare and life-sciences. IISER, Pune will certainly contribute to this achievement with the help of of ‘state-of-the-art’ facilities and this means increased responsibility for both the staff and the students to excel”\r\n\r\nProf Jayant, Director of IISER Pune shared, “This is the first industry and academic interaction with IISER and Cipla and I am sure that this is just the beginning. This collaboration will be more fruitful in the areas of pharma research in the years to come”. He also mentioned about the expansion of the outreach programme especially in training of secondary school students and most importantly, the teachers.','Cipla Foundation sets up a dedicated state-of-the-art chemistry laboratory at IISER Pune','','inherit','closed','closed','','4230-revision-v1','','','2020-01-29 12:52:28','2020-01-29 12:52:28','',4230,'https://microbiozindia.com/uncategorized/4230-revision-v1/',0,'revision','',0),(4233,2,'2020-01-29 12:54:48','2020-01-29 12:54:48','','SAAA','','inherit','open','closed','','saaa-2','','','2020-01-29 12:54:48','2020-01-29 12:54:48','',4230,'https://microbiozindia.com/wp-content/uploads/2020/01/SAAA-1.png',0,'attachment','image/png',0),(4234,2,'2020-01-29 13:00:04','2020-01-29 13:00:04','Pune, January 29<sup>th</sup>, 2020: In continuance of its efforts to advance quality education and promote industry-academia collaboration, Cipla Foundation, the social responsibility arm of Cipla Ltd, has funded the set-up of a world class chemistry research laboratory at the Indian Institute of Science Education and Research (IISER) Pune.\r\n\r\nThe lab aims to provide practical training in Chemistry to undergraduates and researchers in the varsity campus along with support to the national outreach programme for school children.  The centre and the labs will help strengthen science education in India by engaging with various stakeholders, including students, academicians, scientists, teachers of schools and undergraduate level science and mathematics.\r\n\r\nDr. Y. K. Hamied, Chairman, Cipla, Ms. Rumana Hamied, Managing Trustee, Cipla Foundation and Prof. Jayant B Udgaonkar, Director, IISER Pune were present at the campus for the unveiling of the facility along with senior leaders from Cipla and IISER Pune.\r\n\r\nThe expansive 27,000 square feet, ground plus two floor facility has been constructed in an eco-friendly zone in adherence with the green building GRIHA standards. In line with the international standards of chemistry practicals, four state-of-the-art four laboratories have been set up, each appointed with best-in-class equipment including virtual reality functionalities, interactive gadgets, demonstration facilities and more. In addition to academic learning, the facilities will also be utilized for real-life industry driven research projects and contribute to the latest scientific innovation taking place in the country.\r\n\r\nGiven the absence of adequate infrastructure for chemistry laboratories in surrounding Pune Municipal Corporation schools and other colleges, lesser privileged students and teachers from these institutions will also be granted access to this facility. The outreach programme will help impart pedagogy training to teachers as well as hands on science education to teachers and students from schools, colleges and universities and ignite passion for science. Over 1000 teachers and 5000 students will be reached out to each year.\r\n\r\nAt the event, Dr. Y K Hamied, Chairman Cipla Ltd. said, “India has the potential to be at the frontier of research and innovation, particularly in the areas of chemistry, healthcare and life-sciences. IISER, Pune will certainly contribute to this achievement with the help of of ‘state-of-the-art’ facilities and this means increased responsibility for both the staff and the students to excel”\r\n\r\nProf Jayant, Director of IISER Pune shared, “This is the first industry and academic interaction with IISER and Cipla and I am sure that this is just the beginning. This collaboration will be more fruitful in the areas of pharma research in the years to come”. He also mentioned about the expansion of the outreach programme especially in training of secondary school students and most importantly, the teachers.','Cipla Foundation sets up a dedicated state-of-the-art chemistry laboratory at IISER Pune','','inherit','closed','closed','','4230-revision-v1','','','2020-01-29 13:00:04','2020-01-29 13:00:04','',4230,'https://microbiozindia.com/uncategorized/4230-revision-v1/',0,'revision','',0),(4235,2,'2020-01-30 13:55:08','2020-01-30 13:55:08','FLIR Systems announce the FLIR GF77a Gas Find IR camera, its first fixed-mount, uncooled, autonomous leak detection camera designed specifically to visualize methane and other industrial gases.\r\n\r\nA new camera in FLIR Systems\' optical gas imaging (OGI) series, the connected GF77a provides upstream and midstream gas processors, producers, and operators with the ability to monitor continuously for invisible, potentially dangerous methane leaks at natural gas power plants, renewable energy production facilities, industrial plants, and other locations along a natural gas supply chain.\r\n\r\nFLIR designed the GF77a to combine its industry-leading gas detection features with an uncooled, fixed-mount camera platform at nearly half the price of FLIR Systems\' fixed-mount, cooled platform. The camera is engineered to detect industrial gases such as methane, sulfur dioxide, and nitrous oxide to improve inspections and reduce the chance of false readings. Featuring a FLIR-patented High Sensitivity Mode (HSM), the technology enables better detection capabilities by accentuating movement to make gas plumes more visible to the user. The radiometrically-calibrated GF77a also measures temperature, making it a solution for monitoring tank levels and inspecting components that may overheat.\r\n<img class=\"alignnone  wp-image-4237\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/fliratspr231-imageB-300x225.jpg\" alt=\"\" width=\"335\" height=\"251\" />\r\nThe FLIR GF77a provides advanced connectivity protocols that allow for seamless integration into gas monitoring systems to meet the needs of the oil and gas industry, while also making it easy for third-party partners to integrate an analytics solution. This capability provides the industry with a solution that empowers companies to reduce emissions and ensure a safer work environment.\r\n\r\nThe GigE Vision and GeniCam compatible GF77a includes Wi-Fi connectivity, allowing companies to control and stream radiometric thermal data remotely. It\'s also ONVIF-compliant and includes environmental accessories to allow customers to tailor the camera to their daily needs. The FLIR GF77a is available for purchase today globally from FLIR authorized distributors at less than half the price when compared to FLIR Systems\' existing solutions.\r\n\r\nTo learn more about the FLIR GF77a, please visit <a href=\"http://www.flir.com/GF77a\">www.flir.com/GF77a</a> or contact FLIR Systems on <a href=\"mailto:gasimaging@flir.com\">gasimaging@flir.com</a> or +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems\' vision is to be \"The World\'s Sixth Sense,\" creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit <a href=\"http://www.flir.com\">www.flir.com</a> and follow @flir.','Low-Cost Optical Gas Imaging Camera for Continuous and Autonomous Leak Detection','','publish','open','open','','low-cost-optical-gas-imaging-camera-for-continuous-and-autonomous-leak-detection','','','2020-01-30 13:55:08','2020-01-30 13:55:08','',0,'https://microbiozindia.com/?p=4235',0,'post','',0),(4236,2,'2020-01-30 13:54:29','2020-01-30 13:54:29','','AA','','inherit','open','closed','','aa-3','','','2020-01-30 13:54:29','2020-01-30 13:54:29','',4235,'https://microbiozindia.com/wp-content/uploads/2020/01/AA-2.png',0,'attachment','image/png',0),(4237,2,'2020-01-30 13:54:31','2020-01-30 13:54:31','','fliratspr231-imageB','','inherit','open','closed','','fliratspr231-imageb','','','2020-01-30 13:54:31','2020-01-30 13:54:31','',4235,'https://microbiozindia.com/wp-content/uploads/2020/01/fliratspr231-imageB.jpg',0,'attachment','image/jpeg',0),(4238,2,'2020-01-30 13:55:08','2020-01-30 13:55:08','FLIR Systems announce the FLIR GF77a Gas Find IR camera, its first fixed-mount, uncooled, autonomous leak detection camera designed specifically to visualize methane and other industrial gases.\r\n\r\nA new camera in FLIR Systems\' optical gas imaging (OGI) series, the connected GF77a provides upstream and midstream gas processors, producers, and operators with the ability to monitor continuously for invisible, potentially dangerous methane leaks at natural gas power plants, renewable energy production facilities, industrial plants, and other locations along a natural gas supply chain.\r\n\r\nFLIR designed the GF77a to combine its industry-leading gas detection features with an uncooled, fixed-mount camera platform at nearly half the price of FLIR Systems\' fixed-mount, cooled platform. The camera is engineered to detect industrial gases such as methane, sulfur dioxide, and nitrous oxide to improve inspections and reduce the chance of false readings. Featuring a FLIR-patented High Sensitivity Mode (HSM), the technology enables better detection capabilities by accentuating movement to make gas plumes more visible to the user. The radiometrically-calibrated GF77a also measures temperature, making it a solution for monitoring tank levels and inspecting components that may overheat.\r\n<img class=\"alignnone  wp-image-4237\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/fliratspr231-imageB-300x225.jpg\" alt=\"\" width=\"335\" height=\"251\" />\r\nThe FLIR GF77a provides advanced connectivity protocols that allow for seamless integration into gas monitoring systems to meet the needs of the oil and gas industry, while also making it easy for third-party partners to integrate an analytics solution. This capability provides the industry with a solution that empowers companies to reduce emissions and ensure a safer work environment.\r\n\r\nThe GigE Vision and GeniCam compatible GF77a includes Wi-Fi connectivity, allowing companies to control and stream radiometric thermal data remotely. It\'s also ONVIF-compliant and includes environmental accessories to allow customers to tailor the camera to their daily needs. The FLIR GF77a is available for purchase today globally from FLIR authorized distributors at less than half the price when compared to FLIR Systems\' existing solutions.\r\n\r\nTo learn more about the FLIR GF77a, please visit <a href=\"http://www.flir.com/GF77a\">www.flir.com/GF77a</a> or contact FLIR Systems on <a href=\"mailto:gasimaging@flir.com\">gasimaging@flir.com</a> or +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems\' vision is to be \"The World\'s Sixth Sense,\" creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit <a href=\"http://www.flir.com\">www.flir.com</a> and follow @flir.','Low-Cost Optical Gas Imaging Camera for Continuous and Autonomous Leak Detection','','inherit','closed','closed','','4235-revision-v1','','','2020-01-30 13:55:08','2020-01-30 13:55:08','',4235,'https://microbiozindia.com/uncategorized/4235-revision-v1/',0,'revision','',0),(4239,2,'2020-02-01 13:51:50','2020-02-01 13:51:50','Ziath has announced that it will launch a revolutionary web-based 2D-barcoded tube identification product - Datapaq 5 at SLAS 2020** in San Diego, USA.\r\n\r\nIn modern laboratories - samples are typically stored in large -80°C freezers, liquid nitrogen tanks or fully automated stores that are often inconveniently situated in an outbuilding or a basement. Datapaq 5 is the first of a new generation of digital sample management tools being developed by Ziath to allow sample management technicians to quickly and accurately log sample identity at the point of storage or retrieval.\r\n<img class=\"alignnone wp-image-4176\" src=\"https://microbiozindia.com/wp-content/uploads/2020/01/ziathpr12-image-300x168.jpg\" alt=\"\" width=\"518\" height=\"290\" />\r\nDatapaq 5 will run from any computer on a local network or over the internet if your IT rules allow, using a web-based highly intuitive graphical user interface. Datapaq 5 provides visual confirmation of tube identity and individual tube image inspection. From launch, this exciting new product will be available on Ziath\'s popular camera-based 2D barcoded scanners the Mirage, Express and the Cube.\r\n\r\nDatapaq 5 offers a convenient way to use a 2D barcoded tube or rack scanner anywhere across a laboratory or an organisation’s site where a suitable laptop or computer is available. Thanks to its web-based interface, Datapaq 5’s user interface will run on both Microsoft and Apple operating systems.\r\n\r\nThe new web-based software includes a host of features designed to streamline the collection of tube information for subsequent processing in inventory management software, such as Ziath’s popular Samples program.\r\n\r\nIn a further development - Ziath are also debuting an Android app that can run their rack scanners from a mobile device directly, in addition to using a web interface. This will put tube identification directly into the technician’s hands as they access their samples, wherever they may be stored.\r\n\r\nFor further information on Datapaq 5 please visit SLAS Booth 1548 or contact Ziath on +44 (0)1223 855021 or +1 858-880-6920 and via email to <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com/\">www.ziath.com</a>.\r\n\r\n**  SLAS 2020 will take place from January 25 – 29 2020 (see <a href=\"https://www.slas2020.org/\">https://www.slas2020.org/</a>)\r\n\r\n<strong><u>Worldwide HQ</u></strong><strong> </strong>\r\n\r\nZiath Ltd\r\nUnit 2a, Solopark Trading Estate\r\n\r\nStation Road\r\n\r\nPapisford\r\n\r\nCambridge CB22 3HB\r\nUK\r\nTel:     +44 1223 855021\r\n\r\nEmail: <a href=\"mailto:info@ziath.com\">info@ziath.com</a>\r\nWeb    <a href=\"http://www.ziath.com\">www.ziath.com</a>','Reading 2D Barcoded Tubes Directly at the Point of Storage or Retrieval','','inherit','closed','closed','','4181-revision-v1','','','2020-02-01 13:51:50','2020-02-01 13:51:50','',4181,'https://microbiozindia.com/uncategorized/4181-revision-v1/',0,'revision','',0),(4240,2,'2020-01-25 18:33:54','2020-01-25 18:33:54','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the January 2020 edition of the Microbioz India magazine, supported by the cover story entitled <strong>“Smart Laboratory and role in Pharmaceutical Quality Control<em>”</em></strong> covered by editorial of Microbioz India, the cpver story features modern laboratory and focus on Pharmaceutical Quality Control, many aspects of modern life are becoming tied to the digital world. You are using your smartphone to read emails, order taxi, check for directions and order food. But there is a place in this world that remained more or less immune to digitalization – a research laboratory.','Smart Laboratory and role in Pharmaceutical Quality Control','','publish','closed','closed','','smart-laboratory-and-role-in-pharmaceutical-quality-control','','','2020-02-01 18:51:07','2020-02-01 18:51:07','',0,'https://microbiozindia.com/?post_type=magazines&#038;p=4240',0,'magazines','',0),(4241,2,'2020-02-01 18:33:59','2020-02-01 18:33:59','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the December 2019 an annual edition of Microbioz India magazine, supported by the cover story entitled “Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High <em>Throughput Sequencing, Bioinformatics Solutions and Cloud Computing”</em> an insights <em>based on a report on </em><a href=\"https://www.persistencemarketresearch.com/market-research/immune-repertoire-sequencing-market.asp\"><em>Immune Repertoire Sequencing Market</em></a><em> by Persistence Market Research.</em> <em>The immune repertoire sequencing market in terms of revenue, is projected to register a CAGR of 7.3% over the forecast period. The immune repertoire sequencing market is segmented based on product type, application, end users and regions. Based on product type, the immune repertoire sequencing market is segmented into assay kits, software and services.</em>','Immune Repertoire Sequencing Market Growth Anticipated to be driven by Advancements in High Throughput Sequencing, Bioinformatics Solutions and Cloud Computing','','inherit','closed','closed','','4166-autosave-v1','','','2020-02-01 18:33:59','2020-02-01 18:33:59','',4166,'https://microbiozindia.com/uncategorized/4166-autosave-v1/',0,'revision','',0),(4242,2,'2020-02-01 18:36:09','2020-02-01 18:36:09','','MAGCVR','','inherit','open','closed','','magcvr-3','','','2020-02-01 18:36:09','2020-02-01 18:36:09','',4240,'https://microbiozindia.com/wp-content/uploads/2020/02/MAGCVR.png',0,'attachment','image/png',0),(4243,2,'2020-02-01 18:37:19','2020-02-01 18:37:19','','WEB001 (1)','','inherit','open','closed','','web001-1','','','2020-02-01 18:37:19','2020-02-01 18:37:19','',4240,'https://microbiozindia.com/wp-content/uploads/2020/02/WEB001-1.png',0,'attachment','image/png',0),(4244,2,'2020-02-01 18:37:21','2020-02-01 18:37:21','','WEB001 (2)','','inherit','open','closed','','web001-2','','','2020-02-01 18:37:21','2020-02-01 18:37:21','',4240,'https://microbiozindia.com/wp-content/uploads/2020/02/WEB001-2.png',0,'attachment','image/png',0),(4245,2,'2020-02-01 18:37:22','2020-02-01 18:37:22','','WEB001 (3)','','inherit','open','closed','','web001-3','','','2020-02-01 18:37:22','2020-02-01 18:37:22','',4240,'https://microbiozindia.com/wp-content/uploads/2020/02/WEB001-3.png',0,'attachment','image/png',0),(4246,2,'2020-02-01 18:37:24','2020-02-01 18:37:24','','WEB001 (4)','','inherit','open','closed','','web001-4','','','2020-02-01 18:37:24','2020-02-01 18:37:24','',4240,'https://microbiozindia.com/wp-content/uploads/2020/02/WEB001-4.png',0,'attachment','image/png',0),(4247,2,'2020-02-01 18:37:25','2020-02-01 18:37:25','','WEBCBR-1','','inherit','open','closed','','webcbr-1-2','','','2020-02-01 18:37:25','2020-02-01 18:37:25','',4240,'https://microbiozindia.com/wp-content/uploads/2020/02/WEBCBR-1.png',0,'attachment','image/png',0),(4248,2,'2020-02-01 18:43:03','2020-02-01 18:43:03','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the January 2020 edition of the Microbioz India magazine, supported by the cover story entitled <strong>“Smart Laboratory and role in Pharmaceutical Quality Control<em>”</em></strong> covered by editorial of Microbioz India, the cpver story features modern laboratory and focus on Pharmaceutical Quality Control, many aspects of modern life are becoming tied to the digital world. You are using your smartphone to read emails, order taxi, check for directions and order food. But there is a place in this world that remained more or less immune to digitalization – a research laboratory.','Smart Laboratory and role in Pharmaceutical Quality Control','','inherit','closed','closed','','4240-revision-v1','','','2020-02-01 18:43:03','2020-02-01 18:43:03','',4240,'https://microbiozindia.com/uncategorized/4240-revision-v1/',0,'revision','',0),(4249,2,'2020-02-01 18:46:06','2020-02-01 18:46:06','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the January 2020 edition of the Microbioz India magazine, supported by the cover story entitled <strong>“Smart Laboratory and role in Pharmaceutical Quality Control<em>”</em></strong> covered by editorial of Microbioz India, the cpver story features modern laboratory and focus on Pharmaceutical Quality Control, many aspects of modern life are becoming tied to the digital world. You are using your smartphone to read emails, order taxi, check for directions and order food. But there is a place in this world that remained more or less immune to digitalization – a research laboratory.','Smart Laboratory and role in Pharmaceutical Quality Control','','inherit','closed','closed','','4240-revision-v1','','','2020-02-01 18:46:06','2020-02-01 18:46:06','',4240,'https://microbiozindia.com/uncategorized/4240-revision-v1/',0,'revision','',0),(4250,2,'2020-02-01 18:47:19','2020-02-01 18:47:19','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the January 2020 edition of the Microbioz India magazine, supported by the cover story entitled <strong>“Smart Laboratory and role in Pharmaceutical Quality Control<em>”</em></strong> covered by editorial of Microbioz India, the cpver story features modern laboratory and focus on Pharmaceutical Quality Control, many aspects of modern life are becoming tied to the digital world. You are using your smartphone to read emails, order taxi, check for directions and order food. But there is a place in this world that remained more or less immune to digitalization – a research laboratory.','Smart Laboratory and role in Pharmaceutical Quality Control','','inherit','closed','closed','','4240-revision-v1','','','2020-02-01 18:47:19','2020-02-01 18:47:19','',4240,'https://microbiozindia.com/uncategorized/4240-revision-v1/',0,'revision','',0),(4251,2,'2020-02-01 18:49:07','2020-02-01 18:49:07','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the January 2020 edition of the Microbioz India magazine, supported by the cover story entitled <strong>“Smart Laboratory and role in Pharmaceutical Quality Control<em>”</em></strong> covered by editorial of Microbioz India, the cpver story features modern laboratory and focus on Pharmaceutical Quality Control, many aspects of modern life are becoming tied to the digital world. You are using your smartphone to read emails, order taxi, check for directions and order food. But there is a place in this world that remained more or less immune to digitalization – a research laboratory.','Smart Laboratory and role in Pharmaceutical Quality Control','','inherit','closed','closed','','4240-revision-v1','','','2020-02-01 18:49:07','2020-02-01 18:49:07','',4240,'https://microbiozindia.com/uncategorized/4240-revision-v1/',0,'revision','',0),(4252,2,'2020-02-01 18:51:07','2020-02-01 18:51:07','Dear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the January 2020 edition of the Microbioz India magazine, supported by the cover story entitled <strong>“Smart Laboratory and role in Pharmaceutical Quality Control<em>”</em></strong> covered by editorial of Microbioz India, the cpver story features modern laboratory and focus on Pharmaceutical Quality Control, many aspects of modern life are becoming tied to the digital world. You are using your smartphone to read emails, order taxi, check for directions and order food. But there is a place in this world that remained more or less immune to digitalization – a research laboratory.','Smart Laboratory and role in Pharmaceutical Quality Control','','inherit','closed','closed','','4240-revision-v1','','','2020-02-01 18:51:07','2020-02-01 18:51:07','',4240,'https://microbiozindia.com/uncategorized/4240-revision-v1/',0,'revision','',0);
